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Abstract 
 
The purpose of this thesis was to examine the range of prospective memory and 
executive function deficits in ecstasy/polydrug users and the role of these 
processes in accounting for the observed prospective memory performance 
deficits. Using a variety of laboratory and self-report measures of prospective 
memory and a self-report measure of executive function, ecstasy/polydrug users 
were tested in laboratory settings on measures of event and time-based, short and 
long term prospective memory as well as on a wide range of executive function 
components. It was found that ecstasy/polydrug users in relation to non-users 
experience more general prospective memory problems as ecstasy/polydrug-
related deficits were evident on both time and event-based and short and long-
term prospective memory. Ecstasy/polydrug users also demonstrated deficits on 
executive processes suggesting that recreational drug users are impaired in a 
broader range of executive function and ecstasy/polydrug-related deficits are not 
restricted to the three-model component of executive function. It was also found 
that executive dysfunction is associated with poorer time-based prospective 
memory and perhaps some of the drug related prospective memory deficits are 
mediated by drug related executive function impairment. Finally, although few 
prospective memory or executive function performance deficits were evident 
among cannabis-only users a trend was evident in all investigations; 
ecstasy/polydrug users perform the worst, cannabis-only users at intermediate 
levels and drug-naïve perform the best. The most striking finding of the present 
thesis was that the recreational use of cocaine was associated with PM deficits; an 
association that consistently emerged in all studies of PM performance. The 
outcomes of the present thesis provide a fruitful direction for future research. 
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6 
 
ROCF                              Rey-Osterrieth Complex Figure 
ROI                              Regions Of Interest 
SAS                              Supervisory Attentional System 
SERT                              Serotonin Transporter 
SPECT                              Single Photon Emission Computed Tomography 
TBI                              Traumatic Brain Injury  
THP                              Tryptophan Hydroxylase 
TMT-B                              Trail Making Test-B 
TOH                              Tower Of Hanoi 
TOL                              Tower Of London 
TWTE                              Test-Wait-Test-Exit  
VSWM                              Visuospatial Working Memory 
WCST                              Wisconsin Card Sorting Task 
WM                              Working Memory 
WMS-R                              Wechsler Memory Scale-Revised 
WWW                              World Wide Web 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
Contents 
Chapter 1: Thesis overview ............................................................................................... 13 
Chapter 2: Real World Memory and Prospective Memory .............................................. 15 
2.1 Prospective Memory and delayed intentions ......................................................... 17 
2.2 Classification of Prospective Memory ..................................................................... 18 
2.3 Retrieval phase ........................................................................................................ 19 
2.3.1 Time-based Prospective Memory ........................................................................ 19 
2.3.1.1 Theoretical models of time-based Prospective Memory ................................. 23 
2.3.2 Event-based Prospective Memory ....................................................................... 27 
2.3.2.1 Theoretical Models of event-based Prospective Memory ............................... 29 
2.4 Neuroanatomical basis of event-based and time-based Prospective Memory...... 33 
2.5 Chapter summary.................................................................................................... 37 
Chapter 3: Executive Function .......................................................................................... 39 
3.1 What is Executive Function? ................................................................................... 39 
3.2 Theoretical models of Executive Function .............................................................. 40 
3.2.1 Working memory model ...................................................................................... 41 
3.2.2 Miyake et al.’s model of Executive Function ....................................................... 44 
3.3 Assessment of Executive Function .......................................................................... 46 
3.3.1 Laboratory-based measures of Executive Function ............................................. 47 
3.3.2 Self-report measures of Executive Function: The BRIEF-A .................................. 50 
3.4 Biological basis of Executive Function .................................................................... 56 
3.5 The role of executive processes in Prospective Memory ....................................... 59 
3.6 Chapter summary.................................................................................................... 64 
Chapter 4: MDMA neurotoxicity in humans ..................................................................... 65 
4.1 What is MDMA? ...................................................................................................... 65 
4.2 MDMA neurotoxicity in animals ............................................................................. 67 
4.3 MDMA neurotoxicity in humans ............................................................................. 69 
4.3.1 Neuroimaging and neuropsychological evidence ................................................ 71 
4.4 Is MDMA neurotoxic? ............................................................................................. 76 
4.5 Chapter summary.................................................................................................... 77 
Chapter 5: Prospective Memory deficits in ecstasy/polydrug users ................................ 79 
8 
 
5.1 Ecstasy use and memory functioning ..................................................................... 80 
5.2 Prospective Memory deficits in ecstasy/polydrug users: Evidence from self-report 
measures ....................................................................................................................... 81 
5.3 Prospective Memory deficits in ecstasy/polydrug users: Evidence from laboratory 
measures ....................................................................................................................... 90 
5.3.1 ‘Virtual week’ ....................................................................................................... 91 
5.3.2 Rivermead Behavioural Memory Test (RBMT) .................................................... 96 
5.3.3 Cambridge Prospective Memory Test (CAMPROMPT) ........................................ 97 
5.4 Chapter summary.................................................................................................... 99 
Chapter 6: Executive dysfunction in ecstasy/polydrug users ......................................... 102 
6.1 Recreational use of ecstasy and working memory ............................................... 103 
6.1.2 Updating of working memory and access to long term memory ...................... 105 
6.1.3 Visuospatial Working Memory (VSWM) ............................................................ 106 
6.2 Shifting .................................................................................................................. 109 
6.3 Inhibition ............................................................................................................... 113 
6.4 Differential effects of ecstasy, cocaine, and cannabis use on Executive Function116 
6.5 Chapter summary.................................................................................................. 119 
Chapter 7: Everyday and Prospective Memory deficits in ecstasy/polydrug users ........ 121 
7.1 Introduction .......................................................................................................... 122 
7.2 Method ................................................................................................................. 125 
7.3 Results ................................................................................................................... 133 
7.4 Discussion .............................................................................................................. 150 
Chapter 8: Ecstasy/polydrug related deficits on the Cambridge Prospective Memory Test 
(CAMPROMPT) ................................................................................................................ 157 
8.1 Introduction .......................................................................................................... 158 
8.2 Method ................................................................................................................. 162 
8.3 Results ................................................................................................................... 168 
8.4 Discussion .............................................................................................................. 177 
Chapter 9: Self-report measures of executive dysfunction among recreational drug users
 ........................................................................................................................................ 182 
9.1 Introduction .......................................................................................................... 183 
9.2 Method ................................................................................................................. 186 
9.3 Results ................................................................................................................... 189 
9.4 Discussion .............................................................................................................. 197 
9 
 
Chapter 10: The role of executive processes in accounting for Prospective Memory 
deficits in ecstasy/polydrug users ................................................................................... 206 
10.1 Introduction ........................................................................................................ 207 
10.2 Method ............................................................................................................... 211 
10.3 Results ................................................................................................................. 214 
10.4 Discussion............................................................................................................ 225 
Chapter 11: General discussion ...................................................................................... 232 
11.1 Prospective Memory deficits in ecstasy/polydrug users .................................... 232 
11.1.1 Evidence from laboratory measures ................................................................ 234 
11.1.2 Evidence from self-report measures of Real World Memory .......................... 244 
11.1.2.1 Prospective Memory ..................................................................................... 244 
11.1.2.2 Everyday memory ......................................................................................... 245 
11.1.2.3 Cognitive failures .......................................................................................... 245 
11.2 Executive dysfunction in ecstasy/polydrug users ............................................... 246 
11.2.1 Evidence from the BRIEF .................................................................................. 248 
11.3 The role of executive processes in accounting for Prospective Memory deficits in 
ecstasy/polydrug users ............................................................................................... 250 
11.4 The role of Retrospective Memory in Prospective Memory deficits .................. 251 
11.5 Implications of present findings and contribution to the existing literature ..... 251 
11.6 Limitations........................................................................................................... 256 
11.7 Future directions ................................................................................................. 258 
11.8 Overall summary ................................................................................................. 261 
References ...................................................................................................................... 263 
Appendix 1: Participants Overlap Table 
Appendix 2: Drug History Questionnaire 
Appendix 3: Background Information Questionnaires 
Appendix 4: Prospective Memory Questionnaire 
Appendix 5: Prospective Retrospective Memory Questionnaire 
Appendix 6: Everyday Memory Questionnaire 
Appendix 7: Cognitive Failures Questionnaire 
Appendix 8: RBMT Score Sheet 
Appendix 9: Rey’s Auditory Verbal Learning Task Questionnaire 
Appendix 10: Memory Compensation Questionnaire 
Appendix 11: CAMPROMPT Score Sheet 
10 
 
Appendix 12: BRIEF-A 
Appendix 13: Peer Reviewed Publication For Prospective Memory (1) 
Appendix 14: Peer Reviewed Publication For Prospective Memory (2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
List of tables by Chapter 
Chapter 7 
 
Table 7.1. Demographical and background drug use variables for users and 
nonusers……………………………………...…………...……………………134 
 
Table 7.2. Scores on laboratory and self-report measures of real world memory for 
ecstasy/polydrug users and non-ecstasy users…………...……………………136 
 
Table 7.3. Correlations between Real World Memory measures and duration of 
abstinence for the major illicitdrugs………………….………………….….....142 
 
Table 7.4. Correlations between Real World Memory measures and lifetime use 
and frequency of use for the major illicitdrugs………………….………….....144 
 
Table 7.5. Inter-correlations between the laboratory and self-report measures of 
Real World Memory………………………………….…..…...…………….....149 
 
Table 7.6. Inter-correlations between the self-report measures of Real World 
Memory…………….…………………………………...……………….…..…148 
 
Chapter 8 
 
Table 8.1. Age, intelligence, years of education, cigarette and alcohol use by 
group……………………………………………………..…………………….169 
 
Table 8.2. Indicators of illicit drug use….………..………...………………….170 
 
Table 8.3. Outcomes for the Prospective Memory, Executive Functions, and 
memory measures by group……………………………………………………172 
 
Table 8.4. The Relationship between time and event-based Prospective Memory 
and memory functions…………………………………………..……..………174 
 
Table 8.5. The Relationship between time and event-based Prospective Memory 
and indicators of illicit drug use……………………………………….……....176 
 
Chapter 9 
 
Table 9.1. Demographical variables for illicit drug users and nonusers……...190 
 
Table 9.2. Background drug use variables for illicit drug users….…………...192 
 
Table 9.3. Performance on the self-report BRIEF-A measure for ecstasy/polydrug, 
cannabis-only, and nonusers of illicit drugs………..………………………….194 
 
Table 9.4. Simple correlations and semi-partial correlations (from regression) 
between BRIEF subscales and aspects of drug use…………………………….196 
 
12 
 
Chapter 10 
 
Table 10.1. Age, intelligence, years of education, cigarette and alcohol use by 
group……………………………………………………………..…………….214 
 
Table 10.2. Indicators of illicit drug use…..………………………………..…216 
 
Table 10.3. Scores on laboratory measures of Prospective Memory for 
ecstasy/polydrug, cannabis only and drug naïve……………………………...218 
 
Table 10.4. Simple and partial correlations between aspects of drug use and 
Prospective Memory measures………………………………………………..220 
 
Table 10.5. Simple and semi-partial correlations for Executive Function and 
Prospective Memory measures in ecstasy/polydrug and cannabis only users..222 
 
Table 10.6. Correlations between individual components of Executive Functions 
and Prospective Memory measures……………………………………………224 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
 
Chapter 1: Thesis Overview 
 
The aim of this thesis is to provide an insight into the impact of ecstasy/polydrug 
use on aspects of cognition such as Prospective Memory and Executive 
Functioning that are involved in our everyday activities and play a crucial role in 
our day-to-day functioning.  In Chapter 2 the psychological processes that 
underline remembering to perform an intended action are discussed. A concise 
account of the classification of prospective memory, the major theoretical models 
and the neuroanatomical basis of prospective memory is provided.  Chapter 3 
evaluates the multidimentional construct of executive processes by exploring the 
most established executive function models and their biological underpinnings.  
 
Chapter 4 explores the effect of Ecstasy (MDMA) on the brain and its biological 
underpinnings in both animal and human studies. Chapter 5 provides a concise 
account of prospective memory deficits in recreational users of ecstasy throughout 
the literature. It also discusses the different experimental approaches adopted to 
investigate the effect of ecstasy use on this important aspect of day-to-day 
memory functioning. Chapter 6 explores the plethora of studies investigating the 
effect of recreational drug use on the three major components of executive 
function, updating, shifting and inhibition. It therefore summarises most important 
findings in this area in order to establish a coherent understanding of the ecstasy-
related effect on different components of executive function.  
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Chapters 7, 8, 9 and 10 are the empirical chapters of this thesis that investigate 
prospective memory and executive processes in ecstasy/polydrug users. Chapter 7 
investigates the impact of ecstasy/polydrug use on real world memory i.e., 
everyday memory, cognitive failures and prospective memory adopting both 
laboratory-based and self-report measures of prospective memory. In chapter 8 the 
range of laboratory measures of prospective memory is augmented by the use of 
the CAMPROMPT test battery in order to investigate the impact of illicit drug use 
on event and time-based prospective memory in a sample of cannabis only, 
ecstasy/polydrug and drug naïve controls. Measures of retrospective memory and 
learning are also administered in this chapter. Chapter 9 investigates the impact of 
recreational use of ecstasy on executive processes using a self-report measure of 
executive function; the Behavioural Regulation Index of Executive Function- 
Adult Version (BRIEF-A). In chapter 10 both prospective memory and executive 
function measures are adopted in order to investigate the role of executive 
processes in accounting for prospective memory deficits observed in 
ecstasy/polydrug users.  
 
The final chapter is the general discussion of the findings from all four empirical 
chapters. Consequently, Chapter 11 discusses the findings of this thesis in terms 
of their implications for recreational drug users, identifies possible limitations and 
provides directions for future research.  
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Chapter 2: Real World Memory 
and Prospective Memory 
 
Chapter Overview 
 
The purpose of this chapter is to explore the distinct form of memory known as 
prospective memory and evaluate its impact on everyday functioning. Although 
the concept of prospective memory has been investigated extensively for the past 
30 years, it still remains somehow elusive. Different definitional approaches have 
been discussed in the literature debating the role of retrospective memory in 
prospective remembering and the importance of non-cognitive components (such 
as motivation, reward or conflicting goals) in the successful completion of 
prospective memory tasks (Einstein & McDaniel, 1996). The different approaches 
and theoretical models are therefore discussed in this chapter. 
 
When people complain about how poor their memory is, they don’t usually refer 
to the intricacies in remembering the title of a film they watched days ago or 
remembering a newspaper article. They usually refer to their everyday cognitive 
lapses and the failure to recognise acquaintances, forget important events that 
occurred the previous day, forget the location of familiar objects around the house 
or forget to take essential objects when leaving the home or office and so on. 
These aspects of memory lapses fall under the term real world memory and refer 
to everyday memory (Sunderland et al., 1983) and cognitive failures (Broadbent 
et al., 1982). An additional aspect of the term real world memory involves the 
16 
 
ability to remember to attend a meeting, pass on a message or perform everyday 
intended actions such as remembering to buy milk from the store; an aspect that 
has been coined as Prospective memory (PM). According to Brandimonte, 
Einstein and McDaniel (1996) PM refers to the ability to perform activities in the 
future or simply to “remember to remember”. The focus of memory research was 
traditionally on the recollection of past events and information or retrospective 
memory (RM). One of the most important reasons as to why PM has gained 
increased attention in recent years (Crawford et al., 2003; Kliegel et al., 2000; 
2001; 2005; Marsh & Hicks, 1998) is the extent to which PM lapses can interfere 
with an individual’s everyday functioning. For example, forgetting to buy milk 
from the store on your way home or forgetting to pick up your dry-cleaning seems 
inconsequential. Forgetting to take your medication, miss important appointments 
or interviews, however, can have serious consequences.  
 
Loftus in 1971 was the first researcher to focus on PM. Subsequent research in 
this new memory field was very slow due to the fact that only a few researchers 
were interested in this aspect of memory. A milestone for PM was the publication 
of the first book on the topic in 1996 by Brandimonte, Einstein and McDaniel 
which although focusing on only the main developments in the area, identified 
important aspects for future research. From then on, PM has generated 
considerable interest and has become an important research focus for some 
researchers (McDaniel & Einstein, 2000; Einstein & McDaniel, 2005) 
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2.1 Prospective Memory and delayed intentions 
 
According to the literature, PM is the ability to perform activities in the future 
(Brandimonte, Einstein & McDaniel, 1996; Kliegel et al., 2001; Kliegel et al., 
2005) and represents a form of explicit episodic memory that involves the 
completion of intentions that cannot be realized when initially formed (Ellis, 
1996). The ability to retain, recall and realise intentions is an important aspect in 
everyday memory failures, more specifically in PM (Eldridge, Sellen and 
Bekeian, 1991; Terry, 1988). Evidence from diary studies suggests that nearly half 
(West, 1984) or even up to 70% (Terry, 1988) of memory failures in the real 
world context involve the forgetting of intentions rather than the forgetting of 
information. Consequently, in order to capture the multidimentional concept of 
PM, understanding the role of delayed intentions is essential. According to 
Kvavilashvili and Ellis (1996), delayed intentions are the ones that must be 
retained and recalled at another moment in the future. 
 
Ellis (1996) distinguishes five phases that are involved in the realization of a 
delayed intention; Formation and encoding of intention and action (associated 
with the retention of an action i.e., what you want to do, an intent i.e., the decision 
to do something and the retrieval context describing the criteria for recall i.e., 
when the intention and action should be retrieved), Retention Interval (refers to 
the delay between encoding and the initiation of a potential performance interval), 
Performance Interval (refers to the performance interval or period when the 
intended action should be retrieved), Initiation and Execution of Intended Action 
and Evaluation of Outcome.  
18 
 
Ellis (1996) also suggested that for the realization of a delayed intention both 
prospective and retrospective components are important and that the first phase of 
the model (formation and encoding of intention and action) forms the 
retrospective component of the intention and the remaining phases the prospective 
component. In relation to this, Crawford et al., (2003) argued that PM is 
concerned with the timing of when things are to be remembered as opposed to 
RM that is concerned with what should be remembered, and although PM is 
distinct but not entirely independent of RM, both memory processes are essential 
to carry out a successful PM task. This chapter, however, will be concentrating on 
the PM component and its distinct variations.  
 
2.2 Classification of Prospective Memory  
 
As a cognitive construct, PM is more rigorously defined than the typical 
characterization “remembering to do something in the future” (Marsh & Hicks, 
1998). Hereby, in order to capture the many cognitive variables that affect 
prospective remembering different classes of PM tasks have been proposed 
through the literature. For example, Kvavilashvili and Ellis (1996) classified PM 
tasks according to variations in (a) the encoding phase (i.e., importance or 
pleasantness of task), (b) the retrieval phase (i.e., event- vs time- based tasks), (c) 
the storage/retention phase (i.e., short- vs long- term delay) and (d) the 
performance phase (i.e., short or long). Other suggested classes of PM tasks also 
refer to the complexity of the PM activity (Einstein et al., 1992) and whether the 
task is habitually or infrequently performed (Harris, 1980). Other important 
variables affecting prospective remembering include the retrieval context and the 
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strategies people adopt for remembering (Harris, 1980). Regardless of the 
importance of these variables the most widely investigated aspect of PM tasks has 
been the retrieval phase; the focus of the present thesis. 
 
2.3 Retrieval phase 
 
Einstein and McDaniel (1990), proposed that the retrieval phase of PM can be 
divided into two main classes; time-based PM and event-based PM. Retrieval 
phase is probably the most researched and debatable phase of prospective 
remembering and involves the way in which delayed intentions are realized i.e., 
cued by the monitoring of time or cued by external environmental factors; hence 
the concept of both time-based tasks and event-based tasks.  
 
2.3.1 Time-based Prospective Memory 
 
The term time-based PM is given for the type of retrieval of a delayed intention, 
that requires time monitoring i.e., an intention to be performed at a particular time 
or after a specific amount of time has passed (McDaniel & Einstein, 2000). The 
best known experiment on time-based PM is the study by Ceci and 
Bronfenbrenner in 1985 that explored the development of time-based PM in 10 
and 14 year old children. In their study, children had to remove cupcakes from the 
oven after a delay of 30 minutes while they were engaged in a popular video game 
in a room with a clock for time monitoring. Children had to carry out the task 
either in a familiar context (their home) or in a laboratory. The authors found that, 
overall, children checked the clock more often in the laboratory setting and that 
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the task success was higher in the laboratory than in their familiar context. 
However, according to the authors, the number of clock checks cannot predict 
task success as younger children in the familiar context checked the clock more 
often than older children but success rate was higher in older children. Instead it 
was the effective and strategic allocation towards the end of the baking period that 
lead toward the successful completion of the task. Therefore, those children with 
better PM performance tended to intensify their time monitoring activities more 
towards the end of the baking period. Consequently, this investigation suggests 
age-related changes in the development of time-based PM and that strategic clock 
checking is adaptive and increases PM task success rate. 
 
 Craik (1986) went on to suggest that retrieval performance depends on self-
initiated or attention demanding processes as opposed to being dependent on 
environmentally cued automatic processes. Given that the attentional resources 
essential for processing task relevant information decline with age (Hasher 
&Zack, 1979), Craik predicted that age-related changes in performance will be 
larger on PM tasks than on other types of memory processes. Einstein and 
McDaniel (1990;1996), however, argued that relative to event-based PM, time-
based PM performance is more dependent on self-initiated resource demanding 
processes and therefore that age-related performance would be more pronounced 
in time-based PM rather than event-based. Although their view was supported by 
the outcome of some studies (Einstein et al., 1995; Park et al., 1997) a number of 
other investigations have shown that older adults perform better than younger 
adults on time-based tasks given that assessment occurs in the context of their 
everyday life (Martin, 1986; Maylor, 1990; Rendell & Craik, 2000; West, 1988).  
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By way of contrast, Birt (2001), in a meta-analysis showed larger age effects on 
time-based task than on event-based tasks. It is difficult to draw definitive 
conclusions from these studies as the literature is somewhat contradictory as to 
whether age-related differences are more common in event- or time-based tasks.  
 
Context importance 
 
Confusion in the literature might be attributed to the fact that the context in which 
memory performance is assessed is largely ignored. Hereby, in Birt’s meta-
analysis, it was found that the age effect is larger for time-based rather than event-
based tasks; a result that is consistent with Einstein and McDaniel’s (1990) 
prediction. In relation to this, studies on aging have shown that time-based PM 
performance is affected because self-initiated processing is impaired in older 
adults whereas event-based task performance is not affected (Einstein et al., 1995; 
Katai et al., 2003; Kliegel et al., 2001; Khan et al., 2007). Another interesting 
finding from Birt’s meta-analysis was that naturalistic studies (i.e., in the context 
of a familiar setting and everyday life) showed a reverse age effect suggesting that 
older adults are more successful than young adults on time-based tasks when 
those tasks are performed in the context of their everyday life.  
 
In order to understand the importance of the context in which memory 
performance is assessed, Einstein and McDaniel (1990;1996) have pioneered two 
computer based paradigms (one event-based and one time-based) to mimic real-
life prospective remembering when people are busily engaged in other activities. 
Accordingly, in their time-based laboratory paradigm participants monitor a clock 
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and respond at fixed intervals while completing an attention demanding task. 
Much of the literature in this area uses these paradigms to assess time-based and 
event-based prospective remembering in a laboratory environment. 
 
Task importance 
 
Another factor affecting the performance of PM, in particular time-based PM, is 
the perceived importance of the delayed intention. Some studies suggest that the 
importance of the task can affect performance and therefore the successful 
completion of the delayed intention (Ellis, 1988; Kvavilashivili, 1987; Meacham 
& Singer, 1977; Kliegel et al, 2001). Diary studies have reported that successful 
remembering was higher for important appointments (Andrzejewski et al., 1991) 
and that there was a positive relationship between recollection of the intention and 
the perceived importance of the intention (Ellis,1988). Meacham and Singer 
(1977) also suggested that high-incentive is predictive of better performance. 
Participants who were given a monetary incentive to return four prepaid postcards 
on specified dates performed better than participants with no incentive. Similarly, 
Kvavilashvili (1987) demonstrated a significant positive effect of task importance 
on PM performance. As a way of contrast, Goschke and Kuhl (1993) reported that 
subjective importance of delayed intentions had no effect on their recall. Kliegel 
et al. (2000), in a series of experiments labelled a time-based PM task as 
important as opposed to a cover task. Their findings suggested that the importance 
of the task leads to a selective increase of attention allocation towards the PM 
task, particularly during the last period before the completion of the task. They 
also suggested that the accuracy of prospective remembering can be influenced by 
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affecting attention allocation at specific phases of the process when the 
importance of the task is manipulated. 
 
 In relation to this, Kliegel et al. (2001), in a second experiment investigated the 
assumption that event-based PM is an automatic process and does not rely on 
attentional resources. It was found that PM performance was unaffected even with 
an addition of a task that increased overall demands of the ongoing activities. In 
addition to this they found that at least some event-based PM tasks are mediated 
by relatively automatic processes and require very little attention for successful 
performance. In terms of task importance, the authors found that importance has 
an effect on the time-based but not event-based PM tasks. Furthermore, the 
importance of the task improved PM to the degree the task requires the strategic 
allocation of attentional resources.  
 
2.3.1.1 Theoretical models of time-based prospective memory 
 
According to Coren and Ward (1989), attentional resources support the process of 
monitoring. Humans have a limited attentional capacity so higher cognitive load 
can negatively affect monitoring of time in time-based tasks. To investigate this 
assumption, Khan, Sharma and Dixit (2008) explored the relationship between 
cognitive load and event- and time-based PM. They found that performance 
deteriorated in both PM tasks as the cognitive load increased. Nevertheless, 
performance under an event-based task showed less error compared to the time-
based task suggesting that monitoring is more crucial for time-based PM.  
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Although it is clear that retrieval in time-based PM is fundamentally different 
from that in event-based (Einstein & McDaniel 1996), there are only a few 
empirical studies that examined the nature of retrieval in time-based tasks (Ceci 
&Bronfenbrenner, 1985; Cicogna et al., 2005; Cook et al., 2005; Einstein et al., 
1995; Park et al., 1997; Redell & Craik, 2000). One finding that emerged from the 
existing literature involves the participant’s time monitoring behaviour prior to the 
critical time to remember. More specifically, it has been suggested that the 
frequency of rehearsal in a time-based task is positively correlated with PM 
performance (Harris & Wilkins, 1982; Einstein et al., 1995; Park et al., 1997). 
Prior to the emphasis on attentional resources, in order to explain these findings 
an early theoretical account was offered by Harris and Wilkins (1982): the Test-
Wait-Test-Exit (TWTE) model of time-based PM.  
 
This model proposes that people encode a future task and then wait until the time 
is appropriate to carry out the intended task. For example, a person needs to ‘test 
and wait’ until the time is appropriate to take the cookies out of the oven before 
they burn. When the action is carried out, then the ‘test and wait’ cycle is stopped 
(‘exit’). Consequently, successful performance is dependent on monitoring the 
time during the critical period.  This contrast with the more recent perspectives on 
time-based PM, as described in later studies (Einstein et al., 1995; Park et al., 
1997) in which the time monitoring aspect is a self-initiated process that requires 
attentional resources.  
 
Despite the insights provided by these two models the main question remains: 
What is the nature of these self-initiated processes? Harris and Wilkins suggested 
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that the intention spontaneously pops into a person’s mind or is triggered by some 
incidental cues in the environment. An experiment, where time references in a 
film made participants aware of their PM tasks, supports another theoretical 
model of time-based prospective memory proposed by Wilkins and Baddeley 
(1978), the “random walk” model. This model underlines the significance of 
incidental external or internal cues in remembering intentions. In contrast to this 
model Wilkins and Baddeley proposed that our mind is a multidimentional 
semantic space and a trace is formed in this space when an intention is 
formulated. Our thoughts, however, do not remain in this space throughout the 
delayed interval; instead they move in various parts of this area randomly and 
depend on the stimuli we come across in the environment and the activities that 
we are engaged in. If near the time of the execution of the intention, those 
thoughts accidentally wander around the trace of the intention then it is likely that 
we realise that we should carry out an intention, thus successfully carrying out the 
PM task. This model does not therefore regard the retrieval of the intention as a 
self-initiated process. Instead, it proposes that the timely remembering of 
intentions depends entirely on incidental factors.  
 
In order to investigate which of the two models is correct and therefore determine 
what brings a time-based PM task into our minds during the retention interval, 
Kvavilashvili and Fisher (2007) conducted a series of three studies. The authors 
first investigated self-report rehearsal processes in naturalistic time-based PM 
tasks and compared them with event-based PM tasks. The participants were 
expected to phone the experimenter at a prearranged time (time-based) or after a 
text message (event-based). Participants also recorded the details of occasions 
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when they thought about the intention during a seven day delay interval (long 
delay interval). It was found that the intention is either triggered by incidental 
cues or periodically pops into one’s mind for no apparent reason. This opposes 
previous literature and suggests that rehearsal and retrieval of time-based PM 
could be a more automatic process than previously thought.  
 
Kvavilashvili and Fisher (2007) also emphasized the importance of the 
storage/retention phase in the successful completion of a time-based PM task. 
They suggested that the process of retrieval (i.e., automatic/self-initiated) can 
depend on storage/retention phase. For example, most laboratory studies have 
used short time delays (Sellen et al., 1997), so participants are likely to keep the 
task in mind for the entire delay period. Therefore retrieval processes in short-
term laboratory tasks can be regarded as self-initiated and deliberated. On the 
other hand, remembering time-based PM tasks in everyday life with long delay 
intervals cannot occur in the same way, as people are engaged in more activities 
during the delay period. In addition, self-initiated rehearsals, occurring when 
people are engaged in planning their daily activities, were reported in few cases 
regardless of age, and were lower than rehearsals triggered by incidental cues. 
These results suggest that a great variety of cues, such as internal or external 
incidental cues or cues completely unrelated to the intention, can act as triggers 
and promote successful prospective remembering.  
 
These findings are therefore more in line to Harris and Wilkins (1982) model of 
TWTE. Kvavilashvili and Fisher (2007) also suggest that retrieval of event- and 
time-based PM is not mediated by fundamentally different processes and that 
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thoughts about the task/intention occur via three different routes in both event-
based and time-based PM: i.e., by rehearsal prompted by incidental external or 
internal cues, by self-initiated planning thoughts or by no apparent triggers. This 
suggests that the difference between event- and time-based PM is more 
quantitative than qualitative since representations of event-based tasks have low 
level of activation that is sufficient to trigger remembering with the occurrence of 
a target and/or event in the environment. On the contrary, the activation levels in 
time-based tasks may be greater and fluctuate over time leading in periodic 
conscious thoughts about the task.   
 
2.3.2 Event-based Prospective Memory 
 
Beyond the context of time-based PM, event-based PM has been studied 
extensively in its own right. The term event-based PM tasks refers to the situation 
where the intended action is performed at the occurrence of an external or 
environmental cue or event (Einstein & McDaniel, 1990). The authors in their 
laboratory paradigm of event-based PM, tried to mimic real life event cued 
prospective remembering by giving their participants one or two words to 
remember and instructing them to press a key whenever the target words appeared 
while they were busily involved in an ongoing task. Although the laboratory 
paradigms of event-based and time-based PM are very useful in assessing PM 
under laboratory condition in a naturalistic manner, they do not completely 
capture more complex PM situations in which several delayed actions are planned 
to be executed (Kliegel et al., 2000).  
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In relation to this Ellis (1996) suggested that the more complex situations are 
likely to include planning processes such as forming a daily plan of activity. 
Laboratory tasks, however, do not involve such planning. In an attempt to 
investigate the potential role of the complexity of processes involved in many PM 
activities such as developing a plan, remembering the plan and remembering to 
execute the plan sometime in the future, Kliegel, McDaniel, and Einstein (2000), 
used a six element laboratory task based on a paradigm by Shallice and Burgess 
(1991). In this experiment participants had to work within constraints on six 
subtasks to maximise their total points. This paradigm required the participants to 
engage with a range of processes that included making a plan, retaining the 
intended plan and executing a series of multiple intentions. The PM component of 
this task was that participants had to initiate the six subtasks on their own at a 
specific point during the test.  It was found that the planning and executing of PM 
tasks have to be distinguished, since formulating a plan did not overlap 
substantially with the manner in which PM tasks were executed.  
 
The involvement of Retrospective Memory (RM) in the execution of PM tasks 
needs to be addressed when performing a PM task as the literature suggests that 
both the prospective elements and RM are crucial for successful prospective 
remembering (Crawford et al., 2005). Kvavilashvili (1987) found that 
remembering an intention at an appropriate moment and remembering content or 
facts acquired in the past might be considered as two separate forms of memory, 
suggesting that RM and PM are somehow different. 
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Retrieval context and attentional resources in event-based Prospective Memory 
 
According to the literature, the retrieval context plays a key role in prospective 
remembering. McDaniel and Einstein (1992) argue that distinctive cue words, as 
opposed to background words, can increase PM performance. For example, more 
specific cues such as the word “tiger” can trigger better performance than more 
general cues such as “animal”, given that the cue is relevant to the task (Einstein 
et al., 1995). An important question when investigating cues is whether noticing a 
cue is an automatic response or whether conscious attentional resources are 
essential (Marsh & Hicks, 1998). These possibilities have been associated with a 
lot of conflicting evidence throughout the literature and two theories have been 
developed to explain this type of PM retrieval. The first theory assumes that 
attentional and/or working memory resources need to be allocated to monitoring 
the environment for the occurrence of the target event (Smith, 2003). 
Consequently, in order to successfully retrieve an intention, strategic, resource-
demanding processes must be employed before the occurrence of the target event. 
The second theory supports a multiprocess model of PM retrieval that involves 
several processes (McDaniel & Einstein, 2000). The different approaches to 
understand the processes involved in event-based PM are discussed below.    
 
2.3.2.1 Theoretical Models of event-based PM 
 
Similarly to time-based PM, a number of theoretical models have been proposed 
to understand the underlying mechanisms that lead to successful event-based 
retrieval. According to Guynn (2003), in laboratory PM tasks, the monitoring 
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process involves a recognition check to evaluate whether the cue presented is the 
correct one for performing the intended action. If the recognition check indicates 
that the cue represents a target event then the intended action is executed. Failure 
to carry out the intention is therefore, due to the person’s failure to initiate a 
recognition check (in other words failure to monitor) or due to the failure of the 
recognition check to identify the event as a target. This theory is therefore based 
on two main assumptions; that monitoring processes require capacity demanding 
attentional processes and that monitoring processes are essential for prospective 
remembering to occur. If this is the case then the resource demanding processes 
required for PM will reduce the attentional resources available for performing 
ongoing activity and consequently lower the performance success of the ongoing 
task. This assumption is supported by a number of studies (Cohen et al., 2008; 
Einstein et al., 2005; Marsh et al., 2003; Smith, 2003). A specific mechanism 
proposed to support monitoring is the supervisory attentional system (SAS; 
Shallice & Burgess, 1991) which monitors for a cue signalling the appropriateness 
of executing the intended action. When a cue is detected the SAS switches 
attention to the intended action. This suggests that the realisation of an intended 
action is an attentional process supported by executive attentional systems and not 
memory processes per se. 
 
By way of contrast, McDaniel and Einstein (2000) proposed a different 
multiprocess theory suggesting that because of the PM demands in everyday life it 
is adaptive to have a cognitive system to aid PM retrieval through several 
processes. So, in addition to the resource demanding processes such as 
monitoring, prospective remembering can sometimes be spontaneously elicited by 
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features of the target cue even without resources dedicated to the intention. 
McDaniel and Einstein (2004) maintain that this spontaneous retrieval in event-
based PM can involve a number of processes such as the reflexive-associative 
hypothesis, in which the cue is strongly associated with the intention during 
planning and the intention is performed reflexively.  
 
In relation to this, Guynn, McDaniel and Einstein (2001) proposed an alternative 
to conscious cue-focused account based on a memory model proposed by 
Moscovitch (1994); an “automatic-associative” memory system that consciously 
attends to external cues which in turn interact with memory traces previously 
associated with those cues. If there is enough interaction between the external cue 
and a memory trace then the system delivers awareness of the information 
associated with the cue, thus mediating PM retrieval. As opposed to cue focus 
theory, the target event is not necessarily recognised as a cue; it simply stimulates 
a reflexive associative process bringing the intended action into awareness. The 
entire pattern implicates both cue-focused and reflexive associative process and 
more generally supports a multidimensional framework of PM (McDaniel and 
Einstein, 2000). 
 
As previously discussed, some researchers argue that PM declines with age and a 
number of experiments using event-based PM to appear support this assertion (see 
review Henry et al., 2004). However, other studies report no age differences in 
event-based PM (Einstein and McDaniel, 1990). In an attempt to understand this 
anomalous pattern, Einstein and McDaniel (2005) used the multiprocess point of 
view and suggested that age differences depend on whether the PM task uses focal 
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or non-focal target events. According to Einstein and McDaniel (2005) a focal PM 
cue is the one that stimulates the spontaneous retrieval of an intention without the 
need to employ strategic monitoring processes. With non-focal targets attention-
demanding processes (i.e., monitoring) are essential for prospective remembering 
and according to Craik (1986) these resources decline with age. Conversely, focal 
targets require spontaneous retrieval which is assumed to stay relatively intact 
with age. To support this assumption, Rendell and Craik (2000) found minimal 
age-related declines in event-based PM when the event was focal. In contrast, 
when the event was non-focal the age differences were more pronounced.  
 
According to McDaniel, Guynn, Einsten and Breneiser (2004), spontaneous 
retrieval, as opposed to monitoring, can occur even when no resources are devoted 
to monitoring for the target during or prior to the occurrence of the target. To 
support this, Einstein et al.’s (1995) results from a study comparing performance 
on event-based PM tasks between older and younger adults suggest a large 
automatic component to event-based PM. Marsh and Hicks (1998) suggested that 
these mixed findings can be explained by the character of the demands that the 
tasks place on working memory and that poorer event-based PM performance 
depends on an attention demanding component and therefore might be correlated 
with measures of central executive functioning.  
 
To support this view, the notice-search model (Kliegel et al., 2001; Logie et al., 
2004) has also been proposed. This model suggests that for successful PM, 
familiarity and probe search are required. When people encounter the PM cue they 
get a sense of familiarity (noticing) which may then prompt a more conscious 
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probe of memory (search) to determine what the cue means. Therefore, there are 
two stages in a successful event-based PM task: the stage of noticing or a feeling 
of familiarity and the search stage. Burgess (2000b) suggested that PM task 
completion requires many of the skills that are commonly described as executive 
processes. Successful completion of intentions rely on the operation of a number 
of different cognitive processes including attention, action control and memory 
(Dobbs & Reeves, 1996; Ellis, 1996). In particular the literature on PM addresses 
an important debate on the attentional or strategic demands of PM task retrieval 
evaluating the notice-search (strategic component) and automatic activation 
models. According to West and Craik (1999) older adults are more prone to lapses 
of intention and are believed to suffer from attentional or executive deficits. These 
failures are associated with changes in neural activity in a region thought to be 
responsible for the implementation of cognitive control. It is therefore reasonable 
in order to further understand the underlying mechanisms of PM to look at 
changes in neural activities during the realisation of PM tasks. 
 
2.4 Neuroanatomical basis of event-based and time-based PM 
 
Many investigations of PM implicate the role of the frontal lobes, more 
specifically the involvement of the prefrontal cortex (PFC), in the realisation of 
delayed intentions. Processes in both event- and time-based PM can be linked 
with frontal lobe activity. This evidence is coming from patients with frontal lobe 
dysfunction (Fuster, 1997) and age-related literature (McFarland & Glisky, 2009). 
Although the literature has been somehow elusive as to whether age is responsible 
for greater decline in time-based or event-based PM, a vast body of research 
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agrees that younger adults perform better than older adults in PM tasks that 
require self-initiated processing; i.e., time-based PM tasks (Einstein et al., 1995; 
Einstein et al., 1997; Maylor, 1996; McDaniel et al., 2004; Park et al., 1997).  
Time-based PM tasks, although requiring many of the same processes of event-
based PM, have greater monitoring demands and are more likely to be entirely 
self-initiated (Craik, 1986; Einstein and McDaniel, 1990; 1996).  
 
As discussed previously, time-based PM tasks require the formation of an 
association between cue and intention, the maintenance of this intention over a 
delayed period, the division of attention between tasks, monitoring the 
environment for a cue and the interruption and inhibition of ongoing activities. 
Fuster (1997) showed that these operations are impaired in frontal lobe patients; 
thus implicating the role of the frontal lobe in time-based PM tasks. Age-related 
declines in frontal lobe functions have also been showed by West (1996). Support 
for age-related declines comes from a range of studies. For example, 
morphological evidence shows disproportional volume loss in the PFC in relation 
to other brain areas in older adults (Raz et al., 2005).   
 
Neuroimaging studies also suggest that the anterior PFC and more specifically 
Broadmann’s area10 (BA10) is likely to be of central importance to PM (Okuda et 
al., 1998; Burgess et al., 2001,2003; Simons et al., 2006). In particular, Okuda et 
al. (1998) employing Positron Emission Tomography (PET) examined the 
functional neuroanatomy of PM by examining changes in regional cerebral blood 
flow (rCBF). They found increased activity in the left frontal pole, the 
ventrolateral PFC (BA 8/9/47) and anterior cingulate (BA24) during a PM task. 
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Burgess, Quayle and Frith (2001) also found increased activation in BA10 
(bilaterally) across several cognitive tasks. In their study activation during an 
ongoing task was compared to activation in two PM conditions (i.e., cue 
identification and intention retrieval). Increased activation relative to a control 
task in bilateral frontal pole, right lateral, prefrontal and parietal cortex was 
observed. The same authors in a later study (2003) extended their previous 
findings by showing that this bilateral activation of lateral BA10 that is associated 
with retrieving a delayed intention was accompanied by a deactivation in medial 
BA10. In relation to this, an activation was observed in lateral BA10, lateral 
parietal cortex and precuneus. Den Ouden et al. (2005) found that these increased 
activations were associated with holding an intention during an ongoing task.  
 
Furthermore, Simons, Scholvinck, Gilbert, Frith and Burgess (2006) measured 
brain activity (using functional magnetic resonance imaging [fMRI], and a 
combination of two different PM tasks: words and shapes) while manipulating the 
demands on either recognizing the appropriate context to act (cue identification) 
or remembering the action to be performed (intention retrieval). A consistent 
pattern of hemodynamic changes was found in both PM conditions in anterior 
prefrontal cortex (BA10), with lateral BA10 activation accompanied by medial 
BA10 deactivation. These effects were more pronounced when demands on 
intention retrieval were high. This is consistent with the hypothesis that anterior 
prefrontal cortex (area 10) supports the biasing of attention between external 
events (e.g., identifying the cue amongst distracting stimuli) and internal thought 
processes (i.e., maintaining the intention and remembering the intended actions). 
These results suggest that whilst cue identification and intention retrieval may be 
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behaviourally separable, they share at least some common neural basis in anterior 
prefrontal cortex. PM related activation was also evident in areas outside anterior 
PFC region such as lateral PFC and parietal cortex. The anterior cingulate cortex 
was also activated to a greater extent in a cue identification PM task and the 
posterior cingulate and precuneus showed greater activation in the intention 
retrieval task (Simon et al 2006; Okuda et al 1998; Burgess et al 2001). 
 
Further evidence for the involvement of the PFC in PM comes from Okuda et al 
(2002) who looked at PET activation during a time-based PM task. Participants 
had to clasp their hands either at a time point (time-based) or after a cue (event-
based) while performing a mental arithmetic task. Both conditions increased rCBF 
in frontal and medial temporal regions. The authors however did not compare 
brain activity between the two tasks or examine decreases in rCBF thus it was 
unclear if the two tasks made differential demands upon rostral prefrontal brain 
activity consistent with the age-related literature. Reanalysing Okuda’s et al’s 
2002 data Okuda et al., (2007) observed significant rCBF increases in the left 
superior frontal gyrus (including lateral BA10) for the time-based PM relative to 
the event-based task. Deactivations within rostral PFC were evident in the medial 
BA10 as rCBF decreased during the event-based PM task in comparison to the 
ongoing activity alone. The authors also found that the decrease in medial BA10 
during time-based PM was not as significant as in the event-based PM suggesting 
that deactivation in medial BA10 during PM task are specific to event-based PM. 
Okuda et al. (2007) also found that during time-based PM the right superior 
frontal gyrus, anterior medial frontal lobe and anterior cingulate gyrus were more 
active and that the left superior frontal gyrus was more active in the event-based 
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condition. The results suggest the involvement of multiple brain regions of rostral 
prefrontal cortex in both time- and event-based PM.  
 
To conclude, there is growing evidence that the frontal lobes and more 
specifically the PFC are not the only brain regions that are involved in the 
realisation of delayed intentions. Regions such as the right dorsolateral and 
ventrolateral prefrontal cortices, the left frontal pole and medial frontal regions 
and the left parahippocampal region (Okuda et al., 1998) provide the 
neuroanatomical basis for PM. 
 
2.5 Chapter summary 
 
The literature on PM has yet to reach a consensus and there are many theoretical 
models that have been proposed to identify the underlying mechanisms through 
which intentions in either time-based or event-based actions are retrieved and the 
factors affecting this retrieval. What is undisputable is the important role of PM in 
our everyday environment and the need for more investigation in the area. All in 
all, having discussed the most established theoretical models of both event- and 
time-based PM and the role of the frontal lobes in the execution of PM tasks, it 
can be tentatively concluded that time-based PM tasks are reliant on self-initiated 
processes whereas event-based tasks are considered to be dependent on more 
automatic processes. On the whole, the research literature has suggested that 
executive processes such as planning, monitoring or attention are essential for PM 
performance. It is therefore reasonable to assume that there is an association 
between executive processes and prospective remembering.  
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This assumption can be supported by evidence suggesting that PM processes such 
as dividing attention, monitoring the environment for a cue, associating a cue for 
intention and interrupting an ongoing activity may also involve planning which is 
thought to depend on the frontal lobes (Lezak 1982; Shallice, 1982). PM as it has 
been previously discussed depends on self-initiated and attention demanding 
resources and therefore PM performance can be correlated with measures of 
central executive functioning (Marsh and Hicks, 1998). In relation to this, Martin, 
Kliegel and McDaniel (2003) found that executive processes in older adults were 
significantly correlated with performance on three PM tasks. To support this view, 
additional studies have implicated the role of executive processes in PM 
performance (Kliegel et al., 2000; Kliegel et al., 2008).  
 
More direct evidence of the involvement of executive processes in PM comes 
from neuroimaging studies that suggest regions of the frontal lobe (such as rostral 
prefrontal cortex) are involved in supporting both event-based and time-based PM 
tasks (Burgess et al., 2003; Martin et al., 2003; Okuda et al., 2007; Simons et al., 
2006). According to Okuda et al. (2007) these regions are involved in the 
attentional and executive control aspects of PM functions. Having said that, it will 
be sensible to evaluate the term executive function and, essentially, its 
involvement to prospective memory processes. Consequently, the next chapter 
will look in depth the central executive system and the possible involvement of it 
in PM performance. 
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Chapter 3: Executive Function  
 
Chapter overview  
 
Over the last few decades the term executive function has received increased 
attention. Early models of executive function were restricted to cognitive abilities 
using a unitary framework while specific components of executive function were 
not identified and the biological basis of this term was limited to frontal lobes. 
Nowadays, executive functions are known to represent a rather complex, 
interrelated set of cognitive abilities critical for adaptive function. Despite the 
plethora of research and speculation concerning executive functioning the term 
itself and the conceptualization of it still remains somewhat elusive. The purpose 
of this chapter is to provide an up to date perspective of executive processes by 
exploring the most established executive function models and their biological 
underpinnings. 
 
 
3.1 What is Executive Function (EF)? 
 
Before discussing the theoretical models which may be found within the literature 
on EF, it is essential to define the concept. Many definitions have been proposed 
through the years by different researchers that have influenced research and 
clinical practices. For example, Lezak (1995) defines EF as a group of superior 
abilities of organisation and integration; such as anticipating and establishing 
goals, designing plans and programs, self-regulation and monitoring of tasks. 
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Similarly, Welsh and Pennington (1988) suggest that EF is “the ability to maintain 
an appropriate-solving set for attainment of a future goal” (pp. 201). However, 
according to Gioia, Isquith, Guy and Kenealy (2000), EF is not restricted to 
cognitive processes but is also characterised by emotional responses and 
behavioural actions; something that these constructs fail to capture. EF is 
therefore better described as a collection of interrelated tasks or processes that are 
responsible for goal-directed or future-orientated behaviour with the executive 
system acting as the “conductor” that controls, organises and directs cognitive 
ability, emotional responses and behaviour (Gioia et al., 2001). Having said that, 
Gioia et al. (2000), identified the key elements of EF that include the anticipation 
and deployment of attention, impulse control and self-regulation, initiation of 
activity, working memory, mental flexibility and utilisation of feedback, planning 
ability and organization and selection of efficient problem-solving strategies.   
 
3.2 Theoretical models of Executive Function 
 
In order to understand the critical role of executive functioning in our everyday 
lives, researchers throughout the years have tried to provide a theoretical 
framework of this complex term in order to comprehend how executive 
dysfunction affects our everyday life and determine the different neural pathways 
underpinning EF. Although a number of theoretical models of EF have been 
proposed, no one model has been uniformly accepted.  Early attempts to 
conceptualise EF resulted in unitary models such as Baddeley’s (1986) “Working 
memory” model or Norman and Shallice’s (1986) “supervisory acting system”. 
However, later research demonstrated that the unitary view is too simplistic and 
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that the term EF is more likely to be composed of distinct but interrelated 
components (Baddeley, 2000; Miyake et al., 2000). Findings that frontal lobe 
patients rarely exhibit global executive dysfunction provide evidence for 
fractionation of EF (Bigler, 1988; Pennigton & Ozonoff, 1996). In light of this 
new evidence, concepts such as the central executive have been modified in an 
attempt to fractionate the overall construct to derive subcomponents constituting 
the various control systems. Before discussing fractionated accounts of executive 
functioning a description of Baddeley’s working memory model will be outlined 
(Baddeley, 2000).  
 
3.2.1 Working memory model 
 
Baddeley’s model proposes that working memory plays a key role in complex 
activities and is consisted of four major components; the central executive system, 
the phonological loop, the visuospatial sketchpad and the episodic buffer. 
Baddeley (2000) defines working memory as “a limited capacity system allowing 
the temporary storage and manipulation of information necessary for such 
complex processes as comprehension, learning and reasoning” (pp. 418). Figure 1 
represents Baddeley’s (2000) Working memory model. 
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Figure 1. Working Memory model (Baddeley, 2000). 
 
According to this model, working memory consists of the “central executive” 
system that is a limited capacity attentional system and two slave systems; the 
phonological loop and the visuo-spatial sketch pad (See Figure 1). The shaded 
areas represent 'crystallized' cognitive systems that are responsible for 
accumulating long-term knowledge (e.g., language and semantic knowledge), 
whereas unshaded systems represent 'fluid' capacities (e.g., attention and 
temporary storage) and are unchanged by learning, other than indirectly via the 
crystallized systems (Cattell, 1963). The episodic buffer according to Baddeley 
(2000) is a third slave system that links information across domains to form 
visual, spatial and verbal information with chronological order (i.e., memory of a 
story). The episodic buffer is also speculated to have links with long-term 
memory.  
 
According to Baddeley (1996, 2000), the “central executive” has four main 
functions. Firstly, it is responsible for selective attention in that it selectively 
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evaluates a relevant piece of information while ignoring irrelevant information 
and distractions. Impairment of the central executive therefore results in the 
failure to evaluate targeted events/stimuli and maintain goal-directed behaviour as 
the actions of the central executive are influenced by distractions or irrelevant 
information. Secondly, the central executive is capable of coordinating two or 
more simultaneous activities by managing sufficient working memory resources 
across the tasks. The third function of the central executive is the ability to switch 
attention and respond to a task or situation that requires mental flexibility 
prevailing habitual or stereotyped behaviours. Impairment of this can result in 
rigid performance and perseverative behaviour. Finally, the central executive is 
responsible for retrieving information from long-term memory a crucial function 
for responding to the demands of the environment.  
 
The Phonological Loop has the ability to temporarily maintain and manipulate 
speech based information. It is therefore responsible for retaining verbal and 
acoustic information using a temporary store and an articulatory rehearsal system. 
Visuo-spatial sketch pad on the other hand, is responsible for holding and 
manipulating visuospatial information while the episodic buffer is controlled by 
the central executive and provides space for temporary storage of information. It 
also has the ability to integrate information from the two slave systems and long-
term memory to create a unitary episodic event (Baddeley, 2000).  
 
While Baddeley’s model specifies distinct functions for the central executive, it is 
unclear as to whether these are performed by a single unitary system or by a 
collection of discrete and separable executive resources. Furthermore, although 
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the working memory construct has been studied extensively and is considered to 
be a well validated model which offers a coherent conceptual framework for 
describing executive processes and although it accounts for specific patterns of 
executive impairments, nonetheless it neglects important elements of executive 
functioning such as goal setting, reasoning and planning.  
 
3.2.2 Miyake et al.’s model of Executive Function 
 
Another theoretical model of EF that has received increased attention is Miyake et 
al.’s (2000) model which proposes that the central executive is fractionated with 
three components performing separate tasks with varying degrees of competence. 
Miyake et al. proposed the separability of three executive functions: shifting, 
updating and inhibition and their contribution to higher level complex executive 
tasks. The authors focused on these three executive components not only because 
they have been widely discussed in the literature and there are a number of well-
studied cognitive tasks (such as Wisconsin Sorting Card Task (WCST) and Tower 
of Hanoi (TOH)) that tap each target function, but also because these three 
components are likely to be implicated in the performance of complex executive 
tasks. The first component of this model has been proposed as being crucial for 
understanding the failures of cognitive control in brain-damaged patients and 
laboratory tasks where the participant is required to shift between tasks. In other 
words, ‘shifting’, is responsible for shifting back and forth between several tasks 
or mental sets (Monsell, 1996) and is considered to be an important aspect of 
executive control (Norman and Shallice, 1986). 
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The second component of this model refers to ‘updating’ or ‘updating and 
monitoring of working memory representations’ (Miyake et al., 2000, pp. 56). 
This component is responsible for the monitoring and coding of information 
relevant to the current task, revising items in working memory by replacing old 
information that is no longer needed, and incorporating new relevant information. 
Therefore, updating does not passively store information in working memory but 
actively manipulates this information (Morris & Jones, 1990). The third 
component is known as ‘inhibition’ and refers to the ability to consciously inhibit 
dominant, automatic responses when necessary (Miyake et al., 2000).  
 
In order to measure performance on these three components of EF and determine 
whether these components are indeed separable Miyake et al. used a wide variety 
of cognitive tasks that have been extensively used in the literature. They 
administered a total of nine tasks that have been linked to one of the three 
components as well as five complex tasks commonly used as measures of 
executive functioning. The authors used statistical analysis to examine whether 
these three components are functionally separable or are separate facets of a 
unitary system. Confirmatory factor analysis indicated that the three components 
are moderately correlated with each other, but they are clearly separable. 
Additionally, structural equation modelling showed that the three EFs contribute 
differently to performance on complex prefrontal executive tasks. For example, 
performance on the WCST was primarily related to the shifting component, the 
Tower of Hanoi (TOH) to the inhibition component, operation span to updating, 
and Random Number Generation (RNG) to both inhibition and updating. Miyake 
et al.’s results therefore suggest both the unity and diversity of EF.  
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Evidence for this view comes from clinical observations showing differences in 
performance among executive tasks. For example, some patients show 
impairments on the WSCT but not on the TOH, while others show the opposite 
pattern (Shallice, 1988; Godefroy et al., 1999). Further evidence for the 
fractionisation of EF comes from individual differences studies examining a wide 
range of populations on the WCST and TOH such as normal young adults (Lehto, 
1996), normal elderly adults (Robbins et al., 1998), brain-damaged adults 
(Burgess et al., 1998) and children with neurocognitive pathologies (Welsh et al., 
1991). Although the individual differences are evident there is a consistent pattern 
across these studies showing that intercorrelations between the different executive 
tasks are low suggesting that the central executive system is not unitary but 
fractionated. 
 
Therefore, Miyake et al.’s model proposes that EF are fractionated but also 
overlapping to a modest degree. It also suggests that EF is underpinned by 
different neural pathways supporting separable sub-processes that are selectively 
impaired in patients with specific types of executive dysfunction.  
 
3.3 Assessment of Executive Function 
 
It has become evident that patients with frontal lobe damage, as with the 
pioneering case of Phineas Gage, show severe problems in the control and 
regulation of their behaviour and have difficulties functioning in their everyday 
life. Although some patients do not demonstrate impairments on all cognitive 
tasks they may show some impairment on more complex frontal lobe or executive 
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function tasks. Some of these tasks include the WSCT and the TOH. Despite their 
complexity these tasks have become the primary research tools for studying the 
organisation and role of EF in neuropsychological studies with patients of brain 
damage. These EF tasks have provided the basis for the nature of the cognitive 
deficits observed in frontal lobe patients. A vast amount of laboratory-based tasks 
have, therefore, been designed through the years to measure not only specific 
components of EF such as updating, shifting and inhibition, as previously 
discussed, but more complex EF functions. This section will provide a concise 
account of the most established laboratory-based measures of EF that have been 
used extensively in the literature.  
  
3.3.1 Laboratory-based measures of Executive Function 
 
Most laboratory measures of EF have been developed to capture impairments in 
the most prominent components of EF; inhibition, update and shifting. The most 
widely used tests to measure inhibition, among other, are the Stroop task and the 
stop-signal task. The Stroop task, developed by Stroop (1935), has been used in 
research on EF extensively throughout all these years with only minor variation. 
Miyake et al. (2000) has adapted the Stroop Task for computer administration to 
measure levels of inhibition. Participants are required to verbally name the colour 
of a stimulus as quickly as possible with reaction times measured by a voice key. 
The task is comprised of 72 trials where asterisks are printed in one of six colours 
(red, green, blue, orange, yellow or purple), 60 trials with a colour word printed in 
a different colour and 12 trials with coloured words printed in the same colour. 
The different trial types are mixed so the participants are required to consciously 
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inhibit dominant, automatic responses. This test has been used extensively in the 
literature to measure executive dysfunction and cognitive control in patients with 
major depressive disorder (MDD; Hammar et al., 2010), obsessive compulsive 
disorder (OCD; Rao et al., 2010), in children with ADHD (Barkley et al., 1992; 
Lufi, Cohen, & Parish-Plass, 1990) as well as in aging populations (Mittenberg et 
al., 1989; Ludwig et al., 2010). Other tests for inhibition have also been used 
widely in the literature such as the stop-signal task (Logan, 1994; Miyake et al., 
2000) and the antisaccade task (Roberts et al., 1994; Miyake et al., 2000) to name 
a few.  
 
With regard to shifting, laboratory-based measures include the plus/minus task, 
where participants need to alternately add and subtract a number from a series of 
two digit numbers as quickly and accurately as possible, measuring this way the 
cost of shifting between the operations (Jersil, 1927; Spector and Biederman, 
1976; Miyake et al., 2000). The cost of shifting is calculated as the difference 
between the number of correct answers given in the alternating list and the 
average of those in the addition and subtraction lists within the given time period. 
Other measures of shifting include the number/letter task (Rogers & Monsell, 
1995; Miyake et al., 2000) and the local global task (Navon 1977; Miyake et al., 
2000). 
 
 In terms of updating tasks the keep tract task (Yntema, 1963; Miyake et al., 
2000), tone monitoring task (Miyake et al., 2000) and the letter memory task 
(Morris & Jones, 1990) are among the most popular laboratory-based measures 
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that have been used in the literature. These tasks require the individual to 
effectively monitor and update working memory representations.  
 
More complex EF tasks include the Wisconsin Card Sorting Test (WCST; Grant 
& Berg, 1948; Heaton et al., 1981; Kimberg et al., 1997), the Tower of Hanoi 
(TOH; Borys et al., 1982; Humes et al., 1997) or its variant, the Tower of London 
(TOL; Phillips et al., 1999), random number generation (Towse and Neil, 1998) 
and the operation span task (Turner & Engle, 1989). The WCST was primarily 
designed to measure flexibility whilst the TOH measures planning ability and 
working memory. These complex tasks have been used extensively in the 
literature to measure executive dysfunction in patients with autism (for example, 
Bennetto et al., 1996; Ozonoff, 1995), and ADHD (Barkley, Grodzinsky, & 
DuPaul, 1992). 
 
It is evident from the literature that a wide variety of laboratory-based tasks of EF 
have been designed to tap the most discussed components of EF and have been 
used extensively in measuring executive impairments in a wide variety of 
populations. Although laboratory-based measures of EF are still very popular 
when testing executive impairment, in the last decade self-report measures of EF 
have also been designed to examine executive impairment with relation to the 
everyday environment. One of the better known self-report measures of EF that 
has been used extensively in the literature both with clinical and non-clinical 
population is the Behavioural Rating Inventory of Executive Function- Adult 
(BRIEF-A).  
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3.3.2 Self-report measures of Executive Function: The BRIEF-A 
 
For many years the assessment of EF was dependent on laboratory-based 
measures. Although offering strong internal validity, control over extraneous 
variables and the possibility of examining the component EF processes set out 
above, laboratory measures are limited in terms of their ecological validity and in 
their ability to capture executive processes as they are manifested in the everyday 
environment (Gioia et al., 2008). Relying on only laboratory-based measures of 
EF can lead to a limited and incomplete assessment given the fact that EF plays an 
important role in the direction and control of real-world behaviour (Gioia & 
Isquith, 2004). Furthermore, laboratory measures of EF capture only individual 
executive components operating in isolation over a short-time frame in contrast to 
the integrated multidimensional priority-based decision making that is usually 
demanded in real-world situations (Goldberg & Podell, 2000). 
 
In order to overcome the restrictions that, despite their internal validity, 
laboratory-based measures possess, several self-report measures have been 
developed that are specifically designed to capture individuals’ EF in their 
everyday environment. Therefore, these measures offer an ecologically valid 
component that includes more internally valid measures that assess executive 
performance in an everyday environment and offer a more broad idea of EF 
components that laboratory-based measures fail to offer in a single assessment.  
 
A prominent self-report measure of executive functioning is the BRIEF-A, which 
consists of nine subscales each including questions which involve everyday 
activities which contain an executive component. The BRIEF has been used 
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extensively in research with ADHD patients (Chang et al., 2009; Jarratt et al., 
2005; Mahone & Hoffman, 2007; Toplak et al., 2009) autism spectrum disorders 
(Gilotty et al., 2002; Chan et al., 2009) and frontal lobe patients (Malloy & Grace 
2005).  The BRIEF-A has been developed to capture the behavioural 
manifestations of executive dysfunctions. It simultaneously assesses multiple 
inter-related domains of EF that have been commonly discussed in the literature.  
The nine scales of the BRIEF include Inhibition, Shifting, Emotional Control, 
Self-monitor, Initiate, Working Memory, Plan/Organisation, Task Monitor, and 
Organization of Materials. Bodnar, Prahme, Cutting, Denckla, and Mahone (2007) 
argue that everyday instruments such as the BRIEF, measure subtle individual 
differences in discrete real world processes and unlike many laboratory tests are 
unrelated to, and not contaminated by overall differences in general ability 
measures such as IQ.   
 
The reliability and validity of the BRIEF in assessing executive functions has 
been demonstrated in a number of studies. For example, a study of executive 
functions among epileptic participants by Slick, Lautzenhiser, Sherman and Eyrl 
(2006) found that the majority of the sample exhibited selective deficits on 
particular subscales of the BRIEF. Slick et al’s results were also consistent with 
earlier studies (e.g., Gioia et al 2000) in that with one or two qualifications, factor 
analysis revealed the existence of the same two higher level factors: Behaviour 
Regulation and Metacognition. Gioia et al (2002) also investigated the 
psychometric properties of the BRIEF in a mixed clinical sample of children. 
They reported that children with ADHD had significantly higher scores on almost 
all scales of the BRIEF in comparison to the control group. Their results again 
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demonstrate that executive processes are best characterised as fractionated as 
opposed to unitary, although in this case the nine subscales were found to map 
onto three higher level constructs.  Elevated scores on the BRIEF were also 
demonstrated in children and adolescents with moderate to severe traumatic brain 
injury (TBI) (Mangeot et al., 2002) and children with autism (Gilotty et al., 2002). 
Chang et al.(2009) using the BRIEF-A found that students with ADHD faced 
significantly more difficulties in the self-monitor and task monitor scales when 
compared to the control group. This evidence suggests that the BRIEF-A can 
capture effectively the behavioural manifestations of EF in a variety of 
populations.  
 
The utility of the BRIEF in clinical settings has been demonstrated in a number of 
other studies. For example, Toplak et al (2009) found that for those diagnosed 
with ADHD, assessments by significant others (teachers and parents) were 
correlated with performance on executive function tests, although at the level of 
individual component processes the BRIEF ratings did not invariably map 
uniquely onto their equivalent performance test measures. The BRIEF ratings 
however did prove to be better predictors of an ADHD diagnosis compared to the 
objective performance test outcomes which did not account for any unique 
variance in the diagnostic classification. Most of the aforementioned research 
relates to assessments of executive function by significant others. In a recent 
review, Walker and D’Amato (2006) provide evidence for the psychometrical 
integrity of the self-report version of the measure. Their review demonstrates that 
results from the self-report measure do provide a psychometrically valid indicator 
of executive functioning. 
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In an attempt to examine neuropsychological activities, executive dysfunctions 
and their association in children with autism spectrum disorders (ASD), Chan et 
al., (2009) found that children with ASD showed significantly poorer EF in 
everyday activities using the BRIEF and had lower frontal perfusion patterns than 
normal children. In addition, frontal cordance values (an indirect measure of brain 
perfusion assessed using EEG) were significantly associated with executive 
dysfunctions in the Hong Kong list learning test (HKLLT), delayed intrusions, 
object recognition, false alarms and the BRIEF. The reliability of the BRIEF in 
assessing EF has been demonstrated in many studies (Malloy & Grace, 2005). 
According to Walker and D’Amato (2006), the BRIEF serves as a valuable 
addition to the neuropsychological assessment batteries and provides important 
information regarding the decision making process of adolescents. In an attempt 
to evaluate methods of assessing inhibitory control (a variable that is known to be 
central to the executive function construct), Bodnar et al. (2007) found that the 
BRIEF appears to measure different elements of inhibitory control than those 
assessed by computerised continuous performance tests. The BRIEF is designed 
to tap component executive processes within an everyday context and reflects the 
application of processes outside the laboratory and it is not therefore necessarily 
directly related to laboratory measures of executive processes.  
 
Indeed a number of studies have failed to find a significant relationship between 
the BRIEF subscales and laboratory-based neuropsychological measures. For 
example, in a sample of children with traumatic brain injury (TBI), Vriezen and 
Pigott (2002) found that while outcomes on the BRIEF were correlated with 
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measures of IQ they were not significantly related to outcomes on tests such as the 
WCST, TMT-B and verbal fluency. In another study utilising a sample consisting 
of children and adolescents with ADHD, Tourette’s syndrome and normal 
controls, BRIEF ratings were found to be unrelated to word fluency, and Tower of 
London performance although ratings on the BRIEF inhibition component scale 
and performance on a go/no-go task were significantly related (Mahone et al, 
2002). More recently Conklin et al (2008) found that while children with TBI 
were impaired on both backward digit span and the BRIEF, the outcomes on the 
two measures were unrelated to each other (Conklin et al, 2008). Similarly Rabin 
et al (2006) examined individuals with amnesic mild cognitive impairment, older 
persons with cognitive complaints, and healthy controls, on a laboratory based 
neuropsychological test battery while also administering the BRIEF (self-report 
and significant other). Again while the clinical groups were significantly impaired 
on a number of the laboratory tests including learning, immediate and delayed 
recall, and on a number of the BRIEF sub scales, performance on the two classes 
of measures was largely unrelated.  
 
However, a number of other studies have found associations between BRIEF 
ratings and laboratory measures of executive function.  For example, event related 
potential measures of error monitoring processes in a non-clinical population were 
found to be correlated with the task monitoring scale of the BRIEF (Chang et al, 
2009). Similarly in both an autistic spectrum disorder sample and a control group, 
anterior cordance (an EEG indicator of the adequacy of cerebral perfusion) was 
found to be negatively correlated with the metacognition, behaviour regulation 
and global BRIEF scales. Furthermore in both groups the BRIEF scores were 
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significantly correlated with the number of intrusions in a word learning/recall 
task and false alarms in the recognition of line drawings (Chan et al, 2009).  
 
Other researchers have also obtained analogous results. For example, in a mixed 
clinical group which also included normal controls, scores on the metacognitive 
BRIEF scale were significantly correlated with performance on a set shifting task 
(in which participants were required to alternate their response focussing on either 
stimulus shape or colour). Furthermore, verbal fluency performance was 
correlated with a number of the BRIEF component scales including working 
memory and inhibition (Anderson et al, 2002).   
 
The BRIEF has certainly been useful in predicting the behavioural correlates of 
clinical conditions, for example Mares et al (2007) found that the planning and 
organisation and inhibition scales were predictive of behavioural problems 
associated with ADHD. Similarly Feifer and Rattan (2007) found that the BRIEF 
was better at measuring self-regulation in children with emotional disturbances 
compared to more traditional measures of executive functioning such as the 
WCST and the category test (categorising visual stimuli to one of four categories 
according to some defining common characteristic). In a sample of older children 
and adolescents with TBI and an orthopaedic injury control group, Mangeot et al 
(2002) found that there was a linear relationship between the severity of the TBI 
and performance on the aggregate and the two higher level BRIEF scales (based 
on parental ratings).Furthermore, scores on the BRIEF were significantly related 
to performance on a working memory test in which the participant was presented 
with three consonants and a number, and after counting down from the latter were 
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required to recall the former. The BRIEF scores were also found to be predictive 
of parental ratings of behavioural adjustment and adaptive functioning. Taking 
this literature into consideration it is clear that BRIEF-A is a reliable self-report 
measure that can capture behavioural manifestations of EF as effectively as 
laboratory-based measures.  
 
3.4 Biological basis of Executive Function 
 
In order to fully comprehend the term EF, it is essential to explore the neural 
substrates of executive functioning and determine the cerebral areas associated 
with each executive process. Initially, the neural substrates of EF were thought to 
be mediated by the frontal lobes due to the fact that patients with lesions in the 
frontal lobe demonstrated executive dysfunction (Burgess and Shallice, 1996a,b; 
Owen et al., 1990; Shallice, 1982). Nevertheless, there is also evidence suggesting 
that patients with non-frontal lesions can show executive dysfunction similar to 
frontal patients (Andres & Van der Linden, 2000). This evidence indicates that 
frontal lesions do not necessarily predict executive dysfunction and that executive 
processes are not exclusively based upon a network of prefrontal regions. In 
relation to this, recent neuroimaging studies reveal that executive functioning 
relies on a dispersed cerebral network involving frontal and posterior associative 
cortices (Collette & Van der Linden, 2002) and that each executive process is 
associated with specific prefrontal cerebral areas (Collette et al., 2005) supporting 
the idea that EF are fractionated.  
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Goldman-Rakic (1996) suggested the involvement of the dorsorateral frontal 
regions in spatial information and the ventrolateral frontal regions in non-spatial 
information. In relation to this, Owen (2000) proposed that the dorsolateral frontal 
cortex is activated in memory situations that require monitoring of responses and 
understanding of information such as free recall or backward digit span, whilst the 
ventrolateral frontal cortex plays a crucial role in encoding and retrieval strategies. 
The role of mid-dorsolateral, mid-ventrolateral and dorsal anterior cingulate 
cortex was also linked with processes such as response selection, working 
memory maintenance and stimulus retrieval while the rest of the frontal cortex 
remained insensitive to these task demands (Duncan and Owen, 2000). Collette 
and Van der Linden (2002) also found activations during a wide range of 
executive tasks in some prefrontal areas such as Broadmann’s area (BA) 9/46 and 
10 and the anterior cingulate gyrus. Other frontal (BA 6,8,44,45 and 47) and 
parietal regions (BA 7 and 40) were also activated during executive tasks.  
 
Wager and Smith (2003) also showed that specific EF are associated with specific 
cerebral regions. For instance, the right inferior prefrontal cortex (BA 10 and 47) 
is activated during mental operation of switching and inhibition while the superior 
frontal cortex (BA 6,8, and 9) is activated during working memory updating. The 
role of posterior parietal cortex (BA 7) and medial prefrontal cortex (BA 32) is 
also linked with executive functioning during storage and attention tasks. This 
evidence supports the view that EFs are fractionated and are not restricted to 
frontal regions.  
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Further evidence for the diversity and unity of executive functions comes from 
Collette et al. (2005) who investigated Miyake et al.’s (2000) three component 
model of EF. The authors observed increased rCBF in the posterior regions 
located in the left superior parietal gyrus and in the right intraparietal sulcus 
during the execution of executive tasks specific to updating, shifting and 
inhibition. Increased rCBF was also observed in the left middle and inferior 
frontal gyri. These areas are involved in the running of several executive 
processes thus demonstrating the unity of EF.  
 
In order to further demonstrate the diversity of executive processes Collette et al. 
(2005) observed specific activation in cerebral areas during each executive 
process. With regard to the updating component several frontal areas were 
activated such as frontopolar (BA10), superior (BA6), middle (BA9/46), inferior 
(BA44/45) and orbitofrontal (BA11) cortices as well as in the intraparietal sulcus 
and cerebellum. These results are consistent with previous studies that explored 
the neural substrate of the updating component (Collette and Van der Linden, 
2002). Collette et al. (2005) also found that the left frontopolar gyrus (BA 10) is 
associated more specifically with the updating component than any other EF. In 
support of this the frontopolar cortex has been found to be associated with the 
evaluation and selection of internally generated information; an essential process 
for updating (Christoff & Gabrielli, 2000). 
  
Collette et al. (2005) also found activations in specific brain areas during 
performance of shifting tasks. Those activations were observed in the right 
supramarginal gyrus, left precuneus, left superior parietal cortex, the right 
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intraparietal sulcus and left, middle and inferior frontal gyri. Previous research 
also suggests that the intraparietal sulcus is associated with increased activity in 
the prefrontal areas in shifting tasks (Dove et al., 2000; Sohn et al., 2001). Finally, 
Collette et al. (2005) demonstrated that activation during inhibition tasks was 
observed in common cerebral areas already found in the conjunction of the three 
executive processes and also activity in the right inferior frontal gyrus (BA 45). 
They also showed that the right orbitofrontal gyrus (BA11) and the right 
middle/superior frontal gyrus (BA10) are more closely associated with inhibitory 
processes than updating and shifting.       
 
In conclusion, the evidence discussed suggests the involvement of a variety of 
cerebral areas in the execution of executive processes. Additionally, it 
demonstrates both the unity of EF by the activation of common cerebral areas 
during the performance of all three executive tasks but also the diversity of EF by 
the activation of component specific cerebral areas.      
 
3.5 The role of executive processes in Prospective memory 
 
In Chapter 2 the assumption that there is an association between executive 
processes and prospective remembering was made. Evidence for this assumption 
comes from studies demonstrating that PM processes such as dividing attention, 
monitoring the environment for a cue, associating a cue for intention and 
interrupting an ongoing activity, may also involve planning and therefore the 
frontal lobes (Lezak, 1982; Shallice, 1982). Also, Marsh and Hicks (1998) have 
argued that PM depends on self-initiated and attention demanding resources so 
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PM performance can be correlated with measures of central EF. Both 
neuropsychological (Martin et al., 2003; Kliegel et al., 2000; Kliegel et al., 2008) 
and neuroimaging (Burgess et al., 2003; Okuda et al., 2002; Simons et al., 2006; 
Okuda et al. 2007) evidence suggest the involvement of executive processes in 
PM performance since regions of the frontal lobe, such as the rostral prefrontal 
cortex, are involved in both the performance of PM and EF.  
 
In order to examine the effect of external alerting in complex situations Manly et 
al. (2002) used a modification of the six elements test (Shallice and Burgess, 
1991) called the hotel test. These tests have been demonstrated to be more 
sensitive to real-life problems with EF than traditional tests such as the WCST. 
The six elements test and the hotel test require the participant to carry out simple 
subtasks in a limited time period. The participant needs to divide the available 
time evenly across the tasks in order to attempt at least something from each task. 
The purpose of these tests is therefore not to successfully complete all tasks but to 
apply an effective strategy. The authors used the hotel test with Acquired Brain 
Injury (ABI) patients to test the effect of external alerting in complex situations, 
thus reflecting, everyday demands. They found that test performance was no 
different between the ABI patients and the control group in the alerted condition 
(where participants had prompts) as opposed to the control condition where ABI 
patients performed worse than controls. These studies on alerting strategies 
provide evidence that by providing external support (i.e., a cue) for monitoring 
processes, significant improvements in performance can be seen (Fish et al., 
2007).  
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Although these studies use different paradigms they all require goal management 
with an important PM component. According to Fish et al. (2007), any situation in 
which an intention is formed in order to successfully carry out a task and which 
cannot be executed immediately but in the near future, can be considered as 
requiring PM. This retrieval of the intention and the performance of the intention, 
as discussed in the previous chapter, can either be time-based (cued by the 
passage of time) or event- based (cued by an external event). In order to 
successfully remember to carry out the task in the near future, it is important to 
retrieve that memory at the appropriate time and according to Norman and 
Shallice (1986), this is very likely to depend on attentional or executive systems. 
Also, in complex tasks/situations in which several activities run simultaneously, 
additional planning and monitoring processes maybe required (Fish et al., 2007). 
Although strategic and automatic processes are involved in PM retrieval (Einstein 
et al., 2005), it is likely that the extent to which executive processes are involved 
in PM retrieval is dependent on the specific requirements of the task (Glisky, 
1996). For instance, time-based prospective tasks are more likely to rely on EF 
than event-based tasks as they require a higher degree of self-initiated retrieval 
(Einstein et al., 1995).  
 
Having evaluated the role of EF in PM retrieval it is then possible that executive 
dysfunction is correlated with poor PM performance. It is therefore essential when 
studying PM performance to evaluate the role of executive resources as well. Fish 
et al. (2007) examined the contribution of executive monitoring towards the 
completion of a PM task in people with differing brain injuries and PM 
difficulties. After a period of brief training, the participants were required to make 
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telephone calls to a voicemail service at four set times each day over a period of 
10 days. On five randomly selected days, eight text messages with the cue word 
“STOP” were sent to the participants’ mobile telephones (but not within an hour 
of the target time) in order to investigate whether executive monitoring improves 
PM performance. Remarkable improvements were observed on cued days, hence 
demonstrating modulation of PM performance using cues, suggesting that such 
strategies are useful to remediate some negative consequences of executive 
dysfunctions.     
 
Further evidence supporting the role of EF in PM performance comes from the 
definition of PM. Einstein and McDaniel (1990) propose that there are two 
components during a PM task; the retrospective component and the prospective 
component. The retrospective component is a typical memory function whilst the 
prospective component relies mainly on executive processes. Furthermore, in a 
multitask PM paradigm, Kliegel et al. (2000) showed that individual differences 
in executive functioning (e.g., working memory and inhibition) predicted the 
successful initiation and execution of a complex PM task while retrospective 
memory did not. In a later study, Kopp and Thone-otto (2003) tried to separate the 
cognitive processes involved in PM by testing patients with specific cognitive 
deficits in an event-based PM task. They found that patients with brain injury and 
impaired performance on neuropsychological tests of EF performed worse in the 
PM task than patients with no executive dysfunction thus supporting the role of 
EF in PM performance.  
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Executive functions are an integral part of PM performance. PM tasks create the 
need to monitor the environment in order to detect the relevant cue. This means 
that attention needs to be divided between monitoring and performing the ongoing 
task. According to Smith and Jonides (1999), such activity relies on executive 
processes like monitoring and working memory. It is therefore reasonable to 
assume that impairments on EF such as inhibition and working memory might 
predict poor PM performance because patients with impaired EF allocate more 
resources to the ongoing task in order to compensate for their executive deficits 
thus reducing the available resources for monitoring cues. 
 
Another possible mechanism through which EF plays a role in PM is in 
maintaining the activation level of the mental representation of the future 
intention. According to Goschke and Kuhl (1993), delayed intentions are held in a 
higher activational state than other mental representations so they can be retrieved 
more easily when the cue occurs. In relation to this, Einstein and McDaniel (1996) 
maintain that the cue first creates a sense of familiarity (noticing) that is followed 
by a memory search for the content of the intention. Therefore, noticing depends 
on how easily the mental representation of the intention comes to mind.  
 
To conclude, there is growing evidence that the successful performance of a PM 
task is heavily dependent on executive processes and that executive dysfunction 
predicts poor PM performance. Further research for the exact role and the extent 
to which executive processes contribute to successful PM performance is essential 
as both executive processes and PM play a crucial role in our everyday 
functioning.  
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3.6 Chapter summary 
 
Although the research on EF is plentiful, the term EF still remains somewhat 
elusive as different definitions have been proposed throughout the years and 
different theoretical models have been devised to explain this complex term and 
evaluate whether EF are unitary or fractionated. In this chapter the most 
influential models that provide evidence for the fractionisation of EF have been 
discussed as well as the different approaches to measure executive dysfunction in 
clinical cases. The most widely used laboratory-based measures of assessing EF 
and the importance of using self-report measures that are able to capture the 
behavioural manifestations of EF in the everyday environment were also 
discussed. The biological underpinnings of EF and especially the involvement of 
the frontal lobes and their crucial role in our everyday environment and in PM 
performance were also evaluated. 
  
A new line of investigation linking these theoretical constructs is concerned with 
how the common mechanisms supporting EF and PM operate in recreational drug 
users. More specifically, existing research suggests that ecstasy/polydrug users 
perform worse on both PM and EF tasks in comparison to drug naïve persons 
(Montgomery et al., 2005; Fisk & Montgomery, 2009b). Given that recreational 
drugs such as ecstasy, cannabis and cocaine are widely used and that both EF and 
PM play an important role in the everyday functioning, it is crucial to examine the 
possible effects of recreational drug use on these cognitive processes. The 
subsequent chapters will therefore evaluate the effect of ecstasy/polydrug use on 
EF and PM performance and discuss the different approaches of measuring 
executive dysfunction and prospective remembering among recreational users.  
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Chapter 4: MDMA Neurotoxicity 
in humans 
 
 
Chapter overview 
 
3,4 methylenedioxymethamphetamine (MDMA) or Ecstasy is the drug of choice 
for a large number of recreational drug users. Ecstasy is known to have both 
stimulant and hallucinogenic properties and animal studies suggest that ecstasy 
can damage serotonergic nerve terminals in the brain.  A growing body of 
research indicates that the use of ecstasy can have deleterious effects upon 
memory ability and has been associated with a range of cognitive deficits. The 
purpose of this chapter is to explore the effect of Ecstasy on the brain and the 
biological underpinnings of this complex drug.  
 
4.1 What is MDMA? 
 
3,4 methylenedioxymethamphetamine or MDMA is a ring-substituted 
amphetamine derivative and is also structurally related to mescaline; a 
hallucinogenic compound (Green et al., 2003). MDMA was originally created in 
Germany in 1914 as a precursor agent for therapeutically active compounds 
(Cohen, 1998). Shulgin and Nickols (1978) reported that MDMA has 
psychoactive properties in humans and in the 1980s the drug was used in 
psychotherapy to increase patients’ self-esteem and help therapeutic 
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communication. However, increased heart-rate and blood-pressure as well as 
transient anxiety were observed with acute administration (Greer & Straoussman, 
1985). Ecstasy was classed as an illegal drug in the US in 1985 due to its high 
abuse potential, lack of clinical application and evidence that 3,4-
methylenedioxyamphetamine (MDA), a related compound and major MDMA 
metabolite, induced serotonergic nerve terminal degeneration in rat brain 
(Ricaurte et al., 1985). MDMA was also classed an illegal drug in the United 
Kingdom under the Misuse of Drugs Act (1971). Nevertheless, it has become a 
popular recreational drug used at “rave” and “techno” parties to help people dance 
all night. This established ecstasy as a party drug (Green et al., 2003). Ecstasy 
comes in a variety of colours and shapes in the form of tablets and can vary in 
purity. Tablets, however, have been found to contain between 80 and 150mg of 
MDMA (Green et al., 2003). The acute effects of ecstasy include a relaxed, 
euphoric state that leads to emotional openness, empathy and decreased negative 
thoughts and inhibitions (Parrott & Stuart, 1997), hence its appeal as a 
recreational drug. 
 
Due to the increased popularity of ecstasy, research has aimed to determine the 
acute and long-term effects of the drug in animals and humans. These studies have 
been conducted to examine the effects of MDMA on the brain and determine the 
extent to which ecstasy disrupts normal brain functioning. The subsequent 
sections provide a concise account of both animal and human studies on MDMA 
neurotoxicity. 
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4.2 MDMA neurotoxicity in animals 
 
Many of the acute and physiological effects of MDMA are consistent with 
increased serotonin (5-HT) release. Most, if not all, animal studies suggest that 
MDMA disrupts the normal regulation of serotonin (5-HT) in animal brain. 
MDMA is a serotonergic agonist (McDowell and Kleber, 1994) and MDMA 
administration to rats induces an acute and rapid release of 5-HT (Yamamoto et 
al., 1995; Nixdorf et al., 2001; Mechan et al., 2002a). In addition, Gudelsky and 
Nash (1996) demonstrated a dose-related increase in extracellular 5-HT 
concentration in the striatum and medial prefrontal cortex (PFC) following the 
administration of MDMA in rats. MDMA also inhibits the activity of tryptophan 
hydroxylase (TPH), an enzyme required for serotonin synthesis (Stone et al., 
1987a,c; 1988; Johnson et al., 1992). More specifically, TPH activity starts to 
decline in the neostriatum, frontal cortex, hippocampus and hypothalamus within 
15 minutes of MDMA administration (Stone et al., 1987) and remained inhibited 
for another 2 weeks after a single dose of MDMA (Schmidt and Taylor, 1987).  
 
Serotonergic changes have also been demonstrated with dose-dependent 
reductions in 5-HT, 5-HIAA (the main metabolite of serotonin), TPH and 
serotonin uptake sites or neuronal transporters (e.g., SERT) in a variety of animal 
species and are often long-lasting (Fischer et al., 1995). This comes from 
evidence that MDMA-treated rats develop a pronounced loss of serotonin axon 
terminal markers (Ricaurte et al., 1985; Schmidt et al., 1986). Further research 
suggests that MDMA-treated animals develop a persistent loss of not only 
serotonin but also 5-HIAA, TPH and 5-HT transporters (Schmidt, 1987; Ricaurte 
et al., 1988a,b,c). This evidence suggests a distal axotomy of central 5-HT 
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neurons (McCann, 1998). The loss of these axonal markers in primates is long-
lasting (Ricaurte et al., 1988a, b, c) and in some brain regions might even be 
permanent (Ricaurte et al., 1992; Fischer et al., 1995).  
 
Animal studies also provide evidence of regional differences in sensitivity to the 
neurotoxic effects of MDMA. For instance, areas with increased number of 
serotonergic terminals, such as the cerebral cortex, show more severe deficits than 
brain regions containing fibres of passage (e.g., hypothalamus) or cell bodies 
(e.g., brainstem) (Commins et al., 1987; Steele et al., 1994). Consequently, 
repeated administration of MDMA in animals produces long-lasting degeneration 
of serotonergic axons and decrease in brain 5-HT and 5-HIAA concentrations in 
areas such as the neocortex, hippocampus, caudate nucleus, putamen and many 
thalamic nuclei (Ricaurte et al., 1992; Fischer et al., 1995; Hatzidimitriou et al., 
1999).  
 
Because MDMA is a complicated compound neurochemically, it affects a range 
of neurotransmitters in addition to serotonin such as dopamine. For example, there 
is evidence to suggest that MDMA disrupts dopamine levels by increasing its 
release from cerebral tissue (Yamamoto and Spanos, 1988; Colado et al., 1999a; 
Nixdorf et al., 2001). Yamamoto and Spanos (1988) by placing voltametry 
electrodes in the caudate and nucleus accumbens in rats found dose-dependent 
release of dopamine in both brain areas, suggesting that MDMA also alters 
dopamine levels in animals. Although MDMA disturbs both serotonin and 
dopamine levels in cerebral areas in animals, the effect on serotonin levels is 
much more prominent (Yamamoto and Spanos, 1988; Colado et al., 1999a; 
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Nixdorf et al., 2001). The exact mechanism of neuronal damage is unknown. 
However some investigations suggested that neuronal damage may be related to 
ecstasy-induced release of dopamine (Stone et al., 1988) and oxidative stress 
(Colado et al., 1997a,b; Aguirre et al., 1999; Shankaran et al., 1999a,b; Yeh, 
1999). 
 
 
4.3 MDMA neurotoxicity in humans 
 
As discussed previously, it is evident that repeated administration of high doses of 
MDMA can produce long-term reductions in serotonergic activity and the 
degeneration of serotonin neurons in animals. It is therefore possible that this 
neurotoxic potential of MDMA is present in humans as well (McCann, 1998; 
Morgan, 2000). A growing body of empirical investigations support the 
proposition that MDMA is also neurotoxic in humans and there are numerous 
indications of serotonergic damage in the human brain. The potential neurotoxic 
effect of MDMA in humans can be evaluated indirectly by measuring the 
concentration of 5-HIAA in cerebrospinal fluid (CSF) in recreational users of 
ecstasy. Lower levels of CSF 5-HIAA were observed in ecstasy users compared to 
polydrug users that have never used ecstasy (Ricaurte et al.,1990; McCann et al., 
1994; Bolla et al., 1998). 
 
Psychological effects of MDMA such as positive mood and euphoria can be 
explained by the effects of MDMA on neurotransmitters such as serotonin and 
dopamine. Liechti and Vollenweider (2001) attributed positive mood after 
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MDMA use in humans to the release of serotonin and the euphoric effects to the 
release of dopamine in the brain. In addition, human studies have shown that 
some of the psychological effects of MDMA, including positive mood, 
extroversion and elevated sensory perception, are blocked by selective serotonin 
reuptake inhibitors supporting the involvement of 5-HTT(5-hydroxy- tryptamine, 
the serotonin transport protein)  in the mechanism of action of MDMA (Farre et 
al., 2007). MDMA also has physiological effects in both animals and humans that 
include the homeostatic control of body temperature. MDMA-treated rats face 
hypothermia in a cold environment and they are overheated under high 
temperatures (Gordon et al., 1991). The same effect is observed in MDMA users 
in that they report increased body temperature including excess sweating and 
dehydration (Davison and Parrott, 1997). 
 
 Further support for the involvement of MDMA in serotonin levels is the evidence 
that recreational MDMA users face “serotonin syndrome” which according to 
Gillman (1999) is caused by an excess of intrasynaptic 5-HT as a result of adverse 
drug reaction. The symptoms of “serotonin syndrome” include behavioural 
hyperactivity, mental confusion, agitation, fever, tachycardia, shivering and 
tremor. Most MDMA users display mild signs of the serotonin syndrome such as 
hyperactivity, mental confusion, hyperthermia and jaw clenching (Davison and 
Parrott, 1997; Parrott and Lasky, 1998). Therefore, it is evident from this research 
that MDMA alters serotonin levels in both animals and humans. 
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4.3.1 Neuroimaging and neuropsychological evidence   
 
More evidence for the neurotoxic potential of MDMA and its effect on 
serotonergic systems in various brain areas emerges from neuroimaging studies in 
humans. Because of the relative absence and the availability of postmortem 
human brain material, only one marker of brain serotonin neuronal number is used 
in human studies that can be assessed in living human brain. This marker is 
known as the SERT (the site on serotonin neurons which takes released serotonin 
back into the neuron). Neuroimaging studies of brain serotonin neuronal integrity 
in ecstasy users therefore employ radioligands that bind to this transporter (e.g., 
McCann et al., 1998; Semple et al., 1999). Single photon emission computed 
tomography (SPECT) and PET have been used in the literature to provide 
evidence for the neurotoxic effects of MDMA. These neuroimaging studies 
employed radioligand-based methodology designed to detect binding to SERT, 
with the assumption that decreased levels of SERT will reflect decreased number 
of serotonin neurons/nerve endings (Kish, 2002).  
 
Postmortem human brain (Little et al., 1998) and SPECT (Jacobsen et al., 2000; 
Staley et al., 2001) studies have reported above-normal levels of brain SERT in 
human users of cocaine and in tobacco smokers suggesting that brain levels of 
SERT might change following exposure to some drugs independently of any 
changes in levels of nerve terminals. This method of investigation is therefore 
useful in detecting MDMA-related changes.  
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For example, reduced densities of serotonin transporter sites were observed in 
ecstasy users during a PET scan across a wide range of brain regions such as 
hypothalamus, cingulate cortex, frontal cortex, occipital and parietal cortex. In 
addition, this decrease was positively correlated with the extent of prior ecstasy 
use (McCann et al., 1998).  Decreased global brain volume and increased 
percentage of CSF was also observed in ecstasy users with longer duration of use 
(Chang et al., 2000).  
 
Semple et al. (1999) using SPECT with a 5-HT radioligand investigated heavy 
ecstasy users that remained abstinent for 3 weeks and ecstasy-naive controls. 
Ecstasy users showed reduction of cortical 5-HT transporter binding in 
comparison to the control group but had a normal dopamine receptor binding; 
highlighting once again the effect of MDMA on serotonin levels. The authors also 
suggested that at least some of the loss of transporter density might be temporary 
and related to the last use of MDMA. Another SPECT study looking at cortical 5-
HT2A receptor densities demonstrated that MDMA users that remained abstinent 
for an average of 4.6 months had significantly up regulated 5HT2A receptor 
densities in the occipital cortex compared to an ecstasy-naive control group 
(Reneman et al., 2000). These neuroimaging studies provide further support in 
that heavy ecstasy users exhibit persistent serotonergic changes.  
 
More evidence for neuronal damage in a condition restricted to damage to nerve 
terminals (but no cell body loss) can only be obtained by postmortem brain 
examination. In such examination the levels of all markers of serotonin nerve 
terminal integrity (e.g., serotonin, tryptophan hydroxylase, and SERT) are 
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decreased if nerve terminal loss has occurred (Kish, 2002). Kish et al (2000) 
found after an autopsy of a chronic MDMA user that striatal levels of serotonin 
and those of its metabolite 5-hydroxyindoleacetic acid were severely depleted by 
50 to 80% in the brain whereas concentrations of dopamine were within the 
normal control range. The authors therefore suggested that MDMA exposure in 
humans can cause decreased tissue stores of serotonin and the behavioural effects 
of this drug can be caused by massive release and depletion of brain serotonin.  
 
In a more recent study, Kish et al (2010) measured protein levels of SERT and the 
rate-limiting serotonin-synthesizing enzyme tryptophan hydroxylase (TPH) in 
autopsied brain of a high-dose MDMA user. As compared with control values, 
SERT protein levels were markedly reduced in the striatum (caudate, putamen) 
and occipital cortex and less affected in frontal and temporal cortices. TPH protein 
was also severely decreased in caudate and putamen. The magnitude of the striatal 
SERT protein reduction was greater than the SERT binding decrease typically 
reported in imaging studies. These findings therefore extend imaging data based 
on SERT binding and suggest that high-dose MDMA exposure could cause loss of 
two key protein markers of brain serotonin neurones, a finding compatible with 
either physical damage to serotonin neurones or down regulation of components 
within. 
 
Having established the role of MDMA in potentially giving rise to neurotoxic 
lesions of the central serotonergic system, it is necessary to specify which systems 
are most affected in order to try and explain the behavioural manifestations 
observed in recreational users of ecstasy. As mentioned above, Reneman et al. 
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(2000) found that the 5-HT2A receptor binding was significantly elevated in the 
occipital cortex of heavy ecstasy users compared to a control group suggesting 
that the occipito-parietal region of the cortex may be altered by extensive MDMA 
exposure. Chang et al. (2000) in their study found no significant differences in 
rCBF between abstinent heavy ecstasy users and controls. However, within 3 
weeks of administration of total dose of 3.5 mg/kg of MDMA, rCBF remained 
decreased in the visual cortex, the caudate, superior parietal and dorsolateral 
frontal regions. Ecstasy use was also associated with decreased EEG coherence 
specifically in relation to the visual association pathways (Dafters et al., 1999). 
Reduced coherence levels are associated with dysfunctional connectivity in the 
brain suggest disturbances in alertness mechanisms. These findings may explain 
why heavy ecstasy users show deficits in attention and tasks that demand visual 
discrimination (Morgan, 2000).  
 
Reduced glucose metabolic uptake was also observed in MDMA users using PET 
in the hippocampus, amygdala and cingulate cortex bilaterally (Obrocki et al., 
1999). Furthermore, in a recent study Kish et al (2010b) explored the different 
brain areas affected by MDMA use and the possibility that structural brain 
differences might account for serotonin transporter binding changes. The authors 
measured a brain serotonin transporter binding in 50 drug free controls and 49 
chronic abstinent ecstasy users. A magnetic resonance image for positron 
emission tomography image co-registration and structural analyses was 
developed.  It was found that serotonin transporter binding in ecstasy users was 
significantly decreased throughout all cerebral cortices and hippocampus and that 
the decrease was related to the extent of drug use (i.e., years, maximum dose). 
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Serotonin transporter binding, however, was normal in basal ganglia and 
midbrain.  
 
Also, voxel-based analyses confirmed a cortical serotonin transporter binding loss 
with occipital cortex most severely affected. Magnetic resonance image 
measurement revealed no overall regional volume differences between the groups. 
A slight left-hemispheric biased cortical thinning was, however, detected in 
methamphetamine-using ecstasy users. The ecstasy group also reported subnormal 
mood and demonstrated generally modest deficits on some tests of attention, 
executive function and memory, with the latter associated with serotonin 
transporter decrease. The authors also found that low dose (one to two 
tablets/session) chronic ecstasy/polydrug users might display a highly selective 
mild to marked loss of serotonin transporter in cerebral cortex/hippocampus that 
is unrelated to recent use of other drugs or other potential confounds. The striking 
sparing of serotonin transporter-rich striatum observed in this study suggests that 
serotonergic neurons innervating cerebral cortex are more susceptible (for 
unknown reasons) to ecstasy than those innervating subcortical regions. The 
authors therefore concluded that the behavioural problems in some ecstasy users 
during abstinence might be related to serotonin transporter changes limited to 
cortical regions. 
 
The evidence for ecstasy-related decreases in serotonin transporter binding in the 
hippocampus is crucial since the hippocampus is important for memory 
functioning (Hatzidimitriou et al., 1999). It is therefore logical to assume that 
memory functioning is affected in recreational users of ecstasy. Given that lesions 
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of the 3 corticothalamic circuits, the dorsolateral prefrontal circuit, the lateral 
orbitofrontal circuit and the anterior cingulate circuit are associated with executive 
function deficits and disinhibition (Cumming, 1993), findings from PET, SPECT 
and EEG studies support the notion that extensive exposure to MDMA may 
potentially cause, amongst other things, impairments in learning, episodic 
memory, working memory and attention (Morgan, 2000).  
4.4 Is MDMA neurotoxic? 
 
The available human and animal data indicates that recreational use of MDMA is 
associated with loss of serotonin (5-HT), its major metabolite (5-HIAA), its 
biosynthetic enzyme (TPH) and its presynaptic transporter (SERT). These losses 
are persistent after weeks of abstinence and thus are not only due to the short-term 
pharmacological effects of MDMA. Although, human data is limited, there is 
sufficient animal data to suggest that MDMA causes long-lasting decreases in 5-
HT, 5-HIAA, TPH and SERT in a variety of brain regions (such as the 
hippocampus, frontal cortex, etc). It is therefore possible that MDMA has the 
potential to damage serotonergic axon terminals and produce a 5-HT distal 
axotomy. This evidence has been interpreted by several researchers and has been 
referred to as ‘MDMA neurotoxicity’. 
 
However, during the last few years, several studies have questioned the 
neurotoxic potential of MDMA to 5-HT terminals. Such conclusions were based 
on results from western blot studies of the SERT protein showing no change in 
SERT protein abundance regardless of large decreases in 5-HT concentrations; 
what up to that date, had been considered a neurotoxic MDMA treatment in rats 
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(Baumann et al., 2007; Wang et al., 2004; 2005). Another argument put forward 
by some researchers to question the 5-HT neurotoxic potential of MDMA is the 
failure of some studies to demonstrate changes in Glial fibrillary acidic protein 
(GFAP) expression after several treatment regimens with MDMA known to 
deplete central 5-HT concentrations (Wang et al., 2004; 2005). GFAP is the major 
protein constituent of astroglial intermediate filaments and has been used as a 
marker to detect neuronal degeneration (O’Callaghan & Miller, 1993). No 
changes in GFAP expression found in these studies are therefore indicative of no 
neurotoxicity induced by MDMA treatment. Grob (2000) and Kalia (2000) also 
argue that the lack of reactive gliosis in animals exposed to ecstasy suggests 
absence of MDMA-induced neurotoxicity.  These findings therefore raise doubts 
among some investigators as to whether MDMA “serotonergic neurotoxicity” 
involves distal axotomy or alternatively a long-lasting down regulation of 5-HT 
synthesis and SERT expression by the serotonergic neurons (see Puerta & 
Aguirre, 2011 for a review).  
4.5 Chapter summary 
 
Despite the controversy in the literature as to whether MDMA has neurotoxic 
potential or not, there is abundance of evidence that recreational use of ecstasy 
causes long-lasting cognitive and behavioural problems in ecstasy users (see 
Zakzanis et al., 2007 for a review).  A relatively new line of investigation 
suggests that recreational users of ecstasy are impaired in particular memory 
functions such as prospective remembering (Heffernan et al., 2001a,b; 
Montgomery et al., 2007), memory and learning (Parrott et al., 1998; Schifano et 
al., 1998; Morgan, 1999; Bolla et al., 1998; Gouzoulis-Mayfrank; 2000)  and 
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cognitive/executive functioning (Fox et al., 2001; Schifano et al., 1998; Morgan 
et al., 1999; McCann et al., 1999a; Gouzoulis-Mayfrank, 2000). The following 
two chapters will evaluate the effects of ecstasy use on prospective memory and 
executive functioning that are important factors to everyday functioning.  
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Chapter 5: Prospective Memory 
deficits in ecstasy/polydrug 
users 
 
Chapter overview 
A plethora of research has evaluated the effect of ecstasy in humans and its effects 
on various cognitive domains and memory processes (Morgan, 1998; 1999; 
Gouzoulis-Mayfrank et al., 2000). Ecstasy-related research on memory function 
has mainly focused on learning, verbal memory, implicit and episodic memory. It 
is therefore of interest to investigate the extent to which the impairments that have 
been observed impact memory functioning in an everyday context. An important 
aspect of day-to-day memory functioning is Prospective Memory (PM). PM, as 
previously discussed, refers to remembering to execute a particular behaviour in 
the future. For example, remembering to pass on a message or meet a friend or 
pick up milk from the store on your way home. A relatively new line of 
investigation suggests that PM is impaired in recreational users of ecstasy 
(Heffernan et al., 2001a, b; Montgomery and Fisk, 2008; Fisk and Montgomery, 
2008). This chapter will, therefore, provide a concise account of PM deficits in 
recreational users of ecstasy. 
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5.1 Ecstasy use and memory functioning 
 
Ecstasy use has long been associated with neurocognitive deficits (Halpern et al., 
2004; Yip & Lee, 2005) and a growing body of research indicates that ecstasy can 
have deleterious effects upon memory ability (Parrott and Lasky, 1998; Morgan, 
1999; 2000; Rodgers, 2000). Lasting impairments in explicit memory are 
observed in human studies following repeated use of ecstasy (Bolla et al., 1998; 
McCann et al., 1999; Morgan, 1999; Reneman et al., 2000). Ecstasy users are 
therefore impaired on neuropsychological measures of memory that require the 
intentional recollection of an episode or previous experiences (Tulving and 
Markowitsch, 1998).  
 
Measuring the effect of ecstasy on explicit memory, Bolla et al. (1998) compared 
the performance of abstinent ecstasy users and controls (non-ecstasy users) on the 
Rey- Auditory Verbal Learning Test (RAVLT), the Wechsler Memory Scale 
Revised (WMS-R) and Rey-Osterrieth Complex Figure Test (ROCF). The authors 
found that ecstasy users were impaired in immediate verbal and delayed visual 
memory in comparison to controls and also that the impairment was greater with 
increased use of ecstasy. Immediate and delayed recall was also investigated in 
ecstasy users using subtests of the Rivermead Behavioural Memory Test (RBMT; 
Wilson et al., 1985). Ecstasy users recalled significantly fewer ideas from a short 
passage read out to them in both immediate and delayed recall conditions than the 
control group (Morgan, 1999). Decreased recall in ecstasy users was also 
observed immediately after presentation and after a delay in a computerised 
battery of cognitive tasks (Parrott et al., 1998). Zakzanis and Young (2001) 
examined the neurotoxic potential of continued ecstasy use and its consequences 
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over a year. In a longitudinal study 15 ecstasy users completed the RBMT on two 
occasions. The findings indicated that continued use of ecstasy was associated 
with progressive decline in terms of immediate and delayed recall. There is 
therefore adequate evidence to support the proposition that explicit memory 
impairments are present in ecstasy users.  
 
Memory, however, is not a unitary system and as a consequence other memory 
components are likely to be affected by the neurotoxic properties of ecstasy, for 
example PM. Since PM can be conceptualised as a complex cognitive operation 
drawing on explicit memory and varying in both difficulty level and in terms of 
the component processes drawn upon (Gilsky, 1996), it is very likely that PM is 
also impaired in recreational users of ecstasy.  
 
5.2 Prospective Memory deficits in Ecstasy/polydrug users: Evidence from 
self-report measures 
 
It has been long established that recall and recognition are impaired in users of 
ecstasy and the extent to which these impairments impact memory functioning in 
an everyday context has been researched in recent years. An important aspect of 
day-to-day functioning is PM; remembering to do things at some point in the 
future. PM is a relatively new line of investigation (Brandimonte et al., 1996; Ellis 
et al., 1996) that has received increased attention. Research over the years has 
suggested that the neurotoxic effects of ecstasy disrupt normal PM functioning. 
Heffernan et al. (2001a) were the first to examine PM in ecstasy/polydrug users 
using self-report measures of PM, specifically the Prospective Memory 
Questionnaire (PMQ; Hannon et al., 1995).  
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The PMQ is a self-report measure of PM that requires participants to record the 
number of times their PM failed within a period of time. It consists of three 
subscales measuring short-term habitual, long-term episodic and internally cued 
PM. The PMQ also measures the number of strategies people use to aid 
remembering. This has been proven a useful scale in estimating the effectiveness 
of PM in the context of personality differences (Heffernan and Ling, 2001) and 
age-related differences (Heffernan and Elmirghani, 2000). The PMQ has also 
been used with brain damaged patients to evaluate PM performance (Hannon et 
al., 1995) and in recent years has been used extensively to explore self-perceived 
PM deficits in regular users of ecstasy, cannabis, alcohol and tobacco (Heffernan 
et al., 2001a,b;2005; 2010a,b; Rodgers et al., 2001;2003; Fisk and Montgomery, 
2008; Montgomery and Fisk, 2008).  It is therefore, a powerful tool in detecting 
PM deficits in a variety of populations.  
 
Using the PMQ, Heffernan et al. (2001a) investigated the effect of ecstasy use on 
PM for the first time in a sample of 30 regular users (who had taken ecstasy 10 or 
more times per month) and 31 ecstasy free controls. Ecstasy users were impaired 
on all three subscales of the PMQ; short-term habitual PM, long-term episodic 
PM and internally cued PM in comparison to the control group whilst no 
significant difference was observed between the two groups for the techniques to 
remember scale. Therefore, ecstasy users reported global impairments in PM in 
comparison to the control group. These impairments remained even after 
controlling for the use of other drugs such as cannabis and cocaine as well as 
tobacco and alcohol; suggesting that ecstasy is responsible for the PM deficits. 
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 In a subsequent study, Heffernan et al. (2001b) using the PMQ replicated 
previous findings that ecstasy users face global impairments of PM, an effect that 
is unrelated to the use of any other drug. In a different experiment (Heffernan et 
al., 2001b) the authors tested a different group of 30 regular ecstasy users and 37 
non-ecstasy users to examine whether PM and the Central Executive (CE) system 
are linked. Participants were assessed on their PM using the PMQ and on their EF 
by a verbal fluency task. Unlike previous findings, ecstasy users were only 
impaired on the short-term habitual and long-term episodic aspects of PM and not 
on internally cued PM. Ecstasy users in comparison to the non-ecstasy group 
performed worse on the verbal fluency task. The fact that ecstasy users showed 
corresponding impairments in both measures of PM and EF support the notion 
that PM and CE are somehow linked.  
 
Finally, in a third study the authors (Heffernan et al., 2001b) administered the 
Cognitive Failures Questionnaire (CFQ; Broadent et al., 1982) to 15 ecstasy users, 
15 cannabis users and 15 drug naïve persons to measure self-perceived day-to-day 
cognitive slips. No significant differences were observed between the three groups 
suggesting that ecstasy users do not perceive their cognitive performance to be 
worse than the other two control groups. These findings on cognitive performance 
are in line with Rodgers et al. (2000) who also found no differences between 
ecstasy users, cannabis users and drug naïve persons on the CFQ. Collectively 
these studies, therefore, suggest that ecstasy/polydrug users are impaired in both 
PM and EF but do not produce more cognitive slips. 
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These results for cognitive performance are somehow peculiar since cognitive 
impairment is evident in ecstasy users on objective measures (Fox et al., 2001; 
Parrott and Lasky, 1998; Morgan, 1999; 2000; Gouzoulis-Mayfrank et al., 2000). 
Despite these impairments being apparent ecstasy users do not report more 
cognitive failures in their everyday lives. A possibility as to why self-report 
measures of cognitive failures do not show significant impairments can be 
referred to as the ‘memory paradox’, in which people experiencing memory 
impairment are not able to remember and thus report cognitive slips. Another 
possibility may be that ecstasy users utilise compensatory strategies to aid day-to-
day functioning but that such strategies are unavailable during the performance of 
more objective laboratory based tasks. It is therefore possible that ecstasy users 
perceive only some aspects of memory impairment such as PM (Heffernan et al., 
2001a; b).  
 
A problem with investigations in the area of recreational drug use is the small 
sample sizes evident in most studies due to the difficulties associated with 
recruiting larger samples. Overcoming this difficulty, Rodgers et al. (2001) used 
the World Wide Web (WWW) to assess memory in recreational users of ecstasy 
and to investigate the different effects of ecstasy and cannabis on memory 
functioning. They administered two self-report questionnaires; the PMQ to assess 
PM and the Everyday Memory Questionnaire (EMQ; Sunderland et al., 1983) to 
assess common memory lapses in everyday activities, such as returning to check 
whether you have done something you meant to do or repeating a story or a joke. 
The EMQ has been proven useful in the area of recreational drug use (Heffernan 
et al., 2001b; Montgomery and Fisk, 2008; Fisk and Montgomery, 2008) and 
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smoking (Heffernan et al., 2005). Drug use was assessed using the Recreational 
drug use questionnaire (Parrott, 2000) in a sample of 488 people.  
 
Findings revealed a clear double dissociation between the ecstasy and cannabis. 
Consequently, it was found that cannabis was associated with reports of ‘here and 
now’ cognitive problems in short-term and internally cued PM and everyday 
memory. Conversely, ecstasy was associated with reports of long-term memory 
problems that were more related to storage and retrieval difficulties. Findings on 
RM that delayed recall is the most impaired memory function in ecstasy users 
(Rodgers et al., 2000) support the results of this study. Also, these storage deficits 
might be due to serotonergic neural damage in the hippocampus due to extensive 
exposure to ecstasy (Parrott, 2000). Rodgers et al. (2001) also found that the 
errors made in completing the questionnaires were associated with the history of 
ecstasy use. This may be explained as a manifestation of greater impulsitivity and 
less reflective behaviour observed in abstinent ecstasy users (Morgan, 1998) and 
may be related to serotonergic axonal loss in the frontal cortex (McCann et al., 
2000).  
 
Reviewing the results of their previous study, Rodgers et al. (2003), controlled for 
other recreational drugs co-used using statistical analysis and found that effects on 
PM were restricted to the use of ecstasy and cannabis rather than any other drug. 
They also found that greater ecstasy use is associated with more difficulties in 
self-reports of long-term PM and that cannabis use predicts self-reports of failures 
in everyday memory with greater use corresponding with more reported problems. 
Since cannabis and ecstasy contribute to day-to-day functioning problems 
86 
 
differently it is possible that different recreational drugs affect human memory in 
distinct ways.  
 
In order to evaluate the role of cannabis in real-world memory (everyday memory, 
cognitive failures and PM), Fisk and Montgomery (2008) assessed cannabis users 
on self-report measures of everyday memory, cognitive failures and PM as well 
executive components and associative learning. Cannabis users were impaired on 
all three aspects of real-world memory in relation to the control group. The 
findings of this study are broadly consistent with those of Rodger et al. (2001) in 
terms of the role of cannabis in everyday memory deficits and PM. Fisk and 
Montgomery’s (2008) study, unlike Rodgers et al., found that cannabis only users 
exhibited deficits in all aspects of PM and were also impaired on measures of 
cognitive slips, i.e., the CFQ.  
 
The different pattern of PM outcomes reported in the two studies might be a 
product of the different characteristics of the two samples and may be that the 
effects of cannabis in the context of polydrug use are different from those evident 
in cannabis only users. The absence of cannabis related deficits in EF and 
associative learning is somewhat surprising since real-world memory processes 
and especially PM are known to be dependent on prefrontal executive resources 
(Marsh and Hicks; 1998; McDaniel et al., 1999). The authors suggested that these 
findings can be explained by the type of assessment. For example, cannabis users 
appear to perform sufficiently in a laboratory setting whilst in a less controlled 
environment outside the laboratory where more distractions are present users 
might demonstrate impairment. It is therefore essential to administer more 
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ecologically valid EF tasks in real-world contexts, capable of capturing cannabis 
related impairments.  
 
Further evidence for the effect of ecstasy use on PM comes from additional 
studies utilising self-report measures. Montgomery and Fisk (2008) in a study to 
evaluate real-world memory processes in ecstasy/polydrug users administered 
self-report measures of everyday memory, cognitive failures and PM in a 
laboratory setting. They also administered an objective measure of cognitive 
failures i.e., the ‘CFQ for others’ and laboratory measures of EF to explore the 
assumption that there is a link between PM and EF. The authors found that 
ecstasy/polydrug users were impaired relative to non-ecstasy users on the CFQ, 
EMQ and on long-term episodic and internally cued PM as well as on a working 
memory task. Also, ecstasy/polydrug users were rated less favourably by their 
significant others on the CFQ for others measure compared to non-ecstasy users. 
The authors also found no interaction between the source of the CFQ scores (self 
or others) and ecstasy/polydrug use suggesting that users are aware of their 
cognitive slips and therefore a self-report assessment of cognitive failures is 
consistent with ratings from a close family member or a friend. Ecstasy/polydrug 
users were also impaired on the WM task. However, following regression analysis 
WM capacity did not emerge as a significant predictor of memory deficits, 
highlighting the limited importance of WM capacity as a mediator of difficulties 
in everyday memory in ecstasy/polydrug users.  When controlling for the use of 
other recreational drugs, cannabis emerged as the most important predictor of PM 
and everyday memory deficits in ecstasy/polydrug users. In fact, the authors 
found that with the exception of the CFQ for others, cannabis emerged as the only 
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significant predictor for everyday and prospective memory deficits. It is therefore 
evident that cannabis is also an important predictor of PM and real world deficits 
in ecstasy/polydrug users.  
 
In addition to cannabis, tobacco and alcohol have also been suggested to affect 
memory performance. Ling, Heffernan, Buchanan, Rodgers, Scholey and Parrott 
(2003) examined the effects of alcohol on two aspects of memory performance; 
PM and everyday memory. Data were collected using the WWW and participants 
completed the PMQ and EMQ. After controlling for the use of other drugs and 
strategies used to aid remembering it was found that alcohol was associated with 
impairments in long-term PM and with an increased number of cognitive failures. 
Both short-term and long-term PM failures, using the PMQ, were also found in a 
number of studies, (e.g., Heffernan and Bartholomew, 2006; Heffernan et al., 
2006) supporting these findings. In a recent study, Heffernan et al. (2010b) 
measured PM using the Prospective Retrospective Memory Questionnaire 
(PRMQ; Crawford et al., 2003) in 50 alcohol only users; 29 non-binge drinkers 
and 21 binge drinkers. The PRMQ shows high internal consistency and provides a 
self-report measure of memory slips in everyday life. It consists of 16 items, 8 for 
PM (4 short-term and 4 long-term PM) and 8 for RM. In addition to the PRMQ, 
the authors also used an objective measure of PM, the Prospective Remembering 
Video Procedure (PRVP), based on previous research (Seed et al., 2005). The test 
consists of a 10 minute video clip containing footage of a shopping district in 
Scarborough. The view presented in the video was a mixture of shop fronts, 
passers-by and retail stalls. Before watching the video participants were asked to 
remember specific actions or items associated with particular location on the 
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video. Participant then had to write down each action-location combination on a 
response sheet whilst viewing the video and not before. There were 18 location-
action/item associations and a higher score indicated better PM functioning.  
 
Findings suggested that binge drinkers and non-binge drinkers did not differ in 
their PM lapses on PRMQ. However, binge drinkers recalled significantly less 
location-action/item combinations than non-binge drinkers in the PRVP. The 
findings suggest that poorer PM performance is associated with binge drinking. It 
also raises the need to administer objective measures of PM since the PRMQ was 
unable to detect obvious PM failures present in the objective PM task. 
 
Tobacco use has also been implicated with difficulties in PM. Heffernan et al. 
(2005) investigated the effect of tobacco in 2 aspects of real-world memory, long-
term PM and everyday memory in a web based study using the PMQ and EMQ. A 
large sample size of 763 people took part in the investigation. Illicit drugs such as 
ecstasy, cannabis and LSD as well as alcohol use were controlled for in the study. 
In general the authors found that cigarette smokers reported significantly worse 
long-term PM than non-smokers. Findings also revealed that there were 
differences between light and heavy smokers suggesting that nicotine may have a 
dose dependent impact upon PM. A significant ANOVA group effect on the EMQ 
was also observed although the trend for greater memory errors amongst the 
heavier smokers was not significant. The findings of this study suggest that there 
are selective memory deficits associated with smoking and that smoking is a 
factor affecting long-term PM. 
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It is therefore evident that ecstasy is not the only substance that can affect PM 
performance. The major concern with studies in the area of recreational drug use 
is the variety of drugs in addition to ecstasy that recreational users of ecstasy 
consume. Given the difficulty in recruiting ecstasy only users most studies in the 
area recruit ecstasy/polydrug users, i.e., people who consume a variety of drugs in 
addition to ecstasy. This is a concern as the use of other illicit drugs such as 
cannabis, cocaine, amphetamines and LSD will have an effect on 
neuropsychological functioning (Gouzoulis-Mayfrank et al., 2000; Fox et al., 
2001; 2003; Parrott, 2001; 2003; 2006; Rodgers et al., 2003; Heffernan et al., 
2005). It is therefore evident from the literature that ecstasy/polydrug users face 
difficulties in PM, everyday memory and cognitive failures. Although most 
studies in the area have effectively used self-report measures to detect PM deficits 
the use for more objective PM measures are essential since objective measures 
might be more sensitive in capturing PM difficulties.  
  
5.3 Prospective Memory deficits in Ecstasy/polydrug users: Evidence from 
laboratory measures 
 
Studies in the area of recreational drug use have typically used self-report 
measures to capture PM deficits in ecstasy/polydrug users. Whilst self-report 
measures have been proven to be a powerful tool in detecting PM deficits in 
recreational users of ecstasy, laboratory-based measures are essential as they offer 
a more objective assesment of ecstasy-related deficits. Only a limited number of 
studies have used laboratory-based measures to test PM performance in 
ecstasy/polydrug users and where such measures have been employed they have 
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been rather artificial and contrived in nature for example the ‘Virtual week’ 
(Rendell and Craik, 2000). 
 
5.3.1 ‘Virtual week’ 
 
The ‘virtual week’ is a board game where participants move around the board 
with the roll of a dice. The times of the day that people are typically awake are 
marked on the board. Participants are required to circuit the board seven times as 
a simulation of a week in their life, with each circuit representing a day. As 
participants move around the board they need to choose their daily activities (10 
event cards for each virtual day) and then remember to execute them (PM tasks). 
Thus each day of the virtual week includes 10 PM tasks; four regular tasks, four 
irregular tasks and two time-check tasks. The four regular tasks simulate the tasks 
occurring when one undertakes routine duties. Two of these are time-based 
(monitored by passing a particular time on board) and the other two are event-
based (triggered by information on an event card). The four irregular tasks 
simulate occasional tasks that occur in everyday life and two of them are time-
based and the other two event-based. Finally, the two time-check tasks require the 
participant to ‘break set’ from the game activity and monitor real time on a stop 
clock and also indicate when a specified period of time has passed. Correct scores 
indicate that the target item is remembered at the correct time. Late items are 
scored when the item is remembered after the correct time but before the end of 
the virtual week. Wrong items are marked when tasks are incorrectly recalled or 
recalled at the incorrect time. Tasks that are not remembered at any time are 
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marked as missed. The ‘Virtual week’ by the inclusion of regular and irregular 
tasks varies the role of RM in PM processes.  
 
As previously mentioned, PM also involves a retrospective memory component 
(Cohen et al., 2001; McDaniel and Einstein, 1992) that is impaired in ecstasy 
users (Bolla et al., 1998; Morgan, 1999; 2000; Kalechstein et al., 2007). It is 
therefore important to distinguish between regular and irregular PM tasks in the 
‘Virtual week’ as regular PM tasks impose fewer demands on RM (remembering 
what needs to be done) thus permitting an assessment of whether PM failures are 
restricted to the retrospective component or these difficulties extend to the PM 
component. Also the distinction between time and event-based PM tasks is 
important as the two types of PM tasks rely on different neural pathways and 
mechanisms. For example, time-based PM tasks are believed to rely upon internal 
control mechanisms as no external mnemonic aid is employed and this is more 
dependent on self-initiated mental activities such as time monitoring. On the other 
hand, event-based PM tasks are considered to be more automatic processes. 
 
In order to investigate the distinction between time-based and event-based PM 
and the role of RM component in ecstasy users Rendell et al. (2007) have 
employed ‘virtual week’ to investigate PM in ecstasy/polydrug users. Measures of 
perceived sleep quality, psychopathology and cannabis consumption were also 
taken to determine any possible contributory factors to PM impairments. The 
results demonstrated that ecstasy use was significantly associated with increased 
difficulties in PM and that the magnitude of this deficit did not vary as a function 
of task type. Additionally, they found that PM deficits are not secondary to the 
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effects of cannabis use, sleep quality or increased psychopathology. The authors 
also distinguished users as frequent and infrequent users and found that although 
both groups performed significantly worse than the control group, the extent of 
PM failures was associated with the extent of ecstasy exposure. It was therefore 
suggested that more frequent users of ecstasy performed worse than infrequent 
users in the laboratory-based measure of PM.  
 
In relation to the role of RM, Rendell et al’s (2007) study suggested that RM 
failures are not sufficient to account for the magnitude of the PM impairments 
observed, as the regular tasks have minimal demands on RM and yet were 
significantly impaired. Also, in this study the majority of errors included misses 
(i.e., failures to respond) or late responses rather than wrong content (i.e., forget 
what was supposed to be done). Consequently, this study suggests that 
ecstasy/polydrug users are impaired in their time and event-based PM and that 
these impairments in PM are not because of RM failure.  
 
The ‘Virtual week’ has also been used to investigate the effects of other 
recreational drugs. For example, Rendell et al. (2009) found that long-term 
abstinent methamphetamine users were also impaired on the measure in 
comparison to a drug naive control group. Impairments were also evident in 
measures of verbal learning, delayed recall (RAVLT), forward and backward digit 
span, and the Hayling sentence completion task (believed to load on the inhibitory 
executive process). Interestingly, the extent of the methamphetamine-related 
effect in PM was found to co-vary substantially with the degree of impairment on 
the Hayling task (Rendell et al., 2009). The virtual week paradigm has also 
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featured in a number of other studies. For example, Leitz et al. (2009) 
demonstrated that performance on the measure was impaired following the acute 
administration of alcohol. This deficit was eliminated when individuals were 
asked to simulate the required actions at the time of encoding (by imaging the full 
sensory aspects of the context in which the action was to be completed; 
Paraskevaides et al., 2010).  
 
The paradigm has also been used to investigate the basis of PM deficits in 
individuals with mild cognitive impairment and dementia (Thompson et al., 
2010), multiple sclerosis (Rendell et al., 2007b) and schizophrenia (Henry et al., 
2007). Therefore, although somewhat contrived and artificial in nature, the 
‘Virtual week’ provides a more objective measure of PM that detects PM deficits 
in a variety of populations augmenting the traditional self-report measures that 
have been employed by most of the studies in the area of recreational drug use.    
 
Although self-report ecstasy-related PM deficits are well documented (Heffernan 
et al., 2001a,b; Rodgers et al., 2001;2003) the use of self-report measures or of 
single PM tasks are of limited value as performance cannot be discriminated 
beyond being correct or incorrect on a limited number of one-off trials (Zakzanis 
et al., 2003). These studies therefore provide relatively limited information 
regarding the extent, scope or implications of problems experienced by ecstasy 
users. They also fail to investigate the conditions under which PM failures are 
most likely to occur (Rendell et al., 2007). The ‘virtual week’ is an attempt to 
overcome the limitations that self-report measures retain and affords the 
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opportunity to distinguish event and time-based PM and also to investigate the 
role of RM in PM failures.  
 
Whilst the virtual week paradigm has its advantages, the test clearly has an 
associative learning component. For example, before the PM element can be 
completed, the participant is required to learn each of the ten particular responses 
associated with specific locations on the board and to select the appropriate 
response from among the set of available alternatives each time a PM action is 
triggered. Also, some responses are common to different tasks making it easier for 
the participant to complete the task.  Montgomery et al. (2005) have demonstrated 
that ecstasy users are impaired on paired associative learning. It is therefore 
possible that some of the deficits observed on the ‘virtual week’ might be 
attributable to associative learning rather than the PM components. In fact, just 
over half of the virtual week PM sub-tasks are regular and more repetitive in 
nature and thus more readily learned. It is the remaining more irregular tasks that 
have a more substantial learning requirement. In Rendell et al.’s (2007a) study, 
ecstasy users performed worse on these irregular virtual week tasks recording 
65% of the level of correct responses achieved by non-users while for regular 
tasks the percentage was 83%. This suggests that performance is indeed adversely 
affected by the learning component. Nevertheless, there was no statistically 
significant interaction between user group and task type with users demonstrating 
a significant deficit overall. Thus, while group differences in learning may 
partially account for the virtual week results the outcomes obtained are 
nonetheless consistent with an ecstasy-related PM deficit. 
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5.3.2 Rivermead Behavioural Memory Test (RBMT) 
 
In another attempt to offer a more objective perspective for PM failures in ecstasy 
users, Zakzanis et al. (2003) have employed the RBMT (Wilson, 1991) to test 
event and time-based PM. Fifteen abstinent (2 weeks) ecstasy users and 17 non-
ecstasy users completed the RBMT. The authors tested PM memory using three of 
the subscales of the RBMT asking participants to remember to ask for a belonging 
at the end of the test session, ask a specific question when an alarm clock sounded 
and deliver a message at a specific point during testing. Ecstasy users remembered 
to successfully carry out these delayed intentions on significantly fewer occasions 
compared to the control group. It was also suggested that the ability to recall a 
future appointment is related to the frequency of ecstasy use.  
 
Understanding the important contribution of cannabis in memory functioning and 
specifically to PM, McHale and Hunt (2008) investigated cognitive function in 
short-term abstinent cannabis users employing measures of phonemic verbal 
fluency, visual recognition, immediate and delayed recall and PM. Cannabis users 
were compared against a drug free control group and a tobacco using control 
group. Cannabis users compared to both control groups, demonstrated deficits on 
verbal fluency, visual recognition, delayed (but not immediate) visual recall and 
also short-term and long-term PM. This study is one of the few studies in the area 
of recreational drug use that has employed simple laboratory measures for 
measuring PM. The authors measured both time and event-based PM using the 
belonging subtest (remember to ask for a belonging at the end of the test session) 
of the RBMT (Wilson, 1991) to measure event-based PM. Time-based PM was 
measured using short interval (10 minutes) and long-interval (2 days) tasks. The 
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short interval task required the participant to press a timer exactly 10 minutes after 
being instructed to do so. The long-interval task required the participant to post an 
envelope exactly 2 days after the date of the test session. Results suggested that 
cannabis users were impaired in both short and long interval time-based PM in 
comparison to the control groups but not on the event-based task.  
 
The RBMT has been extensively used to measure everyday memory performance 
in age-related literature (Melendez-Moral et al., 2010; Fraser and Glass, 1999), 
autism spectrum disorder (Jones et al., 2011), Schizophrenia (Guaiana et al., 
2004; Tyson et al., 2005), dementia (Glass, 1998); TBI (Anderson et al., 1999; 
Wills et al., 2000) and post-traumatic stress disorder (PTSD; Moradi and Neshat, 
1999). It has also been used in measuring event-based and time-based PM (using 
three sub-tests) in a number of studies within the area of recreational drug use 
(Zakzanis et al., 2003; McHale and Hunt, 2008) and with elderly people 
(Cockburn and Smith, 1994). In addition, it has been used in a few studies to 
measure immediate and delayed recall in ecstasy/polydrug users (Morgan, 1999; 
Zakzanis and Young, 2001). The RBMT has therefore been proven to be a 
powerful tool in detecting both everyday and PM difficulties in clinical and non-
clinical populations. Validity and reliability of this laboratory-based measure has 
been documented in a number of studies (e.g., Man et al., 2009; Wilson et al., 
1989).   
 
5.3.3 Cambridge Prospective Memory Test (CAMPROMPT) 
 
Another laboratory measure that distinguishes event and time-based PM is the 
CAMPROMPT (Wilson et al., 2005). The CAMPROMPT is a more up-to-date 
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test battery that is sensitive to individual differences both within clinical and 
normal populations (Fleming et al., 2008; Groot et al., 2002; Wilson et al., 2005). 
It is a standardised neuropsychological test that relates to Einstein and McDaniel’s 
(1990) paradigm (see Chapter 2). It consists of a total of six PM tasks, three cued 
by time and three cued by events. Participants are asked to work on some 
distractor tasks such as word-finder puzzles or a general knowledge quiz for a 
twenty minute period while they had to remember to perform the PM tasks. The 
participants are allowed to spontaneously use strategies, such as taking notes, to 
help them remember. Total scores are generated on both time-based and event-
based subscales with higher scores reflecting better PM performance. The validity 
and reliability of the CAMPROMPT has been documented in a number of studies 
(i.e., Fleming et al., 2008; Groot et al., 2002; Wilson et al., 2005).  
 
For instance, in a study by Groot, Wilson, Evans and Watson (2002) performance 
on an earlier version of the CAMPROMPT was found to be significantly poorer 
for a group of TBI patients in comparison to a control group. Groot et al. (2002) 
also found that the CAMPROMPT correlated significantly with measures of 
memory, attention and executive functioning. A later edition of the 
CAMPROMPT has since been published and is considered a highly valid tool for 
measuring PM in the TBI population. For example, Fish et al. (2007) used the 
CAMPROMPT to measure PM deficits in individuals with non-progressive brain 
injury and Fleming et al. (2008) assessed PM performance in adults with severe 
TBI using the CAMPROMPT’s time-based and event-based sub-scales as well as 
the incidence of note-taking. The authors concluded that patients with longer 
periods of post-traumatic amnesia (PTA) and EF impairment  display poorer 
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PM. Additionally, the CAMPROMPT has also been used to measure PM deficits 
in individuals with bipolar disorder (BD; Lee et al. 2010). 
  
In a more recent study Heffernan et al. (2010a) investigated whether persistent 
smoking leads to impairments in self-report and objective measures of PM. 
Eighteen smokers and 22 non-smokers were assessed on the PRMQ questionnaire 
and on the CAMPROMPT. After controlling for ecstasy, cannabis and alcohol, 
results suggested that the two groups did not differ significantly in PM or RM as 
assessed by the PRMQ. Nevertheless, smokers were worse in terms of total recall 
on the CAMPROMPT recalling significantly fewer time-based, and event-based 
elements in comparison to the non- smoking group.  
 
On the whole, these findings suggest that the CAMPROMPT is a more sensitive 
objective tool in detecting PM deficits than traditional self-report measures and 
demonstrates the importance of not relying solely on self-report measures, but the 
need to use laboratory tests to detect PM impairment. Nevertheless, the greatest 
advantage of the CAMPROMPT is that, as opposed to the RBMT, it is more 
sensitive in detecting PM problems in non-clinical population. 
 
5.4 Chapter summary 
 
It is evident from the literature that ecstasy/polydrug users are impaired on 
measures of PM. Most studies in the area have employed self-report measures to 
capture any possible PM deficits in recreational users of ecstasy (Heffernan et al., 
2001a,b; Rodgers et al., 2001;2003; Montgomery and Fisk, 2008; Fisk and 
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Montgomery, 2008). Although self-report measures are found to be reliable in 
detecting PM difficulties it is possible that self-perceptions might be distorted. For 
instance, drug users may arrive at the laboratory with the expectation that they 
will underperform (Cole et al., 2006; Bedi & Redman, 2008). This expectation 
can affect their responses on self-report measures exaggerating the extent of any 
deficits present. Also, since the questionnaires assess memory, people 
experiencing memory impairment might not be able to remember and thus report 
memory lapses.  
 
Furthermore, self-report measures of PM fail to capture the distinction between 
time-based and event-based PM tasks (retrieval phase) and concentrate on the 
storage/retention phase of PM i.e., action to be performed in the short or long-
term. Although, objective measures such as the ‘virtual week’ have been 
employed in recent years to overcome this limitation, they have been rather 
artificial and contrived. In particular, the ‘virtual week’ paradigm although 
undoubtedly possessing a PM component, also involves associative learning in 
which ecstasy users are known to show impairment (Montgomery et al., 2005) 
making it unclear whether the deficits observed are due to the PM or learning 
aspects. Consequently, the need to employ more ecologically valid measures to 
assess PM is essential. In order to address some of these limitations this research 
will include simple laboratory measures of PM (event and time-based PM tasks as 
well as short-term and long-term PM tasks) that are designed to be more 
naturalistic and where the PM component is less obvious to the participant 
including the CAMPROMPT (see Chapter 7 and 8). Although CAMPROMPT 
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seems to be rather artificial as a laboratory measure, its main advantage is that it’s 
useful and reliable with non-clinical population as opposed to the RBMT.   
 
As well as the obvious PM impairments in recreational users of ecstasy, 
neuropsychological evidence suggests that Executive Functions (EF) is also 
impaired in ecstasy/polydrug users (Fox et al., 2001; Fisk et al., 2004). In view of 
the potential role of EF in underpinning PM performance, the next chapter will 
evaluate the impact of the recreational use of ecstasy on measures of executive 
functioning.    
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Chapter 6: Executive dysfunction 
in Ecstasy/polydrug users 
 
 
Chapter overview 
It is evident from the previous chapter that PM is impaired in recreational users 
of ecstasy. Other lines of investigation suggest that ecstasy users also face other 
cognitive deficits. The working memory system in general and the executive 
system in particular appear to be affected by the neurotoxic effects of ecstasy. 
Although a lot of studies have investigated the effect of ecstasy on the executive 
processes, it remains unclear why ecstasy users may be impaired in some 
executive function tasks and not others. Most studies in the area have used 
laboratory measures to assess executive dysfunction in ecstasy users that map 
onto Miyake et al’s (2000) theoretical perspective of executive function. This 
chapter will therefore explore the plethora of studies investigating the effect of 
recreational drug use grouping them according to Miyake et al’s three major 
components of EF, updating, shifting and inhibition. Previews reviews on the 
impact of ecstasy on EF suggested that ecstasy-related deficits do not appear on 
all cognitive tasks or in all studies (Morgan, 2000; Parrott, 2000; Murphy et al., 
2009). It is therefore essential to summarise the most important  findings in this 
area in order to establish a coherent understanding of the ecstasy-related effect 
on different components of EF. This chapter will therefore provide a concise 
account of ecstasy–related deficits on the multidimentional construct known as EF 
and the components affected by the neurotoxic effects of ecstasy.    
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Executive functions, as previously discussed, are a group of higher level abilities 
of organisation and integration. EF have been neuroanatomically associated with 
different neural pathways involving the PFC (Roberts et al., 1994). These are 
believed to be underpinned by both serotonin and dopamine systems and are 
potentially compromised by the disruption of these systems (Kish, 2002). 
Functional neuroimaging studies have shown that the majority of these metabolic 
reductions (e.g., reduction in the concentration of serotonin transporters SERT) 
due to the use of ecstasy are concentrated in the dorsolateral and parietal 
prefrontal regions (Cohen et al., 1996). It is therefore possible that recreational 
users of ecstasy demonstrate executive dysfunction during neuropsychological 
assessment. In fact, plenty of neuropsychological evidence suggests that ecstasy 
users face difficulties in different aspects of EF (Fisk et al., 2004; Fisk & 
Montgomery, 2009b; Montgomery et al., 2005; 2007; Montgomery & Fisk, 2008; 
Morgan, 2000; Wareing et al., 2004;).  
 
6.1 Recreational use of ecstasy and working memory 
 
The term WM, according to Baddeley (2000), combines short-term storage 
processes with other aspects of cognitive activity such as learning and reasoning. 
WM is responsible for the storage and retrieval of task-related material as well as 
additional processing relevant to the task (Shah & Miyake, 1999). The allocation 
of processing resources necessary for the successful completion of a task is part of 
the executive function of WM and plays a central role in recruiting cognitive 
resources needed for the person to manage the demands of a task (Murphy et al., 
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2009). WM is known to involve both executive and non-executive processes. 
Specific executive processes of WM have been identified by different techniques 
i.e. logical deduction (Baddeley, 1996), latent variable analysis (Miyake et al., 
2000; 2001) and exploratory factor analysis (Fisk & Sharp, 2004) on data from 
tasks likely to utilize executive processes. The key executive processes that have 
been identified include the updating of WM, shifting mental set, the inhibition of 
prepotent responses and access to semantic long-term memory.  
 
 A number of neuropsychological studies showed that the severity of ecstasy use 
can selectively affect WM (Bolla et al., 1998; Fox et al., 2001; Gouzoulis-
Mayfrank et al., 2000; Verdejo-Garcia et al., 2005). Several processes are known 
to load heavily on the WM components; it is therefore possible that these 
processes are also affected by the neurotoxic effects of ecstasy. For example, 
aspects of WM have been implicated in reasoning performance (Fisk & Sharp, 
2002; Gilhooly et al., 1999; Gilinsky & Judd, 1994), and consistent with this 
ecstasy use appears to impair reasoning processes (Fisk et al, 2005). Other studies 
have demonstrated ecstasy/polydrug related impairment in tasks believed to load 
on updating (Fisk et al., 2004; Montgomery et al., 2007; Wareing et al., 2004), 
access to long-term memory (Fisk et al., 2004; Montgomery et al., 2007; 
Montgomery et al., 2005), and visuospatial WM (Fisk & Montgomery, 2009b; 
Montgomery & Fisk, 2008). It is therefore possible that ecstasy users are impaired 
in these constructs.  
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6.1.2 Updating of WM and access to long term memory 
 
Recreational use of ecstasy is known to have adverse effects on the process of 
updating WM and access to long-term memory. For example, Wareing et al. 
(2004) measured updating in a sample of 42 current ecstasy users, 17 former users 
and 31 non-ecstasy users using a reading span and a computational span task. 
Both user groups showed deficits on both measures of updating in comparison to 
the non-ecstasy user group, an effect that remained after controlling for age, other 
drug use and passive memory storage differences. Similarly, Fisk et al. (2004) 
found updating impairments using the computation span measure in 
ecstasy/polydrug users in comparison to non-ecstasy users even after controlling 
for the use of other drugs.  
 
Also, Montgomery et al. (2007) assessed 103 ecstasy users and 103 non-ecstasy 
users on two updating tasks (i.e., the computation span and consonant updating 
task) and a task measuring access to long-term memory (i.e., Chicago word 
fluency task). After controlling for age, IQ, levels of sleepiness and the concurrent 
use of other drugs the authors found that ecstasy users reported deficits on all 
three EF tasks implicating the recreational use of ecstasy with impairments in 
updating and access to long-term memory. Current ecstasy users in comparison to 
former users, also demonstrated deficits in updating tasks (i.e., the computational 
span); an effect that was unrelated to information processing speed difficulties 
(Wareing et al., 2007).  
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6.1.3 Visuospatial Working Memory (VSWM) 
 
Although deficits in updating and access to long-term memory are clear, 
visuospatial deficits are not as clear cut among ecstasy users. Even though 
evidence suggests that ecstasy use is associated with visuospatial deficits, much of 
the existing research has focussed on visual recall and recognition and not 
VSWM. A number of studies have found ecstasy-related deficits in the ability to 
recall, reconstruct or recognise previously viewed complex visual stimuli (e.g., 
Bolla et al., 1998; Gouzoulis-Mayfrank et al., 2000; Fox et al., 2001; Verkes et 
al., 2001). Although these ecstasy-related impairments on visual processing are 
useful in providing information of the adverse effects of recreational use of 
ecstasy, such processes recruit occipital and medial temporal resources rather than 
prefrontal processes (Dafters et al., 1999; Chang et al., 2000).   
 
Instead, VSWM involves more than just the ability to recall or recognise visual 
information. It involves the temporary storage, maintenance, processing and 
manipulation of visuospatial information in search of goal‐related behaviours and 
is more dependent on prefrontal cortical resources and therefore on executive 
processes (Cabeza & Nyberg, 2000). A number of studies have demonstrated that 
VSWM is affected by the recreational use of ecstasy (e.g., Fox et al., 2002; 
Wareing et al., 2005). For example, Fox et al. (2002) assessed VSWM using a 
spatial WM task in a sample of ecstasy/polydrug users and non-ecstasy users. 
Ecstasy/polydrug users in comparison to the non-ecstasy user group performed 
significantly worse on the spatial WM task consistent with ecstasy-related VSWM 
deficits. Using the same measure, Semple et al. (1999) found that although users 
did not differ significantly from nonusers, there was a significant association 
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between lifetime ecstasy use and the number of errors on the task. Furthermore, in 
a study measuring updating and VSWM in current and former ecstasy users 
against a non-ecstasy user group, both user groups demonstrated deficits in 
VSWM and updating (Wareing et al., 2005). VSWM deficits using a VSWM span 
task were also demonstrated in ecstasy/polydrug users in relation to non-ecstasy 
users (Wareing et al., 2004).  
 
De Sola LLopis (2008) also measured VSWM in a community sample with 
follow-ups at 6, 12 and 24 months. Thirty seven ecstasy/polydrug users, 23 
cannabis-only users and 34 drug naïve controls completed the Corsi block tapping 
task (specifically the backward sequence span). The author found that, at baseline, 
heavy ecstasy/polydrug users (with total lifetime of ecstasy use more than 100 
tablets) showed visuospatial memory impairments that persisted even after 24 
months. Finally, a recent study that sought to determine whether ecstasy use is 
associated with deficits in serial spatial recall and VSWM in a sample of current 
ecstasy/polydrug users, previous ecstasy/polydrug users and non-ecstasy users 
found that both current and previous ecstasy users exhibit impairments in VSWM 
performance (Fisk et al., 2011). It is therefore evident that VSWM performance is 
problematic in ecstasy users.  
 
Although VSWM deficits are evident in ecstasy users, simple visuospatial 
memory impairments are not so clear cut. While some studies identified ecstasy-
related visuospatial memory deficits using the Corsi blocks paradigm (e.g., 
Verkes et al., 2001; Hanson & Luciana, 2010) some others failed to show 
impairments using the same paradigm (e.g., Gouzoulis‐Mayfrank et al., 2000; 
108 
 
Reneman et al., 2006).  No visuospatial memory deficits in ecstasy users were 
also demonstrated in a number of other studies that employed the simple spatial 
span task as a measure of visuospatial memory (e.g., Fisk & Montgomery, 2009; 
Montgomery & Fisk, 2008; Morgan, 1998). For example, Montgomery and Fisk 
(2008) assessed the process of updating the contents of visuospatial memory in a 
large sample of ecstasy/polydrug users and non-ecstasy users. It was found that 
although ecstasy users showed updating deficits, their performance did not differ 
from the non-ecstasy user group in the spatial span test. Similar findings were 
observed on a later study by the same authors. Both heavy and light user groups in 
this study as opposed to the non-ecstasy user group demonstrated deficits on 
measures of updating. Nevertheless, the performance of the three groups did not 
differ on the measure of simple spatial span (Fisk & Montgomery, 2009).   
 
It is therefore evident from the aforementioned research that although ecstasy 
users seem to be underperforming in measures of VSWM, ecstasy-related deficits 
are not as evident in simple visuospatial memory tasks. A possible explanation for 
these results may be that ecstasy-related deficits are evident on tasks loading 
heavily on WM and executive resources (Fisk et al., 2005). For instance, tests 
such as the spatial span involve only a modest processing requirement and a 
relative small memory load. It is therefore possible that ecstasy-related deficits are 
not evident on these tasks because of their low WM load. On the other hand, tasks 
that involve dual task performance such as verbal or visual judgements combined 
with serial recall (e.g., the spatial working memory span) are thought to involve 
an increased memory load and are more dependent on WM resources. 
Consequently, ecstasy-related deficits are more apparent.  
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6.2 Shifting 
 
Shifting between tasks or mental sets refers to the ability to shifting back and forth 
between multiple tasks, operations, or mental sets (Monsell, 1996). It can also 
referred as ‘‘attention switching’’or ‘‘task switching,’’ and it is an important 
function in understanding both failures of cognitive control in brain-damaged 
patients and laboratory tasks that require participants to shift between tasks 
(Monsell, 1996). Models of attentional control, such as the supervisory attentional 
system (SAS) (Norman & Shallice, 1986), often assume that the ability to shift 
between tasks or mental sets is an important aspect of executive control. The most 
common explanation of this EF is that the Shifting process involves the 
disengagement of an irrelevant task set and the active engagement of a relevant 
task set (Miyake et al., 2000). Relatively few studies have been contacted to 
investigate the performance of ecstasy users for the shifting component of EF. 
The most common laboratory tasks for assessing shifting in ecstasy users include 
the Trail Making Task-B (TMT-B), the Plus/minus task, the number/letter task 
and the WCST. 
 
A few studies have employed the TMT-B to measure shifting in ecstasy users. 
This test requires the participant to connect numbers and letters in an alternating 
pattern (e. g., 1-A-2-B-3-C etc.) in as little time as possible. As TMT-B requires 
attentional switching between the letters and numbers, it is more cognitively 
demanding and thus requires more time. Semple et al. (1999) used the TMT-B to 
measure shifting in ecstasy users. The authors failed to find any ecstasy-related 
differences between 10 regular ecstasy users and 10 polydrug users. Also, 
comparing a sample of 30 current heavy ecstasy users, 31 former ecstasy users, 29 
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polydrug controls and 30 drug naive controls, Thomasius et al. (2003) observed 
no significant differences using the TMT-B task. This was supported by McCardle 
et al. (2004) who found no ecstasy-related group differences on the TMT-B in a 
sample of 17 ecstasy users compared to 15 non-ecstasy user controls. 
Furthermore, Morgan et al. (2002) used the TMT-B task to assess executive 
function in four groups: 18 current ecstasy users, 15 former ecstasy users, 16 
polydrug controls (with similar drug use histories to the ecstasy groups) and 15 
drug naive controls. Although completion times for TMT-B did not differ 
significantly between the groups, ecstasy users did commit significantly more 
errors on this task (current users committed slightly more than previous users 
although this was non-significant).  
 
With regards to the plus/minus task (Jersild, 1927; Spector & Biederman, 1976; 
Miyake et al., 2000), three lists two-digit numbers are given to the participant. On 
the first list participants are instructed to add 3 to each two-digit number as 
quickly and accurately as possible. On the second list participants need to subtract 
3 from each number, and finally on the third list the participants are required to 
alternate between adding and subtracting 3 from the two-digit numbers. The cost 
of shifting is calculated as the difference between the number of correct answers 
given in the alternating list and the average of those in the addition and 
subtraction lists within the given time periods. In terms of the number/letter task 
(Rogers & Monsell, 1995), participants are presented with a number/letter pair 
(e.g. 8F) usually in one of four squares on a computer screen. Participants need to 
indicate whether the number was odd or even when the number–letter pair is 
presented in the top two squares and also whether the letter was a consonant or a 
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vowel when the number–letter pair was presented in the bottom two squares. The 
trials within the first two blocks required no task switching, whereas half of the 
trials in the third block required participants to shift between these two types of 
categorization operations. Similar to the plus–minus task, the shift cost for this 
task is the difference between the average response times of the trials in the third 
block that required a mental shift and the average response times of the trials in 
which no shift is necessary.  
 
The only study in the area of recreational drug use that used the plus/minus and 
number/letter tasks to measure shifting is Montgomery et al. (2005). The authors 
assessed shifting performance using these tasks in 51 ecstasy/polydrug users and 
42 non ecstasy university students. No significant difference in performance 
between the two groups on any of the shifting tasks was observed suggesting that 
recreational use of ecstasy leaves the shifting component of EF unimpaired. 
Similar findings were also observed in a number of other studies using the 
Wisconsin Card Sorting Task (WCST; e.g., Fox et al., 2001; Thomasius et al., 
2003; McCann et al., 2007). As discussed in chapter 3, the WCST (Grant & Berg, 
1948; Heaton et al., 1981; Kimberg et al., 1997) requires participants to sort cards 
depending on colour, shape or number. The criterion for sorting changes without 
warning and the participant needs to be able to shift attention to find the new 
sorting criterion. Failure of the participant to shift attention (i.e., number of errors 
until realising the new criterion) is indicative of shifting impairment.  
 
On the whole, no significant differences between ecstasy users and the non-
ecstasy control group were observed using the WCST. For instance, no shifting 
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deficits using the WCST were present between 20 abstinent ecstasy users with 
self-reported ecstasy-related problems, 20 non-problematic users and 20 controls 
with some polydrug use (Fox et al., 2001). Thomasius et al. (2003) also measured 
executive shifting in 30 current ecstasy users, 31 former ecstasy users, 29 
polydrug users and 30 drug-naïve controls using the WCST. Age, education, IQ, 
psychopathology as well as alcohol, tobacco and concurrent drug use were 
controlled in the study. Ecstasy users showed no performance deficits in the 
WCST with both user groups making significantly fewer errors than polydrug 
controls leaving open the question as to which drug is responsible for deficits in 
executive shifting. Reneman et al. (2006) and McCann et al. (2007) measuring 
shifting using the WCST also failed to find performance deficits between ecstasy 
users and non-ecstasy controls.      
 
Traditionally, studies in the area of recreational drug use recruit participants that 
are polydrug users because of the difficulty to recruit a sample of ecstasy users. 
The only study that reported ecstasy-related deficits on the WCST and the shifting 
component of EF in abstinent ecstasy users was the study of Halpern et al. (2004). 
The authors recruited participants from a region in USA where cultural and 
religious norms minimises the exposure to other drugs including alcohol. 
Consequently, 11 heavy ecstasy-only users, 12 moderate ecstasy-only users and 
16 drug naïve controls completed the WCST. Age, gender, parental education, 
parental household income, family substance abuse history and family psychiatric 
history were controlled using regression analysis. Heavy users demonstrated 
shifting deficits when age, gender and family of origin variables were controlled. 
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This evidence therefore suggested that recreational use of ecstasy might have an 
effect on executive shifting.  
 
6.3 Inhibition 
 
The third executive component is inhibition. Inhibition refers to the ability to 
consciously inhibit dominant, automatic, or current responses when necessary. A 
popular measure of inhibition in the area of recreational drug use has been the 
Stroop Task (Stroop, 1935). During the task participants are required to verbally 
name the colour of a stimulus as quickly as possible while the reaction times are 
measured. The task is comprised of 72 trials where asterisks are printed in one of 
six colours (red, green, blue, orange, yellow or purple), 60 trials with a colour 
word printed in a different colour and 12 trials with coloured words printed in the 
same colour. The different trial types are mixed so the participants are required to 
consciously inhibit dominant, automatic responses. No ecstasy-related deficits on 
this task were reported in any of the studies. 
 
 For example, Gouzoulis-Mayfrank et al. (2000) found no performance deficits on 
the Stroop task between a sample of ecstasy users, cannabis-only users and drug 
naïve controls. Morgan et al. (2002) also administered the Stroop Task to measure 
inhibition in a sample of 18 current ecstasy/polydrug users, 15 former 
ecstasy/polydrug users, 16 polydrug users and 15 drug naïve controls. No 
significant differences in the Stroop Task were observed between the four groups 
suggesting that inhibition does not appear to be impaired in recreational ecstasy 
users. Inhibition was also measured with regard to ecstasy dosage. For instance, 
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the stroop task was administered to a sample of moderate ecstasy users, heavy 
current ecstasy users, former ecstasy users and polydrug controls (Reneman et al., 
2006). Once again no performance deficits on the Stroop were observed between 
the groups suggesting that ecstasy exposure also leaves the inhibition component 
of EF unimpaired. 
 
Contrasting with the aforementioned findings, some studies have reported 
significant group differences using the Stroop Task (Croft et al., 2001; Yip & Lee, 
2005; Dafters, 2006). For example, Croft et al. (2001) assessed inhibition in a 
sample of 11 ecstasy/cannabis users, 18 cannabis users and 31 near-drug-naïve 
controls. The authors found that higher MDMA consumption predicted slower 
speed processing in the Stroop task. However, these findings were equivocal since 
the initial ANOVA showed no significant main effect for processing speed across 
their 3 groups while a subsequent ANCOVA analysis with both user groups 
combined and measures of cannabis and ecstasy use as covariates established that 
ecstasy was more strongly related to the performance deficits than cannabis. 
Homogeneity of regression results were not reported in this analysis. Yip and Lee 
(2005) also reported deficits on the Stroop tasks between ecstasy users and drug 
naïve controls. This is a rare study as the ecstasy user group was characterised 
solely by ecstasy use and no other recreational drug including tobacco and 
alcohol. In this study discriminant function analysis significantly classified 
ecstasy users with 99% accuracy based on response time. However, after 
controlling for multiple comparisons, users’ task performance was not 
significantly worse than that of drug naïve controls. Also, ecstasy consumption 
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did not correlate with task performance. It is therefore appears that the findings of 
this study are equivocal.  
 
The tower of London (TOL) is another common measure of inhibition that has 
featured in the recreational drug use literature. This measure requires the 
participants to move coloured balls between different pegs in order to achieve a a 
pre-specified goal configuration in the smallest number of moves. The number of 
moves made to complete the task is a measure of inhibition, i.e., fewer moves is 
indicative of better inhibition performance. Morgan (1998) in a series of two 
studies administered the TOL in a sample of 16 ecstasy/polydrug users, 12 non-
ecstasy users and 16 drug naïve controls for study one and to 25 ecstasy/polydrug 
users, 20 non-ecstasy polydrug controls and 19 drug naïve controls for study two. 
No significant group differences were observed in either of the studies suggesting 
that the inhibition component (measured by TOL) is not impaired in recreational 
users of ecstasy. No inhibition deficits were also observed in a later study using 
the TOL between ecstasy/polydrug users and polydrug controls (Fox et al., 2002). 
 
Despite these non-significant results, some studies have reported ecstasy-related 
deficits on the inhibition component using the TOL. For instance, Fox et al. 
(2001) found impairments on the inhibition component in a sample of self-
reported problematic ecstasy users in comparison to non-problematic users and 
non-ecstasy controls. More specifically, problematic ecstasy users showed 
significantly longer solution times compared to controls with some level of 
polydrug use, whilst non-problematic users showed significantly longer initial 
planning times than both the control group and problematic users. Nevertheless, 
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no performance deficits were reported for the number of errors or trials 
completed. Finally, although De Sola Llopis (2008) found no intergroup 
differences for the total number of movements or for initiation time, estimated 
lifetime ecstasy use was significantly correlated with the total number of 
movements suggesting that ecstasy use is associated with performance on the task.  
 
6.4 Differential effects of ecstasy, cocaine, and cannabis use on Executive 
Function 
 
Although it is evident from the EF literature that ecstasy impairs the updating 
component and tasks that load on WM, the ecstasy-related deficits on inhibition 
and shifting are less evident. Recent neuropsychological studies have investigated 
the differential effects of ecstasy, cannabis and cocaine on executive components 
in order to determine whether these executive components are susceptible to 
other recreational drugs (Verdejo-Garcia & Perez-Garcia, 2007; Verdejo-Garcia 
et al., 2005; Fernandez-Serrano et al., 2010; Madoz-Gúrpide
 
et al., 2011). For 
instance, Verdejo-Garcia et al. (2005) investigated the severity of consumption of 
different drugs and neuropsychological performance on tasks sensitive to 
executive components of working memory, response inhibition, cognitive 
flexibility, and abstract reasoning. Thirty-eight polysubstance abusers completed 
the different tasks along with a severity of drug consumption interview. Using 
multiple regression analyses the authors found that severity of ecstasy use had an 
impact on working memory and abstract reasoning indices whilst severity of 
cocaine use was associated with the inhibitory control index. Severity of cannabis 
use was associated with the cognitive flexibility index.  
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Verdejo-Garcia and Perez-Garcia (2007) also suggested that chronic use of 
cocaine has adverse effects on executive functioning. In their study two groups of 
participants were recruited i.e., abstinent polysubstance users and drug free 
controls. Polysubstance users were further subdivided based on their drug of 
choice (cocaine vs heroin). Tests of fluency, working memory, reasoning, 
inhibitory control, flexibility, and decision making were administered. It was 
found that abstinent polysubstance users had clinically significant impairments on 
all executive components. In fact, cocaine polysubstance users had more severe 
impairments than heroin users and controls on measures of inhibition (using the 
Stroop Task) and shifting (using the go/no go and category test). Indeed, greater 
severity of drug use predicted poorer performance on updating measures. These 
finding therefore suggest that chronic drug use is associated with widespread 
impairment on executive components, with cocaine use inducing more severe 
deficits on inhibition and shifting.  
 
Further evidence for the involvement of cocaine in EF comes for a recent study 
that investigated the relationship between executive deficits and three measures 
of severity of cocaine use: years of use, quantity used, and frequency of use. 
Twenty-four cocaine users were compared with twenty-seven community 
controls on several neuropsychological tests of EF. Chronic cocaine users in 
comparison to the drug naïve controls performed worse on measures of attention 
and working memory, set-shifting abilities, cognitive test of mental flexibility 
and response inhibition and the WCST. All three aspects of cocaine use were 
associated with most of the EF measures suggesting that increased cocaine use is 
associated with more EF problems (Madoz-Gúrpide
 
et al., 2011).  
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Besides the aforementioned cocaine-related effect on several executive 
components, the use of cannabis can also affect adversely EF. For example, the 
use of cannabis was also implicated in deficits on the updating component. 
Montgomery et al. (2005) showed that in relation to non-ecstasy users, ecstasy 
users demonstrated deficits on updating and access to long-term memory tasks. 
The authors also found that cannabis use was negatively correlated with updating 
performance while cocaine use was associated with long-term memory access. 
Also, chronic cannabis users have shown WM deficits on several measures from 
the Cambridge Neuropsychological Test Automated Battery (CANTAB) 
including Rapid Visual Information Processing, Pattern Recognition Memory, 
Spatial Recognition Memory, Spatial Span, Spatial Working Memory and 
Visuospatial Paired Associate Learning (Harvey et al., 2007; Solowij et al., 2008). 
Furthermore, long-term cannabis users were found to be impaired on measures of 
inhibition (such as the Stroop task, Go/NoGo and a variety of decision-making 
and gambling tasks) (Solowij et al., 2002; Bolla et al., 2002; 2005; Smith et al., 
2004; Hester et al., 2009).  
 
It is therefore apparent that different drugs affect executive components in distinct 
ways. Although the recreational use of ecstasy only affects the updating 
component and tasks loading on WM, it leaves the inhibition and shifting 
components intact. Other recreational drugs such as cocaine and cannabis, 
however, have adverse effects on these components. It is therefore crucial to 
evaluate the contribution of these drugs when investigating executive functioning 
in ecstasy/polydrug users.  
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6.5 Chapter summary 
 
In summary, it is evident from the existing literature that ecstasy-related deficits 
exist in laboratory measures of EF. Although, it seems that the updating 
component and in general tasks that load on WM are susceptible to the effects of 
ecstasy, there is little evidence to date to suggest that ecstasy use is associated 
with impairment on executive shifting or executive inhibition. It is therefore 
necessary to further investigate the effect of recreational drug use on these 
components using different laboratory or self-report measures that map on the 
construct components of executive shifting and executive inhibition. It is also 
evident from the ecstasy-related EF literature that assessment of EF is restricted to 
laboratory measures, that although offer strong internal validity, control over 
extraneous variables and the possibility of examining the component EF processes 
individually, laboratory measures are limited in terms of their ecological validity 
and in their ability to capture executive processes as they are manifested in the 
everyday environment (Gioia et al., 2008).  
 
In order to further investigate the effect of recreational use of ecstasy on executive 
components and provide an alternative method of assessment, the present 
investigation will use a self-report measure of EF; the BRIEF-A. As previously 
discussed in chapter 3, the BRIEF-A is a self-report measure of executive 
functioning which consists of nine subscales each including questions which 
involve everyday activities and contain an executive component. The BRIEF-A 
has been developed to capture the behavioural manifestations of executive 
dysfunction in the various interrelated domains of the construct that have been 
commonly discussed in the literature. It is also argued that the BRIEF-A, 
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measures subtle individual differences in discrete real world processes and unlike 
many laboratory tests it is unrelated to, and not contaminated by overall 
differences in general ability measures such as IQ (Bodnar et al., 2007).  
 
Having evaluated the current literature in ecstasy/polydrug use and its adverse 
effects on PM and EF, the following chapters will further investigate the 
ecstasy/polydrug-related effect on these processes. The present investigations will 
also address the identified grey areas in the literature of PM and EF in terms of 
assessing these multidimentional constructs. Consequently, chapters that follow 
will evaluate the impact of recreational use of ecstasy on prospective 
remembering and executive functioning by utilising different assessment 
approaches as opposed to the traditional measures adopted throughout the 
literature and assess components that have previously been neglected in the area 
of recreational drug use.   
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Chapter 7: Everyday and 
prospective memory deficits in 
ecstasy/polydrug users 
 
 
Chapter overview 
This chapter investigates the impact of ecstasy/polydrug use on real world 
memory i.e. everyday memory, cognitive failures and PM. Both laboratory-based 
and self-report measures of PM were administered to a sample of 
ecstasy/polydrug users and non-ecstasy users in order to determine whether 
ecstasy-related deficits were present. Self-report measures of cognitive failures 
and everyday memory were also administered. Everyday memory deficits were 
present in ecstasy/polydrug users. Also, deficits were observed on both laboratory 
and self-report measures of PM within the ecstasy/polydrug user population in 
comparison to non-ecstasy users. This study extends previous research by 
showing that PM deficits observed in recreational users of ecstasy are real and 
not attributed to self-misperceptions. Ecstasy/polydrug-related deficits were 
observed on both time and event-based PM and are not task specific. Surprisingly, 
recreational use of cocaine was also highly associated with PM deficits.  
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7.1 Introduction  
 
An important aspect of memory that has received increased attention in recent 
years is known as real world memory. In the present study, real world memory is 
assessed in terms of three separate but related aspects: everyday memory, 
cognitive failures and PM. Everyday memory and cognitive failures refer to an 
individual’s inability to remember to carry out simple everyday tasks, for 
example, forgetting the location of familiar objects around the house or 
workspace, failing to recognise acquaintances or to recollect important events that 
occurred previously. PM involves remembering to carry out a particular behaviour 
sometime in the future, for example, returning a library book on time, passing on 
a message or taking medication on time.  
 
Previous investigations have demonstrated a link between the use of recreational 
drugs and real world memory problems. For example, ecstasy/polydrug users 
(Montgomery & Fisk, 2008) and cannabis-only users (Fisk & Montgomery, 2008) 
showed deficits in a variety of self-report real world memory measures. Evidence 
for PM impairments in ecstasy/polydrug users (Heffernan et al., 2001a; 2001b) 
and cannabis users (McHale and Hunt, 2008) have also been demonstrated in 
other studies. It also appears that PM impairments might be drug specific and that 
cannabis is associated with “here and now” memory deficits in short-term habitual 
and internally cued PM and ecstasy with long-term PM problems (Rodgers et al., 
2001; 2003).  
 
Most studies in the area of recreational drug use have investigated PM 
performance using self-report measures of PM (Heffernan et al., 2001a; 2001b; 
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Fisk & Montgomery, 2008; Montgomery & Fisk, 2008; Rodgers et al., 2001; 
2003). Although these self-report measures are well validated and have been 
proven to be a powerful tool in detecting PM deficits in recreational drug users, 
they reflect participants’ self-perceptions concerning their memory ability. It is 
therefore possible that these self-perceptions are distorted. For example, drug 
users may arrive at the laboratory with the expectation that they will underperform 
(Cole et al., 2006; Bedi and Redman, 2008), an expectation that can affect their 
responses on self-report measures exaggerating the extent of any deficits present. 
It is also possible that people experiencing memory impairment might not be able 
to remember and thus report their memory lapses.  
 
Nevertheless, the most important limitation of self-report measures is that they 
somehow fail to capture the distinction between time-based and event-based PM 
tasks. Instead, self-report measures focus on  the period over which the PM task is 
executed i.e., the short-term or the long-term. From the existing self-report 
literature it is not clear whether ecstasy/polydrug users are impaired in event-
based, time-based PM tasks or on both types of PM task. It is therefore crucial to 
explore this as these two types of task utilise neural processes that are in part 
separable. Neuroimaging evidence suggests that event-based tasks utilise the 
frontopolar cortex including Broadmann area 10 (BA10; Burgess et al., 2003; 
Gilbert et al., 2005). Whilst time-based tasks not only activate  the frontopolar 
cortex, they also activate more diverse regions including the anterior medial 
frontal regions, the right superior frontal gyrus and the anterior cingulate (Okuda 
et al., 2007).  
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Although, as previously discussed in Chapter 5, objective measures such as the 
‘virtual week’ have been employed to overcome this limitation (Rendell et al., 
2007), they have been rather artificial and contrived in nature. There is a need to 
employ more ecologically valid measures to assess PM because if 
ecstasy/polydrug users are differentially affected on time and event-based PM 
tasks, this will provide further information on which specific neural locations are 
susceptible to specific drug-related effects. 
 
 In order to address the aforementioned limitations this investigation will include 
laboratory measures of event and time-based PM as well as short-term and long-
term PM in addition to the existing self-report measures of real world memory. 
These simple laboratory measures are designed to be more naturalistic, with the 
PM component being less obvious to the participant. Along with the designed 
laboratory measures of PM the Rivermead Behavioural Memory Test (RBMT-II; 
Wilson et al. 1999) will be administered. The RBMT is a laboratory measure of 
everyday memory that includes three PM tasks and it has been extensively used in 
the literature with a variety of populations (Anderson et al., 1999; Fraser and 
Glass, 1997; Guaiana et al., 2004; Jones et al., 2011; Melendez-Moral et al., 
2010; Tyson et al., 2005; Wills et al., 2000) but seldom if ever in the area of 
recreational drug use. Ecstasy/polydrug-related deficits were predicted on all 
measures. 
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7.2 Method 
 
Design 
All measures were analysed using a between participant design with user group at 
two levels (ecstasy users, non-ecstasy users) as the controlled variable. Observed 
variables included background measures such as age, intelligence, years of 
education, self-report health and consumption of cigarettes per day and units of 
alcohol per week. The recreational drugs cannabis and cocaine were also observed 
in terms of their total lifetime of use, frequency, current use and average use. Any 
group differences between these background variables were investigated by a 
series of independent sample t-tests. Where group differences reached 
significance, a further analysis was carried out using MANCOVA with the 
relevant background measure as a covariate.  
 
A series of two MANCOVAs was used to look at group differences for the 
laboratory-based and self-report measures separately where the self-report 
measures in one occasion and the laboratory-based measures on the other 
occasion were used as the dependent variables. Lifetime and frequency of 
cannabis use as well as alcohol and tobacco consumption were used as covariates 
in both cases. Pearson’s correlation coefficients were calculated between the real 
world memory measures and weeks since last use of the four most consumed 
drugs i.e. ecstasy, cannabis, cocaine and amphetamines. Regression analyses were 
also conducted with the lifetime use and frequency of use of the major drugs as 
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independent variables. Pearson’s correlation coefficients were also calculated 
between laboratory and self-report measures.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
 
 
Participants 
Forty two ecstasy/polydrug users (mean age= 21.67, Males=14, Female=28) and 
thirty one non-users (mean age= 21.03, Males=5, Females=26) took part in this 
investigation completing a range of both self-report and laboratory based PM 
measures. All participants completed a drug history questionnaire before taking 
part, describing their pattern of drug use. Measures of alcohol and smoking were 
also accessed in the drug use history questionnaire. Participants were recruited via 
direct approach to university students and the snowball technique i.e., mouth to 
mouth referral (Solowij, 1992). All participants were university students attending 
Liverpool John Moores University or the University of Central Lancashire. Due to 
the nature of the studies, there is some overlap in terms of the participants in some 
of the chapters. Please refer to appendix 1 for specific number of participants 
overlapping in each study. 
 
Materials 
The prior history of ecstasy consumption and the beliefs and behaviours 
associated with ecstasy were assessed using the background drug use 
questionnaire (see appendix 2 for a copy of the questionnaire). Participants were 
also questioned concerning their previous use of other drugs, and using a 
technique employed by Montgomery et al. (2005), these data were used to 
estimate the total lifetime use for each drug (e.g., ecstasy, cannabis, 
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amphetamines, cocaine, etc.). Length of use, average weekly dose and the amount 
of each drug consumed within the previous 10, 30, and 90 days was also assessed. 
Fluid intelligence was measured via Raven’s Progressive Matrices (Raven et al., 
1998). A further questionnaire assessed the number of years of education, the 
participant’s age and gender and their cigarette and alcohol consumption (see 
appendix 3 for the questionnaire).  
 
Self-report measures of Prospective memory 
 
Prospective memory Questionnaire (Hannon et al, 1995) 
 
 The Prospective Memory Questionnaire (PMQ) is an established self-report 
measure (Hannon et al., 1995) using a Likert-type scale to indicate likelihood of 
the occurrence of a memory lapse in set period of time. The PMQ provides 
measures of three aspects of PM on a scale of 1-9 for each aspect (1 revealing 
little forgetting, 9 revealing a great deal of forgetting). Fourteen questions 
measure short-term habitual PM, e.g., “I forgot to turn my alarm clock off when I 
got up this morning”. Fourteen items measure long-term episodic PM, e.g., “I 
forgot to pass on a message to someone”. Ten questions measure internally cued 
PM, e.g., “I forgot what I wanted to say in the middle of a sentence”. In addition, 
14 questions make up the “techniques to remember” scale, which provides a 
measure of the number of strategies used to aid remembering. For each of the four 
scales, a total score is calculated by summing the responses in each section and 
dividing them by the number of items in each section (14 for ST-habitual, LT 
episodic and strategies and 10 for internally cued). Thus high scores being 
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indicative of much forgetting and many strategies used to aid remembering. For a 
copy of the questionnaire please see appendix 4. 
 
Prospective and Retrospective Memory Questionnaire (PRMQ; Crawford et al., 
2003) 
 
The PRMQ provides a measure of memory slips in everyday life. It consists of 
sixteen items, eight related to PM failures e.g. ‘Do you decide to do something in 
a few minutes’ time and then forget to do it?’ and another eight related to RM e.g. 
‘Do you fail recognising a place you have visited before?’. Participants were 
asked to say how often these things happened to them on a 5-point scale: very 
often, quite often, sometimes, rarely or never resulting in minimum and maximum 
scores of 8 and 40 with higher scores indicative of PM difficulties. For a copy of 
the questionnaire please see appendix 5. 
 
Everyday Memory Questionnaire (EMQ; Cornish, 2000; Sunderland et al., 1983) 
 
The EMQ is a self-report measure of memory lapses in everyday activities. It 
consists of twenty seven statements with responses made on a 9-point scale 
ranging from ‘not at all in the last six months’ to ‘more than once a day’. 
Examples of items include ‘forgetting where you put something’ or ‘finding a 
television story difficult to follow’. A total score for everyday memory is 
calculated by adding the responses to all items with higher EMQ score being 
indicative of more everyday memory difficulties. For a copy of the questionnaire 
please see appendix 6. 
129 
 
Cognitive failures questionnaire (CFQ; Broadbent et al., 1982) 
 
The CFQ is a twenty five item measure of cognitive failures or of everyday 
attentional deficits. Items include ‘do you fail to notice signposts on the road?’. or 
‘do you forget what you came to the shops to buy?’. Responses are made on a 5-
point scale with zero corresponding to ‘never’ and four to ‘very often’. A 
maximum possible score of 100 can be obtained, with higher scores being 
indicative of more everyday attentional deficits. For a copy of the questionnaire 
please see appendix 7. 
 
The reliability and validity of the PMQ, CFQ and EMQ have been previously 
evaluated (Hannon et al., 1995; Royle and Lincoln, 2008; Wallace, 2004). 
 
Laboratory-based measures of PM  
 
Prospective memory pattern recognition test 
 
This test is based on the processing speed task (Fisk & Warr, 1996) which was 
amended so as to provide a laboratory-based measure of prospective memory by 
the addition of a concurrent prospective memory element. In the pattern 
comparison speed task, the stimulus is a matrix potentially consisting of a basic 
grid of nine cells (three across and three down).  Line segments define the borders 
of each cell and the target patterns are made up of three, six, or nine such line 
segments randomly selected from the basic grid. Two patterns are displayed, one 
in the top and one in the bottom half of the screen. The objective is to classify as 
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many pairs as "the same" or "different" within a fixed time period.  Participants 
were asked to classify the pairs as quickly as possible by pressing the "/" key on 
the keyboard if the two patterns are the same, and the "z" key if they are different. 
The two patterns are identical in half of the trials but differ by one line segment 
only in the other half.  For the first 30 seconds, patterns consisted of three line 
segments, for the next 30 seconds they comprised six line segments, and for the 
third 30 seconds they were made up of nine line segments.  For each level of 
complexity (three, six, or nine segments), the computer keeps a record of the 
number of correct responses. This task was repeated three times. The PM element 
added to this test required the participant to remember to press the F1 key at the 
end of each trial when the message “please wait a moment” appeared. Participants 
were told that this was in order to save their scores on the task. Failure to press F1 
resulted in the score for that segment being reported as ‘error’ in the screen 
display at the end of the task.  The number of times the participant forgot to press 
F1 for each trial was calculated producing a laboratory event-based PM measure. 
 
Prospective memory fatigue test 
 
At the beginning of the test session, participants were told that they should 
provide an indication of their level of fatigue (using the Karolinska sleepiness 
scale; Gillberg et al., 1994) every 20 minutes throughout the experiment. If the 20 
minute period passed during the completion of a task, participants were asked to 
complete the questionnaire immediately after.  Responses were recorded and the 
percentage of remembering to complete the Karolinska sleepiness scale was 
calculated for the first and second half of the session, as well as for the 
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participant’s overall performance, producing three measures of medium-term 
time-based PM. On occasions where the participant forgot to ask for the 
questionnaire, he/she was reminded to fill in the Karolinska sheet.  
 
Long-term recall PM 
 
A list of 15 words was presented five times, orally, using an audio recording 
device. At the end of each trial the participant wrote down as many words as 
he/she could recall from the list. No time constraint was imposed for recalling the 
items and the total number of correct words recalled was calculated for each trial. 
A long-term PM element was added to the recall test. Participants had to 
remember to return an answer sheet containing the words that they were able to 
recall to the experimenter after a delay of one, two, and three weeks from the time 
of testing. Three prepaid envelopes were provided for this purpose. Participants 
scored 1 if the envelope was returned and 0 otherwise. This data was collected 
separately for each week but the total number of envelops returned (out of three) 
by each participant was used as the score for long-term PM.  
 
These laboratory tasks were based on paradigms developed by Mathias and 
Mansfield (2005) and Einstein et al. (1995). 
 
Rivermead Behavioural Memory Test (RBMT; Wilson et al., 1999)  
 
The RBMT-II combines laboratory-based measures of memory and assessments 
obtained by questionnaire and observation. It aims to provide equivalents of 
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everyday memory situations, thereby avoiding some of the weakness of 
questionnaires, rating scales and checklists.  There are twelve components to the 
RBMT each attempting to provide an objective measure of one of a range of 
everyday memory problems reported and observed in patients with memory 
difficulties. A full description of the RBMT-II may be found elsewhere (Wilson et 
al., 1999). In the present study only the three subtasks relating to PM were used: 
1) Remembering a hidden belonging: Something of minimal value (a pen or pencil 
in this study) is requested from the participant and placed in a specified location. 
The participant is required to ask for his belonging and to remember the location 
when the examiner says “We have now finished this test”.  Participants receive a 
score of 2 if the belonging and location are recalled correctly, 1 if after prompt, or 
0 if neither object nor location is remembered.  
2) Remembering an appointment: a timer is set for 20 minutes. The participant is 
told that when the alarm clock rings he/she should ask a pre-arranged question 
(e.g., ‘What time does this session end’). A profile score of 2 is given if the 
appointment is recalled correctly, 1 if after prompt or 0 if it is not recalled at all. 
3) Delivering a message: A path around the room is traced, and an envelope 
marked “message” is left at a specific location by the experimenter. The 
participant is required to pick up the envelope and leave it in the right place on the 
route both immediately and after a delay. A single score was awarded ranging 
from zero to three depending on the number of errors made over the two attempts. 
For a copy of the RBMT score sheet please see Appendix 8.  
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Procedure 
Participants were informed of the general purpose of the experiment and verbal 
consent was obtained. All tests were administered under laboratory conditions and 
the participant had the right to withdraw from the experiment at any time. The 
drug history Questionnaire was firstly administered followed by Ravens, 
Health/Age/Education questionnaire, Prospective Memory questionnaires 
(Crawford et al., 2005 and Hannon et al., 1995), Prospective Memory Pattern 
recognition Task, Recall PM task and the RBMT-II. The fatigue prospective 
memory task was administered throughout the session. Participants were fully 
debriefed, paid 20 UK pounds in Tesco store vouchers and given drug education 
leaflets. The study was approved by the Ethics committee of the University of 
Central Lancashire.   
 
7.3 Results 
 
Demographic and background variables 
 
The scores for background measures such as age, years of education, intelligence, 
and cigarette and alcohol consumption are summarised in Table 7.1. A series of t-
tests revealed that no significant differences between the two groups were present 
in age, fluid intelligence and years of education. Although the number of 
cigarettes consumed per day by smokers did not differ significantly between the 
two groups, tobacco use was more prevalent among ecstasy/polydrug users than 
non-ecstasy users. In fact, over half of ecstacy/polydrug users were current 
cigarette smokers and less than one third of non-ecstasy users currently smoked 
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cigarettes. Ecstasy/polydrug users consumed significantly more units of alcohol 
per week t(69)= 3.56, p<0.001, than non-ecstasy users. 
 
Table 7.1. Demographical and Background Drug Use Variables for Users and 
Nonusers 
 
 
 
Ecstasy/Polydrug Users Non Ecstasy Users  
    Mean S.D. N Mean S.D. N p 
        
Age (years) 21.67 3.61 42 21.03 3.25 31 ns 
RavensProgressive 
Matrices (maximum 60) 
43.31 10.90 41 44.87 7.57 31 ns 
Years of Education 13.98 4.22 41 14.48 2.99 31 ns 
        
Cigarettes per day 9.76 8.68 21 6.33 6.65 9 ns 
Alcohol (Units per 
week) 
15.07 9.90 41 7.17 8.28 30 <.001 
        
Total Use        
   Ecstasy (Tablets) 668.88 1234.67 42 - - - - 
   Amphetamine (grams) 196.00 254.78 13 - - - - 
   Cannabis (joints) 3259.49 4571.12 39 243.00 323.14 10 <.001 
   Cocaine (lines) 1270.71 1762.69 28 255.00 343.65 2 - 
        
Frequency of Use (times 
per week) 
       
   Ecstasy 0.25 0.32 42 - - - - 
   Amphetamine 0.10 0.27 14 - - - - 
   Cannabis 1.02 1.79 39 0.86 1.59 10 ns 
   Cocaine 0.41 0.51 27 0.54 0.65 2 - 
        
Weeks Since Last Use:        
   Ecstasy      31.56        63.73 42 - - - - 
   Amphetamine    118.90   160.04 16 - - - - 
   Cannabis      30.40     71.08 39    71.80  88.73 10 ns 
   Cocaine      23.65   57.23 32       6.33 2.89 3 - 
        
Number Ever Used        
   Amphetamine    17    0  
   Cannabis   40   10  
   Cocaine   33   3  
        
        
 
135 
 
With respect to illicit drug use, the majority of ecstasy/polydrug users had in the 
past, or were currently consuming cocaine and most of them were cannabis users. 
Less than half of ecstasy/polydrug users had a history of amphetamine use. 
Statistical analyses revealed that there were no significant differences between the 
two groups in the frequency of cannabis and cocaine use. No statistical difference 
was observed in the amount of total cocaine consumed between the two groups. 
Ecstasy/polydrug users, however, smoked significantly more joints in total than 
non-ecstasy users t(39.43)=4.08, p<0.001 thus having greater lifetime exposure to 
cannabis. Given the limited use of cocaine and amphetamines among the non-
ecstasy user group it was not meaningful to statistically analyse group differences 
for these substances.  
 
Before analysing the data for the laboratory and self-report measures of real world 
memory data screening was performed to identify any possible outliers. 
Univariate outliers for the real world memory measures were identified and 
corrected according to Tabachnick and Fidell (2007). The transformed values 
were used to carry out the statistical analysis. A multivariate outlier was also 
identified and that particular person was excluded. 
 
Laboratory-based measures 
 
Outcomes for both laboratory and self-report measures of real world memory for 
ecstasy/polydrug users and non-ecstasy users are summarised in Table 7.2.  
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Table 7.2. Scores on laboratory and self-report measures of real world memory 
for ecstasy/polydrug users and non-ecstasy users (one-tailed) 
 Ecstasy/ 
Polydrug 
Users 
Non Ecstasy 
Users 
P p  
covariates: 
cannabis 
use 
p 
Covariates:  
cannabis 
smoking, 
and alcohol 
use 
 Mean S.D. Mean S.D.    
LABORATORY 
MEASURES 
       
RBMT-II        
Appointment 1.55 0.77 1.65 0.61 ns ns ns 
Belonging 1.19 0.77 1.65 0.61 <.01 <.05 <.05 
Message 1.90 0.30 1.90 0.30 ns ns ns 
        
Fatigue PM Task 
(% recalled) 
       
First half of 
test session  
50.44 36.04 72.20 25.57 <.01 <.01 <.05 
Second half 
of test 
session 
9.48 16.26 44.62 39.52 <.001 <.001 <.001 
        
Processing Speed 
PM Task Errors 
1.60 2.41 0.61 1.23 <.05 <.05 <.05 
        
Long Term 
Recall PM Task 
(max 3) 
0.81 1.21 1.29 1.16 <.05 ns ns 
        
SELF-REPORT 
MEASURES 
       
Everyday 
Memory 
94.51 36.13 79.42 31.77 <.05 <.05 <.05 
        
Prospective 
Memory 
(Hannon et al) 
       
Short Term 1.53 0.69 1.27 0.38 <.05 <.05 ns 
Long Term 2.81 1.00 2.47 0.88 ns ns ns 
Internally 
Cued 
2.62 0.96 2.39 0.95 ns ns ns 
Techniques 
to 
Remember 
2.74 1.10 3.32 1.58 <.05 ns ns 
        
Cognitive 
Failures 
43.40 14.20 40.00 12.71 ns ns ns 
        
Prospective 
Memory 
(Crawford et al) 
22.63 4.96 20.26 5.52 <.05 <.05 ns 
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Regarding the laboratory measures, inspection of Table 7.2 reveals that 
ecstasy/polydrug users were impaired on all but two of the measures. The two 
groups did not differ significantly in one event-based and one time-based PM task 
in the RBMT-II. With regard to the time-based PM tasks, ecstasy/polydrug users, 
with the exception of the appointment test of the RBMT-II, were impaired in 
relation to the non-ecstasy users. In fact, ecstasy/polydrug users forgot to 
complete the fatigue task on more occasions than the control group, especially in 
the second half of the test session. For example, the completion rate for 
ecstasy/polydrug users in the first half of the session was only around 50% as 
opposed to non-ecstasy users’ rate that was as high as 72%. The difference 
between the two groups was more striking in the second half of the session where 
ecstasy/polydrug users remembered to complete the fatigue task an average of 9% 
of the time as opposed to non-ecstasy users who completed around 45% of 
occasions, almost five times more often than ecstasy/polydrug users. Impaired 
time-based PM performance is also evident on the long-term measure. For 
example, during the three weeks following testing, non-ecstasy users posted back 
almost 50% more delayed response sheets compared to ecstasy/polydrug users. 
These group differences were, however, were less evident on the time-based 
RBMT-II appointment task.  
 
In terms of the event-based PM tasks, ecstasy/polydrug users once again 
demonstrated more difficulties performing the tasks than non-ecstasy users as they 
performed worse on the RBMT-II belonging task and the event-based processing 
speed task. More specifically, ecstasy/polydrug users forgot to press the F1 key 
almost three times more than the control group in the processing speed task. 
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Surprisingly, no performance difference was observed in the RBMT-II message 
task between the two groups.          
 
In terms of statistical analysis, MANOVA with the seven laboratory measures of 
PM as dependent variables and the ecstasy/polydrug user group between 
participants as the independent variable revealed a statistically significant group 
effect  = 0.59, F(7,65)=6.49, p<0.001, partial 2=0.411. Univariate analysis 
revealed that all but two of the individual measures yielded statistically significant 
group differences with ecstasy/polydrug users consistently performing worse than 
non-ecstasy users. More specifically, ecstasy/polydrug users performed worse on 
the RBMT-II belonging task (F(1,71)=7.36, p<0.01, partial 2 =0.094), the fatigue 
task (first half: F(1,71)=8.23, p<0.01, partial 2 =0.104 and second half: 
F(1,71)=27.11, p<0.001, partial 2 =0.276), the long-term recall PM task 
(F(1,71)=2.90, p<0.05, partial 2 =0.039) and the processing speed PM task 
(F(1,71)=4.31, p<0.05, partial 2 =0.057). No significant differences were present 
in the RBMT-II appointment task or the RBMT-II message task. The values for 
means and standard deviations for all laboratory measures of PM for both groups 
are summarised in Table 7.2.  
 
Following the inclusion of the covariates relating to lifetime cannabis use (joints) 
and the current frequency of cannabis use (times per week), the multivariate group 
effect remained statistically significant = 0.662, F(7,62)=4.52, p<0.001, partial 
2=0.338. When the previously significant dependent variables were considered 
separately they remained significant with the exception of the long term recall PM 
task F(1,68)=0.72, p=0.201, partial 2=0.010. Following the inclusion of two 
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more covariates relating to alcohol consumption (units per week) and tobacco use 
(cigarettes per day) the multivariate group effect once again remained statistically 
significant = 0.71, F(7,58)=3.41, p<0.01, partial 2=0.292. The inclusion of the 
four covariates reduced the ecstasy/polydrug user group effect size by 11.6%. In 
the univariate analyses three out of the seven dependent variables remained 
statistically significant while the long term recall PM task was no longer 
statistically significant F(1,64)=0.12, p=0.37, partial 2=0.002. Inspection of table 
7.2 suggests that with regard to the laboratory measures, ecstasy/polydrug users 
remained impaired in relation to the non-ecstasy user group even following the 
inclusion of the covariates in almost all the measures. It can therefore be 
concluded that the deficits in the ecstasy/polydrug group are more likely to be 
attributed to ecstasy. 
 
Self-report measures of real world memory 
 
Results for the self-report measures of real world memory in ecstasy/polydrug 
users and non-ecstasy users are summarised in Table 7.2. With the exception of 
cognitive failures, it is evident from looking at Table 7.2 that ecstasy/polydrug 
users experience a greater occurrence of real world memory problems than non-
ecstasy users.  MANOVA with the seven self-report measures of real world 
memory as the dependent variables and the ecstasy/polydrug user group between 
participants revealed a statistically significant group effect = 0.76, F(7,58)=2.68, 
p<0.01, partial 2=0.245. In terms of the univariate analyses, the difference in 
performance between the two groups was statistically significant for the four out 
of the seven real world memory measures with ecstasy/polydrug users performing 
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worse than the non-ecstasy users on all occasions. In more detail, 
ecstasy/polydrug users scored higher than non-ecstasy users, thus had higher 
number of memory slips, in their self-perceived everyday memory (F(1,64)=3.21, 
p<0.05, partial 2=0.048), short term PM (F(1,64)=3.21, p<0.05, partial 2=0.048) 
and overall PM performance (F(1,64)=3.38, p<0.05, partial 2=0.050). Also, non-
ecstasy users were able to use significantly more techniques to aid their 
remembering than ecstasy/polydrug users (F(1,64)=2.99, p<0.05, partial 
2=0.045). No significant differences between the two groups were present in the 
long-term PM, internally cued PM or cognitive failures. The values for means and 
standard deviations for all measures of real world memory for both groups are 
summarised in Table 7.2.  
 
After the inclusion of the two measures of cannabis use as covariates (lifetime and 
frequency of cannabis use) the multivariate group effect for the self-report 
measures of real world memory remained statistically significant (= 0.79, 
F(7,56)=2.18, p<0.05, partial 2=0.214) although the significance was reduced to 
0.05. Inspection of the univariate analyses showed that all previously significant 
self-report measures remained significant but one. The techniques used to 
remember scale from the PMQ was no longer statistically significant 
F(7,62)=2.36, p=0.06, partial 2=0.037. Following the addition of the other two 
covariates, alcohol consumption and tobacco use, the multivariate group effect 
was no longer statistically significant = 0.831, F(7,52)=1.51, p=0.09, partial 
2=0.169. In the univariate analyses, only the everyday memory measure 
remained statistically significant F(1,58)=3.39, p<0.05, partial 2=0.055 while the 
other three measures were reduced to below significance: short-term PM, 
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F(1,58)=0.80, p=0.19, partial 2=0.014; techniques used to remember 
F(1,58)=1.81, p=0.09, partial 2=0.030 and PM performance in the PRMQ 
F(1,58)=2.1, p=0.07, partial 2=0.035. In multivariate terms three out of the four 
covariates produced a statistically significant effect on the self-report real world 
memory measures: lifetime cannabis use = 0.77, F(7,52)=2.20, p<0.05, partial 
2=0.230; tobacco use = 0.73, F(7,52)=2.75, p<0.05, partial 2=0.270 and 
alcohol consumption = 0.745, F(7,52)=2.49, p<0.05, partial 2=0.251. 
 
Relationship between period of abstinence and memory 
 
It is possible that some of the drug-related deficits observed in the real world 
memory measures are a product of short-term post intoxication effects. It is 
therefore important to investigate any possible correlations between weeks since 
last use for the four main illicit drugs and each of the real world memory 
measures. Table 7.3 summarises the aforementioned correlations.  
 
Inspection of Table 7.3 reveals that for most of the real world memory measures 
the correlations were not statistically significant. Although no ecstasy/polydrug 
effect was evident in Table 7.2, performance on the RBMT-II appointment task 
was negatively correlated with the period of abstinence for amphetamines r=-.526, 
p<0.05 suggesting that participants abstaining for a longer period perform better 
on the time-based PM task. 
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Table 7.3. Correlations between Real World memory Measures and Duration of 
Abstinence for the Major Illicit Drugs 
 Weeks Since Last Use: 
 
 
 Ecstasy Cannabis Cocaine Amphetamine 
LABORATORY MEASURES     
RBMT-II     
Appointment -.089 .025 .001 -.526* 
Belonging .137 .082 .030 .078 
Message .001 .175 .066 .212 
     
Fatigue PM Task (% recalled)     
First half of test session  .336* .281 .248 .405 
Second half of test session .113 .124 -.128 .192 
     
Processing Speed PM Task Errors -.037 -.182 -.029 -.174 
     
Long Term Recall PM Task (max 3) -.173 .053 .074 -.010 
     
SELF-REPORT MEASURES     
Everyday Memory -.028 -.048 -.126 -.243 
     
Prospective Memory (Hannon et al)     
Short Term -.119 -.043 .165 -.210 
Long Term -.034 -.023 -.033 -.154 
Internally Cued .044 -.155 -.027 -.043 
Techniques to Remember .024 -.110 -.084 .218 
     
Cognitive Failures      -.556*** -.147 -.070 -.305 
     
Prospective Memory (Crawford et al) -.151 -.113 -.026 -.119 
*** p<.001; * p<.05 one-tailed 
 
Similarly, performance on cognitive failures was highly correlated with the period 
of abstinence in relation to ecstasy use r=-.556, p<0.001 suggesting that a longer 
period of abstinence causes fewer self-reported cognitive failures. A relationship 
between the first half of the fatigue test and the period of abstinence from ecstasy 
was also observed r=.336, p<0.05 suggesting that the longer the period of 
abstinence from ecstasy the better the performance on the time-based PM task.  
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Relationship between aspects of drug use and real world memory measures 
 
The relationship between the lifetime use and frequency of use for the four major 
illicit drugs i.e., ecstasy, cannabis, cocaine and amphetamines and the real world 
memory measures was investigated. Regression analyses were conducted with 
either the frequency or lifetime use of the four major drugs as the independent 
variables and each real world memory measure in turn as the dependent variable. 
Table 7.4 summarises the simple and semi partial correlation coefficients from 
these regression analyses.   
 
For the frequency of use and lifetime use nonusers of each drug were coded as 
zero. Regression analyses were only conducted in those cases where the simple 
correlation between the drug use measure and the real world memory measure 
was statistically significant. Inspection of Table 7.4 reveals that total lifetime use 
of ecstasy and cocaine are related with several laboratory measures of PM, 
suggesting that as the level of use increases so does the PM deficit. More 
specifically, total lifetime use of ecstasy was correlated with the RBMT-II 
belonging task, the second half of the fatigue PM task and the processing speed 
PM task.  Lifetime use of cocaine was correlated with the RBMT-II appointment 
task, the RBMT-II belonging task, the second half of the fatigue task and the 
processing speed PM task. Lifetime use of cannabis was also found to be 
correlated with the RBMT-II belonging task, the second half of the fatigue PM 
task and the long term recall PM task.  
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Table 7.4. Correlations between Real World memory Measures and Lifetime Use 
and Frequency of Use for the Major Illicit Drugs 
  
 
 Lifetime Use  Frequency 
 
Real World Memory 
Measure 
 
Drug 
 
Simple 
 
Semi 
Partial 
  
Simple 
 
Semi 
Partial 
Laboratory Measures       
RBMT-II           
Appointment Cocaine -.258* -.288*  -.265* -.210 
Belonging Ecstasy -.300** -.106      
 Cannabis -.233* -.052      
 Cocaine .408*** -.238*  .482*** -.440*** 
Message Cannabis    -.264* -.273* 
Fatigue PM Task (% 
recalled) 
      
First half of test 
session  
Ecstasy    -.238* -.163 
 Cannabis -.203 -.124  -.247* -.203 
 Cocaine -.204 -.072  -.244* -.101 
Second half of test 
session 
Ecstasy -.231* -.118  -.267* -.167 
 Cannabis -.254* -.178    
 Cocaine -.213* -.033    
Processing Speed PM 
Task Errors 
Ecstasy .284*  .177  .227* .143 
 Cocaine .283* .146  .277* .154 
       
Long Term Recall PM 
Task (max 3) 
Cannabis -.212* -.132  -.289* -.220 
 Cocaine -.191 -.154  -.330** -.271* 
Self-Report Measures       
Everyday Memory       
ProspectiveMemory 
(Hannon et al) 
      
Short Term Ecstasy .304** .279*    
 Cannabis      .265* .218* 
Long Term       
Internally Cued Ecstasy .377** .361**  .271* .181 
 Amphet-
amine 
     .249* .127 
Techniques to 
Remember 
      
       
Cognitive Failures Ecstasy .292*  .212  .350** .251* 
 Cocaine .237*  .027    
 Cannabis .251* -.185    
ProspectiveMemory 
(Crawford et al) 
Ecstasy .330** .188  .253* .100 
 Cocaine .249* .097      
 Amphet-
amine 
.229* .183    
 
*** p<.001; ** p<.01; * p<.05; one-tailed  
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 In terms of frequency of use, cocaine was correlated with almost all the 
laboratory measures of PM whilst the frequency of use for ecstasy was only 
correlated with three out of the seven laboratory measure. Frequency of use for 
cannabis was also correlated with three PM laboratory measures. More 
specifically, frequency of ecstasy use was correlated with the fatigue PM task at 
both times of the test session and the processing speed PM task. Frequency of 
cocaine use was correlated with the RBMT-II appointment task, the RBMT-II 
belonging task, the first half of the fatigue PM task, the processing speed PM task 
and the long term recall PM task. Finally, cannabis was correlated with the 
RBMT-II belonging task, the first half of the fatigue PM task and the long term 
recall PM task. Increased frequency of use of is therefore associated with a greater 
degree of PM impairment. Although the major characteristic of the 
ecstasy/polydrug group is ecstasy use it appears that cocaine is also implicated in 
the observed PM deficits.  
 
As far as the self-report measures of real world memory are concerned it appears 
that lifetime use of ecstasy is responsible for most of the self-report measures, 
whereas the total lifetime use of cocaine is not as prominent in the self-report 
measures as in the laboratory measures of PM. Consequently, short term and 
internally cued PM were correlated with total lifetime use of ecstasy; cognitive 
failure was correlated with lifetime use of ecstasy, cannabis and cocaine and PM 
performance from the PRMQ with ecstasy, cocaine and amphetamines in terms of 
total lifetime use.  
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Similarly, frequency of use for ecstasy was correlated with three of the real world 
memory measures i.e., internally cued PM, cognitive failures and PM 
performance while frequency use of cocaine was not correlated with any of the 
self-report measures. Frequency of cannabis use was associated with short term 
PM while frequency of amphetamine use was correlated with internally cued PM. 
No association with any aspect of drug use was observed in everyday memory or 
techniques use to remember. The significant correlations suggest that increased 
frequency of use is associated with higher scores on the self-report measures 
consistent with more real world memory problems.  
 
Table 7.4 also displays the semi partial correlation values from the regression 
analyses. A semi partial correlation coefficient represents the correlation between 
the dependent variable (real world memory measure) and a predictor (lifetime or 
frequency of use for the four illicit drugs) that has been residualized with respect 
to all other predictors in the equation with the dependent variable remaining 
unaltered.  After removing variance that the specific predictor has in common 
with the other predictors, the semi partial expresses the correlation between the 
residualized predictor and the unaltered dependent variable. It therefore assesses 
the specific effect of each independent variable on the dependent variable.  
 
It was found that the lifetime use of cocaine is primarily responsible for the 
deficits observed in the RBMT-II appointment and belonging tasks, as the semi 
partial correlations were statistically significant.  On the other hand, lifetime use 
of ecstasy is responsible for difficulties in short-term and internally cued PM in 
the self-report measures. Frequency of cocaine was also associated with 
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impairments in the RBMT-II appointment task and the long-term recall PM task 
suggesting that the use of cocaine affects both event and time-based PM. 
Frequency of cannabis use was also responsible for the deficits in the RBMT-II 
message task and the self-report short- term PM, while frequency of ecstasy use 
was only associated with cognitive failures performance, although this measure 
was not statistically significant between the two groups.  
 
It is evident from looking at the correlations in Table 7.4 that, although some of 
the simple correlations were statistically significant for most real world memory 
measures most, of the semi partial correlations did not reach statistical 
significance. This means that although the drug-related effect is evident on the 
particular real world memory measure it is not possible to identify which of the 
four drugs is likely to be primarily responsible.  
 
Inter-correlations between laboratory measures of PM and self-report real world 
memory measures 
 
Disregarding the drug-related differences it would be reasonable to assume that 
laboratory measures of PM will be correlated with each other and with the self-
report measures of PM. Nevertheless, such correlations cannot be perfect as each 
laboratory task has different performance aspects. For example, some laboratory 
tasks measure the time-based aspect of PM and some other the event-based. These 
tasks also differ in terms of the period over they need to be executed either in the 
short-term or the long-term. Furthermore, self-report measures of PM do not 
distinguish the event-based and time-based PM components.  
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Table 7.5 summarises the inter-correlations between the laboratory measures of 
PM and self-report real world memory measures. Inspection of Table 7.5 reveals 
that most of the laboratory measures are inter-correlated with the exception of the 
long-term recall PM task which is not correlated with any of the other laboratory 
measures of PM. In addition, some laboratory measures such as the fatigue PM 
task and the processing speed PM task correlated with a number of self-report 
measures of real world memory. Finally, Table 7.6 reveals that self-report 
measures of real world memory were also correlated with each other.  
 
Table 7.6. Inter Correlations between the Self Report Measures of Real World 
Memory 
 
 Everyday 
Memory 
Prospective Memory Cognitive 
Failures 
  Short 
Term 
Long 
Term 
Internally 
Cued 
Techniques  
SELF-REPORT 
MEASURES 
      
Everyday 
Memory 
      
       
Prospective 
Memory 
(Hannon et al) 
      
Short Term .049      
Long Term .442*** .246*     
Internally 
Cued 
.455*** .379*** .507***    
Techniques 
to 
Remember 
.254* .211* .366** .577***   
       
Cognitive 
Failures 
.477*** .280** .357** .513*** .289**  
       
Prospective 
Memory 
(Crawford et al) 
.615*** .145 .412*** .521*** .328** .707*** 
*** p<.001; ** p<.01; * p<.05; one-tailed 
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Table 7.5 Inter Correlations between the Laboratory and Self Report Measures of Real World Memory 
 RBMT-II  Fatigue PM Task  Processing Speed PM Task Long Term Recall PM Task 
 Appointment Belonging Message First  
Half 
Second Half   
LABORATORY MEASURES        
RBMT-II        
Appointment        
Belonging .334**       
Message -.021 .200*      
Fatigue PM Task (% recalled)        
First half of test session  .238* .291** .056     
Second half of test session .266* .263* .122 .425***    
Processing Speed PM Task Errors -.220* -.270* -.049 -.206* -.185   
Long Term Recall PM Task (max 3) .010 .087 .004 -.018 -.172 -.135  
SELF-REPORT MEASURES        
Everyday Memory -.018 -.041 .140 -.063 -.141 -.033 -.103 
Prospective Memory (Hannon et al)        
Short-Term -.096 -.128 -.003 -.230* -.120 .392*** -.071 
Long-Term -.069 -.155 -.139 -.053 -.312** -.006 -.182 
Internally Cued -.021 -.037 -.014 -.077 -.175 -.024 .038 
Techniques to Remember -.041 .072 -.048 .024 -.002 .035 .200* 
        
Cognitive Failures -.174 -.161 .007 -.223* -.323** .108  .086 
Prospective Memory (Crawford et al)      -.279** -.190 -.003 -.201* -.281** -.008  .035 
*** p<.001; ** p<.01; * p<.05; one tailed  
150 
 
7.4 Discussion  
 
The impact of ecstasy/polydrug use in everyday and PM was investigated in the 
present study. Previous investigations in the area demonstrated that recreational 
users of ecstasy suffer from deficits in real world memory including everyday 
memory, cognitive failures and most noticeably in their PM performance 
(Heffernan et al., 2001a; 2001b; Rodgers et al., 2001; 2003; Montgomery & Fisk, 
2008; Fisk & Montgomery, 2008). Although previous research has demonstrated 
consistently that real world memory problems are evident in ecstasy/polydrug 
users, PM assessment mode was largely restricted to self-report measures that 
assess the self-perception of the participant in relation to their possible memory 
lapses. The need for more objective measures was therefore crucial in order to 
determine whether the reported deficits by ecstasy/polydrug users are real rather 
than imagined. The present investigation is therefore assessing real world memory 
processes with a variety of both objective laboratory measures and self-report 
measures to determine whether these drug-related deficits previously reported are 
real, rather than imagined, and consequently confirm or otherwise the validity of 
the self-reported measures.  
 
In terms of the laboratory measures, multivariate analysis showed that on the 
whole ecstasy/polydrug users were impaired on the PM laboratory measures; an 
effect that remained statistically significant after controlling for total lifetime and 
frequency of cannabis use, tobacco and alcohol use. When looking at the PM 
measures individually, it was evident that ecstasy/polydrug users performed worse 
in all cases compared to non-ecstasy users. All measures, but two (one event and 
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one time-based PM task), reached statistical significance demonstrating that the 
differences in performance between the two groups represent meaningful 
differences. Ecstasy/polydrug users seem to experience greater difficulties in 
event-based, time-based and long term PM than non-ecstasy users. Subsequently, 
the present study extends previous research in which ecstasy/polydrug users were 
impaired in their PM performance (Heffernan et al., 2001a; 2001b; Rodgers et al., 
2001; 2003; Montgomery & Fisk, 2008; Fisk & Montgomery, 2008).  
 
Only a few studies have used the RBMT to investigate the ecstasy-related deficits 
on PM. For example, Zakzanis et al. (2003) administered the RBMT in a group of 
ecstasy/polydrug users and non-ecstasy users. Unlike the present study, Zakzanis 
et al. observed ecstasy-related deficits on the appointment and message PM scale 
of the RBMT but not on the belonging scale. However, it is likely that these 
deficits on the two subscales of the RBMT were due to confounding factors as 
their ecstasy/polydrug user group scored significantly less on the WAIS-III 
vocabulary sub-test compared to the control group. To the best knowledge of the 
author, the present study is the first one to demonstrate ecstasy-related deficits on 
the belonging subscale of the RBMT. Although the RBMT has been consistently 
used to detect memory lapses in clinical populations, it has been criticised as 
lacking the sensitivity to detect memory problems in non-clinical populations 
(Spooner & Pachana, 2006). Thus it may be that the test was not appropriate for 
the university based sample of recreational drug users and the absence of 
impairments in the two subtests might be attributed to the limited sensitivity of the 
test rather than the lack of ecstasy/polydrug related impairments.  
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In terms of the three remaining laboratory tests of PM i.e., the fatigue PM task, 
processing speed PM task and the long-term recall PM task ecstasy/polydrug 
users performed significantly worse on all three measures in comparison to the 
control group and after controlling for covariates all but the long-term recall PM 
task remained statistically significant. More specifically it was found that 
ecstasy/polydrug users remembered to ask for a fatigue questionnaire on fewer 
relevant occasions than non-ecstasy users, they made more errors on the 
processing speed PM task and returned fewer envelops during the three-week 
period following testing. These findings suggest that ecstasy/polydrug users 
experience more general PM problems as deficits were evident on both the 
retrieval phase (time and event-based PM tasks) and storage/retention phase (short 
and long-term PM). This also suggests that ecstasy/polydrug-related deficits 
demonstrate a general feature of PM performance rather than task-specific 
aspects.   
 
It appears, that in terms of the laboratory PM performance the observed deficits 
are more likely to be attributed to the effect of ecstasy/polydrug use rather than 
cannabis as previously suggested (McHale & Hunt, 2008). This is consistent with 
previous findings with studies using self-report measures of PM (Heffernan et al., 
2001a; 2001b; Montgomery & Fisk, 2007; Rodgers et al., 2001; 2003). What is 
also evident from the present findings is that the deficits observed in 
ecstasy/polydrug users are real rather than imagined and they are evident on both 
time and event-based PM and also short and long-term PM.  
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Although the present study is among the first to use a variety of laboratory tasks 
and naturalistic PM tasks, previous research using the ‘virtual week’ paradigm 
also revealed ecstasy-related deficits in event and time-based PM performance 
(Rendell et al., 2007). As previously discussed in Chapter 5 the ‘virtual week’ is a 
board game where the participant is required to complete previously learned tasks 
at specific times during the game. While this test differentiates event and time-
based PM it clearly has an associative learning component since the participant 
needs to learn each response paired with specific location on the board before 
carrying out the PM task. Consequently, the deficits observed during the game 
might at least in part be attributed to associative learning impairments rather than 
difficulties in PM performance. This is possible as previous investigations suggest 
that associative learning is impaired in ecstasy/polydrug users (Montgomery et al., 
2005b). Therefore, the laboratory measures used in the present study required 
minimal learning and retrospective memory. This ensures that the deficits in 
performance observed on these tasks are less likely to be attributed to associative 
learning or retrospective memory problems.  
 
Although the ecstasy/polydrug group differences remained statistically significant 
after the inclusion of aspects of cannabis use as covariates, further analysis 
revealed that cannabis is negatively associated with PM performance. For 
instance, the frequency of cannabis use was associated with performance on the 
RBMT message task performance although the two groups did not differ 
statistically in the main analysis. In fact, after the shared variance with the other 
drugs was excluded the effect of cannabis remained statistically significant. 
Cannabis was also correlated with the fatigue PM task at both times of the test 
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session. For the first half of the session, both frequency and total lifetime use of 
cannabis were associated with poorer PM performance; an effect that nevertheless 
did not remain statistically significant after the exclusion of shared variance with 
the other drugs. Total lifetime use of cannabis was also associated with poorer 
performance in the second half of the session. Finally, both lifetime and frequency 
of cannabis use were associated with the long term recall PM task suggesting that 
cannabis use contributes to poorer long-term PM.  
 
In terms of the recreational use of ecstasy, it was found that lifetime use of ecstasy 
was negatively associated with the RBMT belonging task, the second half of the 
fatigue PM task and the processing speed task whilst frequency of ecstasy use was 
negatively associated with the first half of the fatigue task and the processing 
speed PM task. Nevertheless, after excluding the shared variance of the other 
drugs none of these associations reached significance suggesting that ecstasy use 
is not uniquely responsible for the effects observed. These findings are somewhat 
surprising given those reported by Rodgers et al., (2001; 2003) who found that 
ecstasy use was associated with long term PM deficits while cannabis use was 
associated with short-term PM.  
 
Another surprising finding in the present study is the effect of cocaine on PM 
performance. There was clear evidence that cocaine use is associated with 
performance on a number of laboratory measures of PM. To the best of the 
author’s knowledge the present study is the first to link recreational use of cocaine 
with PM deficits. Either total lifetime, or frequency use of cocaine or both, were 
associated with performance on all PM tasks with the exception of the RBMT 
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message task. In fact, lifetime use of cocaine shared unique variance with the 
appointment and belonging subtests of the RBMT and frequency of cocaine use 
with the long term recall PM task suggesting that recreational use of cocaine 
might be responsible for the observed performance deficits.  
 
As far as the self-report measures are concerned, the drug-related effects were less 
evident. Although ecstasy/polydrug users as a group reported PM deficits, the 
specific drugs responsible for these deficits were less clear. Also the effect of 
cocaine was less evident than in the laboratory measures. Lifetime use of ecstasy 
and frequency of cannabis use seemed to be associated with self-perceived short-
term PM while both lifetime and frequency of ecstasy were associated with 
internally cued PM. Although ecstasy/polydrug users did not appear to experience 
difficulties in cognitive failures, lifetime use of ecstasy, cannabis and cocaine 
were associated with a greater incidence of cognitive failures. In addition, in terms 
of PM performance on the whole, lifetime use of ecstasy, cocaine and 
amphetamines emerged as predictors of self-reported PM deficits. Nevertheless, 
no specific aspect of use for any of the drugs emerged as uniquely responsible for 
the observed self-reported deficits.  
 
To conclude, the present study intended to determine the impact of 
ecstasy/polydrug use on aspects of real world memory such as everyday memory, 
cognitive failures and prospective memory. Ecstasy/polydrug associated deficits 
were observed on both laboratory and self-report measures of prospective 
memory. Ecstasy/polydrug users were impaired on all PM laboratory measures 
with the exception of one event and one time-based PM task from the RBMT-II. 
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Ecstasy/polydrug related deficits were also observed in some of the self-report 
measures of PM and in the EMQ while no deficits were observed in the self-report 
measures of cognitive failures. It can therefore be assumed that ecstasy/polydrug 
users possess some self-awareness of their memory lapses. An unexpected finding 
was that the recreational use of cocaine can be associated with prospective 
memory deficits. Further research is needed, to clarify whether the cocaine related 
deficits are limited to the ecstasy/polydrug population or whether they might be 
present among those persons whose recreational use is largely confined to 
cocaine.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
157 
 
Chapter 8: Ecstasy/polydrug 
related deficits on the 
Cambridge Prospective Memory 
Test (CAMPROMPT) 
 
Chapter overview 
 
It is evident from the previous investigation that ecstasy/polydrug users 
experience difficulties in PM performance; an effect evident on both laboratory 
and self-report measures. It is therefore apparent that PM deficits in 
ecstasy/polydrug users are real rather than imagined. In the present study, as an 
extension to the previous investigation, the range of laboratory measures of PM 
was augmented by the use of the CAMPROMPT test battery in order to 
investigate the impact of ecstasy/polydrug use on event and time-based PM in a 
sample of cannabis only, ecstasy/polydrug and drug naïve controls. Measures of 
retrospective memory and learning were also administered in order to establish 
whether ecstasy/polydrug deficits in PM were mediated by group differences in 
these processes. Ecstasy/polydrug users performed significantly worse on both 
event and time-based PM tasks in comparison to both cannabis-only and drug 
naïve groups. Furthermore, it was found that better retrospective memory was 
associated with greater PM performance. Nevertheless, this association did not 
mediate the drug-related effects that were observed. Consistent with previous 
findings, recreational use of cocaine was linked once again to PM deficits. 
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8.1 Introduction 
 
Previous investigations into the effect of illicit drug use on PM found that PM 
performance is impaired after the recreational use of ecstasy (Heffernan et al., 
2001a; 2001b; Rodgers et al., 2001; 2003; Montgomery & Fisk, 2007). The 
previous investigation, in an attempt to overcome the limitations of previous 
studies, administered simple laboratory measures of PM as opposed to the 
previously adopted self-report PM measures to establish whether reported 
impairments in PM are real rather than imagined. It also distinguished differences 
in event and time-based PM since previous research has mostly investigated drug-
related impairments in the storage/retention phase i.e., short and long-term PM. It 
was found that PM deficits are evident both on self-report and laboratory based 
measures and are apparent on both the retrieval (time and event-based) and 
storage/retention phase (short and long-term).  
 
Evidence suggests that PM is dependent on medial temporal-hippocampal 
processes as well as PFC resources. Evidence for this comes from several clinical 
studies. For instance, Adda et al. (2008) observed PM impairment in a clinical 
group with medial temporal sclerosis. More specifically, they found that patients 
with left hemisphere lesions were also impaired in delayed verbal recall on the 
Rey Auditory Verbal Learning Task (RAVLT) suggesting that PM performance is 
correlated with verbal learning ability. A number of studies using this measure 
suggested that recreational users of ecstasy are also impaired on their verbal 
learning ability. For example, Fox et al. (2001) administered the Auditory Verbal 
Learning task to examine learning of verbal material in short-term and long-term 
ecstasy users and polydrug controls. Both ecstasy user groups recalled 
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significantly fewer words on the initial three recall trials as well as on the delayed 
recall trial in comparison to the polydrug control group with long-term ecstasy 
users performing the worst. Ecstasy-related impairments on verbal learning were 
also observed using the RAVLT in other studies (Reneman et al., 2000; Quednow 
et al., 2006) while memory and learning impairments are evident in 
ecstasy/polydrug users in a number of other studies (Parrott et al., 1998; Parrott & 
Lasky, 1998; Bolla et al., 1998; Rodgers et al., 2000).  
 
 Evidence also suggests that PM performance is correlated with episodic memory 
after alcohol administration (Leitz et al., 2009) and retrospective memory in 
general (Martin et al., 2007; Goto and Grace, 2008). Retrospective memory refers 
to remembering past events or experiences and according to Einstein and 
McDaniel (1990) PM has a retrospective component responsible to retain the 
basic information about action and context. It is therefore possible that 
impairments in PM can lead to RM and verbal learning difficulties. Evidence for 
this association between RM and PM comes from both neuroimaging and animal 
studies. For example, Martin et al. (2007) using magnetoencephalography found 
that during retrospective and prospective memory tasks the hippocampal region 
was activated longer in comparison to the control condition. Conversely, other 
regions were differentially involved as PM tasks were linked with activations in 
the posterior parietal lobe in comparison to the retrospective and control 
conditions.  
 
In an animal study utilising a PM paradigm it was found that while rats searched 
for food rewards in a radial maze the retrospective component while dependent on 
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hippocampal processes also required PFC resources without which the 
prospective component could not be activated (Goto & Grace, 2008). In the same 
study the dopaminergic system appeared to be differentially involved with the two 
components. Specifically, D1 receptors were associated with the retrospective 
component while D2 receptors supported the prospective component.  Since 
ecstasy is known to have an effect on both the serotonergic and dopaminergic 
systems, it is possible that disruption of dopaminergic processes as a consequence 
of using ecstasy might therefore be responsible for the PM deficits observed in 
recreational drug users.  
 
Although PM deficits among illicit drug users are apparent in self-report studies 
(Heffernan et al., 2001a; 2001b; Rodgers et al., 2001; 2003; Montgomery & Fisk, 
2008) apart from the more objective PM measures introduced in the previous 
Chapter differences in performance between recreational drug users and drug 
naïve persons have yet to be established using laboratory based measures. One of 
the few studies to look at PM performance in cannabis users utilising simple 
laboratory measures found that when asked to wait 10 minutes before pressing a 
timer, relative to controls users were less likely to remember to do so. 
Furthermore, compared to the control group they were also less likely to 
remember to post an envelope back to the experimenter two days after the test 
session (McHale & Hunt, 2008).  
 
A recent laboratory measure of PM is the ‘virtual week’ (Rendell et al., 2007). As 
discussed in previous chapters, the virtual week paradigm is a board game in 
which the participant needs to remember to execute previously learned tasks as 
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they progress around the board. Some tasks are triggered by external 
environmental factors (i.e., event-based tasks) while others are cued by the 
passage of time (i.e., time-based tasks). It is therefore a measure that examines 
event and time-based PM performance and it has been proven useful in detecting 
PM deficits among abstinent ecstasy users (Rendell et al., 2007a), long-term 
abstinent methamphetamine users (Rendell et al., 2009), following acute alcohol 
administration (Leitz et al., 2009), and in clinical populations including those with 
multiple sclerosis (Rendell et al., 2007b) and schizophrenia (Henry et al., 2007).  
 
Although the ‘virtual week’ has been proven to be a powerful laboratory measure 
in detecting PM impairments in a variety of populations as noted previously it 
clearly possess an associative learning component as the participants need to learn 
the responses paired with each location on the board before completing the PM 
task. Therefore it is not clear that the observed deficits  specifically reflect PM 
performance or are attributable to associative learning impairments that are known 
to be present in recreational users of ecstasy (Montgomery et al., 2005). 
 
In the previous Chapter, overcoming this limitation, simple laboratory measures 
of PM that did not involve a learning component were used. The RBMT (Wilson 
et al., 1999) was also used with only one of the three PM tasks reaching 
significance. As the RBMT has been criticised as lacking the sensitivity to detect 
memory problems in non-clinical populations, it was not included in the present 
investigation. Instead, a more up-to-date test battery was employed. The 
Cambridge Prospective Memory Test (CAMPROMPT; Wilson et al., 2005) is a 
laboratory measure of PM that examines event and time-based PM within both 
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clinical and non-clinical populations (Fleming et al., 2008; Groot et al., 2002; 
Wilson et al., 2005). Extending the previous investigation the CAMPROMPT was 
consequently adopted in the present study as an additional more up-to-date 
measure of event and time-based PM. Measures of verbal learning were also 
administered in order to capture possible learning impairments in recreational 
drug users. Rey’s Auditory Verbal Learning Test (RAVLT; based on Rey, 1964) 
was employed for this purpose.  
 
In addition to the CAMPROMPT and the learning measure, as an extension to the 
previous investigation a RM measure will be administered in order to uncover 
whether ecstasy/polydrug users are impaired in RM performance and the extent to 
which these impairments affect PM performance. Unlike the previous study, a 
cannabis only user group in addition to the ecstasy/polydrug user group is 
included in order to examine the direct effect of cannabis on memory in general 
and PM in particular. It is expected that both drug user groups will performed 
worse on all memory measures compared to the drug-naïve group while no 
prediction is made for the PM performance between the ecstasy/polydrug and 
cannabis only user groups.           
 
8.2 Method 
 
Design 
A between-participant design with the three groups (cannabis-only, 
ecstasy/polydrug and drug-naïve) as independent variables and the 
CAMPROMPT time and event-based PM scores as the dependent variables was 
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employed. The background variables, retrospective memory and learning 
measures were also evaluated for differences between the three groups. Pearson’s 
correlation coefficients were calculated between the PM measures and the other 
measures. Also, regression analyses were conducted with the time and event-
based PM measures as the dependent variables in order to determine any unique 
drug, retrospective memory or learning contributions to PM performance.  
 
Participants 
Twenty-nine ecstasy/polydrug users (12 females), twelve cannabis-only users (7 
females) and eighteen drug naïve (16 females) took part in the investigation. All 
participants were university students from the University of Central Lancashire or 
Liverpool John Moores University and they were recruited via direct approach or 
via the snowball technique, i.e., mouth to mouth referral (Solowij et al., 1992).   
 
Materials 
In common with the previous investigation, the prior history of ecstasy and other 
drug consumption was assessed using the background drug use questionnaire 
(Montgomery, et al., 2005). Estimates of the total lifetime use, length of use, 
average weekly dose and the amount of each drug consumed within the previous 
10, 30, and 90 days were also calculated. Fluid intelligence was measured via 
Raven’s Progressive Matrices (Raven et al., 1998) and a further questionnaire 
assessed the number of years of education, the participant’s age and gender and 
their alcohol and cigarette consumption.  
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Prospective and retrospective memory questionnaire (PRMQ; Crawford et al., 
2005).  
 
The PRMQ provides a self-report measure of prospective and retrospective 
memory slips in everyday life. It consists of sixteen items, eight referring to 
prospective memory failures time and eight concerning retrospective failures. 
Only the retrospective component was used in this study. For full a description of 
the measure refer to Chapter 7.  
 
Rey Auditory Verbal Learning Test (RAVLT; based on Rey, 1964).  
 
The RAVLT is a test developed to evaluate verbal learning and memory. A list 
(List A) of 15 words was presented to the participant orally, with the aid of an 
audio recording device, for five consecutive times. At the end of each trial the 
participant was asked to write down as many words as possible from the list. After 
the fifth trial, an interference list (List B), also consisting of 15 words was read to 
the participant after which she/he was asked to recall as many words as possible 
from the interference list. Immediately following this the participant was again 
asked to recall the words from list A without hearing it again (trial 6). Next after a 
20-minute interval, the participant was asked to remember the words from list A 
(trial 7) after which a recognition test was administered. For the recognition test a 
list consisting of the 15 words from list A and 15 distracter words was read to the 
participant and the individual was asked to indicate whether the word belonged to 
list A or not. A number of outcome measures were produced, first the total 
number of words correctly recalled over trials one to five, second a measure of 
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proactive interference (number correct on trial one minus number correct on the 
interference list), third retroactive interference (number correct on trial five minus 
number correct on trial six) and fourth, a measure of decay (number correct on 
trial five minus number correct on trial 7). For a copy of the questionnaire please 
refer to appendix 9.  
 
Memory compensation questionnaire (MCQ; Dixon, de Frias & Bäckman, 2001)  
 
The MCQ is a 44 item self-report measure assessing the variety and number 
strategies the participant uses to compensate for deficient memory performance. 
The MCQ is comprised of seven subscales: external (e.g., “Do you use shopping 
lists when you go shopping?”); internal (e.g., “Do you take your time to go 
through and reconstruct an event you want to remember?”): time (e.g., “Do you 
ask people to speak slowly when you want to remember what they are saying?”); 
reliance (e.g., “When you want to remember an important appointment do you ask 
somebody else (for example, spouse or friend) to remind you?”); effort (e.g., “Do 
you put in a lot of effort when you want to remember an important conversation 
with a person?”); success (e.g., “When you want to remember a newspaper article 
is it important to you to remember it perfectly?”); and change (e.g., “Do you use 
such aids for memory as notebooks or putting things in certain places more or less 
often today compared to 5-10 yrs ago?”). Responses for each item are presented 
on a 5-point scale, with higher scores representing more frequent use of the 
specified compensatory behavior (1=never, 5=always) with some items being 
reverse scored. For a copy of the questionnaire please refer to appendix 10.  
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The Cambridge Prospective Memory Test (CAMPROMPT) (Wilson et al., 2005).  
 
The CAMPROMPT is a laboratory measure of PM that consists of a total of six 
prospective memory tasks, three cued by time and three cued by events. 
Participants were asked to work on some distractor tasks such as word-finder 
puzzles or a general knowledge quiz for a twenty minute period while they had to 
remember to perform the prospective memory tasks. Two of the three time-based 
tasks were cued by a countdown kitchen timer. In the first time-based task the 
participant had to remind the experimenter not to forget his/her mug or keys when 
there were seven minutes left to the end of the session. In the second time-based 
task, when the timer showed sixteen minutes the examiner asked the participant to 
remember that “in seven minutes time” he/she had to stop whichever task was 
they were on and change to another. The third time-based task was cued by a 
clock. The participant was asked at a specific time (e.g., ten past eleven; 5 minutes 
after the 20 minute session) to remind the examiner to ring the reception/garage.  
 
For the event-based tasks the participant was asked: 1) to return a book to the 
examiner when he/she came to a question about the television program 
‘EastEnders’ during the general knowledge quiz; 2) to return an envelope with 
“MESSAGE” written on it when he/she was reminded that there were five 
minutes left in the test; and finally, 3) when the examiner informed him/her that 
the session was over, to remind the examiner to pick up five objects that had been 
hidden at the beginning of the session. Six points were awarded for each subtask 
that was successfully completed, unaided. If the task was completed after a single 
general prompt from the experimenter then 4 points were awarded. Alternatively, 
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participants were awarded two points if a second more specific prompt was 
required, one point if after prompting, the required action was completed on the 
second attempt and no points if the participant failed to complete the required 
action after prompting. Total scores were then generated on time-based and event-
based subscales, each scoring a maximum of 18, with higher scores reflecting 
better prospective memory performance. The validity and reliability of the 
CAMPROMPT has been documented previously (e.g., Fleming et al., 2008; 
Groot et al., 2002; Wilson et al., 2005). For a copy of CAMPROMPT’s score 
sheet please refer to appendix 11.  
 
Procedure 
Participants were informed of the purpose of the investigation and their right to 
withdraw at any time. After verbal consent had been obtained the tests were 
administered under laboratory conditions. The drug-use questionnaire 
(Montgomery et al., 2005) was administered first followed by the Raven’s 
progressive matrices (Raven et al., 1998), the age/education questionnaire, the 
PRMQ (Crawford et al., 2005) and the MCQ (Dixon de Frias, & Bäckman, 2001) 
questionnaires. Finally, the RAVLT and the CAMPROMPT (Wilson et al., 2005) 
tests were administered. Participants were fully debriefed, paid £20 in Tesco store 
vouchers and given drug education leaflets. The University of Central 
Lancashire’s ethics committee approved the study.  
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8.3 Results 
 
Data screening revealed that no univariate outliers were present in the two PM 
measures. Where outliers were present, in the other memory measures, were 
replaced by the next highest/lowest score on the particular measure, plus/minus 
one according to Tabachnick and Fidell (2007). No multivariate outliers were 
detected in any of the dependent measures. However, the distribution of the event-
based measure was negatively skewed.  Following the data transformation 
procedure recommended by Tabachnick and Fidell (2007), the event-based scores 
were reflected and the square root was taken. This means that trends in the 
transformed variable are reversed so that higher scores are indicative of worse 
performance. 
 
 As it is evident from Table 8.1, with the exception of cigarette consumption, the 
three groups did not statistically differ in terms of their background measures such 
as age, IQ, years of education and alcohol consumption. The proportion of 
cigarette smokers in the groups varied significantly (χ2 (N=53, df=2) = 8.09, 
p=.017) as almost half of the ecstasy/polydrug users and cannabis only users were 
smokers, while only one drug-naïve reported cigarette consumption.  
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Table 8.1 Age, intelligence, years of education, cigarette and alcohol use by 
group. 
 
 
 
Ecstasy/Polydrug 
Users 
Cannabis-Only 
Users 
Nonusers  P
1 
 Mean S.D. n Mean S.D. n Mean S.D. N  
           
Age (years) 21.17 1.79 29 21.92 1.56 12 20.44 2.28 18 ns 
Ravens 
Progressive 
Matrices 
(maximum 
60) 
39.21 8.39 29 40.25 7.35 12 40.72 8.90 18 ns 
Years of 
Education 
15.27 2.44 26 14.92 4.06 12 16.00 2.00 18 ns 
           
Cigarettes 
per day 
7.42 4.48 12 9.00 3.58 6 15.00 - 1 .017 
Alcohol 
(Units per 
week) 
13.41 12.08 27 15.18 12.95 11 9.47 14.70 15 ns 
           
1  
For one-way ANOVA, except cigarettes where chi-squared test was used
 
 
 
Table 8.2 summarises the means and standard deviations for the most prevalent 
illicit drugs used by the ecstasy/polydrug group and the amount of cannabis used 
by the cannabis-only group in the last 30 days, their frequency of use, total 
lifetime use and weeks since last use. The amount of cannabis consumed by the 
two groups in the four aspects of drug use did not differ significantly although 
there were some noteworthy differences in the means, for example, the average 
lifetime dose was higher among the ecstasy/polydrug users.   
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Table 8.2. Indicators of Illicit Drug Use 
 
 
 
Ecstasy/Polydrug Users Cannabis-Only Users p
1
 
  Mean S.D. n  Mean S.D. N  
          
Total Use          
   Ecstasy (Tablets)  640.86 1284.99 29  - - - - 
   Cannabis (joints)  3048.84 5297.53 25  2242.58 3307.71 12 ns  
   Cocaine (lines)  1037.89 1282.60 19  - - - - 
          
Amount Consumed in 
Previous 30 Days 
         
   Ecstasy (Tablets)  3.14 8.28 29  - - - - 
   Cannabis (joints)  26.08 45.80 25  22.25 33.05 12 ns  
   Cocaine (lines)  8.16 12.74 19  - - - - 
          
Frequency of Use (times per 
week) 
         
   Ecstasy  0.24 0.43 29  - - - - 
   Cannabis  1.87 2.52 25  1.86 2.71 12 ns 
   Cocaine  0.28 0.36 19  - - - - 
          
Weeks Since Last Use:          
   Ecstasy  47.00 76.32 29  - - - - 
   Cannabis  20.34 37.13 25  73.32 113.69 12 ns 
   Cocaine  15.40 24.36 22  - - - - 
          
1. Mann-Whitney U test 
 
A series of one-way ANOVAs were conducted in order to investigate the effect of 
ecstasy/polydrug and cannabis-only use on the PM, RM, learning and memory 
compensation strategies. Table 8.3 summarises the outcomes of these 
comparisons. Inspection of Table 8.3 reveals that in comparison to the two illicit 
drug use groups, the drug naïve group performed significantly better on both time 
and event-based PM tasks. In fact the drug naïve group consistently performed 
better on all of the measures. Post-hoc analysis revealed that both cannabis-only 
users and drug naïve performed significantly better than ecstasy/polydrug users on 
the event-based PM task while cannabis-only users and drug naïve performed 
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similarly since the difference did not reach significance. For the time-based PM 
task the drug-naïve group performed significantly better than the ecstasy/polydrug 
user group whilst no difference in performance was observed between the 
ecstasy/polydrug and cannabis-only user group or cannabis-only and drug naïve 
group.  
 
Furthermore, the drug naïve group also performed better on the self-report 
measures of retrospective memory than all the other groups. However, pairwise 
comparisons revealed that the only difference that reached significance was the 
one between ecstasy/polydrug users and drug naïve, with non-users reporting 
better retrospective memory.  In terms of the memory compensation 
questionnaire, ecstasy/polydrug users made significantly less use of external 
memory aids in relation to drug naïve on the MCQ external scale. Performance on 
the same scale almost reached significance between cannabis only and drug naïve 
participants. No significant differences between the three groups were present on 
the RAVLT measure.  
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Ecstasy/Polydrug 
Users 
 Cannabis-Only Users  Nonusers  F Pairwise Comparisons 
(Tukey’s test)1 
 Mean S.D. N Mean S.D. n Mean S.D. n  E/PU 
vs  
CO 
E/PU 
vs. 
Non 
CO 
vs. 
Non 
CAMPROMPT              
              
Event-Based PM 12.48 3.27 29 15.08 2.39 12 16.00 1.68 18 10.40*** .019 .000   
Event-basedPM
2       
 2.46 0.69 29 1.90 0.59 12 1.66 0.50 18 10.10*** .027 .000  
        Time-Based PM                               10.45
 
3.94 29 12.33 5.65 12 15.11 3.51 18 6.79**  .001  
              
Retrospective Memory 
Questionnaire 
21.63 7.09 27 19.83 5.77 12 16.65 4.33 17   3.48*  .029  
MCQ              
External 25.18 7.61 28 24.25 9.30 12 30.67 4.84 18   3.96*  .041 .055 
Internal 31.32 5.98 28 29.25 6.84 12 33.17 7.88 18   1.21    
Time 14.18 3.39 28 12.67 4.64 12 15.11 3.86 18   1.48    
Reliance 14.79 4.28 28 15.25 4.20 12 13.22 4.86 18   0.95    
Effort 20.61 4.01 28 20.67 3.87 12 21.33 4.19 18   0.19    
Success 14.04 3.29 28 12.83 3.95 12 13.18 3.91 17   0.58    
Change 19.93 3.89 28 21.50 3.45 12 20.33 4.51 18   0.64    
RAVLT              
Learning T1-T5 39.04 9.38 28 40.58 11.11 12 45.22 9.60 18   2.21    
Proactive 0.89 1.77 28 1.58 1.38 12 0.94 1.47 18   0.83    
Retroactive 1.57 2.41 28 2.00 1.86 12 1.39 1.46 18   0.33    
Decay 2.00 2.17 27 2.00 1.76 12 1.22 1.26 18   1.10    
 
***p<.001; ** p<.01; * p<.05.  
 1.Only statistically significant differences or differences approaching statistical significance are reported. 
 2.This is the transformed variable where higher scores are indicative of worse performance.
Table 8.3. Outcomes for the Prospective Memory, Executive Functions, and Memory Measures by Group. 
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In order to investigate any possible associations between the PM and the rest of 
the memory functions, correlations were employed. Table 8.4 summarises the 
correlations between event and time-based PM tasks and the retrospective 
memory measures, the MCQ and the RAVLT measure. Inspection of table 8.4 
revealed that the event-based measure, as expected, was significantly correlated 
with the time-based PM measure. It was also correlated with the two retrospective 
memory measures; the Crawford et al.’s retrospective component of the PRMQ 
and the recall score of the RAVLT over trial 1-5 suggesting that better 
retrospective memory performance predicts better event-based PM performance. 
Event-based PM also approached significance with the reliance scale of the MCQ 
suggesting that as reliance on others as an aid to memory increases, PM 
performance decreases. Similarly, time-based PM was highly correlated with 
Crawford et al.’s retrospective component while the recall score on the RAVLT 
over trials 1-5 approached significance. This demonstrates once again that better 
retrospective memory performance is associated with better time-based PM 
performance.  
 
In order to evaluate the unique contributions of each predictor to PM 
performance, two regressions were employed with the scores on the event and 
time-based PM tasks as the dependent variables. Variables previously statistically 
significant in the correlation analysis were included as predictors. Results from 
the regression analyses are summarised in Table 8.4. 
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Table 8.4. The Relationship between Time and Event-Based PM and Memory 
Functions 
 
Correlate/IV Simple Correlation Semi-partial correlations from regression 
 
 Event- 
Based 
PM
1 
Time-
Based 
PM  
DV = Event- 
Based PM
1 
DV = Time-
Based PM  
 
CAMPROMPT      
Event-Based PM
1  -.523***    
Time-Based PM -.523***     
RetrospectiveMemory 
Questionnaire 
.270* -.381** -.026 *** -.361 *  
MCQ      
External -.075 .052    
Internal -.003 .007    
Time -.084 -.068    
Reliance .258
†
 -.184    
Effort -.193 -.064    
Success .019 .008    
Change .035 -.021    
RAVLT      
Learning T1-T5 -.273* .244
*
 -.239
†
 .217
†
  
Proactive .008 -.042    
Retroactive .095 .033    
Decay .152 -.060  
 
  
 
Ecstasy/polydrug vs all 
others  
Cannabis-only vs all others 
                                                           
  
 
 
.453** 
-.265  
 
.228 
-.073 
 
 
 
***p<.001; ** p<.01; * p<.05; † p<.10. (0ne-tailed) 
 
1. This is the transformed variable where higher scores are indicative of worse performance. 
 
 
Inspection of Table 8.4 reveals that the retrospective components of the self-report 
measure was statistically significant in both event and time-based PM suggesting 
that better retrospective memory may predict better time and event-based PM 
performance.  
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Ecstasy/polydrug users (compared to all other participants) and cannabis-only 
users (compared to all other participants) were also added as predictors in the 
regression analyses. In terms of ecstasy/polydrug use, the semi-partial correlation 
was statistically significant in the event-based PM task reflecting the 
ecstasy/polydrug related PM deficit. No significance was observed on the time-
based PM with ecstasy/polydrug use as the predictor or in either time or event-
based PM with cannabis only use as a predictor.  
 
The polydrug consumption amongst the ecstasy group makes it difficult to clearly 
attribute the PM impairments to specific drugs. In an effort to address this issue, 
simple and partial correlations were employed between different aspects of drug 
use and the two PM measures. The simple and semi-partial correlation 
coefficients are summarised in table 8.5. With respect to time-based PM, only the 
frequency of cannabis use was correlated with time-based PM suggesting the 
involvement of this aspect of cannabis use in time-based PM. Consequently, no 
semi-partial correlations were calculated for the time-based PM task.  
 
Unlike time-based PM, several significant correlations were observed for event-
based PM. In fact, all aspects of drug use i.e., total lifetime use, frequency and 
amount of drug consumed in the last 30 days, were significantly correlated with 
event-based PM for cannabis, cocaine and ecstasy with the exception of the 
amount of ecstasy consumed in the last 30 days. However, when controls for the 
use of other drugs were entered aspects of ecstasy use were no longer significant 
with event-based PM suggesting that ecstasy is not responsible for the event-
based PM impairments. Aspects of cannabis and cocaine yielded statistically 
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significant correlations after controlling for the use of other drugs. In fact, two 
aspects of cannabis use remained significant while all three aspects of cocaine use 
remained statistically significant for the event-based PM suggesting that 
impairments in PM performance might be attributable to cocaine and cannabis use 
rather than ecstasy use.  
 
Table 8.5. The Relationship between Time and Event-Based PM and Indicators of 
Illicit Drug Use 
 Event- 
Based PM
2 
Time 
Based PM 
 Simple 
Correlation 
Semi-Partial  
Correlation
1 
Simple 
Correlation 
Cannabis    
Total Lifetime Use .214* -.197 -.152 
Consumed in last 30 days -.215* -.221* -.152 
Frequency .301** -.382** -.279* 
    
Cocaine    
Total Lifetime Use .308** -.305** -.131 
Consumed in last 30 days .299** -.312** -.130 
Frequency .419** -.453*** -.120 
     
Ecstasy    
Total Lifetime Use .209* -.037 -.155 
Consumed in last 30 days -.170 -.074 -.058 
Frequency .215* -.103 -.064 
    
 
***, p<.001; ** p<.01; * p<.05; one tailed. 
 
1 
Controlling for the use of other drugs on the measure in question, e.g., the correlation between 
total use of cannabis and PM controlling for the total use of cocaine and total use of ecstasy. 
2
Correlation for the transformed variable. 
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8.4 Discussion 
 
The aim of the present investigation was to examine PM performance in a sample 
of ecstasy/polydrug, cannabis only users and drug naïve university students on an 
additional PM laboratory measure that is more sensitive in detecting PM 
differences in normal populations as opposed to the RBMT employed in Chapter 
7 which is most effective with clinical populations. The CAMPROMPT battery 
was administered in order to confirm and extend previous retrieval phase 
impairments between recreational users of ecstasy and non-ecstasy users. As a 
further extension to the previous investigation, in addition to the typical 
ecstasy/polydrug user group, a cannabis-only user group and a drug-naïve group 
were recruited to look at the effect of cannabis as opposed to previous polydrug-
related effects. Learning and RM measures were also administered in order to 
investigate the extent to which these processes are associated with PM 
performance. 
 
In terms of performance on the CAMPROMPT, ecstasy/polydrug users were 
impaired on both the event and time-based PM tasks in relation to the drug naïve 
group. Ecstasy/polydrug users also performed significantly worse than cannabis-
only users in the event-based PM task. Although it was evident on both time and 
event-based measures that ecstasy/polydrug users performed the worst, cannabis 
only users achieving intermediate levels and drug naïve performing the best, the 
cannabis only user group did not differ significantly from the drug naïve group. 
The ecstasy/polydrug related effect observed in the present investigation is in line 
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with previous research using self-report measures (Heffernan et al., 2001a; 2001b; 
Rodgers et al., 2001; 2003; Montgomery and Fisk, 2007) and laboratory measures 
of PM (Rendell et al., 2007). The present findings were also in line with PM 
deficits in laboratory measures observed in the previous chapter. Furthermore, the 
present findings further demonstrate CAMPROMPT’s efficacy in detecting 
individual differences in PM performance among non-clinical populations (Groot 
et al., 2002; Wilson et al., 2005). 
 
With regards to the non PM measures, ecstasy/polydrug related deficits were not 
as evident. Ecstasy/polydrug related deficits were only observed on the 
retrospective memory component of the PRMQ with drug naïve performing 
significantly better than the ecstasy/polydrug users. Also, in terms of memory 
compensation strategies, the non-user group were significantly more likely to 
report using external memory aids in everyday contexts.  On the whole for the non 
PM measures, cannabis-only users did not differ significantly from the drug naïve 
group in any of these measures suggesting that deficits in these measures are not 
attributed to the recreational use of cannabis. For the sample as a whole, 
individual differences on both PM measures were significantly correlated with 
performance on the RM component of the PRMQ and the retrospective 
component of the RAVLT (recall scores for trials 1-5) suggesting better RM is 
associated with better PM performance. This finding is consistent with previous 
research connecting PM performance with medial temporal function (Martin et 
al., 2007; Adda et al., 2008).  
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In order to establish the extent to which drug-related deficits on PM tasks were 
mediated by deficits in RM, regression analyses were employed. For the time-
based task, the variable representing ecstasy/polydrug use and the variable 
representing cannabis-only use were not statistically significant as predictors. This 
leaves open the question of whether drug use or individual differences adversely 
affect time-based PM. Conversely, ecstasy/polydrug use yielded statistically 
significant results in event-based PM suggesting that ecstasy/polydrug use 
adversely affect event-based PM. 
 
While the ecstasy/polydrug related deficits are evident on PM measures, which 
drug or drugs are responsible for these deficits is not very clear. In order to 
determine the contribution of each illicit drug semi-partial correlations controlling 
for the use of other drugs revealed that no aspect of ecstasy use is actually 
significant as a predictor of PM performance. What is somehow surprising is that 
although the cannabis-only group did not appear to be significantly impaired in 
comparison to the drug naïve group, recreational use of cannabis among the whole 
sample was significantly correlated with event-based PM even after controlling 
for the use of other drugs. More specifically, frequency of cannabis use and the 
amount consumed in the last 30 days were associated with poorer event-based PM 
performance. These findings implicate the recreational use of cannabis with PM 
impairments and are in line with previous investigations in which cannabis-related 
deficits have been observed (Rodgers et al., 2003; Fisk & Montgomery, 2008; 
McHale & Hunt, 2008). 
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A striking finding in the present investigation is the contribution of cocaine in 
determining event-based PM performance. All aspects of cocaine were associated 
with poorer event-based PM performance. Specifically, total lifetime use, 
frequency of use and amount of cocaine consumed in the last 30 days remained 
statistically significant as predictors of event-based PM performance even after 
controlling for concurrent use of other drugs. This replicates the cocaine-related 
deficits observed in the previous investigation. To the best knowledge of the 
author, the present and the previous study are the first to link recreational use of 
cocaine with PM deficits. Although the effect of cocaine is obvious in these two 
studies, the mechanism through which cocaine might adversely affect PM 
performance remains unclear.  
 
A methodological issue that needs to be considered is the relatively small sample 
size in the present study which means that the results of the regression analyses 
need to be treated with caution. Nonetheless, the present results are potentially 
informative as a guide for which variables might be incorporated into future 
research utilising larger samples.   
 
To conclude, the present study intended to determine the impact of 
ecstasy/polydrug use and cannabis use on event-based and time-based prospective 
memory using the CAMPROMPT. Measures of RM and learning were also 
administered in order to study the extent to which retrospective memory and 
learning account for the prospective memory deficits in recreational drug users. 
Relative to both drug naive participants and cannabis only users, ecstasy/polydrug 
users performed significantly worse on the event-based PM task while no 
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significant differences in performance were observed between the cannabis user 
and drug naïve groups. However, consistent with the results of the previous study, 
recreational use of cocaine was significantly correlated with event-based 
prospective memory performance, demonstrating the need for a systematic 
investigation of the potential role of cocaine in accounting for the PM deficits that 
have been observed here and in other studies. Having established the impact of 
ecstasy/polydrug use on PM, the next chapter will investigate the potential effect 
of ecstasy/polydrug use on measures of EF. 
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Chapter 9: Self-report measures 
of executive dysfunction among 
recreational drug users 
Chapter overview 
The purpose of the present chapter is to investigate the effect of the recreational 
use of ecstasy on EF. A relatively new line of investigation evaluates the integrity 
of EF in relation to recreational drug use and more specifically in relation to 
ecstasy/polydrug use. Several studies in the area have revealed that 
ecstasy/polydrug users exhibit deficits on a number of laboratory tests of EF (see 
Murphy et al., 2009 for a review). These studies, however, have been restricted to 
Miyake et al.’s (2000) three components of EF i.e., shifting, inhibition and 
updating. Laboratory measures of EF, regardless their validity and reliability, are 
potentially limited in terms of their ecological validity with regard to everyday 
functioning. Consequently, the present study aims to extend previous reports of 
executive dysfunction in ecstasy/polydrug users by investigating the extent to 
which executive deficits are manifested in everyday life using the self-report 
measure of EF BRIEF-A in a university based sample of ecstasy/polydrug, 
cannabis-only and drug naïve individuals. It was found that compared to drug 
naive, ecstasy/polydrug users performed significantly worse on those subscales 
measuring inhibition, monitoring emotional regulation and self, initiating action, 
working memory, planning, task monitoring and organisational ability. However, 
further intergroup comparisons revealed that for the most part ecstasy/polydrug 
users did not differ significantly from cannabis only users who in turn did not 
differ from non-illicit drug users.  
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9.1 Introduction 
 
According to Gioia, Isquith and Guy (2001), EF is a collection of interconnected 
tasks or processes that are responsible for goal directed or future orientated 
behaviour in the everyday or “Real world” environment. The executive system 
has been referred to as the conductor which controls, organises and directs 
cognitive activity, emotional responses and behaviour. Although the concept of 
EF has recently received increased attention it still remains somehow elusive. A 
number of theoretical models of EF have been proposed; however, no model has 
been uniformly accepted. Early attempts to conceptualize EF resulted in unitary 
models such as the “Central Executive” (Baddeley, 1986). After findings showing 
that patients rarely exhibit global executive dysfunction (Bigler, 1988), Miyake et 
al. (2000) suggested that EF is fractionated into 3 separable components; shifting, 
inhibition and updating (a more detailed account of theoretical models of EF can 
be found in chapter 3).  
 
A relatively new line of investigation evaluates the integrity of EF in relation to 
recreational drug use, specifically ecstasy/polydrug use.  MDMA  is known to 
have neurotoxic effects on serotonergic axon terminals in both animals and 
humans (Green et al., 2003) and in view of the important role played by serotonin 
in regulating prefrontal neural processes (Morgan, 2000) executive dysfunction 
among ecstasy users is possible. Several studies utilising laboratory-based 
measures have demonstrated deficits in aspects of executive functioning among 
ecstasy users (Fox et al., 2001; Montgomery et al., 2007; Montgomery & Fisk, 
2008; Verdejo-Garcia et al., 2005; Wareing et al., 2007; also see Chapter 6 for an 
extensive review). Further evidence for the fractionisation of EF comes from 
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evidence suggesting that suggested that it is the updating component of working 
memory and not shifting and inhibition elements that are sensitive to the effects of 
ecstasy (Fisk & Montgomery, 2009; Fisk et al., 2004; McCann et al., 2007; 
Montgomery et al., 2005; Reneman et al., 2006). 
 
The assessment of EF has largely been restricted to laboratory-based measures. 
Although laboratory measures of EF possess strong internal validity, enable 
control over extraneous variables and the possibility to examine individual 
component processes separately, they are limited in terms of their ecological 
validity with regard to everyday functioning (Gioia et al., 2008). Therefore, 
relying on only laboratory-based measures can lead to a limited and incomplete 
assessment given that executive functions play a key role in the direction and 
control of real-world behaviour (Gioia & Isquith, 2004). Consistent with this 
view, Goldberg and Podell (2000) argue that laboratory measures of EF only 
capture narrow aspects of the executive system and not the multidimensional 
aspects of decision making that characterise real world situations.     
 
In order to overcome the limitations of laboratory-based measures, self-report 
measures have been developed that are specifically designed to provide an 
indicator of an individual’s executive functioning in the everyday environment. 
These measures offer ecologically valid and internally consistent indicators of 
executive processes in an everyday context and provide a broader perspective 
compared to that provided by one-off laboratory-based measures obtained in a 
single assessment. Among such everyday measures is the Behavioural Rating 
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Inventory of Executive Function (BRIEF), which includes questions related to 
everyday activities in familiar contexts that participants can readily relate to.  
 
The BRIEF has been developed to capture the behavioural manifestations of 
executive dysfunction in the various interrelated domains of the construct that 
have been commonly discussed in the literature (Bodnar et al., 2007). It also 
provides an indicator of nine separate aspects of executive functioning: Inhibition, 
Shift, Emotional Control, Self-Monitor, Initiate, Working Memory, 
Plan/Organisation, Task-Monitor, and Organization of Materials. Bodnar et al. 
(2007) argue that everyday instruments such as the BRIEF, measure subtle 
individual differences in discrete real world processes and unlike many laboratory 
tests are unrelated to, and not contaminated by overall differences in general 
ability measures such as IQ.  The BRIEF has been used in a wide range of 
contexts, for example, in research focussing on  Attention Deficit/ Hyperactivity 
Disorder (ADHD) (Chang et al., 2009; Gioia et al, 2002; Jarratt et al., 2005; 
Mahone & Hoffman, 2007; Toplak et al., 2009); bipolar disorder (Shear et al., 
2002), autism spectrum disorders (Gilotty et al., 2002; Gioia et al., 2002; Chan et 
al., 2009), childhood epilepsy (Sherman et al., 2006), frontal lobe lesions (Malloy 
& Grace 2005) and traumatic brain injury (Gioia et al., 2002; 2004).   
 
The reliability and validity of the BRIEF in assessing EF has been demonstrated 
in a number of studies (Slick et al., 2006; Gioia et al., 2000; Gioia et al., 2002; 
Toplak et al., 2009; Bodnar et al., 2007; Walker & D’Amato, 2006) and it is 
extensively discussed in Chapter 2.  
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Assessments of EF using laboratory measures are valuable in providing evidence 
that ecstasy users are impaired on some aspects of executive functioning such as 
updating and access to semantic memory while other processes such as inhibition 
and set shifting remain unimpaired to recreational use of ecstasy. Conversely, the 
use of self-report measures of EF such as the BRIEF that are able to tap 
behavioural manifestations of executive functioning in the everyday environment 
would allow a more comprehensive view of the nature of executive deficits in 
ecstasy/polydrug users.  
 
Consequently, the present investigation predicts that ecstasy/polydrug users will 
perform worse on the BRIEF measure compared to cannabis-only users and drug 
naïve. Since evidence from previous investigations (Fisk & Montgomery, 2009a; 
Montgomery et al., 2005) suggest that ecstasy/polydrug use rather than cannabis 
use is associated with executive deficits it is predicted that the cannabis-only and 
nonuser group in the present study will not differ significantly from each other.  
 
9.2 Method 
 
Design 
A between participants design was employed with drug use as the independent 
variable (with three levels, ecstasy/polydrug, cannabis only, and drug naïve). 
Dependent variables were the nine component subscales of the BRIEF-A (i.e., 
inhibit, shift, emotional regulation, self-monitor, initiate, working memory, plan, 
task monitor and organise). Correlation and linear regression analyses were also 
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employed in order to investigate each recreational drug’s possible contribution to 
executive dysfunction.  
 
 
Participants 
Sixty five ecstasy/polydrug users (36 females) 19 cannabis-only users (13 
females) and 38 non-users of illicit drugs (31 females) took part in this 
investigation. This sample of participants also completed some of the measures 
from previous studies. See appendix 1 for participants overlap table. Participants 
were recruited via direct approach to university students and the snowball 
technique i.e., word-of-mouth referral (Solowij et al., 1992). All participants were 
university students attending the University of Central Lancashire (UCLAN) or 
Liverpool John Moores University (LJMU).  
 
Materials 
The background drug-use questionnaire used in the previous investigations was 
administered to assess the prior history of illicit drug consumption and estimate 
the total lifetime use for each drug (e.g., ecstasy, cannabis, cocaine, amphetamines 
etc.), frequency of use as well as the period of abstinence. Fluid intelligence was 
measured via Raven's Progressive Matrices (Raven et al., 1998). The participant's 
age and gender, the number of years of education as well as their current use of 
alcohol and cigarettes were also assessed. A self-reported measure of EF was 
administered to capture the participant's views of their own EF in their everyday 
environment. The self-reported measure of executive functions is described 
below. 
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Behaviour Rating Inventory of Executive Function- Adult Version (BRIEF-A) 
(Roth et al., 2005) 
 
The BRIEF-A is a 75 item measure which provides indicators of nine separate 
aspects of EF.  Eight items measure Inhibition (the ability to resist or control 
impulses), e.g., “I tap my fingers or bounce my legs”. Six items measure the Shift 
process (being able to shift attention, change strategies, act flexibly) e.g., “I have 
trouble changing from one activity to another”. Ten items measure Emotional 
Control (the individual’s ability to control their emotions), e.g., “I have angry 
outbursts”. Six items measure Self-monitoring (insensitivity, inability to infer the 
feelings and emotions of others, behaving in a thoughtless manner), e.g., “I don't 
notice when I cause others to feel bad or get mad until is too late”. Eight items 
measure Initiate (having the impetus to begin tasks, generate ideas and develop 
strategies), e.g., “I need to be reminded to begin a task even when I am willing”. 
Eight items measure Working Memory, (the temporary storage and maintenance 
of information while working on ongoing tasks) e.g., “I have trouble 
concentrating on tasks (such a chores, reading or work)”. Ten items measure 
Planning/Organisation (setting goals and developing tactics to achieve them, 
anticipation of future events and the preparation of strategies to deal with them), 
e.g., “I get overwhelmed by large tasks”. Six items measure Task Monitoring (the 
ability to appraise task requirements and avoid making careless mistakes), e.g., “I 
make careless errors when completing tasks” and finally eight items measure the 
Organization of Materials (disorganised, untidy), e.g., “I am disorganized”. For 
each item participants respond on a three point likert scale; Never, Sometimes and 
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Often. On each of the subscales higher scores are indicative of more executive 
dysfunction.  An additional three scales measure the validity and reliability of the 
participant’s responses, for example, ‘infrequency’ i.e., the extent to which the 
respondent endorses items which are usually rejected by the vast majority of 
people, e.g., “I forget my name”. Scores on certain other items are combined to 
form indicators of ‘negativity’ and ‘inconsistency’. For each of the nine scales, a 
total score is generated by adding the scores for each of relevant the questions. 
For a copy of the questionnaire please refer to appendix 12.  
 
Procedure   
Participants were firstly informed of the general purpose of the investigation and 
their right to withdraw from the experiment at any time. After verbal consent had 
been obtained, the tests were administered in a quiet laboratory. The drug-use 
questionnaire was administered first, followed by Ravens Progressive Matrices, 
and the BRIEF-A (Roth et al., 2005). At the end of the experiment, participants 
were fully debriefed, paid £20 in Tesco store vouchers, and given drug education 
leaflets. The University of Central Lancashire's Ethics Committee approved the 
study. 
 
9.3 Results 
 
Using the criteria suggested by Tabacknick and Fidell (2007) there were no 
univariate outliers. A multivariate outlier was detected and the participant was 
excluded from the analysis. Regarding the distribution of the BRIEF subscales, 
the scores did not deviate significantly from normal and the z scores associated 
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with the statistics in relation to skewness and kurtosis were consistent with 
normality for samples of this size (Tabachnick & Fidell, 2007). 
 
With regard to the validity of the BRIEF, the three validity subscales were 
considered. Inspection of the negativity scores revealed that three cases exceeded 
the score of six, which according to the instruction manual merits further 
investigation. Nevertheless, inspection of the remaining indicators for these cases 
was within acceptable bounds and therefore not excluded from the analysis. In 
terms of the infrequency scales, three cases exceeded the score of three. However, 
after inspection of the cases’ scores on the other validity scales the cases were 
retained. One case was excluded from the analysis as the inconsistency score was 
unusually high.  
 
Table 9.1 below summarises the means and standard deviations of background 
and demographic variables including the amount of alcohol and tobacco 
consumption for the three groups.  
 
Table 9.1. Demographical Variables for Illicit Drug Users and Nonusers  
 
 
 
Ecstasy/Polydrug 
Users 
Cannabis-Only Users Nonusers  p
1
 
 Mean S.D. n Mean S.D. n Mean S.D. n  
           
Age (years) 21.38 2.85 65 21.84 3.58 19 20.50 2.21 38 ns 
Ravens Progressive 
Matrices (maximum 60) 
42.59 9.08 64 42.32 7.23 19 43.11 8.67 38 ns 
Years of Education 14.75 3.43 64 15.05 2.55 19 14.97 2.51 38 ns 
           
Cigarettes per day 8.83 7.60 29 6.63 4.37 8 9.67 7.99 6 ns 
Alcohol (Units per week) 13.91 9.93 64 15.00 14.15 18 8.34 11.80 35 .039 
           
1. For one-way ANOVA 
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Inspection of Table 9.1 revealed that the three groups did not differ significantly 
on any of the background variables with the exception of alcohol consumption. 
On further analysis, Tukey’s post-hoc test revealed that ecstasy/polydrug users 
consumed significantly more units of alcohol per week than drug naïve (p<0.05). 
Although mean alcohol consumption was higher in cannabis-only users than 
ecstasy/polydrug users, Tukey’s post-hoc test revealed that this difference was not 
statistically significant. No other pairwise comparisons yielded statistically 
significant results. Table 9.2 summarises the background drug use variables for 
the ecstasy/polydrug and cannabis-only user groups. The total lifetime use, 
frequency of use and the total amount consumed in the last thirty days for each of 
the major illicit drugs are summarised.  
 
Inspection of Table 9.2 revealed that although there are noticeable differences in 
various indicators of cannabis consumption, only total lifetime use of cannabis 
reached significance. It is worth noticing that the polydrug group, besides the use 
of ecstasy and cannabis, was also characterised by regular use of cocaine. An 
inspection of other recreational drugs reported by polydrug users (such as 
amphetamines, poppers, ketamine and LSD) revealed that the small amount of 
ecstasy/polydrug users that reported such use described their use as ‘occasional’ 
in the past three months. Consequently, these drugs were not included in the 
analysis.  
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Table 9.2. Background Drug Use Variables for Illicit Drug Users  
 
 
 
Ecstasy/Polydrug Users Cannabis-Only Users p
1
 
  Mean S.D. N  Mean S.D. N  
Total Use          
   Ecstasy (Tablets)  613.54 1148.52 65  - - - - 
   Cannabis (joints)  3034.90 4748.40 58  1412.89 2804.90 19 0.020  
   Cocaine (lines)  1099.93 1572.44 42  - - - - 
Amount Consumed in Previous 
30 Days 
         
   Ecstasy (Tablets)  3.58 7.38 65  - - - - 
   Cannabis (joints)  21.83 45.39 58  13.68 28.10 19 ns  
   Cocaine (lines)  8.38 12.98 42  - - - - 
Frequency of Use (times per 
week) 
         
   Ecstasy  0.25 0.37 65  - - - - 
   Cannabis  1.40 2.20 58  1.37 2.45 19 ns 
   Cocaine  0.31 0.42 41  - - - - 
Weeks Since Last Use:          
   Ecstasy  37.78 71.40 65  - - - - 
   Cannabis  25.47 60.42 58  73.05 101.22 19 ns 
   Cocaine  20.29 47.72 48  - - - - 
          
1 For Mann-Whitney U test 
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MANOVA was conducted to investigate the effect of ecstasy/polydrug and 
cannabis-only use on EF. Thus, Table 9.3 summarises the results of the primary 
analysis. Multivariate analysis of variance with the nine subscales of the BRIEF 
as the dependent variables and the three groups as the independent variables was 
conducted revealed a statistically significant group effect, Λ = .707, F(18,202) = 
2.13, p=0.006, partial η2.= .159. Univariate analysis revealed that all subscales of 
the BRIEF were statistically significant, with the exception of the shift subscale 
(see Table 9.3 for the statistical results of univariate analysis). Tukey’s post-hoc 
analysis revealed that, as predicted, ecstasy/polydrug users performed 
significantly worse than drug naïve on all but two (shift and emotional regulation) 
subscales of the BRIEF.  
 
It was also predicted that cannabis-only users would not differ significantly than 
drug naïve; a prediction that was supported with the exception of the emotional 
regulation subscale that reached significance. However, ecstasy/polydrug users 
did not differ significantly from cannabis-only users on any of the EF apart from 
the inhibit subscale. The significance levels for the pairwise comparisons are also 
summarised in Table 9.3.  
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BRIEF subscale   
ecstasy/polydrug 
users   
cannabis-only 
users   drug-naïve    Group overall effect   pairwise comparisons   
  
Mean SD 
 
Mean SD 
 
Mean SD 
 
F(2,109) P 
partial 
2 
 
Ecstasy/polydrug 
users vs drug 
naïve  
ecstasy/polydrug 
users vs cannabis 
only users  
cannabis 
only users 
vs drug 
naïve  
p covariate of 
alcohol  
                   Inhibit 
 
15.67 2.95 
 
14 2.89 
 
13.94 2.86 
 
4.79 0 0.081 
 
0.009 0.048 ns 0.038 
Shift 
 
9.95 2.57 
 
9.24 2.33 
 
10.21 2.41 
 
0.87 Ns 0.016 
 
ns ns ns ns 
emotional 
regulation 17.15 4.45 
 
15.41 4.89 
 
18.76 4.09 
 
3.45 0.018 0.06 
 
ns ns 0.016 0.008 
self monitor 
 
10.38 2.37 
 
9.76 2.33 
 
9.09 2.04 
 
2.98 0.028 0.052 
 
0.022 ns ns ns 
Initiate 
 
15.05 3.19 
 
14.06 2.36 
 
13.15 2.56 
 
4.79 0 0.01 
 
0.004 ns ns ns 
working 
memory 
 
14.84 3.37 
 
14.24 3.19 
 
13.29 2.66 
 
2.63 0.039 0.046 
 
0.031 ns ns ns 
Plan 
 
17.86 4.44 
 
16.76 3.54 
 
15.65 3.18 
 
3.52 0.017 0.061 
 
0.013 ns ns ns 
task monitor 
 
11.34 2.41 
 
10.71 1.83 
 
10.03 1.8 
 
4.08 0.01 0.07 
 
0.007 ns ns ns 
Organise 
 
15 4.04 
 
14.29 4.13 
 
12.5 3.29 
 
4.64 0.006 0.078 
 
0.004 ns ns ns 
 
Table 9.3. Performance on the Self Report BRIEF-A Measure for Ecstasy/Polydrug, Cannabis-Only, and Nonusers of Illicit Drugs. 
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Since the groups differed significantly in their alcohol consumption, a 
multivariate analysis of covariance was conducted to look at the effect of the 
covariate on the EF. In multivariate terms, the overall group effect remained 
statistically significant after the inclusion of the covariate, Λ = .740, F (18,192) = 
1.73, p=0.037, partial η2= .140. This suggests that alcohol does not affect the 
performance of EF. Also, the effect size was only reduced by 1.9% suggesting 
that most of the variance was explained. In the univariate analysis however, with 
the exception of inhibit and emotional regulation, the rest of the EF were 
decreased to below significance.  
 
As with the previous investigations (Chapters 7 and 8), the ecstasy/polydrug user 
group was characterised by recreational use of cocaine and cannabis. It is 
therefore necessary to try and determine the contribution of each of the main illicit 
drugs to executive dysfunction. Correlational analyses were therefore conducted 
to observe any associations between the individual illicit drugs and the nine EFs. 
Table 9.4 summarises the Pearson’s correlation coefficients for the lifetime and 
frequency of use for ecstasy, cannabis and cocaine for each EF.  
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Table 9.4. Simple correlations and semi-partial correlations (from regression) 
between BRIEF subscales and aspects of drug use 
 
                
   
Lifetime use 
 
Frequency 
BRIEF subscale   Drug Simple 
semi 
partial   Simple 
semi 
partial 
        Inhibit 
 
Ecstasy .196* 
  
.283** .213* 
  
Cocaine 
   
.207* 
 Shift 
       Emotional 
regulation 
       self-monitor 
 
Ecstasy .205* 
  
.213* 
 
  
Cannabis 
   
.195* 
 
  
Cocaine .222* .170* 
 
.202* 
 Initiate 
 
Ecstasy 
   
.214* 
 
  
Cannabis 
   
.211* 
 working memory 
 
Cannabis 
   
.183* 
 Plan 
 
Ecstasy .221* 
  
.200* 
 task monitor 
 
Ecstasy .182* 
  
.195* 
 Organise 
 
Ecstasy .200* 
                    
*p<0.05, **p<0.01, (one-tailed) 
 
Inspection of Table 9.4 reveals that lifetime use of ecstasy is positively correlated 
with five out of the nine EFs. Consequently, ecstasy is associated with deficits in 
inhibit, self-monitor, planning, task-monitor and organise subscales. The self-
monitor subscale was also significantly correlated with total lifetime use of 
cocaine whilst no component of EF was associated with total lifetime use of 
cannabis. However, when the variance in relation to the total use of other drugs 
was excluded using regression analysis, total lifetime use of ecstasy was reduced 
to below significance suggesting that the deficits in EF are not uniquely attributed 
to the use of ecstasy. Surprisingly, the only semi-partial correlation that reached 
significance was the total lifetime use of cocaine for the self-monitor subscale, 
suggesting that recreational use of cocaine is responsible for the impairment in 
that aspect of EF.  
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In terms of frequency of use, ecstasy was predominantly associated with EF since 
five out of the nine components of EF were significantly correlated. Frequency of 
cannabis use was significantly correlated with three components of EF and 
frequency of cocaine use with only two components. Nevertheless, when the 
variance in relation to the frequency of use of other drugs was excluded the only 
association that was statistically significant was that between the frequency of 
ecstasy use and the inhibit EF component. It can therefore be assumed that the 
deficits observed on the inhibit component of EF are related to the frequency of 
ecstasy use.   
 
9.4 Discussion 
 
The aim of the present study was to investigate the effect of ecstasy/ polydrug use 
and cannabis use on executive functioning with regards to the everyday 
environment. The present investigation assessed a broader range of EFs as 
opposed to the traditional three-component model often adopted in this area. In 
comparison to drug naïve, ecstasy/polydrug users performed significantly poorer 
on all subscales of the BRIEF with the exception of shift and emotional 
regulation. When ecstasy/polydrug users were compared with the cannabis-only 
group, only the inhibit subscale of the BRIEF produced a statistically significant 
difference with ecstasy/polydrug users performing worse. When evaluating the 
role of cannabis use in executive functioning, cannabis-only users were compared 
to the drug naïve sample and although cannabis only users performed generally 
worse than the drug naïve in all subscales of the BRIEF, the only component of 
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EF that reached significance was emotional regulation. Similar to the previous 
studies on PM, a trend is evident with ecstasy/polydrug users performing the 
worst, cannabis users performing at intermediate levels and the drug naïve group 
performing the best.  
 
Which drug is primarily responsible for the observed deficits in executive 
functioning is therefore not clear. In order to answer this question correlational 
and regression analyses were employed to look at any associations between the 
different components of EF and recreational drug use. These analyses revealed 
that total lifetime and frequency of ecstasy use were associated with most 
executive components while the equivalent measures for the other drugs were 
generally not. Nevertheless, when the variance of other drugs was excluded the 
only component that yielded significant differences in frequency of use was the 
inhibit component. It is therefore possible that the inhibit component is 
particularly sensitive to the recreational use of ecstasy. This is a surprising finding 
as a number of previous laboratory-based investigations suggested that it is the 
updating component of working memory and not the shifting and inhibition 
elements that are sensitive to the effects of ecstasy (Fisk et al., 2004; Montgomery 
et al., 2005; Reneman et al., 2006; McCann et al., 2007).  
 
It is also possible that laboratory measures of EF are less sensitive in detecting 
impairments in the inhibition component of EF as opposed to self-report measures 
of executive functioning. Consistent with this view Bodnar et al. (2007) found 
that the BRIEF appears to measure different elements of the inhibition construct 
than those assessed by computerised performance tests; thus explaining why as 
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opposed to laboratory measures of inhibition this aspect of EF is impaired on the 
BRIEF. The findings of the present investigation therefore suggest that the 
inhibition component of EF is impaired in ecstasy/polydrug users with respect to 
their everyday environment. It also suggests that the reported failures in this 
component are attributed to the recreational use of ecstasy. 
 
 Consistent with Bodnar et al.’s view, Toplak et al. (2009) have in fact observed 
that certain of the BRIEF subscales (e.g. switching/shifting) do not appear to map 
straightforwardly onto the equivalent laboratory measures. In terms of   switching 
(shifting), previous laboratory-based research has generally failed to uncover 
ecstasy-related deficits (see Murphy et al., 2009 for a review). These findings 
were replicated in the present study since deficits were not observed on the 
BRIEF shift subscale.  
 
In terms of working memory, findings are less straightforward. The BRIEF’s WM 
subscale relates most closely to the updating executive process within Miyake et 
al.’s conceptualisation (see Friedman et al, 2008). Previous laboratory-based 
investigations of WM suggest that ecstasy/polydrug users are impaired on tests 
loading on this process (Montgomery et al., 2005; Fisk et al. 2009; also see 
Murphy et al. 2009 for a review).  
 
While the present results also showed that ecstasy/polydrug users had poorer WM 
scores compared to cannabis-only user group, the difference did not reach 
statistical significance. Despite this, the difference between the ecstasy/polydrug 
group and the drug naïve group was statistically significant; a finding consistent 
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with the laboratory outcomes. The remaining BRIEF subscales do not readily map 
onto the laboratory measures underpinning Miyake et al.’s conseptualisation of 
fractionated EF. The present study revealed ecstasy/polydrug related deficits on a 
number of the other BRIEF subscales including planning, initiation, organisation, 
and self and task monitoring. It is possible that these impairments reflect separate 
aspects of another key executive function: the effective maintenance of goal 
directed behaviour. Consequently, the present results potentially identify an 
additional aspect of EF which might be subject to ecstasy/polydrug related effects. 
Further investigation of this, possibly through the use of appropriate self-report 
measures and laboratory tests, might possibly establish a useful direction for 
further research. 
 
Nevertheless, the present findings need to be interpreted with caution with regards 
to the drug-related deficits observed. It is worth mentioning that in the present 
investigation cannabis consumption was higher in the ecstasy/polydrug user group 
than the cannabis-only group. It is therefore possible that the observed deficits in 
executive components are in fact attributed to cannabis use. This would account 
for why cannabis users were impaired (although not significantly) whilst 
ecstasy/polydrug users with higher levels of cannabis consumption were 
significantly impaired. Whilst previous research using laboratory measures of EF 
failed to find cannabis-related deficits (Fisk & Montgomery, 2008), the present 
findings, raise the possibility that although cannabis users perform adequately in 
laboratory settings, executive deficits may be present in their everyday lives. 
Evidence supporting this possibility comes from other non-laboratory measures. 
For instance, Verdejo-Garcia et al. (2006) found that performance on two self-
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report aspects associated with prefrontal lobe neural functioning i.e., an executive 
component (panning, WM and mental flexibility) and an apathy component (loss 
of energy, poor initiation and reduced affective expression) were associated with 
the severity of cannabis use.  
 
Furthermore, more evidence for the importance of administering self-report 
measures of EFs that capture the behavioural manifestations of EF in day-to-day 
functioning and the involvement of cannabis use comes from a recent internet 
study using the Webexec. The Webexec (Buchanan et al., 2010) is a short self-
report measure of problems with EF that is specifically designed for internet-
mediated research. This brief self-report measure of EF generates a global score of 
executive functioning; reflecting the participant’s overall experience of executive 
problems instead of measuring specific aspects. The measure was correlated with 
three cognitive tasks (i.e., reverse digit span, semantic fluency and semantic 
fluency with inhibition) and also with scores on the Dysexecutive questionnaire 
(DEX) indicating good validity. The authors also used this measure to assess 
executive dysfunction in recreational drug users. The findings suggested that 
participants with higher cannabis consumption reported more executive problems 
and also that scores on the Webexec were correlated with PMQ’s long-term PM 
scale. Further evidence for the involvement of cannabis use in deficits in EF 
comes from recent neuropsychological assessment. For example, Fontes et al. 
(2011) using the Frontal Assessment Battery (FAB; a neuropsychological 
instrument evaluating EF), found that abstinent chronic cannabis users performed 
as poorly controls.   
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Brain imaging studies might also be informative for the potential presence of 
cannabis-related deficits in aspects of EF or the lack of it. Neuroimaging evidence 
suggests that  although there are no differences between cannabis users and 
nonusers in tests of WM and visuo-auditory selective attention, neuroimaging  
analysis focussing on specific regions of interest (ROI) revealed differences in 
brain activity between users and nonusers in the superior parietal cortex (Jager et 
al., 2006). In a subsequent fMRI study, during an associative learning task Jager 
et al. (2007) found no structural differences in the particular ROI whilst lower 
activation levels among frequent cannabis users were present in the medial 
temporal structures (especially the para-hippocampal area) and the right DLPFC. 
These findings therefore suggest that the neural structures and processes that 
support performance on EF tasks do not function similarly in cannabis users and 
nonusers and although this appears to be non-problematic in laboratory tasks, in 
more everyday settings such as those assessed by the BRIEF and other self-report 
measures, cannabis-related deficits may be more apparent.  
 
Many ecstasy/polydrug users in the present investigation were also regular users 
of cocaine. Correlational analysis suggested that a number of components were 
associated with the recreational use of cocaine and in the case of self-monitor, 
lifetime use of cocaine appeared to be the only drug use measure uniquely 
accounting for deficits in that aspect of executive functioning. While to the best of 
the author’s knowledge no previous studies of cocaine users have used self-report 
executive measures, other research using laboratory-based tasks have produced 
inconsistent results. For instance, in some studies cocaine users have been found 
to be impaired on laboratory measures of the switching component of EF such as 
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the trailing making test (TMT-B) and the Wisconsin Card Sort Test (WCST) 
(Beatty et al., 1995; Berry et al., 1993; Rosselli et al., 2001) while others failed to 
demonstrate impairment on the same tasks (Gillen et al., 1998; Goldstein et al., 
2004; Verdejo-García & Pérez-García, 2007).  
 
Similar inconsistent findings were also observed on the inhibitory processes; 
while some studies have found cocaine-related impairments on the Stroop task 
(Rosselli et al., 2001; Verdejo-García & Pérez-García, 2007), some others suggest 
that recreational use of cocaine leaves performance on the Stroop task unimpaired 
(Berry et al., 1993; Goldstein et al., 2004). Mixed results have also been observed 
on the WM component of EF in relation to recreational use of cocaine. For 
example, cocaine users were found to be impaired on paced auditory serial 
addition task (PASAT) after three days of abstinence but not after a further two 
week period of abstinence (Berry et al., 1993). Furthermore, Verdejo-García and 
Pérez-García (2007) found that substance dependent polydrug users whose drug 
of choice was cocaine were impaired on the number letter re-sequencing task, on 
forward and backward digit, and on spatial span known to load on the WM 
component. Contradicting these findings, Gonzalez et al. (2004) found that 
cocaine users performed similarly to controls on a combined deficit score for the 
PASAT and the WMS-III number-letter sequencing task. Evidence for EF deficits 
on laboratory-based tasks among recreational cocaine users is therefore unclear 
and inconsistent. Furthermore, the fact that in the present study cannabis-only 
users reported a degree of executive dysfunction (although not at a significant 
level) suggests that cocaine is unlikely to account for the full range of deficits that 
were observed here.  
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Furthermore, alcohol consumption should not be disregarded in the present study 
as groups differed significantly in their levels of alcohol consumption. Since 
previous investigations have linked alcohol abuse with executive dysfunction, it is 
possible that some of the deficits observed on the BRIEF are attributable to effects 
of alcohol rather than drug use per se. For example, according to Scheurich (2005) 
new approaches concerning EF found response inhibition and decision-making 
impairments amongst those consuming alcohol but normal performance in simple 
working memory tasks.  Also, alcohol abuse in early and middle adolescence was 
found to be associated with deficits in verbal recall and visuo-spatial functioning 
(Brown et al., 2000) while comparison of crack cocaine addicted persons, 
alcoholics, and controls revealed deficits in neuropsychological tests of attention 
and executive functioning with deficits being particularly prevalent among the 
alcoholic participants (Goldstein et al., 2004).  
 
Similarly, Loeber et al. (2009) found that alcohol dependent patients did worse 
than healthy controls on tasks believed to load on attention/EFs, however the 
decrement decreased with increasing length of abstinence. Although the 
mechanisms that may underlie such everyday cognitive impairments associated 
with binge drinking are not yet fully understood, it is possible that alcohol-
dependent patients use additional and generally higher-order executive functions 
to compensate for deficient task performance. The compensatory mechanisms 
might help to explain why performance on cognitive tasks may appear to be 
unimpaired on basic cognitive domains (Scheurich, 2005). 
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To conclude, the present study intended to determine the impact of 
ecstasy/polydrug use on executive functioning using the self-report BRIEF-A 
measure. Relative to drug naive persons ecstasy/polydrug users performed 
significantly worse on all subscales, with the exception of the ability to shift 
mental set and to regulate emotions. However, for the most part, ecstasy/polydrug 
users did not differ significantly from cannabis only users, leaving open to 
question which specific aspect of polysubstance use contributed the effects that 
were observed. 
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Chapter 10: The role of 
executive processes in 
accounting for prospective 
memory deficits in 
ecstasy/polydrug users 
 
Chapter Overview 
 
The purpose of the present chapter is to investigate the role of executive processes 
in accounting for prospective memory deficits observed in ecstasy/polydrug users. 
The effect of ecstasy/polydrug and cannabis use is investigated in three previously 
administered laboratory measures of PM. The three general scales from the self-
report measure of EF BRIEF-A (i.e., Behavioural regulation index (BRI), 
metacognition index (MI) and the global executive composite (GEC)) were also 
used to investigate the hypothesis that executive processes are in fact responsible 
for the PM deficits observed in ecstasy/polydrug users. Findings suggested that in 
comparison to drug naïve, ecstasy/polydrug users were impaired on all three 
laboratory measures of PM. It was also found that executive processes were 
correlated with time-based PM measures. It is therefore possible that deficits in 
PM performance are associated with deficits in executive processes and perhaps 
some of the drug related PM deficits are mediated by drug related EF 
impairment.  
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10.1 Introduction 
 
PM, as discussed in previous chapters, refers to the ability to remember to execute 
previously scheduled activities. It is therefore crucial for the management of 
everyday life. Ellis (1996) argues that at the initiation of a PM task, the intention 
to do something, the intended action and the retrieval context need to be encoded 
together. So the intention is held in memory over a short-term or long-term delay 
period. Consequently, when an action is to be retrieved, ongoing activity needs to 
be inhibited in order to switch and execute the intended action. PM failures can 
occur at different stages during this process. For example, retention of the action 
or retrieval context may fail or retrieval of the action at the appropriate time or 
event may be missed. These two stages are characterized as the retrospective 
component of PM (remembering what needs to be executed) and the prospective 
component of PM (remembering when to do something).  
 
According to Einstein and McDaniel (1990), the retrospective component is a 
classic memory function whilst the prospective component depends mainly on EF. 
Supporting this view, Marsh and Hicks (1998) argued that PM depends on self-
initiated and attention demanding resources and therefore PM performance can be 
expected to be correlated with measures of central executive functioning. 
Similarly, Martin et al. (2003) found that executive processes in older adults were 
significantly correlated with performance on three PM tasks. Furthermore, 
additional studies have implicated the role of executive processes in PM 
performance (Kliegel et al., 2000; Kliegel et al., 2008). Both neuropsychological 
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(Martin et al., 2003; Kliegel et al., 2000; Kliegel et al., 2008) and neuroimaging 
(Burgess et al., 2003; Okuda et al., 2003; Simons et al., 2006; Okuda et al., 2007) 
evidence suggest the involvement of executive processes in PM performance 
since regions of the frontal lobe, such as the rostral prefrontal cortex, are involved 
in both the performance of PM and EF.  
 
More evidence for the role of executive processes in PM performance comes from 
studies demonstrating an association between EF and PM performance. For 
instance, in a multitask PM paradigm, Kliegel et al. (2000) showed that individual 
differences in executive functioning (e.g., working memory and inhibition) 
predicted the successful initiation and execution of a complex PM task while 
retrospective memory did not. In a later study, Kopp and Thone-otto (2003) tried 
to separate the cognitive processes involved in PM by testing patients with 
specific cognitive deficits in an event-based PM task. They found that patients 
with brain injury and impaired performance on neuropsychological tests of EF 
performed worse in the PM task compared to patients with no executive 
dysfunction, thus supporting the role of EF in PM performance.  
 
A possible explanation for the important role of executive processes in PM 
performance could be that PM tasks create the need to monitor the environment in 
order to detect the relevant cue. This means that attention needs to be divided 
between monitoring and performing the ongoing task. According to Smith and 
Jonides (1999), such activity relies on executive processes like monitoring and 
working memory. It is therefore reasonable to assume that impairments on EF 
such as inhibition and working memory might predict poor PM performance 
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because patients with impaired EF allocate more resources to the ongoing task in 
order to compensate for their executive deficits, thus reducing the available 
resources for monitoring cues. 
 
Also, in complex tasks/situations in which several activities run simultaneously, 
additional planning and monitoring processes maybe required (Fish et al., 2007). 
It is also argued that the extent to which executive processes are involved in PM 
retrieval might be dependent on the specific requirements of the task (Glisky, 
1996). For example, time-based PM is more likely to depend on executive 
processes than event-based PM, as time-based tasks require a higher degree of 
self-initiated retrieval (Einstein et al., 1995).  
 
A new line of investigation linking these theoretical constructs is concerned with 
how the common mechanisms supporting EF and PM operate in recreational drug 
users. More specifically, existing research including findings in previous chapters 
of this thesis suggest that ecstasy/polydrug users perform worse on both PM and 
EF tasks in comparison to drug naïve persons (Heffernan et al., 2001a; b; Rodgers 
et al., 2001; 2003; Montgomery et al., 2005; Fisk et al., 2009). In previous studies 
(Chapters7-9), the integrity of prospective remembering and executive 
functioning was evaluated in ecstasy/polydrug users. It is evident from these 
studies that ecstasy/polydrug users demonstrate impairments on both PM 
performance and executive processes. Given that executive processes such as 
planning, monitoring or attention are essential for PM performance, it is therefore 
reasonable to assume that there is an association between executive processes and 
prospective remembering within the same cohort of ecstasy/polydrug users. This 
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assumption can be supported by evidence suggesting that PM processes such as 
dividing attention, monitoring the environment for a cue, associating a cue for 
intention and interrupting an ongoing activity may also involve planning which is 
thought to depend on the frontal lobes (Lezak, 1982; Shallice, 1982).  
 
It is therefore apparent that there is growing evidence that the successful 
performance of a PM task is heavily dependent on executive processes and that 
executive dysfunction predicts poor PM performance. Further research for the 
exact role and the extent to which executive processes contribute to successful PM 
performance is essential, as both executive processes and PM play a crucial role in 
our everyday functioning.  
 
Consequently, the aim of this investigation is to confirm the ecstasy/polydrug 
related PM deficits observed in Chapter 7 by adding data from other participants 
to the sample used in Chapter 7. Apart from the bigger sample size, the present 
study adds a cannabis-only user group in order to investigate the effect cannabis 
use on laboratory measures of PM. Finally, the present investigation also aims to 
evaluate the role of executive processes in PM deficits in recreational drug users 
and determine whether ecstasy/polydrug-related deficits in PM can be attributed 
to drug related differences in EF. Taking into consideration previous research 
from other laboratories and also from present findings, it is predicted that 
ecstasy/polydrug users in comparison to drug naïve will demonstrate 
ecstasy/polydrug related deficits in all three laboratory measures of PM. It is also 
predicted that cannabis-only users will perform worse than drug naïve in the 
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measures of PM and that ecstasy/polydrug-related deficits in PM can be attributed 
to drug-related differences in EF.  
 
 
10.2 Method 
 
Design 
A between participant design (MANOVA) with drug use as the independent 
variable (at three levels i.e., ecstasy/polydrug, cannabis-only and drug naïve) and 
the three laboratory measures of PM (Fatigue PM task, PM pattern recognition 
task and long-term PM recall task) was employed. Alcohol consumption was 
included as a covariate in order to test for any alcohol-related effects. 
Correlational and regression analyses were also employed to investigate any 
possible associations between the laboratory measures of PM and the BRIEF 
general scales and whether these associations are drug-related. Correlation and 
regression analyses were also used to examine the effect of each of the three 
major illicit drugs on PM.  
 
Participants 
Seventy four Ecstasy/polydrug users (Female= 42), twenty-one cannabis only 
users (female=13) and forty drug naïve (female=33) took part in this investigation. 
As in Chapter 9, these participants also completed some of the tasks discussed in 
previous investigations. The table summarising the participants overlapping in 
each chapter can be found in appendix 1. Participants were recruited via direct 
approach to university students and the snowball technique i.e., word-to-mouth 
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referral (Solowij et al., 1992). All participants were university students attending 
the University of Central Lancashire or Liverpool John Moores University. 
Demographic details are summarised in Table 10.1.  
 
Materials 
As with the previous investigations the background drug history questionnaire 
was administered in order to assess history of illicit drug use, fluid intelligence 
was measured via Raven’s Progressive Matrices (Raven et al., 1998) and a further 
questionnaire was used to assess participant’s age, gender, education as well as 
their alcohol and smoking consumption. Three laboratory measures of PM were 
administered in order to assess event-based PM (i.e., PM pattern recognition task), 
time-based PM (i.e., Fatigue PM task) and long-term PM (i.e., Long-term recall 
PM task). The three laboratory measures of PM were those used in the previous 
study and a detailed description can be found in Chapter 7. In order to assess 
executive functioning, the three general scales of the self-report measure BRIEF-
A were used in this investigation.  
 
Behaviour Rating Inventory of Executive Function- Adult Version (BRIEF-A) 
(Roth et al., 2005) 
 
The BRIEF-A is a 75 item measure which provides indicators of nine separate 
aspects of executive functions. These aspects of executive function include 
inhibition, shifting, emotional control, self-monitoring, initiate, working memory, 
plan and organisation, task monitor and organization of materials. Description of 
these scales can be found in Chapter 9. Besides the nine components of EF and 
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the reliability scales, the BRIEF-A provides, three general scales i.e., the 
Behavioural Regulation Index (BRI), the Metacognition Index (MI) and the 
Global Executive Composite (GEC). The BRI represents the adult’s ability to 
maintain appropriate regulatory control of his/her behaviour and emotional 
responses. Appropriate emotional regulation enables metacognitive processes to 
successfully achieve problem solving and also support appropriate self-regulation. 
A score for BRI is generated by adding the scores from the inhibit, shift, 
emotional control and self-monitor subscales of the BRIEF-A. The MI represents 
the person’s ability to systematically solve problems via planning and 
organisation while sustaining these task-completion efforts in active working 
memory. Also, this index can be interpreted as a person’s ability to cognitively 
manage attention and problem solving. A score for this index is generated by 
adding scores from the initiate, working memory, plan/organization, task-monitor 
and organisation of materials subscales of the BRIEF-A. Finally, GEC is a 
summary score incorporating all the nine scales of the BRIEF-A and represents an 
accurate reflection of a person’s level of executive dysfunction.   
 
Procedure 
Participants were informed of the general purpose of the experiment and verbal 
informed consent was obtained. All tests were administered under laboratory 
conditions and the participant had the right to withdraw at any time from the 
experiment. The MDMA Questionnaire was administered first followed by 
Ravens, Health/Age/Education questionnaire, Prospective Memory Pattern 
recognition Task, Recall PM task and the BRIEF-A. The fatigue prospective 
memory task was administered throughout the session. Participants were fully 
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debriefed, paid 20 UK pounds in Tesco store vouchers and given drug education 
leaflets. The study was approved by the Ethics committee of the University of 
Central Lancashire.   
 
10.3 Results 
 
With regards to data screening, using the criteria suggested by Tabacknick and 
Fidell (2007), where univariate outliers were present they were replaced by the 
next highest/lowest score on the particular measure, plus/minus one. Where 
multivariate outliers were detected, the participants were excluded from the 
analysis. Regarding the distribution of the BRIEF subscales, the scores did not 
deviate significantly from normal and the z scores associated with the statistics in 
relation to skewness and kurtosis were consistent with normality for samples of 
this size (Tabachnick and Fidell, 2007). 
 
As it is evident from Table 10.1, with the exception of alcohol consumption, the 
three groups did not differ significantly in terms of their age, intelligence, years of 
education or cigarette consumption.  
 
Table 10.1. Age, intelligence, years of education, cigarette and alcohol use by 
group. 
 
 
 
Ecstasy/Polydrug Users Cannabis-Only Users Nonusers  P1 
 Mean S.D. N Mean S.D. N Mean S.D. N  
           
Age (years) 21.42 2.96 74 21.42 3.51 21 20.55 2.24 40 ns 
Ravens Progressive Matrices 
(maximum 60) 
41.90 10.00 73 42.19 7.57 21 43.10 8.46 40 ns 
Years of Education 14.97 3.03 70 15.19 3.14 21 15.56 2.25 40 ns 
           
Cigarettes per day 9.22 7.35 36 7.00     4.24 9 9.67 7.99 6 ns 
Alcohol (Units per week) 14.80 10.76 71 13.75 13.93 20 8.24 11.51 37 <.05 
           
1For one-way ANOVA 
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Table 10.2 summarises the means and standard deviations for the most prevalent 
recreational drugs used by the ecstasy/polydrug group and the amount of cannabis 
used by the cannabis-only group. Measures include the amount consumed in the 
last 30 days, the frequency of use, total lifetime use and weeks since last use. It is 
worth noticing that the polydrug group, besides the use of ecstasy and cannabis, 
was also characterised by regular use of cocaine. An inspection of other 
recreational drugs reported by polydrug users such as amphetamines, poppers, 
ketamine and LSD revealed that the small amount of ecstasy/polydrug users that 
reported such use described their use of the aforementioned drugs as ‘occasional’ 
in the past three months. Consequently, these drugs were not included in the 
analysis.  
 
Non parametric statistical analysis was also employed to examine possible 
differences between different aspects of cannabis consumption between the two 
groups. As is evident from Table 10.2, the total lifetime use of cannabis differed 
significantly between the two groups with ecstasy/polydrug users consuming 
twice as much cannabis as the cannabis-only group.  
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                         Table 10.2. Indicators of Illicit Drug Use 
 
 
 
Ecstasy/Polydrug Users Cannabis-Only Users p
1
 
  Mean S.D. N  Mean S.D. N  
          
Total Use          
   Ecstasy (Tablets)  694.86 1300.39 74  - - - - 
   Cannabis (joints)  3044.69 4756.85 67  1348.24 2678.53 21 <.019  
   Cocaine (lines)  1219.98 1593.54 50  - - - - 
          
Amount Consumed in 
Previous 30 Days 
         
   Ecstasy (Tablets)  5.53 15.26 74  - - - - 
   Cannabis (joints)  19.70 42.65 67  13.14 26.83 21 ns  
   Cocaine (lines)  12.24 23.31 50  - - - - 
          
Frequency of Use 
(times per week) 
         
   Ecstasy  0.27 0.42 74  - - - - 
   Cannabis  1.30 2.09 67  1.33 2.35 21 ns 
   Cocaine  0.42 0.59 49  - - - - 
          
Weeks Since Last 
Use: 
         
   Ecstasy  36.44 67.97 74  - - - - 
   Cannabis  25.55 58.76 67  68.58 97.40 21 ns 
   Cocaine  20.18 45.63 57  - - - - 
          
1. Mann-Whitney U test
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Multivariate analysis of variance (MANOVA) was employed in order to 
investigate the effect of ecstasy/polydrug and cannabis-only use on the three 
laboratory measures of PM. Table 10.3 summarises the means and standard 
deviations of the three groups as well as the overall effect and pairwise 
comparisons.  
 
As can be seen from Table 10.3, inspection of the means reveals that 
ecstasy/polydrug users consistently perform worse than cannabis-only users who 
in turn perform worse than drug naïve on all laboratory measures of PM. In fact, 
the multivariate group effect was statistically significant Λ = .518, F(6,258) = 
16.62, p<0.001, partial η2.= .280 suggesting an overall difference in PM 
performance across the three groups. In univariate terms, the three groups differed 
significantly on all three laboratory measures of PM. Tukey’s post-hoc analysis 
revealed that performance on the fatigue PM task differed significantly between 
ecstasy/polydrug users and drug naïve as well as between cannabis-only and drug 
naïve groups, with ecstasy/polydrug and cannabis-only performing worse 
respectively. No significant differences were observed in performance of the 
fatigue PM task between ecstasy/polydrug users and cannabis-only users.  
 
With regards to the PM pattern recognition task ecstasy/polydrug users performed 
significantly worse i.e., committed more errors than the drug naïve group while no 
significant group pairwise differences were observed between ecstasy/polydrug 
users and cannabis only or between cannabis only and the drug naïve control 
group. 
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                 Table 10.3. Scores on laboratory measures of PM for ecstasy/polydrug, cannabis only and drug naïve (one-tailed) 
 
  
Ecstasy/Polydrug 
Users 
cannabis-only 
users drug naïve  F 
Pairwise Comparisons 
(Tukey’s test) 
Covariates: 
units of 
alcohol 
 
Mean S.D. Mean S.D. Mean S.D.   
E/PU 
vs  
E/PU 
vs. 
Non 
CO vs. 
Non 
 
 
CO 
 PM fatigue 
task 33.06 22.14 45.56 20.11 73.23 23.57 41.39*** ns <0.001 <0.001 37.20*** 
PM pattern 
recognition 
task 2.15 2.98 0.67 1.06 0.54 1.12 7.41** ns <0.01 ns 6.17** 
Long-term PM 
task 0.59 1.04 1.05 1.16 1.59 1.27 10.05*** ns <0.001 ns 6.17** 
 
                          ***p<.001; ** p<.01; * p<.05; P values at one-tailed  
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Ecstasy/polydrug-related performance deficits were also observed on the long-
term PM recall task where ecstasy/polydrug users remembered to post back 
significantly fewer envelopes than non-recreational drug users.  
 
Since the groups differed significantly in their alcohol consumption, a 
multivariate analysis of covariance was conducted to look at the effect of this 
covariate on the three laboratory measures of PM. In multivariate terms, the 
overall group effect remained statistically significant after the inclusion of the 
covariates, Λ = .549, F(6,242) = 14.10, p<0.001, partial η2= .259. This suggests 
that alcohol consumption did not affect the performance on measures of PM. 
Also, the effect size was only reduced by 2.1% suggesting that most of the 
variance was explained. The group effect for each of the PM task also remained 
statistically significant in the univariate analysis suggesting that PM performance 
is not affected by differences in alcohol consumption.  
 
As with previous investigations, the ecstasy/polydrug user group was 
characterised by recreational use of cocaine and cannabis. It is therefore necessary 
to determine the contribution of each of the main illicit drugs to PM performance. 
Correlation analysis was therefore conducted to observe any associations of the 
illicit drugs and the three laboratory measures of PM. Table 10.4 summarises the 
Pearson’s correlation coefficients for the lifetime, frequency and current use for 
ecstasy, cannabis and cocaine for each of the PM tasks.                
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                  Table 10.4. Simple and partial correlations between aspects of drug use and PM measures 
 
 Fatigue PM task 
(Time-based PM) 
PM pattern Recognition 
task (Event-based PM) 
Long-term PM recall 
task 
(Long-term PM) 
 Simple 
Correlation 
Semi-partial  
Correlation 
Simple         Semi-partial 
Correlation   Correlation 
Simple           Semi-
partial  
Correlation    
Correlation 
Cannabis     
Total Lifetime Use .002 -.162 -.182*         -.084 -.194*              -.178* 
Consumed in last 30 days .037 -.200* -.204** .005 -.212**             -.237** 
Frequency .150* -.185* -.210** .122 -.205**             -.224* 
     
Cocaine     
Total Lifetime Use .223** -.206** -.279** .151* -.212**              -.194* 
Consumed in last 30 days .173* -.117 -.197* .045 -.210**              -.217** 
Frequency .419** -.164* -.273** .099 -.259**              -.235** 
      
Ecstasy     
Total Lifetime Use .197** -.017 -.184* .131 -.085                  .061 
Consumed in last 30 days .189* -.013 -.196** .092 -.137                  .108 
Frequency .173* -.075 -.263** .067 -.153*                 .040 
     
 
                            ***p<.001; ** p<.01; * p<.05; P values at one-tailed  
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With regards to the fatigue PM task, all three aspects of cocaine and ecstasy were 
associated with performance deficits in this time-based PM measure. Only 
frequency of cannabis was associated with the fatigue PM task. Nevertheless, 
when the variance of other drugs on the measure in question was excluded using 
regression analysis, two out of the three aspects of cannabis use were statistically 
significant suggesting that the frequency and current use of cannabis is associated 
with deficits in time-based PM performance. Total lifetime use and frequency of 
use of cocaine semi-partial correlations were also statistically significant after 
controlling for the use of other drugs while no aspect of ecstasy use yielded any 
statistically significant associations with the fatigue PM task following controls 
for other drug use.  
 
With respect to the PM pattern recognition test significant associations were 
observed in all aspects of use for three drugs during correlation analysis. 
However, during regression analysis total lifetime use of cocaine appeared to be 
the only aspect of drug use significantly associated with performance deficits in 
the event-based PM task. Finally, for the long-term PM task all aspects of 
cannabis and cocaine use as well as the frequency of ecstasy use produced 
significant correlations with the measure.  When the variance of other drugs was 
excluded from the analysis the three aspects of cocaine and cannabis use 
accounted for statistically significant unique variance while no aspect of ecstasy 
use was actually significant. It is therefore evident from these results that it is 
cannabis and cocaine rather than ecstasy that are responsible for the observed 
deficits in PM performance.  
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The purpose of this investigation was also to evaluate the role of executive 
processes in PM deficits and also determine whether these deficits in executive 
functioning can account for the PM deficits in ecstasy/polydrug users. In order to 
do this, the three general scales of the BRIEF-A (used in the previous chapter) 
were correlated with the three laboratory measures of PM. Regression analyses, 
with the BRIEF-A MI and BRI scales as predictors, was also employed in order to 
determine whether executive processes are responsible for the PM deficits in 
ecstasy/polydrug users and cannabis only users. Table 10.5 summarises the simple 
correlations from correlation analysis and the semi-partial correlations from 
regression analysis. 
 
Table 10.5. Simple and semi-partial correlations for EF and PM measures in 
ecstasy/polydrug and cannabis only users 
Correlate/IV   Simple correlation   Semi-Partial correlation 
    
Fatigue  
PM task 
PM pattern  
recognition task 
long-term  
PM task   
Fatigue  
PM task 
PM pattern  
recognition task 
long-term 
 PM task 
Model 1         
BRI 
 
-0.078 -0.083 -0.108 
    MI 
 
-0.277** 0.046 -0.017 
 
-.271* 
  Model 2         
GEC 
 
-0.205* -0.007 -0.069 
    Ecstasy/polydrug 
vs all others  
     
.576*** -.290** .337*** 
Cannabis-only 
vs  
all others           .331***  
 
  
***p<.001; ** p<.01; * p<.05; P values at one-tailed  
 
As it is evident from Table 10.5, only the Metacognition index and the Global 
Executive Composite scale of the BRIEF-A are significantly correlated with the 
fatigue PM task, suggesting that impairments in executive processes are 
associated with impairments in time-based PM. Regression analysis with the 
laboratory measures of PM as dependent variables and the BRIEF BRI and MI as 
predictors also revealed that MI shared statistically significant unique variance 
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with  the fatigue PM task (only significant associations are displayed in Table 5 
for regression analysis). Another regression was also employed to determine 
whether ecstasy/polydrug-related deficits in PM can be attributed to drug related 
differences in EF. In order to do this, Ecstasy/polydrug users (compared to all 
other participants), cannabis-only users (compared to all other participants) and 
the BRIEF GEC score were added as predictors in the regression analyses. The 
three laboratory measures of PM were the dependent variables.  
 
Regression analysis revealed that ecstasy/polydrug users (relative to all other 
participants) accounted for statistically significant unique variance in all PM tasks 
reflecting the ecstasy/polydrug-related PM deficits. Therefore, it appears that the 
ecstasy/polydrug effect on laboratory measures of PM cannot be entirely 
attributed to drug-related differences in executive functioning. Cannabis-only 
users (relative to all other participants) also accounted for statistically significant 
unique variance in the PM fatigue task reflecting cannabis-related PM deficits. It 
is also worth noting that the GEC was significantly correlated with the Fatigue 
PM Task, although not significant in the regression analysis. This suggests that 
GEC shares variance in common with either one or the other of the drug use 
predictors or both and the Fatigue PM. It is therefore possible that some of the 
ecstasy-related (or cannabis-related) variance in Fatigue PM might co-vary with 
GEC related variance in Fatigue PM. If this is the case, then it can be argued that 
there is a possible link between polydrug use, EF and PM, with perhaps some of 
the drug related PM deficits mediated by drug related EF impairment. However, 
this interpretation should be treated with caution.  
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It is evident that executive processes are correlated with the time-based PM task. 
What is interesting to look at will be which of these executive components are 
correlated with the fatigue PM task and also whether specific executive 
components can be associated with performance deficits in the other PM 
measures. In order to do this the nine subscales of the BRIEF-A were correlated 
with the PM measures. Table 10.6 summarises the simple correlations.  
 
Table 10.6. Correlations between individual components of Executive Functions 
and PM measures 
Executive Components Fatigue PM task 
Long-term PM 
recall task 
PM pattern 
recognition task 
Inhibit  -0.162* -0.183* -0.092 
Shift          -0.090 0.034 0.039 
Emotional regulation           0.074 0.007 -0.102 
Self-monitor -0.181* -0.199* -0.040 
Initiate    -0.248** -0.025 0.020 
Working memory          -0.208* 0.018 0.045 
Plan          -0.171* -0.003 0.072 
Task monitor  -0.256** 0.043 0.018 
Organise   -0.213** -0.100 0.008 
** p<.01; * p<.05; P values at one-tailed  
 
Inspection of Table 10.6 revealed that for the fatigue PM task all but two 
individual components of executive function were significantly correlated with 
performance in time-based PM task. Also, the inhibit and self-monitor scales were 
significantly correlated with the long term PM recall task suggesting that worse 
performance on executive functions predicts poor PM performance. No significant 
correlations were observed on the PM pattern recognition task suggesting that 
executive processes are only involved in time-based PM tasks.   
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10.4 Discussion 
 
The aim of the present study was to reproduce findings from Chapter 7 that 
ecstasy/polydrug users are impaired in their PM performance. It also aimed to 
evaluate the role of executive processes in accounting for these PM deficits. On 
the whole, ecstasy/polydrug users in comparison to drug naïve performed 
significantly worse on all three laboratory measures of PM; a finding that is 
consistent with results from Chapter 7. These findings are also in line with 
previous investigations implicating ecstasy/polydrug use with PM impairments 
using self-report measures (Heffernan et al., 2001; Rodgers et al., 2001; 2003; 
Montgomery et al., 2005; Fisk et al., 2009). It can therefore be concluded that 
ecstasy/polydrug users underperform in time and event-based as well as long-term 
PM tasks.  
 
The performance of recreational drug users whose drug choice was cannabis was 
also assessed in the present investigation. Although cannabis users performed 
worse than non- users of illicit drugs in all PM tasks, the only comparison that 
reached significant difference was the performance on the fatigue PM task where 
cannabis-only users remembered to complete a questionnaire every twenty 
minutes on less occasions than the drug naïve. Consistent with the previous 
studies, a trend is evident; ecstasy/polydrug users perform the worst on the PM 
tasks, cannabis-only users perform at intermediate levels and drug naïve perform 
the best.  
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Nevertheless, it is worth noting that in the present investigation the level of 
cannabis consumption in the ecstasy/polydrug user group was significantly higher 
than the one in the cannabis-only group. In fact, ecstasy/polydrug users consumed 
more than twice the amount of cannabis than the cannabis-only group. It is 
therefore possible that the observed deficits in PM performance are in fact 
attributed to cannabis use. This would account for why cannabis users were 
impaired in the PM pattern recognition task and long-term PM recall task 
(although not significantly) whilst ecstasy/polydrug users with higher levels of 
cannabis consumption were significantly impaired. Previous research on 
cannabis-related deficits in PM performance demonstrated that cannabis users are 
impaired in their PM performance. For example, Fisk and Montgomery (2008) 
found cannabis-related deficits in a sample of cannabis only users compared to 
controls on all subscales of the PMQ (i.e., long-term episodic, short-term habitual 
and internally cued PM as well as on the techniques aiding remembering). 
Similarly, McHale and Hunt (2008) demonstrated that abstinent cannabis users 
exhibit performance deficits on the long and short-term interval PM. 
Consequently, the present findings in relation to drug-related differences need to 
be interpreted with caution. 
 
The ecstasy/polydrug user group was also characterised by recreational use of 
cocaine in addition to cannabis. In order to further investigate cocaine and 
cannabis-related interactions, correlation and regression analyses were employed. 
With regards to the fatigue PM task, for the most part aspects of ecstasy and 
cocaine use were significantly correlated with the time-based PM measure. 
However, when the variance of the other drugs was excluded (using regression 
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analysis) no aspect of ecstasy use yielded a significant association with the PM 
measure. Instead, all aspects of cocaine use (i.e., total lifetime use, frequency of 
use and the amount consumed in the last 30 days) produced significant 
associations. Most aspects of cannabis use were also significantly associated, 
suggesting that it is the recreational use of cocaine and cannabis rather than 
ecstasy use that are responsible for deficits in time-based PM performance.  
 
Similarly, no aspect of ecstasy use was associated with poor performance on the 
long-term PM recall task while aspects of cannabis and cocaine produced 
significant associations. Finally, although all aspects of all three drugs were 
significantly correlated with performance on the PM pattern recognition task, 
regression analysis revealed that only lifetime use of cocaine was significantly 
associated with poor performance on the event-based task thus suggesting that 
impaired performance in the event-based PM task is attributable to the 
recreational use of cocaine. This is not a surprising result as cocaine was linked to 
impaired PM performance in all previous studies of this thesis. It can therefore be 
concluded that it is the recreational use of cocaine and cannabis rather than 
ecstasy that are responsible for poor overall PM performance.  
 
It is therefore evident that ecstasy/polydrug users are indeed impaired in their PM 
performance and that for the most part recreational use of cannabis and cocaine is 
responsible for these deficits. What is not very clear is the role of executive 
processes in these PM performance deficits. It is known that PM is dependent on 
prefrontal executive processes as well as the medial temporal-hippocampal 
processes that support memory functions (Goldstein & Polkey, 1992; Kliegel et 
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al., 2005; West, 1996). PM processes such as dividing attention, monitoring the 
environment for a cue, associating a cue for intention and interrupting an ongoing 
activity may also involve planning that clearly draws on the prefrontal cortices 
and consequently on executive resources (Lezak, 1982; Shallice, 1982; Marsh & 
Hicks, 1998; McDaniel et al., 1999; Whyte et al., 2006).  
 
It is therefore possible that ecstasy/polydrug-related deficits in PM are originating 
from deficits in executive functioning. The findings of the present investigation 
provide evidence for this assumption. It was found that the general scales of the 
BRIEF-A i.e., the Metacognition Index and the Global Executive Composite 
scales were significantly associated with the fatigue PM task suggesting that 
better EF performance predicts better PM performance. It was also suggested that 
there is a possible link between polydrug use, EF and PM, with perhaps some of 
the drug related PM deficits mediated by drug related EF impairment. 
Nevertheless, this interpretation should be treated with caution.  
 
With regards to the role of executive processes in PM, looking at the individual 
components of EF from the BRIEF-A all but two scales were significantly 
correlated with the fatigue PM task. The inhibit and self-monitor subscales of the 
BRIEF-A were also significantly correlated with the long-term PM recall task 
suggesting that executive dysfunction is correlated with poor PM performance. 
Since no significant correlations were observed between EF and the event-based 
measure, it can be concluded that it is the time-based component of PM that rely 
on executive processes and not the event-based PM component. This is in line 
with Einstein et al’s (1995) view that time-based prospective tasks are more likely 
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to rely on EF than event-based tasks. A possible explanation for this is that 
although strategic and automatic processes are involved in PM retrieval (Einstein 
et al., 2005), it is likely that the extent to which executive processes are involved 
in PM retrieval is dependent on the specific requirements of the task (Glisky, 
1996). For instance, time-based prospective tasks are more likely to rely on EF 
than event-based tasks as they require a higher degree of self-initiated retrieval 
(Einstein et al., 1995). This could explain why deficits in executive functions are 
associated with deficits in time-based PM and not event-based PM.  
 
The ecstasy/polydrug user group was also characterised by higher level of alcohol 
consumption. MANCOVA analysis with alcohol consumption as a covariate 
revealed that the overall group effect remained statistically significant, suggesting 
that alcohol consumption was not responsible for the deficits in PM performance. 
Nevertheless, alcohol consumption should not be overlooked, since previous 
investigations have linked alcohol abuse with executive dysfunction, it is possible 
that some of the deficits observed on the BRIEF are attributable to effects of 
alcohol rather than drug use (Brown et al., 2000; Loeber et al., 2009; Goldstein et 
al., 2004).  
 
Despite deficits in EF, alcohol also has adverse effects on PM performance 
(Heffernan et al., 2010; Montgomery et al., 2011).  In relation to this, 
Montgomery et al. (2011) found that acute alcohol intoxication selectively 
impairs executive function and PM. In their study, participants in the 
alcohol condition performed worse on the planning, prioritisation, creativity and 
adaptability executive subscales and also on the time-based and event-based PM 
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tasks. However, alcohol did not impair the selection executive function task or the 
action-based PM task. Consistent with alcohol-related deficits in PM, Heffernan et 
al. (2010) also found that binge drinkers were impaired on a video based 
prospective memory task. Heffernan et al. (2003) examined the effects of alcohol 
on two aspects of memory performance; PM and everyday memory. Data was 
collected using the WWW and participants completed the PMQ and EMQ. After 
controlling for the use of other drugs and strategies used to aid remembering, it 
was found that alcohol was associated with impairments in long-term PM and 
with an increased number of cognitive failures. Both short-term and long-term PM 
failures using the PMQ were also found in a number of studies (e.g., Heffernan 
and Bartholomew, 2006; Heffernan et al., 2006) supporting these findings. 
Finally, the level of alcohol consumption and tobacco should be kept in mind as 
several investigations suggest that these legal substances are related with PM 
deficits (Heffernan et al., 2003; Heffernan & Bartholomew, 2006; Heffernan et 
al., 2006; Heffernan et al., 2010). 
 
To conclude, the present study aimed to investigate the impact of 
ecstasy/polydrug use on PM and the role of executive processes in accounting for 
these PM deficits. Relative to drug naïve, ecstasy/polydrug users were impaired 
on all three laboratory measures of PM. Furthermore, executive processes were 
correlated with time-based PM measures. It is therefore possible to assume that 
deficits in PM performance are attributed to deficits in executive processes and 
perhaps some of the drug related PM deficits are mediated by drug related EF 
impairment. Recreational use of cannabis and cocaine was also associated with 
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laboratory measures of PM leaving open to question which drug is primarily 
responsible for the observed deficits in PM performance.  
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Chapter 11: General Discussion 
 
The aim of the present thesis was to investigate the impact of ecstasy/polydrug use 
on prospective memory and executive processes. The role of executive processes 
in accounting for prospective memory deficits in ecstasy/polydrug users was also 
explored. 
 
11.1 Prospective memory deficits in ecstasy/polydrug users 
 
Previous investigations on the effects of ecstasy/polydrug use on prospective 
memory demonstrated that ecstasy/polydrug users are impaired on self-report 
measures of prospective memory (Heffernan et al., 2001a; b; Rodgers et al., 2001; 
2003; Montgomery & Fisk, 2007; Fisk & Montgomery, 2008) raising the 
possibility that that PM performance is adversely affected by the neurotoxic 
effects of ecstasy.  
 
Limitations of the existing literature on Prospective Memory performance 
 
With the exception of a few studies (e.g. Rendell et al., 2007; Zakzanis et al., 
2003; McHale & Hunt, 2008) the majority of investigations in the area of 
recreational drug use have used self-report measures to assess PM performance. 
Although self-report measures of PM have been extensively used in the literature 
and have been proven to be a powerful tool in detecting PM deficits in a variety of 
populations, they reflect participants’ self-perceptions concerning their memory 
ability.  These self-perceptions might therefore be distorted since people 
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experiencing memory impairments might not be able to remember and thus report 
their memory lapses.  
 
Nonetheless, the most important limitation of self-report measures is that they fail 
to fully capture the distinction between time-based and event-based PM tasks. 
Instead, the scope of self-report measures is restricted to the period over the PM 
task is executed i.e., the short-term or the long-term. From the existing literature it 
is clear that ecstasy/polydrug users report deficits in both long and short-term PM 
(Heffernan et al., 2001a; b; Rodgers et al., 2001; 2003). However, it is not clear 
whether ecstasy/polydrug users are impaired in event-based, time-based PM task 
or both. It is therefore crucial to explore this as these two types of tasks utilise 
neural processes that are in part separable (Burgess et al., 2003; Gilbert et al., 
2005; Okuda et al., 2007).  
 
These studies of self-report measures, despite their utility in detecting general PM 
deficits, provide relatively limited information regarding the extent, scope or 
implications of problems experienced by ecstasy/polydrug users. They also fail to 
investigate the conditions under which PM failures are most likely to occur 
(Rendell et al., 2007). Although some investigations have tried to overcome these 
limitations by administering laboratory measures of PM (e.g., Rendell et al., 
2007) where these measures were used they have tended to be rather artificial and 
contrived in nature. In addition, they also appear to possess an associative learning 
component and  that aspect of cognition is known to be impaired in recreational 
users of ecstasy (Montgomery et al., 2005) making it difficult to determine the 
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extent to which any deficits that are observed are attributable to the PM 
component.   
 
Research Aim  
 
The aim of this thesis with regards to PM failures in ecstasy/polydrug users was to 
administer a number of naturalistic simple laboratory measures that require 
minimum learning and with the PM component being less obvious to the 
participant. Using both self-report and simple laboratory measures of PM a series 
of investigations (Chapters 7, 8 and 10) assessed the impact of ecstasy/polydrug 
use on both the storage/retention phase (i.e., the period over which the action is 
executed; short -term or long-term) and the retrieval phase (i.e., whether the action 
is triggered by monitoring time -time-based PM- or by external environmental 
factors -event-based PM-). These particular aspects have been under investigated 
in the area of recreational drug use.  
 
11.1.1 Evidence from laboratory measures  
 
On the whole, a variety of laboratory measures of PM have been used during the 
investigations. In order to measure retrieval phase (i.e. event and time-based PM) 
a number of laboratory measures were employed. For example, in Chapter 7 
event-based PM was measured by employing the PM processing speed task where 
the participant was required to perform an action when presented with a cue. The 
RBMT was also administered to the participants and three of the subtests were 
used to measure time-based and event-based PM. With regards to time-based PM, 
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the Fatigue PM task was designed where the participant was required to monitor 
time and remember to ask for a questionnaire every twenty minutes throughout 
the test session. This test was also useful in assessing short-term PM as the period 
over which the action needed to be executed was of limited duration. Long-term 
PM was assessed by asking the participant to complete a simple recall test and to 
post their answers back to the experimenter at weekly intervals over the three-
week period following testing. 
 
 In Chapter 8, time and event-based PM were assessed by the use of the 
CAMPROMPT test battery: a laboratory measure of event and time-based PM. 
Chapter 10 confirmed findings from Chapter 7 assessing event-based, time-based 
and long-term PM using the same laboratory measures with a larger sample. In 
addition, using a self-report measure of EF the role of executive processes in 
accounting for PM deficits was investigated. 
 
Chapter 7 revealed that, on the whole, ecstasy/polydrug users were impaired on all 
PM laboratory measures. When looking at these PM measures individually, it was 
evident that ecstasy/polydrug users in comparison to non-ecstasy users 
underperformed in all cases. All measures, but two (one event and one time-based 
PM task from the RBMT), reached statistical significance demonstrating that the 
differences in performance between the two groups were meaningful. More 
specifically, on the PM processing speed test measuring event-based PM, 
ecstasy/polydrug users forgot to press a key on the computer when presented with 
the relevant cue on more occasions than non-ecstasy users. They also remembered 
to ask for a questionnaire assessing their level of fatigue (the fatigue PM task 
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measuring time-based PM) on fewer occasions than non-ecstasy users. Similarly, 
they forgot to post back their delayed recall responses in a prepaid envelope 
(long-term PM task) more often than non-ecstasy users. It is therefore evident that 
ecstasy/polydrug users seem to experience greater difficulties in event-based, 
time-based, short-term and long-term PM than non-ecstasy users.  
 
With regards to the RBMT, ecstasy/polydrug users performed significantly worse 
than non-ecstasy users only on one of the three PM subtests of this measure: the 
RBMT belonging test measuring time-based PM. To the best knowledge of the 
author, the present study is the first one to demonstrate ecstasy-related deficits on 
the belonging subscale of the RBMT. For example, Zakzanis et al. (2003) 
administered the RBMT in a group of ecstasy/polydrug users and non-ecstasy 
users. Unlike the present study, Zakzanis et al. observed ecstasy-related deficits 
on the appointment and message PM scale of the RBMT but not on the belonging 
scale. Although ecstasy-related deficits were observed on the two subscales it is 
possible that these deficits were due to confounding factors as their 
ecstasy/polydrug users scored significantly less on the WAIS-III vocabulary sub-
test compared to the control group. Unlike Zakzanis et al’s study the present 
groups did not differ in background variables such as age, IQ, gender or years of 
education. Although the RBMT has been consistently used to detect memory 
lapses in clinical populations, it has been criticised as lacking the sensitivity to 
detect memory problems in non-clinical populations (Spooner & Pachana, 2006). 
Thus, it may be that the test was not appropriate for the university based sample of 
recreational drug users and the absence of impairments in the two subtests might 
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be attributed to the limited sensitivity of the test rather than the lack of 
ecstasy/polydrug related impairments.  
 
Consistent with the results obtained in Chapter 7, using a different measure, the 
CAMPROMPT, Chapter 8 revealed that once again ecstasy/polydrug users were 
impaired on event and time-based PM. Unlike the RMBT, the CAMPROMPT has 
been developed for use with non-clinical populations and is better able to detect 
the subtle differences that may be present in these groups. In comparison to the 
drug naïve control group, ecstasy/polydrug users performed significantly poorer 
on both time and event-based scales of the CAMPROMPT supporting 
ecstasy/polydrug-related deficits on the retrieval phase found on the previous 
investigation (Chapter 7). In this study, the effect of the recreational use of 
cannabis on the retrieval phase (time and event-based PM) was also assessed by 
recruiting a cannabis-only user group. Although previous investigations suggest 
that the recreational use of cannabis is associated with PM deficits (McHale & 
Hunt, 2008), in this study cannabis-only users did not differ significantly from the 
drug naïve control group in event or time-based PM performance.  
 
However, what is noteworthy is that although the cannabis-only group did not 
appear to be significantly impaired in comparison to the drug naïve group, 
recreational use of cannabis among the whole sample was significantly correlated 
with event-based PM even after controlling for the use of other drugs. More 
specifically frequency of cannabis use and the amount consumed in the last 30 
days were associated with poorer event-based PM performance. These findings 
link the recreational use of cannabis with PM impairments and are in line with 
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previous investigations in which cannabis-related deficits have been observed 
(Rodgers et al., 2003; Fisk & Montgomery, 2008; McHale & Hunt, 2008). The 
possibility that the observed deficits in ecstasy/polydrug users are in fact 
attributable to higher levels of cannabis consumption should therefore not be 
discarded. Nevertheless, a trend is evident from this investigation. In terms of PM 
performance, ecstasy/polydrug users perform the worst, followed by cannabis-
only users performing at intermediate levels and drug naïve controls performing 
the best. 
 
Chapter 10 also revealed ecstasy/polydrug-related deficits in laboratory measures 
of PM using a larger sample size (using participants from both Chapters 7 and 8). 
Ecstasy/polydrug users consistently performed worse than the drug naïve control 
group on all the laboratory measures of PM (i.e., PM fatigue task, PM pattern 
recognition task and long-term recall PM task) consistent with previous literature 
in the area of recreational drug use (Heffernan et al., 2001a; b; Rodgers et al., 
2001; 2003; Rendell et al., 2007). The increased sample size in Chapter 10 
relative to Chapter 7 allowed the inclusion of a cannabis only group. The trend for 
PM performance in ecstasy/polydrug users, cannabis-only users and drug naïve 
was similar to that observed in the CAMPROMPT. Once again ecstasy/polydrug 
users performed worse on laboratory measures on PM, cannabis-only users 
performed at intermediate levels and drug naïve performed the best.  
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Contribution of recreational use of cannabis to Prospective Memory 
performance  
 
Although it is evident from the three studies of PM that ecstasy/polydrug users 
perform poorly in laboratory measures of PM in comparison to all the other 
groups (non-ecstasy, cannabis-only and drug naïve controls), what is less evident 
is which drug is primarily responsible for the observed deficits in PM 
performance. Further investigation looking at different aspects of drug use was 
therefore employed across the studies in order to establish a relationship between 
aspects of drug use and PM performance.  
 
With regards to the contribution of recreational use of cannabis on PM 
performance, cannabis was associated with a number of laboratory measures of 
PM. For example, both frequency of cannabis use and amount consumed in the 
last 30 days was associated with poorer performance on the fatigue PM task and 
event-based scale of the CAMPROMPT, frequency of use with the RBMT 
message task while all three aspects of cannabis use (lifetime, frequency and 
amount consumed in the last 30 days) were associated with poorer performance 
on the long-term recall PM task. It is therefore evident that recreational use of 
cannabis is involved in time and event-based and long-term PM performance. 
These findings are not surprising as previous investigations have linked the 
recreational use of cannabis with PM deficits (Rodgers et al., 2003; Fisk & 
Montgomery, 2008; McHale & Hunt, 2008). However, the present studies 
augment previous findings by demonstrating which aspects of cannabis use appear 
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to be related to PM performance and by the inclusion of more naturalistic and 
purer laboratory measures of the PM construct. 
 
Contribution of recreational use of cocaine in Prospective Memory 
performance  
 
A surprising revelation in the series of investigations on PM performance 
presented here was the fact that no aspect of ecstasy use was correlated with any 
of the laboratory measures of PM. Instead, in all three investigations there was 
clear evidence that recreational use of cocaine is associated with performance on a 
number of laboratory measures. In fact, either total lifetime or frequency of use of 
cocaine or both were associated with performance on all PM tasks (RBMT 
appointment and belonging tasks, Fatigue PM task, PM processing speed task and 
Long-term recall PM task) except the RBMT message task. Indeed, the 
recreational use of cocaine shared unique variance with the appointment and 
belonging subtests of the RBMT and the long-term recall task. With regards to the 
CAMPROMPT, recreational use of cocaine was also associated with the event-
based PM scale but not with the time-based PM. Actually, all three aspects of 
cocaine use were associated with poorer event-based PM performance. Total 
lifetime use, frequency of use and amount of cocaine consumed in the last 30 days 
remained statistically significant as predictors of event-based PM performance 
even after controlling for the use of other drugs.  
 
More evidence for the involvement of recreational use of cocaine in PM deficits 
come from the last study of this thesis (Chapter 10) that, using a larger sample 
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size, revealed cocaine-related deficits in the fatigue PM task, PM processing 
speed task and the long-term recall task. It is therefore evident that recreational 
use of cocaine plays an important role in the observed PM deficits in 
ecstasy/polydrug users. Although no previous investigation has linked cocaine use 
with PM deficits, the mechanism through which the recreational use of cocaine 
might impact PM performance can be explained neuroanatomically.  
 
As discussed in previous chapters, PM performance is dependent on prefrontal 
executive resources. In fact, several studies demonstrated that event-based PM 
tasks utilise the frontopolar cortex and more specifically Broadmann area 10 
(BA10; Burgess et al., 2003) and the left superior frontal gyrus (Okuda et al., 
2007). On the other hand, time-based PM tasks activate various regions including 
the anterior medial frontal regions, the right superior frontal gyrus and the anterior 
cingulate. Similarly to the event-based tasks, time-based tasks also activate the 
BA10 and the superior frontal gyrus (Okuda et al., 2007). BA10 is known to 
support several executive functions and in most specifically those that involved 
updating contents of working memory (Collette et al., 2005). Consequently, 
updating deficits may be associated with PM deficits in both time and event-
based. A number of studies suggested that cocaine users are in fact impaired in 
different measures of working memory i.e., impairments were observed on the 
paced auditory serial addiction task (PASAT; Berry et al., 1993), the number 
letter re-sequencing task and on forward and backward digit and spatial span 
(Verdejo-Garcia & Perez-Garcia, 2007).  This can therefore explain the observed 
cocaine-related deficits on PM performance in the present study.  
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Another explanation for the cocaine-related deficits in PM comes from studies 
looking at dopaminergic activity in the PFC in those areas known to support 
executive processes. A number of studies suggest that cocaine has an effect on 
dopamine levels thereby influencing behaviour (Heien et al., 2005; Zhang et al., 
2005; Sidiropoulou et al., 2009). More specifically, according to neuroimaging 
evidence, cocaine users experience hypoactivation in the mesencephalon where 
dopamine cell bodies are located and projections originate. In relation to a control 
group, cocaine users also exhibit a deactivation in regions with high levels of 
dopamine projections such as the putamen, anterior cingulate, parahippocampal 
gyrus and amygdala (Tomasi et al., 2007). This deactivation in dopamine 
projection regions was associated with a compensatory hyperactivation in cortical 
regions enhancing executive functions. Nonetheless, Tomasi et al. found that the 
activation of these cortical regions (prefrontal and parietal cortices) during the 
performance of a working memory task was less in cocaine users than in non-
users. It is therefore possible that prior history of cocaine use can interrupt 
dopaminergic operations in the PFC causing executive dysfunction and therefore 
impairment in PM performance.  
 
Further evidence for the involvement of dopamine in PM performance comes 
from studies investigating Parkinson’s disease which is characterised by 
disruption of dopaminergic functioning in the cortico-striatal pathway. For 
example, a recent study demonstrated that the administration of L-dopa 
significantly improves PM performance in a sample of Parkinson’s patients in 
comparison to an unmedicated condition (Costa et al., 2008). Since it is known 
that both cocaine and ecstasy potentially disrupt the functioning of dopaminergic 
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systems, it is possible that the PM deficits observed in Chapters 7, 8 and 10 of this 
thesis are due to impaired dopaminergic processes in the cortico-striatal pathway.   
 
Summary of laboratory measures of PM 
 
Summarizing the findings from laboratory measures of PM, it is evident that 
ecstasy/polydrug users underperform in objective measure of PM. Consequently, 
the present series of investigations extend previous research using self-report 
measures in which ecstasy/polydrug users were impaired in their PM performance 
(Heffernan et al., 2001a; 2001b; Rodgers et al., 2001; 2003; Montgomery & Fisk, 
2007; Fisk & Montgomery, 2008). The ecstasy/polydrug related effect observed in 
the present investigations is also consistent with recent research using laboratory 
measures of event and time-based PM (Rendell et al., 2007). The present findings 
also augment the existing literature demonstrating the efficacy of the 
CAMPROMPT measure in capturing individual differences in PM performance 
among non-clinical populations (Groot et al., 2002; Wilson et al., 2005). It is also 
clear that reported PM deficits in ecstasy/polydrug users are real rather than 
imagined since the self-reported impairments have been confirmed by the 
outcomes of the laboratory measures. What is also worthy of note is that the 
recreational use of ecstasy was not associated with any laboratory measure of PM 
in any of the three investigations reported here. Instead, recreational use of 
cocaine appeared to be the main predictor for the observed PM deficits in 
ecstasy/polydrug users.  
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11.1.2 Evidence from self-report measures of real world memory 
 
11.1.2.1 Prospective memory 
 
In addition to the variety of laboratory measures that were administered, a number 
of self-report measures that have been used extensively in the literature to assess 
PM performance in ecstasy/polydrug users were also employed. For instance, in 
Chapter 7 two questionnaires were employed to assess participants’ perceptions of 
their PM performance. The PMQ questionnaire assessed short-term PM, long-
term PM, internally cued PM and techniques people employ to help them 
remember. The PRMQ was also administered to measure overall PM 
performance.  
 
It was revealed that in comparison to the non-ecstasy user group, ecstasy/polydrug 
users reported more deficits on the short-term PM scale and also used fewer 
techniques to help them remember. Although findings from previous studies are in 
line with the reported deficits on the short-term PM scale of the PMQ (Heffernan 
et al., 2001a; b; Rodgers et al., 2001; 2003; Montgomery & Fisk, 2007) the lack 
of deficits on the long-term PM and internally cued PM scales are inconsistent 
with previous literature (Heffernan et al., 2001a; Rodgers et al., 2001; 2003; 
Montgomery & Fisk, 2007). In terms of the PRMQ, ecstasy/polydrug users 
reported general PM problems as opposed to the non-ecstasy user group 
suggesting that on the whole ecstasy/polydrug users perceive their PM 
performance to be impaired.   
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11.1.2.2 Everyday memory 
 
In Chapter 7, ecstasy/polydrug users also reported their everyday memory ability 
to be impaired relative to non-ecstasy users. This provides further evidence for 
ecstasy/polydrug-related deficits in everyday memory performance found in a 
number of previous investigations (Heffernan et al., 2001b; Montgomery & Fisk, 
2008; Fisk & Montgomery, 2008).  
 
11.1.2.3 Cognitive failures 
 
However, on a different self-report measure administered in Chapter 7, no 
differences in the incidence of self-perceived cognitive failures was observed 
between ecstasy/polydrug and non-ecstasy users. While at variance with the 
results obtained on some of the other self-report measures, this is not 
unprecedented as previous studies in the area have failed to find deficits in 
everyday cognitive lapses using the CFQ (Rodgers et al., 2000; Heffernan et al., 
2001b). 
 
Contribution of other drugs in self-report measures of real world memory  
 
Although ecstasy/polydrug users as a group reported real world memory deficits, 
the specific drugs responsible for these deficits were less clear. For instance, 
lifetime use of ecstasy and frequency of cannabis use were positively associated 
with self-perceived short-term PM while lifetime use of ecstasy was positively 
associated with internally cued PM. Although ecstasy/polydrug users did not 
appear to experience difficulties in cognitive failures, lifetime use of ecstasy was 
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positively associated with cognitive failures. Furthermore, in terms of PM 
performance on the whole, lifetime use of ecstasy, cocaine and amphetamines 
were positively associated with the self-reported PM deficits. These positive 
associations suggest that increased frequency and lifetime use is related with 
higher scores on the self-report measures consistent with more real world memory 
problems. Nevertheless, most of the semi-partial correlations did not reach 
statistical significance meaning that it is not possible to identify which of the four 
drugs is likely to be primarily responsible for the real world memory deficits in 
ecstasy/polydrug users. 
 
 Also, the effect of the recreational use of cocaine was less evident in the self-
report measures of real world memory as opposed to the prominent role of 
cocaine in relation to the outcomes on the laboratory measures of PM. It is 
therefore clear that although the use of cocaine appears to affect the outcomes on 
the laboratory PM measures there appears to be less awareness of this link in the 
self-perceptions of cocaine users.   
 
11.2 Executive dysfunction in ecstasy/polydrug users 
 
Limitations of the existing literature 
 
Ecstasy/polydrug-related deficits have been demonstrated in aspects of executive 
functioning in several investigations (see Murphy et al., 2009 for a review). 
Although ecstasy/polydrug-related EF deficits have been established, assessment 
of EF in the area of recreational drug use has been restricted to laboratory-based 
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measures that despite their obvious advantages are limited in terms of their 
ecological validity with regard to everyday functioning (Gioia et al., 2008). Also, 
laboratory measures of EF capture only narrow aspects of the executive system 
and not the multidimensional aspects of decision making that characterise real-
world situations (Goldberg & Podell, 2000). Therefore, relying on only 
laboratory-based measures can lead to a limited and incomplete assessment given 
that executive functions play a key role in the direction and control of real-world 
behaviour (Gioia & Isquith, 2004). 
 
Research aim  
 
While laboratory measures are of vital importance in identifying the processes and 
interrelationships underpinning EF, self-report measures such as the BRIEF-A 
contextualise executive processes placing them in the naturalistic real world 
environments in which PM behaviour is manifested. Compared to the low level 
component processes that characterise laboratory measures, the component scales 
comprising the BRIEF-A provide a broader more effective operationalization of 
the EF construct potentially making it easier to identify which aspects of EF are 
relevant to successful PM performance. As a first step, Chapter 9 administered the 
BRIEF-A, thereby obtaining data for the nine aspects of EF that have been 
commonly discussed in the literature.  
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11.2.1 Evidence from the BRIEF 
 
This investigation revealed that in comparison to drug naïve, ecstasy/polydrug 
users demonstrated deficits on all subscales of the BRIEF, with the exception of 
shift and emotional regulation. Evaluating the role of cannabis use in executive 
functioning cannabis-only users were compared to the drug naïve sample and 
although cannabis only users performed generally worse than drug naïve in all 
subscales of the BRIEF the only component of EF that reached significance was 
emotional regulation. Similar to the previous studies on PM, a trend is evident in 
EF performance as well; ecstasy/polydrug users performing the worst following 
cannabis users performing at intermediate levels and drug naïve performing the 
best. The present findings are broadly in line with previous literature questioning 
the integrity of EF in ecstasy/polydrug users (e.g., Fox et al., 2001; Verdejo-
Garcia et al., 2005; Montgomery et al., 2007; Wareing et al., 2007; Montgomery 
& Fisk, 2008). 
 
Contribution of recreational drugs 
 
With regards to which drug or drugs are associated with EF performance, Chapter 
9 revealed that aspects of ecstasy use rather than any other drug were associated 
with most executive components. Nevertheless, when the variance of other drugs 
was excluded only the inhibit EF component yielded a statistically significant 
(adverse) association specifically with the frequency of ecstasy use. It is therefore 
possible that the inhibit component is sensitive to the recreational use of ecstasy.  
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This was unexpected as a number of previous investigations using laboratory-
based measures suggested that it is the updating component of working memory 
and not the shifting and inhibition elements that are sensitive to the effects of 
ecstasy (Fisk et al., 2004; Montgomery et al., 2005; Reneman et al., 2006; 
McCann et al., 2007). A possible explanation as to why laboratory measures of 
inhibition appear unaffected by ecstasy use while the self-report measure is 
associated with ecstasy-related deficits may be that the BRIEF measures different 
elements of the inhibition construct than those assessed by computerised 
performance tests (Bodnar et al., 2007).  
 
The potential role of recreational cannabis use in accounting for the EF deficits 
observed in this investigation should not be disregarded since cannabis 
consumption in the ecstasy/polydrug user group was generally significantly 
greater than that of the cannabis-only group. It is therefore possible that the 
observed deficits in executive components are in fact attributed to cannabis use. 
This might explain why cannabis users were impaired (although not significantly) 
whilst ecstasy/polydrug users with higher levels of cannabis consumption were 
significantly impaired.  The present findings raise the possibility that although 
cannabis users perform adequately in laboratory settings, in a less controlled 
environment i.e., their everyday lives, they might demonstrate executive 
dysfunction. Chapter 9 also revealed ecstasy/polydrug related deficits on a 
number of the other BRIEF subscales including planning, initiation, organisation, 
and self and task monitoring. It is possible that these impairments reflect separate 
aspects of another key executive function: the effective maintenance of goal 
directed behaviour.  
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11.3 The role of executive processes in accounting for Prospective Memory 
deficits in ecstasy/polydrug users 
 
What is evident from the empirical chapters of this thesis is that ecstasy/polydrug 
users are impaired in measures of PM and EF. What is less evident is the role of 
executive processes in accounting for these ecstasy/polydrug-related PM deficits. 
PM processes such as dividing attention, monitoring the environment for a cue, 
associating a cue for intention and interrupting an ongoing activity may also 
involve planning that clearly draw on prefrontal cortices and consequently on 
executive resources (Lezak, 1982; Shallice, 1982; Marsh & Hicks, 1998; 
McDaniel et al., 1999; Whyte et al., 2006).  It is therefore possible that the 
observed ecstasy/polydrug-related deficits in PM are originating from 
ecstasy/polydrug-related deficits in executive functioning.  
 
Chapter 10 provides evidence for this assumption since the general scales of the 
BRIEF-A (i.e., the metacognition index and the Global Executive Composite 
scales) were significantly associated with the fatigue PM task suggesting that 
deficits in EF performance predicts poorer time-based PM performance. Chapter 
10 also revealed a possible link between polydrug use, EF and PM, with perhaps 
some of the drug related PM deficits mediated by drug related EF impairment. 
Nevertheless, this interpretation should be treated with caution.  
 
Given that no association was found between EF and the event-based measure, it 
is reasonable to assume that it is the time-based component of PM that rely on 
executive processes and not the event-based PM component. This provides 
evidence for Einstein et al.’s (1995) view that time-based prospective tasks are 
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more likely to rely on EF than event-based tasks as they require a higher degree of 
self-initiated retrieval (Einstein et al., 1995).  
 
11.4 The role of Retrospective Memory in Prospective Memory deficits 
 
Since PM has a retrospective component, responsible for retaining the basic 
information about the required action and the contextual cue (Einstein & 
McDaniel, 1990) it is possible that impairments in PM observed in 
ecstasy/polydrug users might stem from RM and verbal learning difficulties. 
Since neuroimaging evidence suggesting that the hippocampal region and the 
dopaminergic system are involved in both retrospective and prospective memory 
(Martin et al., 2007; Goto & Grace, 2008) it is possible that ecstasy/polydrug 
users are also impaired in their RM and verbal learning. Findings from Chapter 8 
revealed that ecstasy/polydrug users in comparison to drug naïve reported RM 
problems and that these problems in RM (both in the retrospective component of 
the PRMQ and RAVLT) are associated with both event and time-based PM. Since 
RM plays an important role in PM performance the present findings raise the need 
for further research. Unlike previous research (Reneman et al., 2000; Quednow et 
al., 2006) the present thesis failed to find any ecstasy/polydrug related deficits on 
verbal memory.  
 
11.5 Implications of present findings and contribution to the existing 
literature 
 
Findings from the present investigations of PM performance provide further 
evidence for ecstasy/polydrug-related deficits in short and long-term PM 
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previously reported in self-report studies. It is therefore evident that deficits in the 
storage/retention phase are real in ecstasy/polydrug users and not falsely 
perceived. In this thesis ecstasy/polydrug users reported deficits on the short-term 
PM scale of the PMQ. However, they appeared unaware of their long-term PM 
deficits that were apparent on the objective measure. It is therefore possible that 
laboratory measures of PM are more efficient in capturing PM deficits than the 
traditional self-report measures. Although on the subjective measures, 
ecstasy/polydrug users reported general PM impairment, on its own this does not 
fully explore the nature of deficits in the retrieval phase (i.e., event and time-based 
PM); a phase that has been under-investigated in the area of illicit drug use. 
Evidence from the laboratory measures of event and time-based PM employed in 
this thesis provide evidence for ecstasy/polydrug-related deficits in the retrieval 
phase and also that PM deficits in recreational drug users are not task specific; 
instead they consistently underperform in all PM measures.    
 
The evidence for such deficits on objective measures and the significant 
association between these and the outcomes on subjective measures provides 
support for the efficacy of self-report measures in detecting general PM 
impairments. However, it is clear from the present results that self-report 
measures are ineffective in assessing important components of the PM construct, 
such as event and time-based PM. The results reported here demonstrate that both 
of these are clearly impaired in recreational drug users.  
 
An important advantage of the laboratory measures of PM employed in this thesis 
is that they require minimum learning. This contrasts with other laboratory tasks 
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that have been used in this area that require a greater degree of learning. This is an 
important improvement since associative learning is impaired in ecstasy/polydrug 
users (Montgomery et al., 2005) and reported deficits on these laboratory 
measures (for example the Virtual Week; Rendell et al., 2007) might be attributed 
to associative learning impairments rather than PM problems. Consequently, the 
present thesis provides objective evidence for ecstasy/polydrug related deficits in 
PM performance in both the retrieval and storage/retention phase suggesting that 
reported PM deficits in ecstasy/polydrug users are real rather than imagined and 
highlights the importance of employing objective measures in assessing PM 
performance in the area of recreational drug use.  
 
Another important contribution to the existing knowledge of PM problems in 
recreational drug users is the revelation that recreational use of cocaine is 
associated with PM deficits. In fact, aspects of cocaine use were associated with 
performance on all PM tasks and for the most part recreational use of cocaine 
shared unique variance with most laboratory measures of PM. The present thesis 
has therefore implicated the recreational use of cocaine, for the first time, in 
accounting for the PM deficits observed in ecstasy/polydrug users. Another 
surprising revelation was the fact that recreational use of ecstasy was not 
associated with any of the laboratory measures of PM, instead recreational use of 
cocaine emerged as the primary contributor to PM deficits. This is an important 
finding since previous literature has attributed PM impairments in 
ecstasy/polydrug users to the recreational use of ecstasy. It is therefore possible 
that these impairments are in fact attributable to the recreational use of cocaine 
and not exclusively to the effects of ecstasy use. The effects of cocaine use, 
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although evident on objective measures of PM, were not as evident on the self-
report measures of PM within the same cohort of ecstasy/polydrug users. This, 
once again emphasises the importance of using more objective measures of PM 
performance in studies of recreational drug users.    
 
While the importance of using objective measures of PM performance has been 
emphasised, the present thesis employed a self-report measure of EF performance 
in the everyday environment as opposed to the laboratory measures employed in 
previous studies in the area. Ecstasy/polydrug users underperformed on most 
components of the BRIEF including the inhibit component. This is an interesting 
finding as previous investigations have failed to observe deficits on laboratory 
measures mapping on the inhibit component. It is therefore possible that self-
report measures of EF are more capable of detecting the behavioural 
manifestations of EF in the everyday environment. The reason for the reported 
ecstasy/polydrug-related deficits on the inhibit component is that the BRIEF may 
measure different elements of the inhibition construct than those assessed by 
computerised performance tests (Bodnar et al., 2007). This therefore not only 
emphasizes the utility of the BRIEF in capturing the behavioural manifestations of 
EF but also the need for employing measures of EF that characterise real-world 
situations in recreational drug-users.  
 
Also, the present findings identify another key executive function: the effective 
maintenance of goal directed behaviour. Consequently, this thesis potentially 
identifies an additional aspect of executive function which might be subject to the 
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adverse effects of recreational use of ecstasy, providing a useful direction for 
further research.  
 
Finally, the present thesis has evaluated the contribution of executive processes 
and retrospective memory in PM performance in ecstasy/polydrug users. Findings 
provide evidence that the observed ecstasy/polydrug-related deficits in PM (time-
based PM) are originating from ecstasy/polydrug-related deficits in executive 
functioning. There was also evidence to support that problems in RM are 
associated with both event and time-based PM. These findings therefore 
emphasize the need to investigate the contribution of such processes to PM 
performance within the population of recreational drug users.  
 
To conclude, given the role of PM and EF in a person’s day-to-day functioning, 
perhaps the most important implication of the findings of this thesis is that the 
recreational use of illicit drugs may have serious consequences for the everyday 
functioning of users.  The evidence for PM and EF deficits found in this thesis in 
ecstasy/polydrug users suggests that recreational drug use adversely affects 
performance on key everyday activities. For example, while forgetting to pass on 
a message, post an envelope or meet a friend may often be inconsequential, 
forgetting to take your medication, missing important appointments or interviews, 
can have serious consequences. The possibility that some of the important 
processes that are essential for day-to-day functioning might be impaired in 
ecstasy/polydrug users is a clear cause for concern.  
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11.6 Limitations  
 
As with most studies in this area, there are a number of limitations. For example, 
the ecstasy/polydrug user group was characterised by the recreational use of 
cannabis and cocaine in addition to ecstasy. Due to the quasi-experimental design 
of the studies the concurrent use of other illicit drugs may have contributed to 
group differences in both PM and EF. Although the employment of statistical 
procedures that excluded the variance attributable to other drugs went some way 
to overcoming  this limitation (as in previous studies in the area), it is not possible 
to totally control for confounding effects of this nature.  
 
Also, the purity of MDMA tablets obviously cannot be guaranteed. Although a 
review by Parrott (2004) reports that the MDMA content of ecstasy tablets 
retrieved from amnesty bins in nightclubs was approaching 100%, from a lifetime 
perspective it is not possible to be definitive as to the amount of MDMA and other 
chemical compounds present in ecstasy tablets. Similarly to MDMA, cocaine and 
cannabis purity cannot be guaranteed either. For example, potency of cannabis 
(i.e., THC content) varies widely in the UK (Potter et al., 2008). Within the UK 
two distinct types of cannabis are circulating. One form contains floral and foliar 
material from outdoor grown pollinated female plants; referred to as herbal 
cannabis or marijuana. The second form, and most frequently used, is 
predominantly grown indoors using all-female plants and highly technical 
equipment and is referred to as skunk. The investigations in this thesis, as with 
most neuropsychological studies in the area, do not discriminate between the two 
available forms of cannabis dried-plant material. This is a potential limitation as 
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previous studies demonstrated that the content of THC and other major 
cannabinoids varies widely in illicit cannabis (ElSohly et al., 2000).   
 
Similarly, purity of cocaine cannot be guaranteed either. According to Schifano 
and Corkery (2008), however, purity of cocaine powder has remained fairly stable 
in the UK during 1990-2004 with mean purity levels varying between 42- 60% 
within this timeframe (as reported by Police and may reflect what is available in 
the street market).  
 
A further limitation of the present investigations was the lack of objective 
measures of recent drug use such as hair or urine analysis. Instead, a self-report 
measure of history of drug use was administered. Although this is clearly a 
limitation, previous studies in the area have not used these techniques and have 
relied on self-report measures instead (Morgan, 1999; Heffernan et al. 2001a; b; 
Rodgers et al., 2001; 2003; Fisk & Montgomery, 2007). Also, the drug use history 
questionnaire (Montgomery et al., 2005b) employed in this investigation provided 
a number of checks for internal consistency, verifying the reliability of the 
information provided by participants.  Nonetheless future research would benefit 
from the inclusion of objective measures of recent drug use. 
 
Another possibility is that the apparent ecstasy/polydrug related deficits may not 
necessarily be a consequence of illicit drug use but instead be due to pre-existing 
differences between the groups originating before the onset of illicit drug use. For 
example, there has been evidence of PM deficits (Kliegel et al., 2006) and 
executive dysfunction (Barkley, 1997) in children with ADHD. Executive 
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dysfunction has also been demonstrated in patients with unipolar depression (see 
Fossati, 2002 for a review). In relation to this, Pope (2002) has emphasized the 
importance of considering differences in sociodemographic factors, personal 
dispositions and underlining psychopathology between users and non-users. It is 
therefore possible that impairments observed on PM and EF performance, are not 
necessarily attributed to the use of illicit drugs. Furthermore, lifestyle differences 
or the effects of illicit drug use on other physiological processes such as altered 
sleep patterns and cognitive deficits (Fisk & Montgomery, 2009b) might be the 
actual cause of the observed deficits.  The contribution of alcohol consumption 
and tobacco in PM and executive processes should also be kept in mind as several 
investigations suggest that these legal substances are related with PM deficits 
(Heffernan et al., 2003; Heffernan and Bartholomew, 2006; Heffernan et al., 
2006; Heffernan et al., 2010). Although the series of investigations in this thesis 
have tried to control for alcohol consumption, the possible involvement of alcohol 
in the observed deficits should not be disregarded.   
 
11.7 Future directions 
 
In reflecting on the research questions addressed in this thesis, several interesting 
findings that potentially provide a useful direction for future research were 
observed. With regards to PM in recreational drug users, the present thesis 
emphasized the importance of using more objective measures of PM rather than 
self-report measures since laboratory measures of PM were more sensitive in 
detecting PM deficits in ecstasy/polydrug users. It also provided further evidence 
for the effect of ecstasy/polydrug use on the time and event-based PM that is 
259 
 
under-investigated in the area of illicit drug use. It is therefore evident from the 
findings of this thesis that recreational drug users face a range of PM deficits that 
are not restricted to the storage/retention phase (i.e., short and long-term PM). 
Hence, this provides a useful direction for future research as it is essential to 
investigate the whole range of PM deficits experienced by ecstasy/polydrug users 
using more objective measures in order to further establish the scope, extent or 
implications of such deficits in PM.  
 
Another finding from the present thesis that merits further investigation is the 
potential role of executive processes and RM in accounting for the observed 
deficits in PM in recreational drug users. Although the present thesis provides 
evidence for the contribution of EF and RM in PM performance, further research 
is essential to identify the extent of which these processes affect PM performance. 
Consequently, a wider range of laboratory measures of PM that are less artificial 
in nature and require minimum contribution of executive processes and RM in 
order to identify whether drug-related deficits in PM are not a result of drug-
related deficits in executive processes and/or RM are crucial.   
 
In terms of EF in ecstasy/polydrug users, an alternative assessment was 
introduced in the present thesis. The efficacy of the BRIEF to capture deficits on 
the inhibit scale while previous laboratory measures of the components failed to 
do so, outlines the importance of employing different assessment methods to 
measure executive dysfunction in ecstasy/polydrug users. The findings of the 
present thesis in relation to EF also suggest that ecstasy/polydrug users are 
impaired in a wider range of EF than previously thought. In fact, ecstasy/polydrug 
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users demonstrated a range of EF deficits with regards to the everyday 
environment. Impairment on a number of BRIEF subscales including planning, 
initiation, organisation, and self and task monitoring were also revealed. 
Therefore this thesis identifies another key executive function: the effective 
maintenance of goal directed behaviour that might be subject to the adverse 
effects of recreational use of ecstasy.  Further investigation of this possibility 
through the use of appropriate self-report measures and laboratory tests might 
constitute a fruitful direction for further research. 
 
Perhaps the most striking revelation of the present investigations on PM 
performance in ecstasy/polydrug users is the contribution of recreational use of 
cocaine in the observed PM deficits. Evidence demonstrated that all laboratory 
measures of PM were associated with the recreational use of cocaine, and for the 
most part cocaine shared unique variance with most of these measures. This 
revelation provides a fundamental direction for further research in order to 
understand the origin of ecstasy/polydrug related deficits in PM performance. 
Consequently, further research is essential in order to determine the exact role 
played by cocaine in PM performance amongst recreational drug users and also to 
clarify whether the cocaine-related deficits are limited to the ecstasy/polydrug 
population or whether they might be present among those persons whose 
recreational use is largely confined to cocaine. 
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11.8 Overall summary  
 
The aim of this thesis was to expand on previous research as to the impact of 
ecstasy/polydrug use on prospective remembering and executive functioning. 
Evidence from a series of investigations suggests that ecstasy/polydrug users 
experience more general PM problems as ecstasy/polydrug-related deficits were 
evident on both the retrieval phase (time and event-based PM tasks) and 
storage/retention phase (short and long-term PM). This also suggests that 
ecstasy/polydrug-related deficits demonstrate a general feature of PM 
performance rather than task-specific aspects. These deficits on both laboratory 
measures of PM and (some) self-report measures of real world memory therefore 
suggest that ecstasy/polydrug users possess some self-awareness of their memory 
lapses. The findings of the present thesis with relation to laboratory measures of 
PM also emphasize the importance of employing more objective measures to 
assess PM in the area of recreational drug use. An unanticipated finding in the 
present thesis was that the recreational use of cocaine was associated with PM 
deficits; an association that consistently emerged in all studies of PM 
performance.  
 
Ecstasy/polydrug users also demonstrated deficits on executive processes using 
the self-report measure BRIEF suggesting that recreational drug users are 
impaired in a broader range of EF with regards to the everyday environment and 
ecstasy/polydrug-related deficits are not restricted to three-model component of 
EF. The present thesis also identified another key executive function: the effective 
maintenance of goal directed behaviour that appears to be susceptible to the 
adverse effects of recreational use of ecstasy.  It was also revealed that 
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ecstasy/polydrug users face RM problems and that these problems in RM are 
associated with both event and time-based PM. Furthermore, evidence to suggest 
that executive dysfunction is associated with poorer time-based PM performance 
was suggested. It is therefore possible that deficits in PM performance are 
associated with deficits in executive processes and perhaps some of the drug 
related PM deficits are mediated by drug related EF impairment.  
 
Finally, although few PM or EF performance deficits were evident among 
cannabis-only users, a trend is evident in all investigations of PM and EF; 
ecstasy/polydrug users perform the worst, cannabis-only users at intermediate 
levels and drug-naïve perform the best. All in all, ecstasy/polydrug related deficits 
are evident on both prospective remembering and executive processes. The 
outcomes of the present thesis, despite addressing some of the grey areas in the 
literature of PM and EF in relation to recreational drug use, also provide a fruitful 
direction for future research. 
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APPENDIX 1: PARTICIPANTS 
OVERLAP TABLE 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
This table shows the number of participants overlapping in chapters 7-10 
 
 
 EP= Ecstasy/polydrug users 
CO= Cannabis-only users 
DN= Drug naïve  
 Chapter 7 Chapter 8 
Chapter 7 (PMQ, PRMQ, RBMT, 
CFQ, EMQ, PM fatigue, PM procspeed, PM 
long) 
- - 
Chapter 8 (CAMPROMPT, RAVLT, 
MCQ, RM) 
- - 
Chapter 9 (BRIEF-A) 37EP 
7CO 
20DN 
28EP 
12CO 
18DN 
Chapter 10 (BRIEF-A, PM fatigue, 
PM procspeed, PM long) 
37EP 
7CO 
20DN 
28EP 
12CO 
18DN 
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APPENDIX 2: DRUG HISTORY 
QUESTIONNAIRE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
Participant Number     Height  
 
       Weight  
 
       Gender  
 
       Age      
 
 
 
1. Have you ever used the drug ecstasy?  Yes/No* 
(If  ‘No’ please move on to Question 16) 
 
2. How long have you been taking ecstasy?        Months            Years 
 
3.       How aware are you that using the drug ecstasy may have harmful long  
term effects on your health? 
 
(Please tick relevant answer) 
 
Very aware      ____ 
 
Quite aware        ____ 
 
Unsure                ____ 
 
Quite unaware    ____ 
 
Very unaware           ____ 
 
Can you explain below what these harmful effects may be? 
 
 
 
 
4.        Are you concerned about the possible dangers of using ecstasy? 
 
(Please tick relevant answer) 
 
 
Extremely Concerned ____ 
 
Very Concerned ____ 
 
Concerned  ____ 
 
Slightly Concerned ____ 
 
Not Concerned  ____ 
 2 
5. How do you find out information about ecstasy? 
(Please tick all relevant answers) 
 
TV-News  Radio  
TV-Specialist 
Programes\Debate 
 Drug Agencies  
Daily Newspaper  Drug Leaflets  
Music Magazines  Friends  
Magazine  Clubs  
Other   
 
 
 
 
 
6.        Where do you usually take ecstasy? 
(Please tick relevant boxes) 
 
Pubs/Bars  
Night-clubs  
Rave Events  
Private House/Flat  
Parties  
Own Home  
Friends Home  
Other 
 
 
 
 
 
7.       What activities do you participate in when under the influence of ecstasy? 
(Please tick relevant boxes) 
 
Dancing  
Listen to Music  
Talking  
Driving  
Sexual Behaviour  
Drinking  
Smoking  
Other 
 
 
 
 
 
 
 
 
 
 3 
8. Do you take any sort of precautions when using ecstasy?  Yes\No 
 (E.G. Vitamins) 
  
If yes please give details 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9.          Are you aware that medical advice suggests that            Yes___    No ____ 
you should take precautions when using ecstasy? 
 
If yes can you explain below what precautions should be taken and why 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
 
10.       When under the influence of ecstasy: 
 
(a) Do you take regular rest-breaks when dancing Yes---   No--- 
 
(b) Do you monitor your fluid intake   Yes---   No--- 
 
(c) Is there anything else you do   Yes---   No--- 
  
             If yes please give details 
 
 
 
 
 
 
 
 
 
11.       Is there a maximum number of ecstasy tablets  
you will take in one session?   Yes---   No--- 
 
If Yes, what is the maximum number  __________ 
 
 
 
 
 
 
 
12.    What factors decide when you have taken enough ecstasy tablets in one session? 
  (Please give details below) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5 
13. Do you believe that since using ecstasy you have changed in any way? 
 
 
Please look at the following list very carefully 
 
 
(For example, if you believe that since using ecstasy you have become more caring then tick 
caring under the heading MORE.  If however you feel that you have become less caring then 
tick caring under the heading LESS.  If you feel that you have not become any more or less 
caring the tick caring under the heading NO CHANGE) 
 
 
 
 MUCH  
MORE 
MORE NO 
CHANGE 
    LESS MUCH 
LESS 
CARING      
PARANOID      
ALERT      
DEPRESSED      
SOCIABLE      
AGGRESSIVE      
HAPPY      
HEALTHY      
MOODY      
PATIENT      
IRRITABLE      
CONFIDENT      
SAD      
LOVING      
CONFUSED      
 
 
 
Any other changes _______________________________________________ 
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14.      What has stopped you taking ecstasy in the past? 
(Please tick relevant boxes) 
 
 
 
Bad Experience          (You) 
 
 
Bad Experience          (Other)  
 
 
Work/College 
 
 
Parents 
 
 
Short Term Health      (Physical) 
 
 
Long Term Health       (Physical) 
 
 
Death 
 
 
Responsibilities 
 
 
Prison 
 
Psychological Problems 
(Short Term - in the last 1 month) 
 
 
                      Anxiety 
 
 
                      Depression 
 
 
                      Flashbacks 
 
 
                      Panic Attacks 
 
 
                      Paranoia 
 
Psychological Problems 
(Long Term - continuing after 1 month) 
 
 
                      Anxiety 
 
 
                      Depression 
 
 
                      Flashbacks 
 
 
                      Panic Attacks 
 
 
                      Paranoia 
 
Other (please specify) 
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15. From the following list, please indicate what type of other drugs you use at the same time 
as ecstasy and the frequency of use. 
 
(Please tick all relevant boxes) 
 
       Drug         Always             Frequently           Occasionally         Never 
 
Alcohol 
    
 
Amphetamine 
    
 
Cannabis 
    
 
Cocaine 
    
 
Crack 
    
 
DMT 
    
 
GHB 
    
 
Herbal E 
    
 
Heroin 
    
 
Ketamine 
    
 
LSD 
(Acid\Blotters) 
    
 
LCB 
    
 
Mushrooms 
    
 
Poppers 
    
 
Prozac 
    
 
Salvia 
Divindrum 
    
 
Tranquillisers 
    
Tobacco     
Viagra     
Other     
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16. From the following list, please indicate what type of other drugs you have used in the last 
three months use and the frequency of use. 
 
(Please tick all relevant boxes) 
 
       Drug         Always             Frequently           Occasionally         Never 
 
Alcohol 
    
 
Amphetamine 
    
 
Cannabis 
    
 
Cocaine 
    
 
Crack 
    
 
DMT 
    
 
GHB 
    
 
Herbal E 
    
 
Heroin 
    
 
Ketamine 
    
 
LSD 
(Acid\Blotters) 
    
 
LCB 
    
 
Mushrooms 
    
 
Poppers 
    
 
Prozac 
    
 
Salvia 
Divindrum 
    
 
Tranquillisers 
    
Tobacco     
Viagra     
Other     
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17. From the following list, please indicate which types of drugs you have used in the past. 
Please indicate when you first began using and when you last used the drug. 
       
 
 
Drug 
 
When did 
you first 
use? 
 
When did you last use? 
(Please circle one only) 
 mm/yr. Hours 
Previous 
Days Previous Weeks 
Previous 
Months  
Previous 
Years Previous 
 
Ecstasy (MDMA) 
   
 0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Alcohol 
   
 0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Amphetamine 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Cannabis 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Cocaine 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Crack 
   
0 1 2 3 4 5 6  
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
DMT 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
GHB 
   
0 1 2 3 4 5 6  
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Herbal E 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Heroin 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Ketamine 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
LSD 
(Acid\Blotters) 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
LCB 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Mushrooms 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Poppers 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Prozac 
   
0 1 2 3 4 5 6  
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Salvia Divindrum 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Tranquillisers 
   
0 1 2 3 4 5 6   
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Tobacco 
   
0 1 2 3 4 5 6 
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Viagra 
   
0 1 2 3 4 5 6 
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
Other 
   
0 1 2 3 4 5 6 
 
1    2    3   
1  2  3  4  5  6  
7  8  9  10  11  
1 2 3 4 5 6 7 8 9 
10 
 
If less than a day, indicate hours previous 
 
 10 
 
18. Please list any controlled substances, prescription medications, and alcohol you have  
consumed in the last 10 days? Please list ALL occasions during the last 10 days. 
 
 
 
 
 
Substance 
 
Form, 
e.g., 
skunk, 
rocky, 
tablets, 
powder 
Days/ 
hours 
previous 
 
                              Amount taken 
Grams            Cost                  Units                           Dose 
                                       e.g. bags/wraps          e.g.  joints, line 
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19. How would you describe you current pattern of ecstasy use? 
 
times per week OR  
 
times per month  OR  
 
times per year OR  
 
previous user (more than 6 months since last used)  
 
Please estimate your pattern of use from the first year of taking the drug to present use 
 
 Fill in the year you began taking ecstasy 
 Select an average month of use within that year 
        Estimate the total number of ecstasy tablets you would normally have                     
              taken during one session 
        Indicate frequency of use, e.g., number of times per week/month/year 
 
Continue to fill in each consecutive year regardless of whether you used 
ecstasy or not.  If you have not used for a particular year, continue to enter the 
year and specify a month, and then enter zero in the space provided for the 
total number of tablets taken. 
 
 
                       Total number of  
                       tablets taken in        Frequency            Route of 
               Year             Month   one session                of use          Administration   
e.g. Year 1 
1993 
 
 June                
 
1                           
 
One a  Week 
 
e.g. swallow, sniff, inject 
     
     
     
     
     
     
     
     
     
This year Last 30 
days 
 How many times?  
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20. How would you describe you current pattern of Amphetamine use? 
 
times per week OR  
 
times per month  OR  
 
times per year OR  
 
previous user (more than 6 months since last used)  
 
 
In what form do you take amphetamine? 
Powder (amphetamine sulphate)              __________ 
 
Tablets (please indicate type)   __________ 
 
Other      __________ 
 
Please estimate your pattern of use from the first year of taking the drug to present use 
 
 Fill in the year you began taking amphetamine 
 Select an average month of use within that year 
  Estimate the total number of amount of powder you would normally       
 have taken during one session 
 Indicate frequency of use, e.g., number of times per week/month/year 
 
                         Total amount 
                          taken in                Frequency          Route of administration 
               Year             Month     one session            of use 
e.g. Year 1 
1993 
 
 June                
 
e.g. 1                                 
 
One a  Week 
 
e.g. swallow, sniff, inject 
     
     
     
     
     
     
     
     
     
This year Last 30 
days 
 How many times?  
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21. How would you describe you current pattern of Cannabis use? 
 
times per week OR  
 
times per month  OR  
 
times per year OR  
 
previous user (more than 6 months since last used)  
 
 
In what form do you take Cannabis? 
 
Joints      __________ 
 
Other      __________ 
 
Please estimate your pattern of use from the first year of taking the drug to present use 
 
 Fill in the year you began taking Cannabis 
 Select an average month of use within that year 
  Estimate the total number of joints you would normally       
                                  have taken during one session 
 Indicate frequency of use, e.g., number of times per week/month/year 
 
                         Total number 
                          of joints in            Frequency          Route of administration 
               Year             Month     one session            of use 
e.g. Year 1 
1993 
 
 June                
 
e.g. 1                                 
 
One a  Week 
 
e.g. Smoke, Swallow,  
     
     
     
     
     
     
     
     
     
This year Last 30 
days 
 How many times?  
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22a. Other drug regularly used: Please estimate your pattern of use from the first year of  
taking the drug to present use. 
 
times per week OR  
 
times per month  OR  
 
times per year OR  
 
previous user (more than 6 months since last used)  
 
 
Which Drug? ___________________________________ 
 
In what form? ___________________________________ 
 
Please estimate your pattern of use from the first year of taking the drug to present use 
 
 Fill in the year you began taking the drug 
 Select an average month of use within that year 
 Estimate the total amount you would normally       
                                 have taken during one session 
 Indicate frequency of use, e.g., number of times per week/month/year 
 
                          Total  
                          amount in             Frequency          Route of administration 
               Year             Month     one session          of use 
e.g. Year 1 
1993 
 
 June                
 
e.g. 1                                 
 
One a  Week 
 
e.g. Smoke, Swallow, 
Inject, Snort 
     
     
     
     
     
     
     
     
     
This year Last 30 
days 
 How many times?  
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22b. Other drug regularly used: Please estimate your pattern of use from the first year of  
taking the drug to present use. 
 
times per week OR  
 
times per month  OR  
 
times per year OR  
 
previous user (more than 6 months since last used)  
 
 
Which Drug? ___________________________________ 
 
In what form? ___________________________________ 
 
Please estimate your pattern of use from the first year of taking the drug to present use 
 
 Fill in the year you began taking the drug 
 Select an average month of use within that year 
 Estimate the total amount you would normally       
                                 have taken during one session 
 Indicate frequency of use, e.g., number of times per week/month/year 
 
                          Total  
                          amount in             Frequency          Route of administration 
               Year             Month     one session          of use 
e.g. Year 1 
1993 
 
 June                
 
e.g. 1                                 
 
One a  Week 
 
e.g. Smoke, Swallow, 
Inject, Snort 
     
     
     
     
     
     
     
     
     
This year Last 30 
days 
 How many times?  
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23. How many years of full time education have you completed from primary school to date?  
   
                                                         ____________Years 
 
 
 
24. From the following list, please indicate if you have obtained any of the  
following educational qualifications? 
   Qualification   Y\N  Details 
 
CSE 
  
 
GCE 
  
 
GCSE 
  
 
A LEVEL 
  
 
NVQ 
  
 
GOV. EMPLOYMENT 
TRAINING SCHEME 
  
 
CRAFT\TRADE (EG CITY & 
GUILD) 
  
 
HND 
  
 
DEGREE 
  
 
OTHER 
  
 
NONE 
  
 
 
 
25. Do you have any convictions for drugs   Yes---   No--- 
 If yes, would you please give details below? 
             E.g. year of conviction, type of drug, type of offence   
 
 
 
 
26. Do you have any other convictions   Yes---   No--- 
 If yes, would you please give detail below? 
  E.g. year of conviction, type of offence  
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27.       What are your current living circumstances? 
(Please tick relevant box) 
 
 
Live Alone 
 
 
Parental Home 
 
 
Live with partner 
 
 
Marriage Partner 
 
 
Single Parent Family 
 
 
Live with Friends 
 
 
 
 
No Fixed Abode 
 
 
Other 
 
 
 
28.       On Average approximately how much alcohol do you normally consume? 
(E.g. 1 unit = 1 glass of wine; 1 measure of spirit pint of beer) 
 
 
Daily 
 
 
Weekly 
 
 
Fortnightly 
 
 
Monthly 
 
 
Other 
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29. Have you ever experienced or been hospitalised for any of the following conditions? 
 
 
 Neurological    *Yes/No 
 
 Heart     *Yes/No 
 
 Respiratory     *Yes/No 
 
*If yes, can you please explain what they were. 
 
 
 
 
 
30. Have you ever been diagnosed as suffering from any of the following conditions? 
 
 Diabetes     *Yes/No 
 
 Anxiety     *Yes/No 
 
 Depression     *Yes/No 
 
 Flashbacks     *Yes/No 
 
 Panic Attacks    *Yes/No 
 
 Paranoia     *Yes/No 
 
 Phobias     *Yes/No 
 
 Schizophrenia    *Yes/No 
 
 
*If yes, did you receive treatment? - Please give details 
 
 
 
 
 
31. Are you currently taking any prescription drugs *Yes/No 
 
 *If yes, please give the name of the drug ___________________________________ 
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32. Do you consider yourself to be in good health? 
         (Please tick relevant box) 
 
 
Very Good 
 
 
Good 
 
 
Average 
 
 
Poor 
 
 
Very Poor 
 
 
 
33. What is your current employment status? 
(Please tick relevant box) 
 
Employed          full-time  
Employed          part-time  
Unemployed  
Self-employed  
Student  
Other. e.g. Sick, Disabled, 
Homemaker 
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APPENDIX 3: BACKGROUND 
INFORMATION QUESTIONNAIRES 
 
 
 
 
 
Participant Number: 
 
 
 
HEALTH/EDUCATION QUESTIONNAIRE.  Your answers to the questions 
below will provide us with brief details of your health status and educational 
background.    The tests you will carry out today will just be used to measure 
individual differences in performance and will not be used for the purpose of 
diagnosing any medical condition. 
 
 
1.  What is your age in years? 
 
 
 
 
 
 
2.  How would you rate your overall health on a scale from 1 = poor  to 5 = excellent 
with 3 = average ? 
 
 
 
 
 
 
3.  How many prescription medications do you take each week? 
 
 
 
 
 
 
4.  How many times in the past 5 years have you been hospitalised or received other 
treatment for cardiovascular or neurological problems (e.g., heart attacks, stroke, or 
high blood pressure)? 
 
 
 
 
 
 
5.  Please indicate the number of years that you have been in  FULL TIME education 
from your first infant school to the present date. 
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APPENDIX 4: PROSPECTIVE MEMORY 
QUESTIONNAIRE 
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APPENDIX 5: PROSPECTIVE 
RETROSPECTIVE MEMORY 
QUESTIONNAIRE 
 
Crawford et al PM Questionnaire 
 
Please read carefully each statement listed below decide how much each item describes you 
recently.  Indicate your response for each item by circling the number that corresponds to your 
choice.  Please circle one answer for each statement.  
 Nev
er 
R
a
rely
 
S
o
m
etim
es 
Q
u
ite O
ften
 
V
ery
 O
ften
 
1. Do you decide to do something in a few minutes’ time and then forget to 
do it?   
 
1 2 3 4 5 
2. Do you fail to recognize a place you have visited before? 
 
1 2 3 4 5 
3. Do you fail to do something you were supposed to do a few minutes later 
even though it’s there in front of you, like take a pill or turn off the 
kettle? 
 
1 2 3 4 5 
4. Do you forget something that you were told a few minutes before? 
 
1 2 3 4 5 
5. Do you forget appointments if you are not prompted by someone else or 
by a reminder such as a calendar or diary? 
 
1 2 3 4 5 
6. Do you fail to recognize a character in a radio or television show from 
scene to scene? 
 
1 2 3 4 5 
7. Do you forget to buy something you planned to buy, like a birthday card, 
even when you see the shop? 
 
1 2 3 4 5 
8. Do you fail to recall things that have happened to you in the last few 
days? 
 
1 2 3 4 5 
9.  Do you repeat the same story to the same person on different occasions? 
 
1 2 3 4 5 
10. Do you intend to take something with you before leaving a room or 
going out, but minutes later leave it behind, even though it’s there in 
front of you? 
 
1 2 3 4 5 
11. Do you mislay something that you have just put down, like a magazine 
or glasses? 
 
1 2 3 4 5 
12. Do you fail to mention or give something to a visitor that you were asked 
to pass on? 
 
1 2 3 4 5 
13. Do you look at something without realising that you have seen it 
moments before? 
 
1 2 3 4 5 
14. If you tried to contact a friend or relative who was out, would you forget 
to try again later? 
 
1 2 3 4 5 
15. Do you forget what you watched on television the previous day? 
 
1 2 3 4 5 
16. Do you forget to tell someone something you had meant to mention a 
few minutes ago? 
 
1 2 3 4 5 
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APPENDIX 6: EVERYDAY MEMORY 
QUESTIONNAIRE 
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APPENDIX 7: COGNITIVE FAILURES 
QUESTIONNAIRE 
 
 
  Cognitive Failure Questionnaire.    
Participant Number: 
 
The following questions are about minor mistakes which everyone makes from time to time, 
but some of which happen more than others. We want to know how often these things have 
happened to you over the last six months. Please circle the appropriate number. 
 
 Very 
Often 
Quite 
Often 
Occasio
nally 
Very 
rarely 
Never 
1. Do you read something and find you haven’t 
been thinking about it and must read it again? 
4 3 2 1 0 
2. Do you find you forget why you went from 
one part of the house to the other? 
4 3 2 1 0 
3. Do you fail to notice signposts on the road? 4 3 2 1 0 
4. Do you find that you confuse right and left 
when giving directions? 
4 3 2 1 0 
5. Do you bump into people? 4 3 2 1 0 
6. Do you find that you forget whether you’ve 
turned off a light or fire or locked the door? 
4 3 2 1 0 
7. Do you fail to listen to people’s names when 
you are meeting them? 
4 3 2 1 0 
8. Do you find that you say something and 
realise that it might be taken as insulting? 
4 3 2 1 0 
9. Do you fail to hear people speaking to you 
when you are doing something else? 
4 3 2 1 0 
10. Do you lose your temper and regret it? 4 3 2 1 0 
11. Do you leave important letters unanswered 
for days? 
4 3 2 1 0 
12. Do you find you forget which way to turn on 
a road you know well but rarely use? 
4 3 2 1 0 
13. Do you fail to see what you want in a 
supermarket (although it’s there)? 
4 3 2 1 0 
14. Do you find yourself suddenly wondering 
whether you’ve used a word correctly?  
4 3 2 1 0 
15. Do you have trouble making up your mind? 4 3 2 1 0 
16. Do you find you forget appointments? 4 3 2 1 0 
17. Do you forget where you put something like 
a newspaper? 
4 3 2 1 0 
Please turn over to complete the questionnaire. 
  
 
Very 
Often 
Quite 
Often 
Occasio
nally 
Very 
rarely 
Never 
18. Do you find you accidentally throw away the 
thing you want and keep what you meant to 
throw away- as in the example of throwing away 
the matchbox and putting the used match in your 
pocket? 
4 3 2 1 0 
19. Do you daydream when you ought to be 
listening to something? 
4 3 2 1 0 
20. Do you forget people’s names? 4 3 2 1 0 
21. Do you start doing one thing at home and get 
distracted into doing something else? 
4 3 2 1 0 
22. Do you find you can’t quite remember 
something although it’s “on the tip of your 
tongue”? 
4 3 2 1 0 
23. Do you find you forget what you came to the 
shops to buy? 
4 3 2 1 0 
24. Do you drop things? 4 3 2 1 0 
25. Do you find you can’t think of anything to 
say? 
4 3 2 1 0 
 
Thank you very much for your time in participating in this study. 
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APPENDIX 8: RBMT SCORE SHEET 
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APPENDIX 9: REY’S AUDITORY VERBAL 
LEARNING TASK QUESTIONNAIRE 
 
  
RAVLT 
 
 Trial 1 Trial 2 Trial 3 Trial 4 Trial 5 Serial 
Position 
Interference Trial 6 Trial 7 
(20 minute delay 
Plum       Hawk    
Door      Oil    
Sage      Salt    
Ball       Mile    
Corn      Wool    
Lily      Plate    
Flute        Saw    
Spoon      Eye    
Rain      Rope    
Rock       Oak    
Silk      Pear    
Foot      Sock    
Frog       Gold    
Horse      Jazz    
Trout      Inch    
           
Intrusions           
           
TOTAL 
CORRECT 
          
 
Participant Number: 
  
 Yes No 
   
Ant _ _ _ ____ 
Frog ____ _ _ _ 
Nail _ _ _ ____ 
Plum ____ _ _ _ 
Wine _ _ _ ____ 
Bed _ _ _ ____ 
Trout ____ _ _ _ 
Bus _ _ _ ____ 
Sage ____ _ _ _ 
Herb _ _ _ ____ 
Spoon ____ _ _ _ 
China _ _ _ ____ 
Ball ____ _ _ _ 
Horse ____ _ _ _ 
Book _ _ _ ____ 
Flute  ____ _ _ _ 
Corn ____ _ _ _ 
Rain ____ _ _ _ 
Opal _ _ _ ____ 
Milk _ _ _ ____ 
Fork _ _ _ ____ 
Lily ____ _ _ _ 
Rock ____ _ _ _ 
Door ____ _ _ _ 
Shoe _ _ _ ____ 
Silk ____ _ _ _ 
Aunt _ _ _ ____ 
Chair _ _ _ ____ 
Foot ____ _ _ _ 
Rake _ _ _ ____ 
   
 
 
 Hit 
(solid line, 
column 1) 
Correct 
Rejection 
(solid line, 
column 2) 
Miss  
(dashed line, 
column 2) 
False Alarm 
(dashed line, 
column 1) 
Total Score 
 
    
 
Participant Number: 
 324 
 
APPENDIX 10: MEMORY COMPENSATION 
QUESTIONNAIRE 
 
 
 
 
 
 
 
Memory Compensation Questionnaire 
(MCQ) 
 
Roger A. Dixon and Lars Bäckman 
© 1993, 2001, 2007 
 
Dixon, R.A., Garrett, D.D., & Bäckman, L. (in press). Principles of compensation in 
cognitive neuroscience and neurorehabilitation. In D.T. Stuss, G. Winocur, & I.H. 
Robertson (Eds.), Cognitive neurorehabilitation. Cambridge: Cambridge University 
Press. 
Dixon, R.A., & de Frias, C.M. (2007). Mild memory deficits differentially affect six-year 
changes in compensatory strategy use. Psychology and Aging, 22, 632-638. 
de Frias, C.M., & Dixon, R.A. (2005). Confirmatory factor structure and measurement 
invariance of the Memory Compensation Questionnaire. Psychological Assessment, 
17, 168-178. 
de Frias, C.M., Dixon, R.A., & Bäckman, L. (2003). Older adults' use of memory 
compensation strategies is related to psychosocial and health indicators. Journal of 
Gerontology: Psychological Sciences, 58, 12-22. 
Dixon, R.A., Hopp, G.A., Cohen, A.-L., de Frias, C.M., & Bäckman, L. (2003). Self- 
reported memory compensation: Similar patterns in Alzheimer’s disease and very old 
adult samples. Journal of Clinical and Experimental Neuropsychology, 25, 382-390. 
Dixon, R.A., de Frias, C.M., & Bäckman, L. (2001). Characteristics of self-reported 
memory compensation in late life. Journal of Clinical and Experimental 
Neuropsychology, 23, 650-661. 
Dixon, R.A., & Bäckman, L. (Eds.). (1995). Compensating for psychological deficits 
and declines: Managing losses and promoting gains. Mahwah, NJ: Erlbaum. 
Bäckman, L., & Dixon, R.A. (1992). Psychological compensation: A theoretical 
framework. Psychological Bulletin, 112, 259-283. 
Contact:  rdixon@ualberta.ca, vlslab@ualberta.ca 
Date:____ _/_____/_____      Participant #: ____           _ 
  d      m      y       Scorer’s Initials:___________ 
 
 
MEMORY QUESTIONNAIRE 
  
Directions 
 
     Different people use their memory in different ways in their everyday lives. For 
example, some people make shopping lists, whereas others do not.  Some people 
are good at remembering some things, whereas others are not.  In this questionnaire, 
we would like you to tell us about how you use your memory. There are no right or 
wrong answers to these questions because people are different. Please take your 
time and answer each of these questions to the best of your ability. 
 
     Each question is followed by five choices. Read the choices carefully for each 
question. Choose one of the choices and draw a circle around the letter 
corresponding to that choice. Mark only one number for each question. 
 
     Some of the questions ask how often you do certain things that may be related to 
our memory. For example: y 
 
Do you make a list of things to be       1. Never 
accomplished during the day?              2. Seldom 
                                             3. Sometimes 
                                            4. Often 
                                              5. Always 
 
In this example you could choose any one of the answers. Choose the one that 
comes closest to what you usually do. Don't worry if the time estimate is not exact or 
if there are some exceptions. 
 
 
Keep these points in mind 
 
(1) Please answer every question, even if it doesn’t seem to apply to you very well. 
(2) Answer as honestly as you can what is true for you.  Please do not mark       
something because it seems like the “right thing to say”. 
 
1. Do you use shopping lists 1. Never 
    when you go shopping? 2. Seldom  
  3. Sometimes 
  4. Often 
  5. Always 
  
 
2. Do you ask people to speak slowly 1. Never 
    when you want to remember what 2. Seldom  
    they are saying? 3. Sometimes 
  4. Often 
  5. Always 
  
 
3.  When you want to remember an  1. Never 
 important appointment do you ask  2. Seldom  
    somebody else (for example,  3. Sometimes 
    spouse or friend) to remind you?  4. Often 
  5. Always 
  
 
1.  Do you put in a lot of effort when  1. Never 
    you want to remember an important 2. Seldom  
    conversation with a person? 3. Sometimes 
  4. Often 
  5. Always 
  
 
5.  When you want to remember a story 1. Always 
    do you read it more than once? 2. Often 
  3. Sometimes 
  4. Seldom  
  5. Never 
  
 
6.  When you are reading a book, do 1. Always 
    you use a bookmark to indicate 2. Often  
   where you stopped reading last     3. Sometimes 
   time? 4. Seldom  
  5. Never 
  
 
 
7.  Do you put in effort when you want 1. Always 
    to memorize a funny story? 2. Often 
  3. Sometimes 
  4. Seldom  
  5. Never 
  
 
8.  When you want to remember a newspaper 1. Never 
    article is it important to you to  2. Seldom  
    remember it perfectly?  3. Sometimes 
  4. Often 
  5. Always 
  
 
9.  When an interesting T.V. program is 1. Always 
    going to be on in the next few days 2. Often 
    do you ask somebody else to help you 3. Sometimes 
    remember (for example, spouse or  4. Seldom  
    friend)? 5. Never 
  
 
10.  Do you concentrate a lot to learn 1. Never 
     something you really want to  2. Seldom  
    remember? 3. Sometimes 
  4. Often 
  5. Always 
  
 
11. When you want to remember a newspaper 1. Never 
     article do you read it more slowly? 2. Seldom  
  3. Sometimes 
  4. Often 
  5. Always 
  
 
12.  When you want to remember an event  1. Never 
     such as a birthday, do you ask  2. Seldom  
     somebody else (for example, spouse or 3. Sometimes             
friend) to help you remember? 4. Often 
  5. Always 
  
 
 
13.  Do you post notes on a board or   1. Never 
     other prominent place to help you 2. Seldom  
     remember things for the future 3. Sometimes 
     (for example, meetings or dates)? 4. Often 
  5. Always 
  
 
14.  When you want to remember the name  1. Always 
     of a particular person, do you ask 2. Often 
    somebody else (for example, spouse 3. Sometimes 
     or friend) to help you remember?  4. Seldom  
        5. Never 
  
 
15.  When you are reading something that  1. Always 
     really interests you (and that you 2. Often 
    want to remember) do you slow down  3. Sometimes 
    your reading speed? 4. Seldom  
  5. Never 
  
 
16.  When you want to remember a 1. Always 
      conversation is it important to you 2. Often 
      to remember it perfectly? 3. Sometimes 
  4. Seldom  
  5. Never 
  
 
17.  Do you sometimes ask someone  1. Never 
     (for example, spouse or friend)  2. Seldom  
     to help you remember when you  3. Sometimes 
     are going to start a trip? 4. Often 
  5. Always 
  
 
18.  Do you put things (for example,  1. Always 
      glasses or keys) in particular 2. Often 
      places to remember where they are  3. Sometimes 
      for future purposes? 4. Seldom 
  5. Never 
  
 
19.  Do you ask other people  1. Much more often 
     (for example, spouse or friend)  2. More often 
     to help you remember things more 3. No difference 
     or less often today compared  4. Less often 
     to 5 - 10 years ago?  5. Much less often 
  
 
20.  Do you try hard when you want to    1. Always 
     remember an important telephone   2. Often 
    number? 3. Sometimes 
  4. Seldom  
  5. Never 
  
 
21.  Do you put things in obvious 1. Never 
     places (for example, briefcase in   2. Seldom  
     front of the door) in order to  3. Sometimes 
     remember them when you're going out? 4. Often 
  5. Always 
  
 
22.  When you want to remember something 1. Always 
     from a T.V. program do you use 2. Often 
     "memory tricks" like grouping or 3. Sometimes 
     repeating to yourself? 4. Seldom  
  5. Never 
  
 
23.  Do you take your time to go through 1. Never 
     and reconstruct an event you want 2. Seldom 
     to remember?             3. Sometimes 
  4. Often 
  5. Always 
  
 
24.  Do you write down appointments  1. Always 
     (for example, with the hairdresser 2. Often 
     or the dentist) in a notebook 3. Sometimes 
     or calendar? 4. Seldom  
  5. Never 
  
 
 
25.  Before an important day do you  1. Never 
     think about or plan the things      2. Seldom  
     you have to do?     3. Sometimes 
  4. Often 
  5. Always 
  
 
26.  Do you spend a lot of time on  1. Always 
    " memory tricks" or other aids for 2. Often 
     memory in your daily life? 3. Sometimes 
  4. Seldom  
  5. Never 
  
 
27.  Do you note birthdays in a notebook 1. Never 
     or calendar in order to remember  2. Seldom  
    them? 3. Sometimes 
  4. Often 
  5. Always 
  
 
28.  Do you repeat telephone numbers 1. Always 
     to yourself in order to remember  2. Often 
     them well? 3. Sometimes 
  4. Seldom  
  5. Never 
  
 
29.  Do you spend more or less time   1. Much more time 
     learning important things today  2. More time 
     compared to 5 - 10 years ago (for  3. No difference 
        example, reading things more slowly 4. Less time 
    or reading them more than once)? 5. Much less time 
  
 
30.  Do you write down telephone numbers 1. Always 
     in a calendar or notebook in order  2. Often 
     to remember them?  3. Sometimes 
  4. Seldom  
  5. Never 
  
 
31.  When you want to remember the name 1. Never 
     of a person do you try to associate 2. Seldom           
  the name with the person's face? 3. Sometimes 
  4. Often 
  5. Always 
  
 
32.  Do you concentrate when you want to 1. Never 
     learn the name of a person you have 2. Seldom  
        just met? 3. Sometimes 
  4. Often 
  5. Always 
  
 
33.  When you want to remember something 1. Always 
     that happened in a particular day 2. Often 
     do you review and reconstruct the 3. Sometimes 
     events of that day in order to 4. Seldom 
    help you remember? 5. Never 
  
 
34.  Do you use such aids for memory as 1. Much less often 
     notebooks or putting things in 2. Less often 
     certain places more or less often  3. No difference 
     today compared to 5 - 10 years ago? 4. More often 
  5. Much more often 
  
 
35.  When you want to remember an event  1. Never 
    that took place when you were a  2. Seldom  
     child, is it important for you to 3. Sometimes 
    remember it as perfectly as 4. Often 
    possible? 5. Always 
  
 
36.  Do you use letters as cues (in  1. Never 
     other words, go through the alphabet) 2. Seldom  
    when you want to remember the name 3. Sometimes 
     of a person, a city, or something  4. Often 
    else? 5. Always 
  
 
 
37.  Do you put in effort when you want 1. Always 
     to remember the time of an important 2. Often 
     meeting? 3. Sometimes 
  4. Seldom  
  5. Never 
  
 
38. When you want to remember something 1. Always 
     do you try to relate it to  2. Often 
     something else you know well in  3. Sometimes 
     order to remember it better? 4. Seldom  
  5. Never 
  
 
39.  If you want to remember a funny  1. Always 
     story is it important to you to  2. Often 
     remember it perfectly? 3. Sometimes 
  4. Seldom  
  5. Never 
  
 
40.  Do you use mental images or pictures 1. Never 
     to remember some types of 2. Seldom  
     information? 3. Sometimes 
  4. Often 
  5. Always 
  
 
41.  Do you put in effort and concentrate 1. Much more often 
     to remember important things more or 2. More often 
     less often today compared to 5 - 10 3. No difference 
     years ago? 4. Less often 
  5. Much less often 
  
 
42.  Is it important for you to remember 1. Never 
     things perfectly (as verbatim as 2. Seldom  
     possible)? 3. Sometimes 
  4. Often 
  5. Always 
  
 
 
 
 
43.  Do you repeat important appointments 1. Always 
     to yourself in order to remember  2. Often 
     them as well as possible? 3. Sometimes 
     4. Seldom  
  5. Never 
  
 
44.  Is it more or less important to you  1. Much more       
to remember things perfectly today     important     
 compared to 5 – 10 years ago? 2. More important 
  3. No difference 
  4. Less important 
  5. Much less  
      important 
  
 
45.  Do you use memory tricks such as 1. Much less often 
     repeating things to yourself or 2. Less often 
     grouping things in categories 3. No difference 
    more or less often today compared 4. More often 
     to 5 - 10 years ago? 5. Much more often 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Coding For the Compensations Questionnaire 
 
Notes: 
• All of the questions for this questionnaire are coded in the same 
manner, regardless of the response choices for each question. 
• The is no scoring required for this questionnaire 
• Composite variables are created at a later date when they are required 
for analysis (the details are given later in this manual) 
• If the participant does NOT answer one of the questions, a value of “99" 
is entered for that variable 
• The value of “98" is not applicable for this task, since the participants 
should answer all of the questions 
• If a participant circles 2 responses, then enter “99" into the computer for 
that question. 
• If a participant circles 2 responses and then scribbles one of them out, 
then enter the response that has not been scribbles out for that 
question 
• If the participant has included handwritten comments beside a question, 
it may be possible to use the comments to determine an answer that 
was previously ambiguous (e.g. if the participant has circled 2 answers, 
but has made a comment that directs his or her answer towards a 
certain response).  In this case, it is important to check with the lab co-
ordinator(s) if you are unclear as to how to proceed 
• The coding method is as follows: 
 
1= 1 So, if a participant were to select response 
2= 2 ‘4,' (either “often” or “seldom”) then his or 
3= 3 her response would be entered as ‘4' in the 
4= 4 data 
  5= 5  
 
• Note: This coding method has changed from previous waves, where a 
response of ‘1' was coded as ‘0,' a response of ‘2' as ‘1,' etc. 
 
• A listing of the variable names for each question is given below 
 
 
id  particpant’s id 
  
c1 Do you use shopping lists when you go shopping? 
 
c2 Do you ask people to speak slowly when you want to remember what they 
are saying? 
 
c3 When you want to remember an important appointment do you ask 
somebody else (for example, spouse or friend) to remind you? 
c4 Do you put in a lot of effort when you want to remember an important 
conversation with a person? 
 
c5 When you want to remember a story do you read it more than once? 
 
c6 When you are reading a book, do you use a bookmark to indicate where 
you stopped reading last time? 
  
c7 Do you put in effort when you want to memorize a funny story? 
  
c8 When you want to remember a newspaper article is it important to you to 
remember it perfectly? 
 
c9 When an interesting T.V. program is going to be on in the next few days do 
you ask somebody else to help you remember (for example, spouse or 
friend)? 
 
c10 Do you concentrate a lot to learn something you really want to remember? 
   
c11 When you want to remember a newspaper article do you read it more 
slowly? 
 
c12 When you want to remember an event such as a birthday, do you ask 
somebody else (for example, spouse or friend) to help you remember? 
 
c13 Do you post notes on a board or other prominent place to help you 
remember things for the future (for example, meetings or dates)? 
 
c14 When you want to remember the name of a particular person, do you ask 
someone else (for example, spouse or friend) to help you remember? 
  
c15 When you are reading something that really interests you ( and that you 
want to remember) do you slow down your reading speed? 
  
c16 When you want to remember a conversation is it important to you to 
remember it perfectly? 
 
c17 Do you sometimes ask someone (for example, spouse or friend) to help 
you remember when you are going to start a trip? 
 
c18 Do you put things (for example, glasses or keys) in particular places to 
remember where they are for future purposes? 
  
c19 Do you ask other people (for example, spouse or friend) to help you 
remember things more or less often today compared to 5-10 yrs ago? 
 
c20 Do you try hard when you want to remember an important telephone 
number? 
 
c21 Do you put things in obvious places (for example, briefcase in front of the 
door) in order to remember them when you’re going out? 
 
c22 When you want to remember something from a T.V. program do you use  
“memory tricks” like grouping or repeating to yourself? 
   
C23 Do you take your time to go through and reconstruct an event you want to 
remember? 
  
c24 Do you write down appointments (for example, with the hairdresser or the 
dentist) in a notebook or calendar? 
 
c25 Before an important day-do you think about or plan the things you have to 
do? 
 
c26 Do you spend a lot of time on “memory tricks” or other aids for memory in 
your daily life? 
  
c27 Do you note birthdays in a notebook or calendar in order to remember 
them? 
 
c28 Do you repeat telephone numbers to yourself to remember them well? 
 
c29 Do you spend more or less time learning important things today compared 
to 5-10 yrs ago (for example, reading things more slowly or reading them 
more than once)? 
  
c30 Do you write down telephone numbers in a calender or notebook in order 
to remember them? 
  
c31 When you want to remember the name of a person do you try to associate 
the name with the person's face? 
  
c32 Do you concentrate when you want to learn the name of a person you have 
just met? 
 
c33 When you want to remember something that happened in a particular day 
do you review and reconstruct the events of that day in order to help you 
remember? 
  
c34 Do you use such aids for memory as notebooks or putting things in certain 
places more or less often today compared to 5-10 yrs ago? 
 
 
c35 When you want to remember an event that took place when you were a 
child, is it important for you to remember it as perfectly as possible? 
  
c36 Do you use letters as cues (in other words, go through the alphabet) when 
you want to remember the name of a person, a city, or something else? 
 
c37 Do you put in effort when you want to remember the time of an important 
meeting? 
  
c38 When you want to remember something do you try to relate it to something 
else you know well in order to remember it better? 
c39 If you want to remember a funny story is it important to you to remember it 
perfectly? 
  
c40 Do you use mental images or pictures to remember some types of 
information? 
 
c41 Do you put in effort and concentrate to remember important things more or 
less often today compared to 5-10 yrs ago? 
  
c42 Is it important for you to remember things perfectly (as verbatim as 
possible)? 
  
c43 Do you repeat important appointments to yourself in order to remember 
them as well as possible? 
 
c44 Is it more or less important to you to remember things perfectly today 
compared to 5-10 yrs. ago? 
 
c45 Do you use memory tricks such as repeating things to yourself or grouping 
things in categories more or less often today compared to 5-10 years ago? 
 
Compensation Composite Variables 
 
Notes: 
• The following pages contain a listing of the composite variables that are 
derived from the Compensation questionnaire for data analysis purposes. 
• The first part of this section names the raw data variables that need to be 
reverse-coded prior to the creation of the new composite variables. 
 
The following variables need to be reverse coded: 
 
c5, c6, c7, c9, c14, c15, c16, c18, c19, c20, c22, c24, c26, c28, c29, c30, c33, c37, 
c38, c39, c41, c43, c44 
 
Therefore, the variables will now be coded as follows: 
 
a choice of ‘1' will receive a code of ‘5,’ a choice of ‘2' will receive a code of ‘4,' etc. 
 
The new variable names are as follows: 
 
c5r, c6r, c7r, c9r, c14r, c15r, c16r, c18r, c19r, c20r, c22r, c24r, c26r, c28r, c29r, c30r, 
c33r, c37r, c38r, c39r, c41r, c43r, c44r 
 
Special Note: 
 
• The variables will have a suffix attached to them to reflect which wave of 
testing they are from.  For example, “mia1rw5' means that this variable 
was used for the data from the group of participants in sample 1 wave 5. 
 
• the suffixes may be changed to reflect each wave of testing 
 
The Compensation Questionnaire Composite Variables 
 
Composite Variable Name Variables in the Composite 
External (cqext) c1, c6r, c13, c18r, c21, c24r, c27, c30r 
Internal (cqint) c22r, c23, c25, c28r, c31, c33r, c36, c38r, c40, c43r 
Time (cqtime) c2, c5r, c11, c15r, c26r 
Relative (cqrel) c3, c9r, c12, c14r, c17  
Effort (cqeffo) c4, c7r, c10, c20r, c32, c37r 
Success (cqsuc) c8, c16r, c35, c39r, c42 
Change (cqchan) c19r, c29r, c34, c41r, c44r, c45 
 
 
COMPENSATION QUESTIONNAIRE: DATA ENTRY INSTRUCTIONS 
 
COMMENTS: The Compensation questionnaire is an indicator of how Participants 
use their memory. 
 
Instructions for Data entry: 
 
1. NO SCORING required for this task. 
 
2. Enter the response that has been circled by the Participant (ex. 1-5) into the 
correct column in the SPSS data file. 
 
3. “99" = NO RESPONSE given. 
 
4. “98" = is NOT APPLICABLE for this task because Participant is supposed to 
answer every question, except in the case where “NO RESPONSE” is given as 
mentioned above. 
 
5. If a Participant circles 2 responses, then enter “99" into the computer for that 
question. 
 
6. If a Participant circles 2 responses and then scribbles one of them out, then enter 
the response that has not been scribbled out for that question. 
 
7. DO NOT compute values (this will be done later by a data analyst). 
 
 
 
Special Note: In some cases, the Participant may have handwritten comments 
beside some of the questions in the questionnaires.  In the case where Participants 
have circled 2 responses or have circled one response and partly another (ex. they 
circled “a” and then started to circle “c” and stopped half-way), the Participants’ 
handwritten comments, in some cases, help determine which response the 
Participant may have intended to circle.  When dealing with scoring situations such 
as this, be sure to ask the Lab Co-ordinators what decision should be made if you are 
not clear. 
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APPENDIX 11: CAMPROMPT SCORE SHEET 
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APPENDIX 12: BRIEF-A 
 
Behavior Rating Inventory of Executive Function- Adult Version (BRIEF-A) Questionnaire
Participant Number: 
Date:
Gender:     Male          Female
Age:
Date of Birth:
Years of Education:
Level of education: Less than High School    
                                 High School
                                 College
                                 Master's Degree
                                 Doctorate
                                 Other
During the past month, how often has each of the following behaviors been a problem ?
N=Never           S=Sometimes              O=Often
1 I have angry outbursts N S O
2 I make careless errors when completing tasks N S O
3 I am disorganized N S O
4 I have trouble concentrating on tasks (such as chores, reading or work) N S O
5 I tap my fingers or bounce my legs N S O
6 I need to be reminded to begin a task even when I am willing N S O
7 I have a messy closet N S O
8 I have trouble changing from one activity or task to another N S O
9 I get overwhelmed by large tasks N S O
10 I forget my name N S O
11 I have trouble with jobs or tasks that have more than one step N S O
12 I overreact emotionally N S O
13 I don't notice when I cause others to feel bad or get mad until its too late N S O
14 I have trouble getting ready for the day N S O
15 I have trouble prioritizing activities N S O
16 I have trouble sitting still N S O
17 I forget what am I doing in the middle of things N S O
18 I don’t check my work for mistakes N S O
19 I have emotional outbursts for little reason N S O
20 I lie around the house a lot N S O
21 I start tasks (such as cooking, projects) without the right materials N S O
22 I have trouble accepting different ways to solve problems with work, friends, or tasks N S O
23 I talk at the wrong time N S O
24 I misjudge how difficult or easy tasks will be N S O
25 I have problems getting started on my own N S O
26 I have trouble staying on the same topic when I am talking N S O
27 I get tired N S O
28 I react more emotionally to situations than my friends N S O
29 I have problems waiting for my turn N S O
30 people say that I am disorganized N S O
31 I lose things (such as keys, money, wallet, homework, etc.) N S O
32 I have trouble thinking of a different way to solve a problem when I am stuck N S O
33 I overreact to small problems N S O
34 I don't plan ahead for future activities N S O
35 I have a short attention span N S O
36 I make inappropriate sexual comments N S O
37 when people seem upset with me, I don't understant why N S O
38 I have trouble counting to three N S O
39 I have unrealistic goals N S O
40 I leave the bathroom a mess N S O
41 I make careless mistakes N S O
42 I get emotionally upset easily N S O
43 I make decisions that get me into trouble (legally, financially, socially) N S O
44 I am bothered with having to deal with changes N S O
45 I have difficulty getting excited about things N S O
46 I forget instructions easily N S O
47 I have good ideas but I cannot get them on paper N S O
48 I make mistakes N S O
49 I have trouble getting started on tasks N S O
50 I say things without thinking N S O
51 my anger is intense but ends quickly N S O
52 I have trouble finishing tasks (such a s chores, work) N S O
53 I start things at the last minute (such as assignments,chores, tasks) N S O
54 I have difficulty finishing a task on my own N S O
55 people say that I am easily distracted N S O
56 I have trouble remembering things, even for a few minutes (such as directions, phone numbers) N S O
57 people say I am too emotional N S O
58 I rush through things N S O
59 I get annoyed N S O
60 I leave my room or home a mess N S O
61 I get disturbed by unexpected changes in my daily routine N S O
62 I have trouble coming up with ideas for what to do with my free time N S O
63 I don't plan ahead for tasks N S O
64 people say that I don't think before acting N S O
65 I have trouble finding things in my room, closet, or desk N S O
66 I have problems organizing activities N S O
67 after having a problem I don't get over it easily N S O
68 I have trouble doing more than one thing at a time N S O
69 my mood changes frequently N S O
70 I don't think about consequences before doing something N S O
71 I have trouble organizing work N S O
72 I get upset quickly or easily over little things N S O
73 I am impulsive N S O
74 I don't pick up after myself N S O
75 I have problems completing my work N S O
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Abstract
The impact of ecstasy/polydrug use on real-world memory (i.e. everyday memory, cognitive failures and prospective memory [PM]) was investigated in a
sample of 42 ecstasy/polydrug users and 31 non-ecstasy users. Laboratory-based PM tasks were administered along with self-reported measures of PM to
test whether any ecstasy/polydrug-related impairment on the different aspects of PM was present. Self-reported measures of everyday memory and
cognitive failures were also administered. Ecstasy/polydrug associated deficits were observed on both laboratory and self-reported measures of PM and
everyday memory. The present study extends previous research by demonstrating that deficits in PM are real and cannot be simply attributed to
self-misperceptions. The deficits observed reflect some general capacity underpinning both time- and event-based PM contexts and are not task
specific. Among this group of ecstasy/polydrug users recreational use of cocaine was also prominently associated with PM deficits. Further research
might explore the differential effects of individual illicit drugs on real-world memory.
Keywords
cannabis, cocaine, cognitive failures, ecstasy, everyday memory, prospective memory
Introduction
An important topic of investigation that has received increas-
ing attention in recent years concerns real-world memory pro-
cesses (i.e. everyday memory, prospective memory (PM) and
cognitive failures). Examples of everyday memory problems
and cognitive failures might include, for example, forgetting
the location of familiar objects around the house, forgetting
to take essential objects when leaving the home or oﬃce, fail-
ing to recognize acquaintances, or forgetting important events
that occurred the previous day. Prospective memory (PM)
involves remembering to execute a particular behaviour at
some point in the future, for example, remembering to
attend a meeting, meet a friend or pass on a message.
Previous investigations from our laboratory in which we eval-
uated the integrity of real-world memory processes in ecstasy/
polydrug (Montgomery and Fisk, 2007) and cannabis-only
users (Fisk and Montgomery, 2008) have shown that users
of illicit substances exhibit deﬁcits in real-world memory on a
range of measures. Evidence of ecstasy/polydrug- (Heﬀernan
et al., 2001a,b) and cannabis-related (McHale and Hunt,
2008) impairment has emerged in other studies.
Furthermore impairments may be speciﬁc to particular
drugs. For example, Rodgers and co-workers found that can-
nabis was related to short-term and internally cued PM def-
icits while ecstasy was related to deﬁcits in long-term PM
(Rodgers et al., 2001, 2003).
Most of the research into real-world memory functioning
among users of illicit substances has utilized self-reported
measures (Fisk and Montgomery, 2008; Heﬀernan et al.,
2001a,b; Montgomery and Fisk, 2007; Rodgers et al., 2001,
2003). However, it is possible that self-perceptions may be dis-
torted. For example, drug users may arrive at the laboratory
with the expectation that they will under-perform (Bedi and
Redman, 2008; Cole et al., 2006). This may aﬀect their
responses on self-reported measures causing them to imagine
or overstate the magnitude of any deﬁcits that might be pres-
ent. Clearly it would be desirable to conﬁrm the results
obtained through self-reported measures utilizing laboratory
measures of the relevant constructs. To date relatively few
studies in this area have used laboratory tests of PM. Where
such tests have been included they have been rather artiﬁcial
and contrived in nature. For example the ‘virtual week’ is a
board game completed in the laboratory in which the partici-
pant is required to complete previously learned tasks at speciﬁc
points as they progress around the board. Deﬁcits were
observed on this measure among currently abstinent ecstasy
users including those who used infrequently (Rendell et al.,
2007). While this test undoubtedly possesses a PM component
it has been acknowledged that more ecologically valid mea-
sures are needed (Will et al., 2009). In order to address some
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of these limitations, the present research will include labora-
tory measures of PM which are designed to be more natural-
istic and where the PM component is less obvious to the
participant.
Cognitive failures and PM are known to utilize prefrontal
executive processes including the working memory system.
Neuroimaging studies have revealed the involvement of the
frontopolar cortex (Brodmann area 10 [BA10]) and neigh-
bouring prefrontal areas during the performance of
PM tasks (Okuda et al., 2007). Other research utilizing
dual-task methodology (Marsh and Hicks, 1998) cognitive
ageing paradigms (McDaniel et al., 1999) and Parkinson’s-
related deﬁcits (Kliegel et al., 2005) has also linked PM func-
tioning to prefrontal lobe capacity. Therefore, if ecstasy or
other illicit drugs are associated with real-world memory def-
icits among currently abstinent users, then this would pro-
vide evidence consistent with a disruption of the
processes supported by these speciﬁc neural locations and in
particular BA10.
Prospective memory tasks may be deﬁned as either
event-based or time-based. For example, some predeﬁned
external event may trigger the retrieval of the intention to
act, or alternatively the trigger may be the elapse of a given
period of time. Self-reported measures do not adequately cap-
ture this distinction and thus while there is evidence of
self-reported ecstasy/polydrug-related deﬁcits in PM it is not
clear whether users exhibit deﬁcits on one or both types of
task. This is an important question since there is evidence to
suggest that the two classes utilize neural processes that are at
least in part separable. For example, Burgess et al. (2003) and
Gilbert et al. (2005) have shown that event-based tasks utilize
the frontopolar cortex, including BA10. More recently posi-
tron emission tomography (PET) scanning has revealed that
while the left superior frontal gyrus was involved in both
types of tasks, diﬀerent areas within this structure were
found to be activated. Furthermore, in addition to the fron-
topolar cortex, the time-based tasks also activated more
diverse regions including anterior medial frontal regions, the
right superior frontal gyrus and the anterior cingulate (Okuda
et al., 2007). Thus, if ecstasy/polydrug users are diﬀerentially
aﬀected on time- and event-based PM tasks then this would
provide further information on which speciﬁc neural loca-
tions are susceptible to speciﬁc drug-related eﬀects.
To address these issues laboratory-based and self-reported
measures of PM and real-world memory were administered.
Ecstasy/polydrug-related deﬁcits were predicted on all
measures.
Method
Participants
Forty-two ecstasy/polydrug users (14 males, 28 females) and
31 non-users (ﬁve males, 26 females) took part in this inves-
tigation. Participants were recruited via direct approach to
university students and the snowball technique, i.e.
word-of-mouth referral (Solowij et al., 1992). All participants
were university students attending Liverpool John Moores
University (LJMU) or the University of Central Lancashire
(UCLAN).
Materials
The prior history of illicit drug consumption was assessed
using a background drug-use questionnaire which has been
used extensively in previous research from our laboratory
(e.g., Montgomery et al., 2005b). These data were used to
estimate the total lifetime use for each drug (e.g. ecstasy,
cannabis, amphetamines, cocaine, etc). Period of abstinence
and frequency of use were also assessed. Fluid intelligence
was measured via Raven’s Progressive Matrices (Raven
et al., 1998) and the number of years of education, the par-
ticipant’s age and gender, and their current use of cigarettes
and alcohol were assessed.
Self-reported measures of real-world memory
Everyday memory: The Everyday Memory Questionnaire
(EMQ) (Cornish, 2000; Sunderland et al., 1983) is a
self-reported measure of memory lapses in everyday activities.
The measure consists of 27 statements with responses made
on a nine-point scale ranging from ‘not at all in the last six
months’ to ‘more than once a day’. Examples of statements
include: ‘forgetting where you put something’; ‘ﬁnding a tele-
vision story diﬃcult to follow’. A total score is calculated by
summing the responses to all items.
Cognitive failures: The Cognitive Failures Questionnaire
(CFQ) (Broadbent et al., 1982) is a 25-item measure of every-
day attentional deﬁcits. Questions include ‘Do you fail to
notice signposts on the road?’ and ‘Do you forget what you
came to the shops to buy?’. Responses are made on a
ﬁve-point scale with zero corresponding to ‘never’ and four
to ‘very often’ yielding a maximum possible score of 100.
Prospective Memory Questionnaire: The Prospective
Memory Questionnaire (PMQ) (Hannon et al., 1995) is a
self-reported measure indicating the likelihood of a memory
lapse in given time period. The PMQ provides measures of
three aspects of PM on a scale of 1–9 for each aspect (1
revealing little forgetting, 9 revealing a great deal of forget-
ting). Fourteen questions measure short-term habitual PM,
e.g. ‘I forgot to turn my alarm clock oﬀ when I got up this
morning’. Fourteen items measure long-term episodic PM,
e.g. ‘I forgot to pass on a message to someone’. Ten questions
measure internally cued PM, e.g. ‘I forgot what I wanted to
say in the middle of a sentence’. In addition, 14 questions
make up the ‘techniques to remember’ scale, which provides
a measure of the number of strategies used to aid remember-
ing. For each of the four scales, an average score is calculated
by summing the responses and dividing by the number of
items in that section (14 for ST-habitual, LT episodic and
strategies and 10 for internally cued). Thus, higher scores
are indicative of more forgetting and many strategies used
to aid remembering.
The Prospective and Retrospective Memory Questionnaire
(PRMQ): The Prospective and Retrospective Memory
Questionnaire (PRMQ) (Crawford et al., 2003) provides a
measure of memory slips of this kind in everyday life. It con-
sists of 16 items, eight related to PM failures, e.g. ‘Do you
decide to do something in a few minutes’ time and then forget
to do it?’. Participants were asked to say how often these
things happened to them on a ﬁve-point scale, very often,
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quite often, sometimes, rarely, never, resulting in minimum
and maximum possible scores of eight and 40.
The reliability and validity of the CFQ, EMQ and PMQ
have been documented previously (see, for example, Hannon
et al., 1995; Royle and Lincoln, 2008; Wallace, 2004).
Laboratory measures of prospective memory
Prospective memory pattern recognition test: This test is
based on a processing speed task (see, e.g., Fisk and Warr,
1996) which was amended so as to provide a laboratory-based
measure of PM by the addition of a parallel PM element. In
the pattern comparison speed task, participants indicated as
quickly as possible whether two patterns appearing on the
computer screen were the same or diﬀerent by pressing
respectively the ‘/’ key or the ‘Z’ key on the keyboard.
After each 30-second period the patterns increased in com-
plexity and for each level of complexity the computer kept a
record of the number of correct responses. The PM element of
this test required the participant to remember to press the ‘F1’
key at the end of each 30-second period when the message
‘please wait a moment’ appeared. Participants were told that
this was in order to save their scores on the task. Failure to
press F1 resulted in the score for that segment being reported
as an ‘error’ in the screen display at the end of the task. This
task was repeated three times. The number of times the par-
ticipant forgot to press F1 for each trial was calculated pro-
ducing a laboratory event-based PM measure.
Prospective memory fatigue test: At the beginning of the
test session, participants were told that they should provide
an indication of their level of fatigue (using the Karolinska
Sleepiness Scale; see Gillberg et al., 1994) every 20 minutes
throughout the experiment. If the 20-minute period elapsed
during the completion of a task, participants were asked to
complete the fatigue measure immediately after. The percent-
age of occasions on which the participant remembered to
complete the Karolinska sleepiness scale was calculated.
This was done for the ﬁrst and second half of the test session
thereby producing two measures of medium-term time-based
PM. On each occasion, participants who forgot were
reminded to ﬁll in the questionnaire.
Long-term recall prospective memory: A list of 15 words
was presented ﬁve times, orally, using an audio recording
device. At the end of each trial the participant had to write
down as many words as they could recall from the list. No
time constraint was imposed in this regard. A long-term PM
element was added to the recall test. Participants had to
remember to return an answer sheet to the experimenter
with the words that they were able to recall after a delay of
1, 2 and 3 weeks from the time of testing. Three prepaid
envelopes were provided for this purpose. Participants
scored 1 if the envelope was returned and 0 otherwise.
This data was collected separately for each week but the
score was the total number of sheets returned (out of a max-
imum of three).
These laboratory tasks were based on similar
paradigms devised by Mathias and Mansﬁeld (2005) and
Einstein et al. (1995).
Rivermead Behavioural Memory Test (RBMT-II): A full
description of the RBMT-II may be found elsewhere
(Wilson et al., 1999). In the present study only the three sub-
tasks relating to PM were used:
(1) Remembering a hidden belonging. A small object (a pen or
pencil in this study) was requested from the participant
and placed in a speciﬁed location. The participant was
told to remember to retrieve the belonging later doing
so when the examiner said the words: ‘We have now ﬁn-
ished this test’. Participants received a score of two if the
belonging and location was recalled correctly, one if after
a prompt and zero if neither object nor location was
remembered.
(2) Remembering an appointment. A timer was set for 20 min-
utes. The participant was told that when the alarm clock
rang they should ask a pre-arranged question (e.g., ‘What
time does this session end’). A proﬁle score of two is given
if the question is recalled correctly, one if after a prompt
or zero if it is not recalled at all.
(3) Delivering a message. Having ﬁrst observed the experi-
menter, the participant was required to replicate a short
route around the test room depositing a message at a
speciﬁed location on the way. This was done immediately
and after a delay and a single score was awarded ranging
from zero to three depending on the number of errors
made over the two attempts.
Procedure
Participants were informed of the general purpose of
the experiment and their right to withdraw any time.
After consent had been obtained the tests were administered
under laboratory conditions. The drug-use questionnaire
was administered ﬁrst followed by the Ravens intelligence
test, the age/education questionnaire, and the PM question-
naires (Crawford et al., 2003; Hannon et al., 1995). Next
the PM pattern recognition task, the recall PM task and
the RBMT-II tasks were administered. The fatigue PM
task was administered throughout the session. Participants
were fully debriefed, paid 20 in Tesco store vouchers
and given drug education leaﬂets. The University of
Central Lancashire’s Ethics Committee approved the study.
Results
Demographic and background variables
Inspection of Table 1 reveals that the ecstasy/polydrug users
did not diﬀer from non-ecstasy users on most of the demo-
graphic and background drug use variables. Ecstasy/polydrug
users consumed signiﬁcantly more units of alcohol per week
compared with non-ecstasy users. Although the number of
cigarettes consumed per day by smokers did not diﬀer signif-
icantly between the groups, tobacco use was more prevalent
among ecstasy/polydrug users with over one-half of the group
currently smoking while less than one-third of non-ecstasy
users currently smoked cigarettes.
With regard to illicit drug use, a majority of the ecstasy/
polydrug group had in the past or were currently consuming
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cocaine and almost all were cannabis users. Around 40% of
the group were also amphetamine uses. However, the corre-
lation between estimated lifetime use of ecstasy and cannabis,
r¼ 0.041 (p> 0.05, n¼ 39), was not statistically signiﬁcant
while that between lifetime ecstasy and cocaine use
approached signiﬁcance, r¼ 0.332 (p¼ 0.084, n¼ 28).
Estimated lifetime use of cocaine and cannabis was also
not signiﬁcantly related r¼ 0.172 (p> 0.05, n¼ 29). Among
non-ecstasy users the use of illicit drugs was largely
conﬁned to cannabis, although three of the group had also
used cocaine. Given the limited use of cocaine and amphet-
amine among non-ecstasy users it was not meaningful to sta-
tistically analyse group diﬀerences in these substances.
However, ecstasy/polydrug users had signiﬁcantly greater
total lifetime exposure to cannabis compared with
non-ecstasy users.
Laboratory-based prospective memory measures
With regards to the laboratory measures of PM, examination
of Table 2 reveals that ecstasy/polydrug users were impaired
on all but two of the measures. With regard to the time-based
tasks, remembering to complete the fatigue task proved prob-
lematic for ecstasy/polydrug users especially during the
second half of the test session. Overall the completion rate
among ecstasy users was only 51% of that achieved by
non-users. From a longer-term perspective during the three
weeks following testing non-users posted back 77% more
delayed recall response sheets compared with users.
However, on the time-based RMBT-II appointment task,
group diﬀerences were less evident.
With regard to the event-based tasks, although ecstasy/
polydrug users and non-ecstasy users performed similarly
on the RMBT-II message task, ecstasy users performed
worse on the RMBT-II belonging task. Similarly users were
between two and three times more likely to forget to press the
‘F1’ key during the processing speed task.
Multivariate analysis of variance (MANOVA) with the
seven laboratory measures of PM as dependent variables
and ecstasy/polydrug user group between participants
revealed a statistically signiﬁcant eﬀect of group, ¼ 0.598,
F(7,65)¼ 6.25, p< 0.001, partial g2¼ 0.402. As can be seen
in Table 2, univariate analyses revealed that all but two of
the individual measures yielded statistically signiﬁcant group
diﬀerences with ecstasy/polydrug users consistently perform-
ing worse than non-ecstasy users. Following the inclusion of
covariates relating to lifetime cannabis use (joints) and fre-
quency of cannabis use (times per week), the multivariate
group eﬀect remained statistically signiﬁcant, ¼ 0.671,
F(7,62)¼ 4.34, p< 0.001, partial g2¼ 0.329. Following
the inclusion of two further covariates relating to alcohol
consumption (units per week) and tobacco use (cigarettes
per day), again the multivariate group eﬀect was signiﬁ-
cant, ¼ 0.712, F(7,58)¼ 3.34, p< 0.01, partial g2¼ 0.288.
Table 1. Demographical and background drug use variables for users and non-users
Ecstasy/polydrug users Non-ecstasy users
Mean SD n Mean SD n p-value
Age (years) 21.67 3.61 42 21.03 3.25 31 ns
Ravens Progressive Matrices (maximum 60) 43.32 10.90 42 44.87 7.57 31 ns
Years of Education 15.05 3.15 42 15.63 1.57 31 ns
Cigarettes per day 9.45 8.60 22 6.33 6.65 9 ns
Alcohol (Units per week) 14.85 10.11 41 7.17 8.28 30 <0.01
Total Use
Ecstasy (Tablets) 668.88 1234.67 42 – – – –
Amphetamine (grams) 196.00 254.78 13 – – – –
Cannabis (joints) 3259.49 4571.12 39 243.00 323.14 10 <0.001
Cocaine (lines) 1270.71 1762.69 28 255.00 343.65 2 –
Frequency of Use (times per week)
Ecstasy 0.25 0.32 42 – – – –
Amphetamine 0.10 0.27 14 – – – –
Cannabis 1.02 1.79 39 0.85 1.59 10 ns
Cocaine 0.41 0.51 27 0.54 0.65 2 –
Weeks Since Last Usea
Ecstasy 4 26 42 – – – –
Amphetamine 46 254 16 – – – –
Cannabis 2 23 39 18 154 10 ns
Cocaine 4 18.5 32 8 5 3 –
Number Ever Used
Amphetamine 17 0
Cannabis 40 10
Cocaine 33 3
Ecstasy 42 0
aFor weeks since last use, median and inter-quartile range are reported.
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Thus, the inclusion of the four covariates reduced the ecstasy/
polydrug user group eﬀect size by 28%. However, none of the
covariates were statistically signiﬁcant as predictors of the
dependent variables, F< 1.20, for the multivariate eﬀect, in
all cases. Inspection of Table 2 reveals that in univariate terms
four of the seven dependent variables produced statistically
signiﬁcant group diﬀerences following inclusion of the covari-
ates. Thus, with regard to the laboratory measures, ecstasy/
polydrug users remained impaired relative to non-ecstasy
users even following the inclusion of the covariates. This sug-
gests that the deﬁcits among this group are more likely to be
attributable to ecstasy.
Self-reported real-world memory measures
Outcomes for the self-reported measures of real-world
memory may be found in Table 2. With just one exception,
it is clear that ecstasy/polydrug users exhibit higher scores on
all of the measures consistent with a greater incidence of
real-world memory problems. MANOVA with the seven
self-reported measures of real-world memory as dependent
variables and ecstasy user group between participants
revealed a statistically signiﬁcant eﬀect of group, ¼ 0.756,
F(7,58)¼ 2.68, p< 0.05, partial g2¼ 0.244. Inspection of
Table 2 reveals that in terms of the univariate analyses, the
diﬀerence between the two groups was statistically signiﬁcant
for four of the seven dependent variables. The inclusion of the
two measures of cannabis use as covariates reduced the multi-
variate eﬀect to borderline signiﬁcance, ¼ 0.786,
F(7,56)¼ 2.18, p¼ 0.05, partial g2¼ 0.214. Furthermore
when all four covariates were included (the two measures of
cannabis use plus the tobacco and alcohol use indicators) the
multivariate eﬀect was no longer statistically signiﬁcant
¼ 0.826, F(7,52)¼ 1.57, p> 0.05, partial g2¼ 0.174 and
inspection of Table 2 reveals that only one of the univariate
analyses continued to yield a statistically signiﬁcant group
diﬀerence: the everyday memory measure. In multivariate
terms, two of the four covariates produced a statistically sig-
niﬁcant eﬀect on the self-reported real-world memory mea-
sures, total cannabis use, ¼ 0.769, F(7,52)¼ 2.23, p< 0.05,
partial g2¼ 0.231; and tobacco use ¼ 0.723, F(7,52)¼ 2.84,
p< 0.05, partial g2¼ 0.277.
Relationship between period of abstinence and
memory
It is possible that some of the drug-related deﬁcits observed in
the real-world memory measures may have been due to
short-term post-intoxication eﬀects. For the four main illicit
drugs, Table 3 contains the correlations between weeks since
last use and each of the real-world memory measures.
Inspection of Table 3 reveals that for the most part the cor-
relations not were statistically signiﬁcant. With regard to the
cognitive failures measure, although no ecstasy/polydrug
eﬀect was evident in Table 2, it is clear that performance on
the task is correlated with the period of abstinence speciﬁcally
in relation to ecstasy. Those abstaining for a longer period
self-reported fewer cognitive failures.
Table 2. Scores on laboratory and self-reported measures of real-world memory for users and non-users
Ecstasy/polydrug users Non-ecstasy users
p p
Mean SD Mean SD p-value
Covariates:
cannabis
use
Covariates:
cannabis smoking,
and alcohol use
LABORATORY MEASURES
RBMT-II
Appointment 1.55 0.77 1.65 0.61 ns ns ns
Belonging 1.19 0.77 1.65 0.62 <0.01 <0.05 <0.05
Message 1.83 0.50 1.87 0.50 ns ns ns
Fatigue PM Task (% recalled)
First half of test session 50.44 36.04 72.20 25.57 <0.01 <0.01 <0.05
Second half of test session 9.48 16.26 44.62 39.52 <0.001 <0.001 <0.001
Processing Speed PM Task Errors 1.64 2.55 0.61 1.23 <0.05 <0.05 <0.05
Long-term Recall PM Task (max 3) 0.95 1.32 1.68 1.30 <0.05 ns ns
SELF-REPORTED MEASURES
Everyday Memory 94.51 36.13 79.42 31.77 <0.05 <0.05 <0.05
Prospective Memory
(Hannon et al., 1995)
Short Term 1.53 0.72 1.27 0.38 <0.05 <0.05 ns
Long Term 2.81 1.00 2.47 0.88 ns ns ns
Internally Cued 2.62 0.96 2.39 0.95 ns ns ns
Techniques to Remember 2.74 1.10 3.32 1.58 <0.05 ns ns
Cognitive Failures 43.40 14.20 40.00 12.71 ns ns ns
Prospective Memory
(Crawford et al., 2003)
22.63 4.96 20.56 5.52 <.05 <.05 Ns
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Relationship between aspects of drug use and the
memory measures
Table 4 contains the simple Pearson’s correlation coeﬃcients
between the laboratory and self-reported measures of
real-world memory on the one hand and lifetime use and
frequency of use of the four main illicit drugs on the other
(for non-users of a particular drug, lifetime and frequency of
use have been coded as zero). Only those correlations that
were statistically signiﬁcant at p< 0.05 one-tailed are dis-
played. Examination of Table 4 reveals that total lifetime
use of both ecstasy and cocaine are related to several of the
laboratory measures indicating that as the level use increases,
the real-world memory deﬁcits increase in magnitude. With
regard to frequency of use, cocaine is signiﬁcantly correlated
with ﬁve of the seven laboratory measures of real-world
memory while the frequency of ecstasy use is signiﬁcantly
correlated with just three. In all cases increased frequency
of use is associated with a greater degree of memory impair-
ment. While the deﬁning characteristic of the polydrug group
is ecstasy use, clearly it appears that cocaine is also implicated
in the real-world memory deﬁcits identiﬁed here.
With regards to the self-reported measures of real-world
memory, correlations with lifetime use are generally larger in
absolute magnitude for ecstasy compared with cocaine.
Similarly, in relation to frequency of use, while ecstasy
yields signiﬁcant correlations for three of the real-world
memory measures, only one is statistically signiﬁcant in rela-
tion to cocaine use. For all of the statistically signiﬁcant cor-
relations, increased use is associated with higher scores on the
self-reported measures consistent with more real-world
memory problems.
While it would have been potentially informative to con-
duct regression analyses with the measures of lifetime use and
frequency of use for each drug as predictors and the measures
of real-world memory as dependent variables, this was not
possible. The sample size was inadequate given the number
of predictors and the predictors were substantially intercorre-
lated reﬂecting the degree of polysubstance abuse within the
ecstasy/polydrug group. Indeed all but two of the predictors
possessed tolerances of less than 0.5 rendering testing and
interpretation of the regression coeﬃcients problematic
(Tabachnick and Fidell, 2001).
However, while the standardized regression coeﬃcients are
not especially informative in the present context, a compari-
son of the simple correlation and semi-partial correlation
coeﬃcients does provide an indication of which variables
share statistically signiﬁcant unique variance with the
real-world memory measures. Thus, where the simple correla-
tions were statistically signiﬁcant the semi-partial correlation
between that drug-use measure and the real-world memory
performance was computed controlling for the use of the
other drugs on the measure in question. Thus, in relation to
the RBMT-II belonging measure lifetime and frequency of
cocaine use appear to be important determinants. For the
RBMT-II message measure the frequency of cannabis use,
and for the long-term recall PM task the frequency of both
cocaine and cannabis use account for statistically signiﬁcant
unique variance. Of the self-reported measures lifetime
ecstasy use is signiﬁcantly associated with unique variance
in the short-term and internally cued Hannon et al. (1995)
PM measures and frequency of ecstasy use with the cognitive
failures measure. The frequency of cannabis use shares unique
variance with the short-term PM measure.
Table 3. Correlations between real-world memory measures and duration of abstinence for the major illicit drugs
Weeks since last use
Ecstasy Cannabis Cocaine Amphetamine
LABORATORY MEASURES
RBMT-II
Appointment 0.089 0.025 0.001 0.526*
Belonging 0.137 0.082 0.030 0.078
Message 0.001 0.175 0.066 0.212
Fatigue PM Task (% recalled)
First half of test session 0.336* 0.281 0.248 0.405
Second half of test session 0.113 0.124 0.128 0.192
Processing Speed PM Task Errors 0.037 0.182 0.029 0.174
Long-term Recall PM Task (max 3) 0.174 0.025 0.074 0.011
SELF-REPORTED MEASURES
Everyday Memory 0.028 0.048 0.126 0.243
Prospective Memory (Hannon et al., 1995)
Short Term 0.119 0.043 0.165 0.210
Long Term 0.034 0.023 0.033 0.154
Internally Cued 0.044 0.155 0.027 0.043
Techniques to Remember 0.024 0.110 0.084 0.218
Cognitive Failures 0.556*** 0.147 0.070 0.305
Prospective Memory (Crawford et al., 2003) 0.151 0.113 0.026 0.119
***p< 0.001; *p< 0.05 one-tailed.
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Semi-partial correlation is a conservative procedure in
which the pooled variance between the real-world memory
measure and two or more of the drug-use variables is
excluded. For a number of the real-world memory measures
some of the simple correlations with drug use were statisti-
cally signiﬁcant while none of the semi-partial correlations
proved to be so. Thus, in these cases there is a signiﬁcant
drug-related eﬀect but it is not possible to identify which
drug was likely to be primarily responsible. For example,
with respect to processing speed task PM errors, total use
of ecstasy yields a correlation of 0.284, which implies that
the shared variance between the two measures was over
8%. However following control for total use of the other
drugs, the semi-partial correlation was reduced to 0.177,
implying that total ecstasy use shared just over 3% of the
variance with the processing speed task PM errors measure
after the overlapping eﬀects of the other drugs were elimi-
nated. The equivalent ﬁgures for total use of cocaine were
8% and 2%. Thus, in this case, while there is evidence of
potential cocaine and ecstasy-related eﬀects, similar patterns
of use for these two drugs in those persons exhibiting diﬀerent
degrees of PM deﬁcits make it impossible to identify which
drug may be associated with outcomes on this PM measure.
Inter-correlations between the prospective memory and
real-world memory measures
Ignoring for the moment drug-related diﬀerences, it would be
reasonable to expect that the laboratory measures of PM
would be correlated with each other. However, the correla-
tions would not be expected to be perfect since each task
would have performance aspects speciﬁc to it. Furthermore,
the separate tasks reﬂect diﬀerent aspects of PM functioning
such as event-based versus time-based tasks and in the latter
case PM deﬁcits may be reﬂected with respect to both
short-term and longer-term phenomena. Inspection of
Table 5 reveals that with the exception of the long-term
Table 4. Correlations between real-world memory measures and lifetime use and frequency of use for the major illicit drugs
Lifetime Use Frequency
Real-world Memory Measure Drug Simple Semi Partial Simple Semi Partial
Laboratory Measures
RBMT-II
Appointment Cocaine 0.258* 0.288* 0.265* 0.210y
Belonging Ecstasy 0.300** 0.106
Cannabis 0.233* 0.052
Cocaine 0.408*** 0.238* 0.482*** 0.440***
Message Cannabis 0.264* 0.273*
Fatigue PM Task (% recalled)
First half of test session Ecstasy 0.238* 0.163y
Cannabis 0.203* 0.124 0.247* 0.203y
Cocaine 0.204* 0.072 0.244* 0.101
Second half of test session Ecstasy 0.231* 0.118 0.267* 0.167y
Cannabis 0.254* 0.178y
Cocaine 0.213* 0.033
Processing Speed PM Task Errors Ecstasy 0.284* 0.177y 0.227* 0.143
Cocaine 0.283* 0.146 0.277* 0.154
Long-term Recall PM Task (max 3) Cannabis 0.276* 0.173y 0.260* 0.207*
Cocaine 0.254* 0.161 0.330** 0.271*
Self-Reported Measures
Everyday Memory
Prospective Memory (Hannon et al., 1995)
Short Term Ecstasy 0.304** 0.279*
Cannabis 0.265* 0.218*
Long Term
Internally Cued Ecstasy 0.377** 0.361** 0.271* 0.181y
Amphetamine 0.249* 0.127
Techniques to Remember
Cognitive Failures Ecstasy 0.292* 0.212y 0.350** 0.251*
Cocaine 0.237* 0.027
Cannabis 0.251* 0.038
Prospective Memory (Crawford et al., 2003) Ecstasy 0.330** 0.188y 0.253* 0.100
Cocaine 0.249* 0.097
Amphetamine 0.229* 0.183y
***p< 0.001; **p< 0.01; *p< 0.05; yp< 0.10; one-tailed.
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recall task, where two of the outcomes only approached sig-
niﬁcance, the remaining laboratory tasks did reveal a number
of statistically signiﬁcant inter-correlations. Furthermore, for
each of the laboratory tasks performance was correlated with
the scores obtained on one or more of the self-reported mea-
sures. Finally, not surprisingly, Table 6 reveals that the out-
comes for the self-reported measures were also correlated
with each other.
Discussion
In multivariate terms ecstasy/polydrug users were found to be
impaired on the laboratory-based PM measures. The
group-related eﬀect remained statistically signiﬁcant follow-
ing controls for lifetime and frequency of cannabis use and
current use of tobacco and alcohol. In terms of the individual
laboratory measures, ecstasy/polydrug users exhibited poorer
performance in all cases. These deﬁcits were statistically sig-
niﬁcant on all but two of the measures (the two exceptions
were the RBMT appointment and message subscales) and
remained statistically signiﬁcant in four of the seven measures
following controls for cannabis, alcohol and tobacco use. In
demonstrating that ecstasy/polydrug users were impaired on a
variety of PM tasks the present study extends previous
research in which ecstasy users have been found to exhibit
impairment on a range of cognitive tasks, for example, selec-
tive deﬁcits have been observed in aspects of verbal and
visuospatial executive functioning, on the Tower of Hanoi,
and Tower of London tasks, as well as on the Stroop measure
(for a review, see Murphy et al., 2009). Ecstasy users have also
exhibited performance decrements in aspects of deductive rea-
soning (Fisk et al., 2005).
Table 5. Inter-correlations between the laboratory and self-reported measures of real-world memory
RBMT-II Fatigue PM Task
Processing
Speed PM Task
Long-term
Recall PM Task
Appointment Belonging Message First Half Second Half
LABORATORY MEASURES
RBMT-II
Appointment
Belonging 0.334**
Message 0.021 0.200*
Fatigue PM Task (% recalled)
First half of test session 0.238* 0.291** 0.056
Second half of test session 0.266* 0.263* 0.122 0.425***
Processing Speed PM Task Errors 0.220* 0.270* 0.049 0.206* 0.185y
Long-term Recall PM Task (max 3) 0.026 0.190y 0.060 0.073 0.028 0.182y
SELF-REPORTED MEASURES
Everyday Memory 0.018 0.041 0.140 0.063 0.141 0.033 0.094
Prospective Memory (Hannon et al., 1995)
Short Term 0.096 0.128 0.003 0.230* 0.120 0.392*** 0.135
Long Term 0.069 0.155 0.139 0.053 0.312** 0.006 0.096
Internally Cued 0.021 0.037 0.014 0.077 0.175y 0.024 0.046
Techniques to Remember 0.041 0.072 0.048 0.024 0.002 0.035 0.241*
Cognitive Failures 0.174y 0.161y 0.007 0.223* 0.323** 0.108 0.044
Prospective Memory (Crawford et al., 2003) 0.279** 0.190y 0.003 0.201* 0.281** 0.008 0.048
***p< .001; **p< .01; *p< .05; yp< .10; one-tailed.
Table 6. Inter-correlations between the self-reported measures of real-world memory
Everyday
Prospective Memory
Cognitive
Memory Short Term Long Term Internally Cued Techniques Failures
SELF-REPORTED MEASURES
Everyday Memory
Prospective Memory (Hannon et al., 1995)
Short Term 0.049
Long Term 0.442*** 0.246*
Internally Cued 0.455*** 0.379*** 0.507***
Techniques to Remember 0.254* 0.211* 0.366** 0.577***
Cognitive Failures 0.477*** 0.280** 0.357** 0.513*** 0.289**
Prospective Memory (Crawford et al., 2003) 0.615*** 0.145 0.412*** 0.521*** 0.328** 0.707***
***p< 0.001; **p< 0.01; *p< 0.05; one-tailed.
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Returning to the ﬁndings of the present study, with regard
to the RBMT-II, only the belonging sub-scale yielded statis-
tically signiﬁcant group diﬀerences. To the best of our knowl-
edge the present study is the ﬁrst to demonstrate a deﬁcit on
the RBMT belonging scale (ecstasy users scored lower on this
scale in Zakzanis et al.’s (2003) study, however the diﬀerence
was not statistically signiﬁcant). There have been few studies
investigating ecstasy-related deﬁcits on the RBMT PM mea-
sures. Zakzanis et al. (2003) observed ecstasy-related deﬁcits
on the ‘appointment’ and ‘message’ PM RBMT component
measures while neither of these yielded statistically signiﬁcant
diﬀerences in the present study. It is possible that the deﬁcits
observed by Zakzanis et al. (2003) might have been due to
confounding factors. For example, their ecstasy users scored
signiﬁcantly lower on the WAIS-III vocabulary sub-test com-
pared with the control group.
The three remaining laboratory-based tasks, i.e. the fati-
gue PM task (remembering to periodically complete the fati-
gue measure during the test session), the processing speed PM
task (remembering to press ‘F1’ to store the participant’s
scores), and the long-term recall PM task (remembering to
mail the delayed recall test in the successive weeks following
the test session) all yielded consistent ecstasy/
polydrug-related deﬁcits which for the most part remained
statistically signiﬁcant following the inclusion of the covari-
ates. Furthermore, deﬁcits were evident on both time-based
(fatigue PM task) and event-based PM tasks (RBMT-II
belonging; processing speed PM task) which suggests that
the ecstasy/polydrug deﬁcit reﬂects some general feature of
PM task performance rather than more task-speciﬁc aspects.
Thus, it appears that some aspects of ecstasy use or some
other characteristic of the ecstasy-using group gives rise to
PM deﬁcits independent of any eﬀects which might be attrib-
utable to cannabis use. This is consistent with the results of
those studies which have used self-reported measures and
have found ecstasy-related deﬁcits, for example, those from
our own laboratory (Montgomery and Fisk, 2007) and else-
where (Heﬀernan et al., 2001a,b; Rodgers et al., 2001, 2003).
The present results suggest that these deﬁcits are likely to be
real rather than imagined and are evident in both time- and
event-based PM contexts. Ecstasy-related deﬁcits were also
evident on both short-term (fatigue) and long-term (weekly
word recall) PM tasks although in the latter case the deﬁcit
was no longer signiﬁcant following controls for group diﬀer-
ences in cannabis use. These results are perhaps somewhat at
odds with those reported by Rodgers et al. (2001, 2003) who
found that, on the basis of self-reports, ecstasy use was asso-
ciated with long-term deﬁcits while cannabis use was asso-
ciated with short-term. While the present study is among
the ﬁrst to use a range of laboratory-based and naturalistic
PM measures, previous research using the ‘virtual week’ par-
adigm did reveal ecstasy-related deﬁcits with users performing
worse than non-users on time- and event-based PM compo-
nents of the task. Furthermore, the deﬁcits were present in
both frequent and infrequent users (Rendell et al., 2007). In a
subsequent study, methamphetamine users also exhibited def-
icits on this task (Rendell et al., 2009). As noted above the
‘virtual week’ is a board game conducted in the laboratory in
which the participant is required to complete previously
learned tasks at speciﬁc points as they progress around the
board. While this test has its merits, before the PM element
can be completed it is necessary to learn each of the particular
responses that is paired with speciﬁc locations on the board.
Thus, the test has a substantial associative learning compo-
nent. Montgomery et al. (2005a) have demonstrated that
ecstasy users are impaired on paired associative learning
and so it is possible that the deﬁcits evident on the virtual
week might be attributable to this aspect rather than the PM
components. In the present study, the retrospective memory
element was minimal and little learning was necessary. Thus,
the PM deﬁcits observed here are less likely to be due to
associative learning problems.
While it is noteworthy that the ecstasy/polydrug group
diﬀerences remained statistically signiﬁcant following the
inclusion of the cannabis use measures as covariates there
are indications that cannabis use may be negatively associated
with PM. For example the frequency of cannabis use
accounted for unique variance in the long-term recall PM
task with more frequent users returning fewer recall answer
sheets in the weeks following testing. Furthermore, while
there was no ecstasy/polydrug-related diﬀerence on the
RBMT message score, the frequency of cannabis use again
was associated with unique variance on this task with more
frequent users achieving lower scores. Furthermore the can-
nabis use measures were signiﬁcantly correlated with a
number of the other laboratory PM tasks with greater lifetime
exposure and increased frequency of use associated with
poorer PM performance. However, in these cases the eﬀects
were reduced to below statistical signiﬁcance when the shared
variance with the other drug use measures was excluded.
Among ecstasy/polydrug users there was clear evidence that
cocaine use was associated with adverse outcomes on a number
of the laboratory tests of PM. As far as the authors are aware
the present study is the ﬁrst to link recreational use of cocaine
with PM deﬁcits. Either lifetime, or frequency of use, or both,
were associated with performance on all but one of the labo-
ratory measures of PM and one or other of these aspects of
use were found to share unique variance with three of the
PM laboratory measures. As noted above PM performance
is dependent on pre-frontal executive resources. Of particular
relevance to the present paper, a number of studies have shown
that event-based PM tasks utilize the frontopolar cortex, i.e.
BA10 (Burgess et al., 2003; Gilbert et al., 2005) and the left
superior frontal gyrus (Okuda et al., 2007). Similarly while
time-based PM tasks activated more diverse regions including
anterior medial frontal regions, the right superior frontal gyrus
and the anterior cingulate, they also utilized BA10 and the
superior frontal gyrus (Okuda et al., 2007). Thus, the
cocaine-related deﬁcits observed on both the time- and
event-based laboratory PM tasks might be arise from the
eﬀects of the drug on the processes supported by BA10.
Neuroimaging studies in normal populations have revealed
that the dorsolateral prefrontal cortex including BA10 sup-
ports a broad range of executive functions and in particular
those which involve updating the contents of working memory
(Collette et al., 2005). This raises the possibility that cocaine
use is associated with speciﬁc executive function deﬁcits which
in turn give rise to PM deﬁcits. Few studies of cocaine users
have focused on this particular component executive process.
Deﬁcits among cocaine users have been observed on the paced
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auditory serial addition task (PASAT) (Berry et al., 1993; but
see also Gonzalez et al., 2004). Furthermore, substance-
dependent polydrug users whose drug of choice was cocaine
were found to be impaired on a number letter re-sequencing
task, and on forward and backward digit and spatial span
(Verdejo-Garcı´a and Pe´rez-Garcı´a, 2007). These tasks all
require the contents of working memory to be updated and
the results are therefore consistent with a cocaine-related def-
icit in the updating component process.
At the neurotransmitter level dopaminergic activity in the
prefrontal cortex is known to underpin executive processes.
Equally cocaine is known to inﬂuence behaviour through its
eﬀects on dopamine expression (Heien et al., 2005;
Sidiropoulou et al., 2009; Zhang et al., 2005). Unifying these
separate aspects, Tomasi et al.’s (2007) fMRI results demon-
strated that compared to controls, cocaine users exhibited
hypoactivation in the mesencephalon, where dopamine cell
bodies are located and projections originate, together with a
deactivation in dopamine projection regions (putamen, ante-
rior cingulate, parahippocampal gyrus and amygdala). These
outcomes were associated with a compensatory hyperactiva-
tion in cortical regions involved with executive functions (pre-
frontal and parietal cortices). However, during the
performance of a task loading on working memory resources
the activation of these prefrontal regions was less than that
observed in non-users. Interestingly, those users with urine
samples positive for cocaine were signiﬁcantly less likely to
exhibit these tendencies relative to abstinent users. Thus,
Tomasi et al. (2007) argue that a prior history of cocaine use
disrupts the operation of those dopaminergic systems in the
prefrontal cortex which underpin executive functioning. One
manifestation of this disruption may be the cocaine-related
deﬁcit in PM functioning which could stem from impairment
to the updating executive process due the possible susceptibil-
ity of BA10 to dopamine-mediated deﬁciency.
A further possibility is that cocaine might give rise to
impairment in medial temporal and hippocampal processes.
Fox et al. (2009) observed deﬁcits in various aspects of per-
formance on the Rey Auditory Verbal Learning Task
(RAVLT) among cocaine-dependent individuals receiving
treatment as inpatients. Deﬁcits in learning and recall were
related to between group self-reported stress levels and among
cocaine users with raised early morning cortisol levels. Fox
et al. argue that the stress-related increase in cortisol levels
and associated memory deﬁcits are potentially symptomatic
of hippocampal damage among cocaine-dependent indivi-
duals. Such deﬁcits might potentially aﬀect the recall compo-
nent of PM performance and if present among recreational
cocaine users might therefore provide an explanation for the
results obtained here.
While the laboratory PM measures demonstrated clear
drug-related eﬀects, outcomes in relation to the self-reported
measures were less clear-cut. Although the ecstasy/polydrug
group exhibited impairment this was substantially attenuated
following the inclusion of the other measures as covariates. It
may be that although ecstasy/polydrug users as a whole are
aware of their PM problems they may be uncertain as to
which illicit drug is responsible for their perceived deﬁcits.
As with most studies in this area, there are a number of
limitations. Owing to the quasi-experimental design of the
study the concurrent use of other illicit drugs may have con-
tributed to group diﬀerences in PM as the two groups also
diﬀered signiﬁcantly on these variables. Also, the purity of
MDMA tablets obviously cannot be guaranteed (but see
Parrott, 2004) and as with previous studies in this area
(Heﬀernan et al., 2001a,b; Morgan, 1999) no objective mea-
sure of recent drug use such as urinalysis was employed.
A further limitation of research of this kind is that the appar-
ent ecstasy/polydrug-related deﬁcits may not necessarily be a
consequence of illicit drug use but perhaps reﬂect some
pre-existing diﬀerence between users and non-users which
had its origins before the initiation of drug use. Consistent
with this possibility, in the context of the longer-term conse-
quences of cannabis use Pope (2002) has emphasized the
importance of considering whether or not the apparent diﬀer-
ences between users and non-users might reﬂect pre-morbid
conditions perhaps in sociodemographic factors, personal dis-
positions, or underlying psychopathology. A further possibil-
ity is that the eﬀects observed here may not have a direct
pharmacological basis but instead be related to lifestyle dif-
ferences or may be due to the eﬀects of drugs on aspects of
physiological functioning, for example sleep quality (but see
Fisk and Montgomery 2009; Montgomery et al., 2007).
To conclude, the current study intended to determine the
impact of ecstasy/polydrug use on aspects of real-world
memory such as everyday memory, cognitive failures and
PM. Ecstasy/polydrug associated deﬁcits were observed on
both laboratory and self-reported measures of PM. Ecstasy/
polydrug users were impaired on all PM laboratory measures
with the exception of one event- and one time-based PM task
from the RBMT-II. Ecstasy/polydrug-related deﬁcits were
also observed in some of the self-reported measures of PM
and in the EMQ while no deﬁcits were observed in the
self-reported measures of cognitive failures. We can therefore
assume that ecstasy/polydrug users possess some self-
awareness of their memory lapses. An unanticipated ﬁnding
was that the recreational use of cocaine can be associated with
PM deﬁcits. Further research is needed to clarify whether the
cocaine-related deﬁcits are limited to the ecstasy/polydrug
population or whether they might be present among those
persons whose recreational use is largely conﬁned to cocaine.
Disclosure/Conflict of Interest
The authors declare that, except for income received from
their primary employers, no ﬁnancial support or compensa-
tion has been received from any individual or corporate entity
over the past three years for research or professional service
and there are no personal ﬁnancial holdings that could be
perceived as constituting a potential conﬂict of interest.
This research received no speciﬁc grant from any funding
agency in the public, commercial, or not-for-proﬁt sectors.
References
Bedi G, Redman J (2008) Metamemory in recreational ecstasy
polydrug users: what do self reports of memory failures mean?
J Psychopharmacol 22: 872–881.
Berry J, van Gorp WG, Herzberg DS, et al. (1993) Neuropsycholo-
gical deficits in abstinent cocaine abusers: preliminary findings
after two weeks of abstinence. Drug Alcohol Depend 32: 231–237.
10 Journal of Psychopharmacology 0(00)
Broadbent DE, Cooper PF, FitzGerald P, Parkes KR (1982)
The Cognitive Failure Questionnaire (CFQ) and its correlates.
Br J Clin Psychol 21: 1–16.
Burgess PW, Scott SK, Frith CD (2003) The role of the rostral frontal
cortex (area 10) in prospective memory: a lateral versus medial
dissociation. Neuropsychologia 41: 906–918.
Cole JC, Michailidou K, Jerome L, Sumnall HR (2006) The effects
of stereotype threat on cognitive function in ecstasy users.
J Psychopharmacol 20: 518–525.
Collette F, Van der Linden M, Laureys S, et al. (2005) Exploring the
unity and diversity of the neural substrates of executive function-
ing. Human Brain Mapping 25: 409–423.
Cornish IM (2000) Factor structure of the everyday memory ques-
tionnaire. Br J Psychol 91: 427–438.
Crawford JR, Smith G, Maylor EA, Della-Sala S, Logie RH (2003)
The prospective and retrospective memory questionnaire,
(PRMQ): normative data and latent structure in a large
non-clinical sample. Memory 11: 261–275.
Einstein GO, McDaniel MA, Richardson S, Guynn M, Cunfer A
(1995) Aging and prospective memory: examining the influences
of self-initiated retrieval processes. J Exp Psychol Learn Mem
Cogn 21: 996–1007.
Fisk JE, Montgomery C (2008) Real world memory and executive
processes in cannabis users and nonusers. J Psychopharmacol 22:
727–736.
Fisk JE, Montgomery C (2009) Sleep impairment in ecstasy/polydrug
and cannabis-only users. Am J Addictions 18: 430–437.
Fisk JE, Montgomery C, Wareing M, Murphy P (2005) Reasoning
deficits in ecstasy (MDMA) polydrug users. Psychopharmacology
181: 550–559.
Fisk JE, Warr P (1996) Age and working memory: the role of per-
ceptual speed, the central executive, and the phonological loop.
Psychol Aging 11: 316–323.
Fox HC, Jackson ED, Sinha R (2009) Elevated cortisol and learning
and memory deficits in cocaine dependent individuals: relation-
ship to relapse outcomes. Psychoneuroendocrinology 34:
1198–1207.
Gillberg M, Kecklund G, Akerstedt T (1994) Relations between per-
formance and subjective ratings of sleepiness during a night
awake. Sleep 17: 236–241.
Gilbert SJ, Frith CD, Burgess PW (2005) Involvement of rostral
prefrontal cortex in selection between stimulus-oriented and
stimulus-independent thought. Eur J Neurosci 21: 1423–1431.
Gonzalez R, Rippeth JD, Carey CL, et al. (2004) Neurocognitive
performance of methamphetamine users discordant for history
of marijuana exposure. Drug Alcohol Depend 76: 181–190.
Hannon R, Adams P, Harrington S, Fries-Dias C, Gibson MT (1995)
Effects of Brain injury and age on prospective memory self-rating
and performance. Rehab Psychol 40: 289–297.
Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J (2001a)
Prospective memory, everyday cognitive failure and central exec-
utive function in recreational users of Ecstasy. Human
Psychopharmacol 16: 607–612.
Heffernan TM, Ling J, Scholey AB (2001b) Subjective ratings of
prospective memory deficits in MDMA (‘ecstasy’) users. Human
Psychopharmacol 16: 339–344.
Heien MLAV, Khan AS, Ariansen JL, et al. (2005) Real-time mea-
surement of dopamine fluctuations after cocaine in the brain of
behaving rats. Proc Natl Acad Sci U S A 102: 10023–10028.
Kliegel M, Phillips LH, Lemke U, Kopp UA (2005) Planning and
realisation of complex intentions in patients with Parkinson’s dis-
ease. J Neurol Neurosurg Psychiatry 76: 1501–1505.
Marsh RL, Hicks JL (1998) Event-based prospective memory and
executive control of working memory. J Exp Psychol Learn
Mem Cogn 24: 336–349.
Mathias JL, Mansfield KM (2005) Prospective and declarative
memory problems following moderate and severe traumatic
brain injury. Brain Injury 19: 271–282.
McDaniel MA, Glisky EL, Guynn MJ, Routhieaux BC (1999)
Prospective memory: a neuropsychological study. Neuropsychol-
ogy 13: 103–110.
McHale S, Hunt N (2008) Executive function deficits in short-term
abstinent cannabis users. Human Psychopharmacol Clin Exp 23:
409–415.
Montgomery C, Fisk JE (2007) Everyday memory deficits in
ecstasy-polydrug users. J Psychopharmacol 21: 709–717.
Montgomery C, Fisk JE, Newcombe R (2005a) The nature of
ecstasy-group related deficits in associative learning.
Psychopharmacology 180: 141–149.
Montgomery C, Fisk JE, Newcombe R, Murphy PN (2005b) The
differential effects of ecstasy-polydrug use on executive functions:
shifting, inhibition, updating and access to semantic memory.
Psychopharmacology 182: 262–276.
Montgomery C, Fisk JE, Wareing M, Murphy PN (2007) Self
reported sleep quality and cognitive performance in ecstasy
users. Human Psychopharmacol Clin Exp 22: 537–548.
Morgan MJ (1999) Memory deficits associated with recreational use
of ‘ecstasy’ (MDMA). Psychopharmacology 141: 30–36.
Murphy PN, Wareing M, Fisk JE, Montgomery C (2009) Executive
working memory deficits in ecstasy/MDMA users: a critical
review. Neuropsychobiology 60: 159–175.
Okuda J, Fujii T, Ohtake H, et al. (2007) Differential involvement of
regions of rostral prefrontal cortex (Brodmann area 10) in time-
and event-based prospective memory. Int J Psychophysiol 64:
233–246.
Parrott AC (2004) Is ecstasy MDMA? A review of the proportion of
ecstasy tablets containing MDMA, their dosage levels, and the
changing perceptions of purity. Psychopharmacology 173:
234–241.
Pope HG, Jr (2002) Cannabis, cognition, and residual confounding.
JAMA 287: 1172–1174.
Raven J, Raven JC, Court JH (1998) Manual for Raven’s Progressive
Matrices and Vocabulary Scales. Oxford: Oxford Psychologists
Press.
Rendell PG, Gray TJ, Henry JD, Tolan A (2007) Prospective
memory impairment in ecstasy (MDMA) users. Psychopharmacol-
ogy 194: 497–504.
Rendell PG, Mazur M, Henry JD (2009) Prospective memory impair-
ment in former users of methamphetamine. Psychopharmacology
203: 609–616.
Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott
A (2001) Differential effects of ecstasy and cannabis on
self-reports of memory ability; a web based study. Hum
Psychopharmacol Clin Exp 16: 619–625.
Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrot
AC (2003) Patterns of drug use and the influence of gender on
self-reports of memory ability in ecstasy users: a web-based study.
J Psychopharmacol 17: 389–396.
Royle J, Lincoln NB (2008) The everyday memory questionnaire-
revised: development of a 13-item scale. Disabil Rehab 30:
114–121.
Sidiropoulou K, Lu F-M, Fowler MA, et al. (2009) Dopamine mod-
ulates an mGluR5-mediated depolarization underlying prefrontal
persistent activity. Nature Neurosci 12: 190–199.
Solowij N, Hall W, Lee N (1992) Recreational MDMA use in
Sydney: a profile of ecstasy users and their experiences with the
drug. Br J Addiction 87: 1161–1172.
Sunderland A, Harris JE, Baddeley AD (1983) Do laboratory tests pre-
dict everyday memory? J Verbal Learn Verbal Behav 22: 341–357.
Tabachnick BG, Fidell LS (2001) Using Multivariate Statistics, 4th
edn. Boston, MA: Allyn and Bacon.
Hadjiefthyvoulou et al. 11
Tomasi D, Goldstein RZ, Telang F, et al. (2007) Widespread disrup-
tion in brain activation patterns to a working memory task during
cocaine abstinence. Brain Res 1171: 83–92.
Verdejo-Garcı´a A, Pe´rez-Garcı´a M (2007) Profile of executive deficits
in cocaine and heroin polysubstance users: common and differen-
tial effects on separate executive components. Psychopharmacol-
ogy 190: 517–530.
Wallace JC (2004) Confirmatory factor analysis of the cognitive fail-
ures questionnaire: Evidence for dimensionality and construct
validity. Personality Indiv Differences 37: 307–324.
Will CM, Rendell PG, Ozgis S, Pierson JM, Ong B, Henry JD (2009)
Cognitively impaired older adults exhibit comparable difficulties
on naturalistic and laboratory prospective memory tasks. Appl
Cogn Psychol 23: 804–812.
Wilson BA, Clare L, Baddeley AD, Cockburn J, Watson P, Tate R
(1999) The Rivermead Behavioural Memory Test- Extended
Version (RBMT-E). Bury St Edmunds: Thames Valley Test
Company.
Zakzanis KK, Young DA, Campbell Z (2003) Prospective memory
impairment in abstinent MDMA (‘ecstasy’) users. Cogn
Neuropsych 8: 141–153.
Zhang D, Zhang L, Tang Y, et al. (2005) Repeated cocaine admin-
istration induces gene expression changes through the dopamine
D1 receptors. Neuropsychopharmacology 30: 1443–1454.
12 Journal of Psychopharmacology 0(00)
 328 
 
APPENDIX 14: PEER REVIEWED 
PUBLICATION FOR PROSPECTIVE 
MEMORY (2) 
 
ORIGINAL INVESTIGATION
Prospective memory functioning among ecstasy/polydrug
users: evidence from the Cambridge Prospective
Memory Test (CAMPROMPT)
Florentia Hadjiefthyvoulou & John E. Fisk &
Catharine Montgomery & Nikola Bridges
Received: 7 October 2010 /Accepted: 10 January 2011 /Published online: 8 February 2011
# Springer-Verlag 2011
Abstract
Rationale Prospective memory (PM) deficits in recreational
drug users have been documented in recent years. However,
the assessment of PM has largely been restricted to self-
reported measures that fail to capture the distinction
between event-based and time-based PM. The aim of the
present study is to address this limitation.
Objectives Extending our previous research, we augmented
the range laboratory measures of PM by employing the
CAMPROMPT test battery to investigate the impact of
illicit drug use on prospective remembering in a sample of
cannabis only, ecstasy/polydrug and non-users of illicit
drugs, separating event and time-based PM performance.
We also administered measures of executive function and
retrospective memory in order to establish whether ecstasy/
polydrug deficits in PM were mediated by group differ-
ences in these processes.
Results Ecstasy/polydrug users performed significantly worse
on both event and time-based prospective memory tasks in
comparison to both cannabis only and non-user groups.
Furthermore, it was found that across the whole sample, better
retrospective memory and executive functioning was associ-
ated with superior PM performance. Nevertheless, this
association did not mediate the drug-related effects that were
observed. Consistent with our previous study, recreational use
of cocaine was linked to PM deficits.
Conclusions PM deficits have again been found among
ecstasy/polydrug users, which appear to be unrelated to
group differences in executive function and retrospective
memory. However, the possibility that these are attributable
to cocaine use cannot be excluded.
Keywords Ecstacy . Cocaine . Cannabis . Prospective
memory . CAMPROMPT
Introduction
Prospective memory (PM) involves remembering to exe-
cute a particular behaviour at some future point in time,
which may be in the short or long term, for example
remembering to turn off the lights when leaving a room or
remembering to attend a meeting, meet a friend or pass on a
message. Self-report measures of this construct have been
developed (e.g. Crawford et al. 2003; Hannon et al. 1995),
and in previous research from our laboratory, Fisk and
co-workers have demonstrated apparent impairments on these
measures among ecstasy/polydrug users (Montgomery and
Fisk 2007) and cannabis-only users (Fisk and Montgomery
2008). Other researchers have also reported deficits on self-
report PM measures among users of illicit drugs (Heffernan
et al. 2001a, b; Rodgers et al. 2001, 2003) and studies from
our own laboratory and elsewhere have revealed deficits
among illicit drug users in laboratory measures of PM
(Hadjiefthyvoulou et al. 2010; Rendell et al. 2007a; Rendell
et al. 2009).
Unsurprisingly, given their role in supporting memory
functions in general, evidence suggests that PM is depen-
dent on medial temporal–hippocampal processes. For
example, in a clinical group with medial temporal sclerosis,
Adda et al. (2008) found that PM performance was
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impaired and that among those with left hemisphere lesions
the degree of impairment was correlated with that in
delayed (7 day) verbal recall on the Rey Auditory Verbal
Learning Task (RAVLT). Leitz et al. (2009) found that PM
performance was significantly correlated with episodic
memory recall following acute administration of alcohol.
In another recent study utilising magnetoencephalography,
Martin et al. (2007) found that that the hippocampal region
was activated longer during both retrospective and pro-
spective memory tasks relative to a control condition.
Interestingly, other regions were also differentially impli-
cated, since compared to the retrospective and control tasks,
the PM task was associated with earlier onset of activation
in the posterior parietal lobe. In an animal study by Goto
and Grace (2008), in which rats searched for food rewards
in a radial maze, prospective and retrospective memory
elements of PM were explored. The results suggested that
the retrospective aspect, although requiring hippocampal
input, also recruits PFC resources before the prospective
component can be activated. Furthermore, the dopaminer-
gic system appeared to differentially support this process
with the D1 receptor apparently supporting the former
aspect and the D2 receptor the latter prospective compo-
nent. Since ecstasy impacts both serotonergic and dopami-
nergic processes, this raises the possibility that disruption of
dopaminergic processes might be responsible for the PM
deficits that have been observed in human drug users.
Aside from its reliance on medial temporal structures, PM
is known to utilise prefrontal executive processes including
the working memory system. Neuroimaging studies have
revealed the involvement of the frontopolar cortex (Brodmann
area 10) and neighbouring prefrontal areas during the
performance of PM tasks (Okuda et al. 2007). Other research
utilising dual-task methodology (Marsh and Hicks 1998),
cognitive ageing paradigms (McDaniel et al. 1999) and
Parkinson’s-related deficits (Kliegel et al. 2005) has also
linked PM functioning to prefrontal-lobe capacity.
It is worthy to note that prospective memory functions may
be defined as either event-based or time-based. For example,
some predefined external event may trigger the retrieval of the
intention to act, or alternatively, the trigger may be the elapse
of a given period of time. There is evidence to suggest that the
two classes utilise neural processes that are at least in part
separable. For example, Burgess et al. (2003) and Gilbert et
al. (2005) have shown that event-based tasks utilise the
frontopolar cortex, including Brodmann area 10 (BA10).
Similar findings were reported by Fleming et al. (2008) in
patients with frontally based traumatic brain injury, particu-
larly in relation to event-based PM. More recently, PET
scanning has revealed that while the left superior frontal
gyrus was involved in both types of tasks, different areas
within this structure were found to be activated. Further-
more, in addition to the frontopolar cortex, the time-based
tasks also activated more diverse regions, including anterior
medial frontal regions, the right superior frontal gyrus and
the anterior cingulate (Okuda et al. 2007). Given the clear
dependence of PM on medial temporal/hippocampal pro-
cesses and on the PFC, it is also clearly of relevance that
ecstasy/polydrug-related deficits have been observed on tasks
supported by these structures, including aspects of executive
functioning (see Murphy et al. 2009 for a review). It would
therefore be of value to determine whether or not the drug-
related deficits in medial temporal processes and in PFC
functions are responsible for the ecstasy/polydrug-related
deficits that have been observed in PM.
While a number of researchers have used self-report
measures to investigate PM deficits among illicit drug users
(Heffernan et al. 2001a, b; Montgomery and Fisk 2007;
Rodgers et al. 2001, 2003), to date, relatively few studies in
this area have used laboratory tests of prospective memory.
McHale and Hunt (2008) administered two simple labora-
tory tests: remembering to press a timer 10 min after being
instructed to do so and remembering to post an envelope
back to the experimenter 2 days after the test session.
Cannabis users were found to be impaired on both of these
measures. A popular recent addition to laboratory measures
of PM is the ‘virtual week’ paradigm. This PM test is a
board game completed in the laboratory, in which the
participant is required to execute previously learned tasks at
specified points as they progress around the board at
specific times or in conjunction with specific events. This
measure has featured in a number of studies. For example,
deficits were observed on this measure among currently
abstinent ecstasy users including those who used infre-
quently (Rendell et al. 2007a). Long-term abstinent
methamphetamine users were also found to be impaired
on the measure relative to a drug naive control group
(Rendell et al. 2009). Furthermore, impairments were also
evident in measures of verbal learning and delayed recall
(RAVLT), forward and backward digit span and the
Hayling Sentence Completion Task (believed to load on
the inhibitory executive process). The extent of the
methamphetamine-related effect in PM was found to co-
vary substantially with the degree of impairment on the
Hayling task (Rendell et al. 2009). In other research
utilising the virtual week, Leitz et al. (2009) demonstrated
that performance was impaired following the acute admin-
istration of alcohol. However, in a subsequent study, the
deficit was eliminated when individuals were instructed
simulate the required actions at the time of encoding (by
imaging the full sensory aspects of the context in which the
action was to be completed; Paraskevaides et al. 2010). The
measure has also been used to investigate the basis of PM
deficits in individuals with mild cognitive impairment and
dementia (Thompson et al. 2010), multiple sclerosis (Rendell
et al. 2007b) and schizophrenia (Henry et al. 2007).
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While the virtual week paradigm has its merits, before
the PM element can be completed, it is necessary to learn
each of the ten particular responses that is paired with
specific locations on the board and select the appropriate
response from among the set of available alternatives each
time a PM action is triggered. This is made easier by the
fact that some responses are common to different tasks.
However, the test clearly has an associative learning
component, and Montgomery et al. (2005a) have demon-
strated that ecstasy users are impaired on paired-associative
learning. Thus, it is possible that some of the deficits
evident on the virtual week might be attributable to this
aspect rather than the PM components. That said, it is
worthy of note that just over half of the virtual week, PM
sub-tasks are regular and more repetitive in nature, and
thus, more readily learned. It is the remaining more
irregular tasks that have a more substantial learning
requirement. Interestingly, ecstasy users performed worse
on these irregular virtual week tasks, recording 65% of the
level of correct responses achieved by non-users, while for
regular tasks, the percentage was 83% (computed from
Table 2; Rendell et al. 2007a). This suggests that
performance is indeed adversely affected by the learning
component. Nonetheless, it must be acknowledged that
there was no statistically significant interaction between
user group and task type with users demonstrating a
significant deficit overall. Thus, while group differences
in learning may partially account for the virtual week
results, the outcomes obtained are nonetheless consistent
with an ecstasy-related PM deficit.
In our previous study (Hadjiefthyvoulou et al. 2010), in
order to minimise the learning requirement, we used a small
number of more simple PM tasks, for each of which only a
single stimulus–response paring needed to be learned. We
also used the Rivermead Behavioural Memory Test (RBMT;
Wilson et al. 1999) battery, which includes three separate
PM tasks. In our study, only one of the three RBMT PM
measures produced statistically significant ecstasy/polydrug-
related deficits. However, the RBMT has been criticised as
lacking the sensitivity to detect memory problems in non-
clinical populations (Spooner and Pachana 2006). Thus, it
may be that the test was not appropriate for the university-
based sample of recreational drug users, which was featured
in our previous study. A more up-to-date test battery that is
sensitive to individual differences, both within clinical and
normal populations, is the Cambridge Prospective Memory
Test (CAMPROMPT; Fleming et al. 2008; Groot et al. 2002;
Wilson et al. 2005). The purpose of the present study is to
confirm and extend our previous findings utilising the more
sensitive CAMPROMPT measure. At the same time, we will
take measures of executive functioning and retrospective
memory in order to establish the extent to which any
ecstasy/polydrug deficits in PM that are uncovered are
mediated by deficits in those memory and executive
functions that are known to underpin PM processes. This
aspect was not addressed in our previous study. A further
innovation in the present study is the inclusion of a
cannabis-only control group (i.e. individuals whose illicit
drug use is restricted to cannabis). Using self-report
measures, we (Fisk and Montgomery 2008) have previ-
ously documented PM deficits among cannabis-only users
(relative to non-users of illicit drugs). However, we have
not previously assessed a cannabis-only user group on
laboratory measures of PM and not in relation to ecstasy/
polydrug users. It is expected that both illicit drug-using
groups will perform worse than non-users of illicit drugs
on the CAMPROMPT measures. No prediction is made in
relation to PM differences between the two illicit drug-
using groups.
Method
Design and analytical strategy
A between-participants design was employed with drug-
using group with three levels (ecstasy/polydrug, cannabis-
only and non-users of illicit drugs) as the independent
variable. The dependent variables were the CAMPROMPT
time and event-based PM scores. Background variables and
the executive and recall measures were also assessed for
group differences.
Pearson’s correlation coefficients were calculated between
the PM measures and the executive and recall measures,
respectively. Regression analyses were conducted with the
PM measures as dependent variables. In each regression,
those variables that were significantly correlated with the PM
measures and any background measures, yielding statistically
significant drug-related differences, were included as predic-
tors. Since the drug use IV had nominal level of measurement,
it was not possible to include it directly in the regression.
Following the procedure outlined by Tabachnick and Fidell
(2007), group differences were incorporated into the regres-
sion by constructing two dichotomous variables. In the first,
ecstasy/polydrug users were coded as ‘1’ and all other
persons coded as ‘0’; in the second, cannabis-only users
were coded as ‘1’ with all other persons coded as ‘0’. In this
way, it was possible to establish whether each group
accounted for statistically significant unique variance while
controlling for the effects of the other predictors.
Participants
Twenty-nine ecstasy/polydrug users (12 females), 12
cannabis-only users (7 females) and 18 non-users of illicit
drugs (16 females) took part in this investigation (for
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demographic details, see Table 1). The gender composition
differed significantly between the groups with females
predominating among the non-illicit user group and males
among the ecstasy/polydrug users, χ2 (N=59, DF=2) =
10.40, p<0.01. Participants were recruited via direct
approach to university students and the snowball technique,
i.e. word-of-mouth referral (Solowij et al. 1992). All
participants were university students attending the Univer-
sity of Central Lancashire (UCLAN) or Liverpool John
Moores University (LJMU).
Materials
A background drug-use questionnaire that has been
previously employed by us (Montgomery et al. 2005b)
assessed the history of illicit drug use and estimated the
total lifetime use, frequency of use, recent consumption, as
well as the period of abstinence for each drug (e.g. ecstasy,
cannabis, amphetamines, cocaine etc.). Fluid intelligence
was measured via Raven’s Progressive Matrices (Raven et
al. 1998), and a further questionnaire assessed the partic-
ipant’s age and gender, the number of years of education
and their current use of alcohol and cigarettes.
Prospective and retrospective memory questionnaire
(PRMQ; Crawford et al. 2003). The PRMQ provides a self-
report measure of prospective and retrospective memory slips
in everyday life. It consists of 16 items, 8 referring to
prospective memory failures, e.g. ‘Do you decide to do
something in a few minutes time and then forget to do it?’
and 8 concerning retrospective failures, e.g. “Do you fail to
recognize a place you have visited before?”. Participants were
asked to specify “how often these things happened to them
on a 5-point scale” very often, quite often, sometimes, rarely,
never. Ratings were subsequently assigned numerical values
of 5 (very often) to 1 (never). A total score for each subscale
(prospective memory and retrospective memory) was also
calculated with minimum score of 8 and maximum score of
40, with higher scores indicative of more memory problems.
Rey Auditory Verbal Learning Test (RAVLT; based on
Rey 1964). The RAVLT is a test developed to evaluate
verbal learning and memory. A list (list A) of 15 words was
presented to the participant orally, with the aid of an audio
recording device, for five consecutive times. At the end of
each trial, the participant was asked to recall as many words
as possible from the list. After the fifth trial, an interference
list (list B), also consisting of 15 words, was read to the
participant, after which she/he was asked to recall as many
words as possible from the interference list. Immediately
following this, the participant was again asked to recall the
words from list A without hearing it again (trial 6). Next,
after a 20-min interval, the participant was asked to
remember the words from list A (trial 7), after which a
recognition test was administered. For the recognition test,
a list consisting of the 15 words from list A and 15
distracter words was read to the participant, and the
individual was asked to indicate whether the word belonged
to list A or not. A number of outcome measures were
produced; first, the total number of words correctly recalled
over trials one to five; second, a measure of proactive
interference (number correct on trial 1 minus number
correct on the interference list); third, retroactive interfer-
ence (number correct on trial 5 minus number correct on
trial 6); and fourth, a measure of decay (number correct on
trial 5 minus number correct on trial 7).
Memory compensation questionnaire (MCQ; Dixon et al.
2001). The MCQ is a 44-item self-report measure assessing
the variety and number strategies the participant uses to
compensate for deficient memory performance. The MCQ is
comprised of seven subscales: external (e.g. “Do you use
shopping lists when you go shopping?”); internal (e.g. “Do
you take your time to go through and reconstruct an event
you want to remember?”); time (e.g. “Do you ask people to
speak slowly when you want to remember what they are
saying?”); reliance (e.g. “When you want to remember an
important appointment, do you ask somebody else (for
example, spouse or friend) to remind you?”); effort (e.g.
“Do you put in a lot of effort when you want to remember an
important conversation with a person?”); success (e.g. “When
you want to remember a newspaper article, is it important to
you to remember it perfectly?”); and change (e.g. “Do you
use such aids for memory as notebooks or putting things in
certain places more or less often today compared to 5–10 year
ago?”). Responses for each item are presented on a five-point
scale, with higher scores representing more frequent use of
the specified compensatory behaviour (1=never, 5=always)
with some items being reversely scored.
Behavior Rating Inventory of Executive Function-Adult
Version (BRIEF-A) (Roth et al. 2005). The BRIEF-A is a
75-item measure of executive function. For each item, the
participant responds on a three-point scale: never, some-
times and often. The measure provides indicators of nine
aspects of executive functions. These map onto two higher
level indices the Behavioral Regulation Index (BRI) and the
Metacognitive Index (MI). The BRI refers to the ability of
the individual to maintain appropriate regulatory control of
their own behaviour and emotional responses and is
comprised of four subscales: inhibit (e.g. “I tap my fingers
or bounce my legs”); shift (e.g. “I have trouble changing
from one activity to another”); emotional control (e.g. “I
have angry outbursts”); and self-monitor (e.g. “I don’t
notice when I cause others to feel bad or get mad until it is
too late”). The MI refers to the individual’s ability to
systematically solve problems through effective planning and
organization. It relates directly to the ability to engage in
active problem solving across a variety of contexts and is
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comprised of five subscales: initiate (e.g. “I need to be
reminded to begin a task even when I am willing”);working
memory (“I have trouble concentrating on tasks (such as
chores, reading or work)”); plan/organize (e.g. “I get over-
whelmed by large tasks”); task monitor (e.g. “I make careless
errors when completing tasks”); and organization of materials
(e.g. “I am disorganized”). For both the BRI and the MI,
higher scores are indicative of more executive dysfunction.
The Cambridge Prospective Memory Test (CAM-
PROMPT) (Wilson et al. 2005). The CAMPROMPT is a
laboratory measure of prospective memory that consists of
a total of six prospective memory tasks, three cued by time
and three cued by events. Participants were asked to work
on some distractor tasks such as word-finder puzzles or a
general knowledge quiz for a 20-min period while they had
to remember to perform the prospective memory tasks. The
participants were allowed to spontaneously use strategies,
such as taking notes, to help them remember. Two of the
three time-based tasks were cued by a countdown kitchen
timer, and the participant had to remind the experimenter
not to forget his/her mug or keys when there were 7 min
left to the end of the session. In the second task, when the
timer showed 16 min, the examiner asked the participant to
remember that “in 7 minutes time”, he/she had to stop
whichever task they were on and change to another. The
third time-based task was cued by a clock. The participant
was asked at a specific time (e.g. 10 past 11; 5 min after the
20-min session) to remind the examiner to ring the
reception/garage. For the event-based tasks, the participant
was asked: (1) to return a book to the examiner when he/
she came to a question about the television program
‘EastEnders’ during the general knowledge quiz; (2) to
return an envelope with “MESSAGE” written on it when
he/she was reminded that there were 5 min left in the test;
and finally, (3) when the examiner informed him/her that
the session was over, to remind the examiner to pick up five
objects that had been hidden at the beginning of the session.
Six points were awarded for each subtask that was
successfully completed, unaided. If the task was completed
after a single general prompt from the experimenter, then
four points were awarded. Alternatively, participants
were awarded two points if a second more specific
prompt was required, one point if after prompting, the
required action was completed on the second attempt and
no point if the participant failed to complete the required
action after prompting. Total scores were then generated
on time-based and event-based subscales, each scoring a
maximum of 18, with higher scores reflecting better
prospective memory performance. The validity and
reliability of the CAMPROMPT has been documented
in a number of studies (i.e. Fleming et al. 2008; Groot et
al. 2002; Wilson et al. 2005).
Procedure
Participants were informed of the purpose of the investigation
and their right to withdraw at any time. After consent had been
obtained, the tests were administered under laboratory
conditions. The drug-use questionnaire (Montgomery et al.
2005b) was administered first followed by the Raven’s
progressive matrices (Raven et al. 1998), the age/education
questionnaire, the PRMQ (Crawford et al. 2003), the MCQ
(Dixon et al. 2001) and the BRIEF-A (Roth et al. 2005)
questionnaires. Finally, the RAVLT and the CAMPROMPT
(Wilson et al. 2005) tests were administered. Participants
were fully debriefed, paid £20 in Tesco store vouchers and
given drug education leaflets. The University of Central
Lancashire’s Ethics Committee approved the study. Data for
the BRIEF-A obtained in the present study have been
included with similar data that were collected previously by
us from another group of participants and are the subject of a
separate publication (Hadjiefthyvoulou et al. 2010). Partic-
ipants also performed a range of other tasks that are beyond
the scope of the present investigation.
Results
As is apparent from inspection of Table 1, with the
exception of tobacco smoking, the groups did not differ
Table 1 Age, intelligence, years of education, cigarette and alcohol use by group
Ecstasy/polydrug users Cannabis-only users Nonusers pa
Mean SD Number Mean SD Number Mean SD Number
Age (years) 21.17 1.79 29 21.92 1.56 12 20.44 2.28 18 ns
Raven’s progressive matrices (maximum 60) 39.21 8.39 29 40.25 7.35 12 40.72 8.90 18 ns
Years of education 15.27 2.44 26 14.92 4.06 12 16.00 2.00 18 ns
Cigarettes per day 7.42 4.48 12 9.00 3.58 6 15.00 − 1 ..017
Alcohol (units per week) 13.41 12.08 27 15.18 12.95 11 9.47 14.70 15 ns
a For one-way ANOVA, except cigarettes where chi-squared test was used
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significantly on any of the background variables. The
proportion of smokers differed significantly between the
groups, χ2 (N=53, df=2)=8.09, p=0.017; however, the
expected frequency in one of the cells, 3.94, was below the
critical value of 5, thus, although there are clear differences
between the groups with 40–50% of illicit drug users
regularly smoking and only one nonuser, the statistical
significance of this outcome cannot be confirmed by chi-
square. The daily consumption of cigarettes did not differ
significantly between ecstasy/polydrug and cannabis-only
users, t (16) = 0.75, p>0.05. Indicators of illicit drug use
may be found in Table 2. It is clear that the ecstasy/
polydrug group used a range of other illicit substances in
addition to ecstasy, including cannabis, cocaine and
ketamine. Furthermore, for all of the measures of drug
use, the median was substantially less than the mean;
indeed, in all cases, the measures exhibited a positive
skew, with a small minority of users demonstrating
relatively high levels of use, while the majority were
clustered around the median. Members of both illicit
drug-using groups had also used poppers (amyl nitrate)
during the preceding 3 months (as had one individual
among the non-illicit drug users). It is worthy of note
that the various indicators of cannabis use did not differ
significantly between the two illicit drug-using groups.
Data screening revealed that there were no univariate
outliers on the PM scores. However, the distribution of the
event-based PM measure deviated significantly from normal
exhibiting a negative skew. Following the data transformation
procedure recommended by Tabachnick and Fidell (2007),
the event-based scores were reflected and the square root
was taken. This means that trends in the transformed variable
are reversed so that higher scores are indicative of worse
performance. Subsequent tests revealed that the distribution
of the transformed variable did not deviate significantly from
normal. Table 3 contains both the untransformed and the
transformed event-based PM measure. However, the analy-
ses reported below relate to the latter.
Inspection of Table 3 reveals that compared to the other
two groups, non-illicit drug users displayed better PM
performance on both the time and event-based measures.
The ecstasy/polydrug users’ scores were the worst, while
cannabis-only users’ scores were between those of the other
two groups. These trends were associated with statistically
significant overall group differences. Subsequent post-hoc
tests revealed that with respect to the event-based PM
Table 2 Indicators of illicit drug use
Ecstasy/polydrug users Cannabis-only users p1
Median Mean SD Number Median Mean SD Number
Total use
Ecstasy (tablets) 194 640.86 1284.99 29 − − − − −
Cannabis (joints) 728 3048.84 5297.53 25 1,118 2242.58 3307.71 12 ns
Cocaine (lines) 416 1037.89 1282.60 19 − − − −
Amount consumed in previous 30 days
Ecstasy (tablets) 0 3.14 8.28 29 − − − − −
Cannabis (joints) 1 26.08 45.80 25 0.50 22.25 33.05 12 ns
Cocaine (lines) 2 8.16 12.74 19 − − − − −
Frequency of use (times per week)
Ecstasy 0.04 0.24 0.43 29 − − − − −
Cannabis 0.25 1.87 2.52 25 0.15 1.86 2.71 12 ns
Cocaine 0.06 0.28 0.36 19 − − − − −
Weeks since last use:
Ecstasy 12 47.00 76.32 29 − − − − −
Cannabis 4 20.34 37.13 25 7.50 73.32 113.69 12 ns
Cocaine 6 15.40 24.36 22 − − − − −
Use of other drugs during the previous 3 months Percent Percent
Amphetamine 3 0
Ketamine 31 8
LSD 3 0
Magic mushrooms 3 0
Poppers 45 17
a For Mann–Whitney U test
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measure, ecstasy/polydrug users performed significantly
worse than the other two groups, which in turn, did not
differ significantly from each other. The only statistically
significant pairwise difference on the time-based PM
measure was with respect to the ecstasy/polydrug group,
which performed significantly worse than the non-illicit
drug users group.
With regard to the BRIEF-A, the MCQ and the RAVLT
measures, two univariate outliers were identified, one on
the decay score of the RAVLT and the other on the change
score of the MCQ. These were replaced by the next highest/
lowest score on the particular measure, plus/minus one
(Tabachnick and Fidell 2007). On the basis of Mahalanobis
distance, no multivariate outliers were detected. Examina-
tion of Table 3 reveals that there were statistically
significant group differences on only two of the non-PM
measures. First, the groups differed significantly on
Crawford et al. (2003) self-report retrospective memory
measure, with ecstasy/polydrug users scoring significantly
worse than non-illicit drug users (neither of the other
pairwise comparisons were statistically significant). Sec-
ond, non-illicit drug users made significantly more use of
external memory aids compared to ecstasy/polydrug users.
The difference between the nonusers and cannabis-only
users on the same measure approached significance.
For the sample as a whole, correlations between the PM
and the other measures are set out in Table 4. The event-
based PM measure was significantly correlated with the
time-based measure (as might be expected). It was also
significantly correlated with two of the retrospective
memory measures: the Crawford et al. (2003) self-report
measure and the recall score on the RAVLT over trials 1–5.
Unsurprisingly, better retrospective memory performance
was associated with better PM performance (High scores on
the Crawford et al. measure are indicative of retrospective
memory problems, while the reverse is true of the time-
based and untransformed event-based PM measures. Hence,
the correlation with the Crawford et al. measure is negative
in the former case and positive in relation to the trans-
formed event-based PM measure.) The correlation between
the ‘Reliance’ subscale on the MCQ and the event-based
PM measure approached statistical significance: as reliance
on others as an aid to memory increased, so PM
performance decreased. Interestingly, the event-based PM
measure was not significantly correlated with either of the
BRIEF-A composite scales. The time-based PM measure,
like the event-based, was significantly correlated with the
Crawford et al. (2003) self-report retrospective memory
measure, and with the recall score on the RAVLT over trials
1–5, the correlation approached significance; in both cases,
better retrospective memory was associated with better
time-based PM performance. The correlation between the
time-based PM measure and the BRIEF-A metacognitive
index also approached statistical significance. Higher
executive functioning was associated with better time-
based PM performance.
In order to evaluate the unique contributions of each of
the predictors to PM performance, two regressions were run
with respectively the transformed event-based PM measure
and the time-based PM measure as dependent variables.
Variables were included as predictors if they were signif-
icantly correlated (in bivariate terms) with the dependent
variable or if they were associated with significant group
differences on the dependent measure. In instances where
the univariate or bivariate outcomes approached statistical
significance, the variables in question were also included as
predictors. The results for the regression analyses are set
out in the penultimate two columns of Table 4. None of the
individual predictors for time-based PM were statistically
significant; however, the overall model accounted for
statistically significant variance (r2=0.285, p<0.05). The
likely implication of this is that there was a degree of
overlapping variance with pairs or larger combinations of
predictors sharing pooled variance with the dependent
variable, making it impossible to allocate statistically
significant unique variance to any one predictor. More
specifically, it is possible that the statistically significant
drug-related PM effects apparent in the ANOVA are in part
mediated by drug-related differences on the other predic-
tors, in particular, aspects of retrospective memory.
Switching the focus to event-based PM, the regression
model accounted for statistically significant variance, (r2=
0.378, p<0.01). Of the individual predictors, the recall
score on the RAVLT over trials 1–5 approached statistical
significance; unsurprisingly, better recall was associated
with better PM performance. Of the other predictors,
ecstasy/polydrug users (relative to other participants)
accounted for statistically significant unique variance
(reflecting the ecstasy/polydrug-related PM deficit). Thus,
it appears that the ecstasy/polydrug effect on event-based
PM cannot be entirely attributed to drug-related differences
in retrospective memory and executive functioning. Sur-
prisingly, the dichotomous gender variable was also
statistically significant as a predictor. Given the manner in
which the variable was coded and the sign of the beta
weight, this would suggest that females were performing
worse than males on the event-based PM task. Paradoxi-
cally, a subsequent t test revealed no statistically significant
gender difference on the event-based PM task, t (57) =
0.13, p>0.05. However, further examination of the gender
differences within the drug-using groups showed that the
gender deficit was only apparent among ecstasy/polydrug
users. Among other participants, females were actually
performing better. This raised the possibility of an
interaction between gender and ecstasy/polydrug use in
determining event-based PM scores. In order to test this
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possibility, the regression was repeated, this time, in
addition to the ecstasy/polydrug and gender variables, their
product was included as an independent variable in order to
establish whether or not there was a statistically significant
interaction. The results are set out in the final column of
Table 4, inspection of which reveals that in this expanded
model, only the interaction between gender and ecstasy/
polydrug use accounts for statistically significant unique
variance. Given the manner in which the dichotomous
variables were coded, the positive beta coefficient indicates
that female ecstasy/polydrug users were especially impaired
on the event-based CAMPROMPT task. By way of clarifica-
tion subsequent analyses revealed that the mean scores for
female ecstasy/polydrug users was 65% higher than that for
female non-ecstasy users, while the equivalent difference for
males was just 16% (as noted above higher scores are
indicative of poorer event-based PM performance).
The incidence of polydrug use among the ecstasy users
makes it difficult to unambiguously attribute the impair-
ments evident in PM to specific illicit drugs. In an attempt
to address this issue, Table 5 contains the simple and partial
correlation coefficients between aspects of drug use on the
one hand and the two PM measures on the other. Where an
individual does not use a specific drug, their usage has
been coded as zero. Inspection of the Table reveals that
only one aspect of drug use is correlated with time-based
PM, i.e. the current frequency of cannabis use. In view of
this outcome, no partial correlations were calculated for
time-based PM. By way of contrast, virtually all aspects of
drug use were correlated with event-based PM. However,
when controls for the use of other illicit drugs were entered,
aspects of ecstasy use were no longer significantly
correlated with event-based PM; rather, it was aspects of
cannabis and cocaine use which yielded statistically
significant correlations.
The illicit drug users among our sample were requested
to refrain from cannabis use for 24 h prior to testing and
from cocaine, ecstasy and other drug use for 7 days prior to
testing. In order to address the possibility that the PM
differences that we observed were due to post-intoxication
effects, we excluded all individuals who indicated that they
had consumed ecstasy, cocaine or cannabis during the
10 days prior to testing. This reduced the size of the
cannabis-only group, thereby reducing statistical power
such that three-way group comparisons were not meaning-
ful. For this reason, the non-illicit drug users and cannabis-
only users were merged to form a single group (drug naive/
cannabis only n=25; ecstasy/polydrug n=14). For the
event-based PM task, the corresponding means (standard
deviations) for the ecstasy/polydrug and combined drug
naive/cannabis-only users were respectively 2.20 (0.73) and
1.69 (0.47) which differed significantly, F(1,37) = 7.10, p<
0.05. For the time-based PM task, the equivalent figures
were respectively 10.92 (3.65) and 14.40 (4.65) which
again differed significantly, F(1,37) = 5.78, p<0.05. Thus,
the ecstasy/polydrug-related PM deficits remained statisti-
cally significant following removal of those persons who
indicated that they had used illicit drugs during the previous
10 days.
Discussion
On the event-based PM measure, ecstasy/polydrug users
were impaired relative to both cannabis-only and nonusers
of illicit drugs. This group was also impaired relative to
nonusers on the time-based measure. While a trend was
evident on both measures with ecstasy/polydrug users
performing worse, cannabis-only users achieving interme-
diate levels of performance and non-illicit drug users
Event-based PMa Time-based PM
Simple correlation Partial correlationb Simple correlation
Cannabis
Total lifetime use 0.246* 0.208 −0.154
Consumed in last 30 days 0.259* 0.230* −0.158
Frequency 0.338** 0.390** −0.286*
Cocaine
Total lifetime use 0.339** 0.328** −0.139
Consumed in last 30 days 0.257* 0.261* −0.126
Frequency 0.403** 0.416*** −0.133
Ecstasy
Total lifetime use 0.261* −0.002 −0.160
Consumed in last 30 days 0.210 −0.036 −0.058
Frequency 0.268* −0.028 −0.065
Table 5 The relationship be-
tween time and event-based PM
and indicators of illicit drug use
***p<0.001; **p<0.01; *p<
0.05; one-tailed
a Correlation for the transformed
variable
b Controlling for the use of other
drugs on the measure in question,
e.g. the correlation between total
use of cannabis and PM control-
ling for the total use of cocaine
and total use of ecstasy
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performing best, cannabis-only users did not differ signif-
icantly from nonusers of illicit drugs on either PM measure.
The ecstasy/polydrug-related deficit observed here in
relation to non-illicit drug users is consistent with previous
findings from our own and other laboratories using self-
report (Hadjiefthyvoulou et al. 2010; Heffernan et al.
2001a, b; Montgomery and Fisk 2007; Rodgers et al.
2001, 2003) and laboratory measures (Hadjiefthyvoulou et
al. 2010; Rendell et al. 2007a). They also demonstrate the
utility of the CAMPROMPT measure in detecting individ-
ual differences in PM performance among non-clinical
populations augmenting the existing literature in this regard
(Groot et al. 2002; Wilson et al. 2005).
For the most part, ecstasy/polydrug deficits were not
evident on the other measures that were administered. Deficits
were only evident on the retrospective memory questionnaire
and nonusers of illicit drugs were significantly more likely to
report using external memory aids in everyday contexts.
Cannabis-only users did not differ significantly from either of
the other two groups on any of the non-PM measures.
For the sample as a whole, individual differences on
both PM measures were significantly correlated with
outcomes on the retrospective memory questionnaire and
with the RAVLT recall scores for the first five trials. In both
cases, better retrospective memory was associated with
better PM performance. Scores on the BRIEF-A metacog-
nitive index were also related to performance on the time-
based PM task with better executive functioning associated
with improved PM performance; however, this trend only
approached statistical significance two-tailed (although
given the directional nature of the anticipated effect, the
outcome is statistically significant on a one-tailed basis).
These findings are consistent with the outcomes reported
above linking PM performance with medial temporal
functioning (Adda et al. 2008; Martin et al. 2007) and with
PFC processes (e.g. Okuda et al. 2007).
In order to establish the extent to which drug-related
deficits on the PM tasks were mediated by deficits in
retrospective memory and executive functions, regressions
were run with each of the PM variables as the criterion. For
the time-based PM task, the dummy variable representing
the effects of ecstasy/polydrug use was not statistically
significant as a predictor. Indeed, although the model as
a whole accounted for statistically significant variance,
none of the individual predictors were statistically
significant. This suggests that any effects associated with
ecstasy/polydrug use covary with individual differences
in the other predictors and with the criterion leaving
open the question of whether drug use per se adversely
affects time-based PM.
The regression analysis for event-based PM yielded
different results with only ecstasy/polydrug use and gender,
accounting for statistically significant unique variance. A
further regression revealed that the two predictors, in fact,
significantly interacted, such that the ecstasy/polydrug-
related deficit was most pronounced amongst female users.
Indeed, neither of the main effects was statistically significant
in the amended model. Of the other predictors in the model,
the RAVLT recall scores for the first five trials approached
statistical significance. It is noteworthy that the sum of the
squared semi-partial correlation coefficients (0.139) is far less
than the overall R-squared value (0.431), indicating that most
of the explained variance in the criterion reflects the over-
lapping effects of two or more predictors.
The emergence of gender-specific illicit drug-related
effects is not without precedent. For example, women who
were heavy users of cannabis were impaired relative to
female light users on visuo-spatial memory, while no such
deficit emerged among male cannabis users (Pope et al.
1997). Gender was also found to moderate the extent of
ecstasy-related deficits in design fluency (with female users
exhibiting a deficit, while male users actually performed
better than controls), although it was not a moderating
factor on deficits observed in verbal learning (Medina et al.
2005). Reneman et al. (2001) found that female ecstasy
users exhibited a larger reduction in serotonin transporter
densities relative to males. However, in a subsequent study
in which ecstasy users were found to be impaired in various
aspects of memory performance, female users were not
significantly more affected than male users (Reneman et al.
2006). It is also worthy of note that the gender–drug use
interaction only emerged on event-based PM tasks and not
on the time-based PM measure. Thus, the apparent gender
difference observed in the present study should be treated
with a degree of caution.
While deficits in aspects of PM are clearly evident
among ecstasy/polydrug users, what is less clear is which
illicit drug or drugs may be responsible for these deficits. It
is striking that when the use of other drugs is controlled
through partial correlation, no aspect of ecstasy use is
statistically significant as a predictor of PM performance. It
is also worthy of note that while cannabis-only users were
not significantly impaired relative to non-illicit drug users,
they did performance worse on both PM measures
compared with controls, and cannabis use among the whole
sample was significantly correlated with event-based PM
even following statistical controls for the effects of other
illicit drugs. Higher levels of consumption during the
previous 30 days and increasing frequency of use were
associated with poorer event-based PM performance. Thus,
the present results suggest that cannabis use does adversely
affect PM performance, although the effect may be accentu-
ated among polydrug users. The present results augment those
of other studies in which cannabis-related PM deficits have
been observed, (e.g. Fisk and Montgomery 2008; McHale
and Hunt 2008; Rodgers et al. 2003).
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A striking feature of the present results was that cocaine
use was significantly correlated with event-based PM
performance even following statistical controls for the use
of other illicit drugs. Increasing lifetime dose, greater
consumption during the previous 30 days and an increased
frequency of use are all associated with poorer event-based
PM performance. This replicates the results of our previous
study (Hadjiefthyvoulou et al. 2010), this time, with a
different sample and with an alternative laboratory-based
PM measure. As far as we are aware, the present study and
our previous one are the first to link the recreational use of
cocaine with prospective memory deficits. The mechanisms
through which cocaine might adversely affect PM functions
remain unclear. On the basis of the results from their fMRI
study, Tomasi et al. (2007) argue that a prior history of
cocaine use disrupts the operation of those dopaminergic
systems in the prefrontal cortex, which underpin executive
functioning. Given the key role of executive functions in
supporting PM processes, this might account for the adverse
association between cocaine use and PM functioning.
It is also noteworthy that PM deficits have been observed in
Parkinson’s patients (Kliegel et al. 2005), and since the disease
is characterised by disruption of dopaminergic functioning in
the corticostriatal pathway, this is consistent with a direct role
for dopamine in supporting PM functions. Evidence, consis-
tent with this proposition, emerged in a recent study by Costa
et al. (2008), in which administration of L-dopa significantly
improved PM performance in a sample of Parkinson’s
patients relative to an unmedicated condition. As noted
above, animal studies have also suggested a direct role for
mesocortical dopaminergic systems in supporting prospective
memory processes (Goto and Grace 2008). Since it is known
that both cocaine and ecstasy potentially disrupt the func-
tioning of dopaminergic systems, it is possible that the basis
of the prospective memory deficits observed in the present
study reside in impaired dopaminergic processes in the
corticostriatal pathway.
A further possibility is that cocaine might give rise to
impairment in medial temporal and hippocampal processes.
In a recent study, Fox et al. (2009) found that performance
on various aspects of the RAVLT was impaired among an
inpatient cocaine-dependent group. Relative to controls,
deficits were related to self-report stress levels and within
the cocaine-dependent group with raised early morning
cortisol levels. Fox et al. attribute the stress-related increase
in cortisol levels and the associated memory deficits to
hippocampal damage stemming from cocaine use. If this
were the case, in the present context, the recall component
of PM performance might be compromised among recrea-
tional cocaine users, thereby accounting for the results
obtained here.
A number of limitations can be identified for this study.
First, as with many studies in this area, no objective
measure of recent drug use, such as urinalysis or hair
analysis, was used. Thus, the period of abstinence cannot
be objectively verified. Also, the purity of the ecstasy
tablets or any other consumed drug cannot be guaranteed,
making it still more difficult to attribute the effects
observed here to specific psychoactive drugs. Another
important factor that should not be overlooked is that the
apparent ecstasy/polydrug-related deficits may not neces-
sarily be a consequence of illicit drug use but instead be
due to pre-existing differences between users and nonusers
originating before the onset of illicit drug use. In addition,
the possibility that current lifestyle differences or the effects
of illicit drug use on other physiological processes (e.g.
impaired sleep quality) might be the actual cause of the
deficits observed in the current study cannot be entirely
excluded. A methodological issue that needs to be
considered is the relatively small sample size in the present
study, which means that the results of the regression
analyses need to be treated with caution. Indeed, before
definitive statements can be made regarding the relative
importance of individual predictors, the regression analysis
would need to be replicated with a substantially larger
sample. Nonetheless, the present results are potentially
informative as a guide for which variables might be
incorporated into future research, utilising larger samples.
Other methodological aspects of the present study might
warrant a different approach in future research. For
example, we used a self-report measure of executive
functioning rather than laboratory-based measures. It might
have been desirable to incorporate laboratory-based tests of
executive functioning; however, recent conceptualisations
of executive functioning have emphasised the non-unitary
nature of these processes, identifying four or more
separable processes: updating, inhibition, switching and
access to semantic memory (Fisk and Sharp 2004; Miyake
et al. 2000) each with a number of specific measures.
Furthermore, ecstasy/polydrug users appear to be differen-
tially affected on each of these (Montgomery et al. 2005b).
Thus, the inclusion of such a comprehensive test battery
would have substantially expanded the length of the test
session and was not possible given the resource constraints
of the present study. Nonetheless, future research might
incorporate such measures, perhaps utilising latent variable
analysis, in order to evaluate the potential role of the
various executive component processes with respect to a
range of different PM measures.
To conclude, the present study intended to determine the
impact of ecstasy/polydrug use and cannabis use on event-
based and time-based prospective memory using the
CAMPROMPT. Measures of executive functioning and
retrospective memory were also administered in order to
study the extent to which executive processes account for
the prospective memory deficits in recreational drug users.
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Relative to both drug-naive persons and cannabis-only
users, ecstasy/polydrug users performed significantly worse
on both event-based and time-based prospective memory
tasks, while no significant differences in performance were
observed between the cannabis user and nonuser groups.
However, consistent with the results of our previous study,
recreational use of cocaine was significantly correlated with
event-based prospective memory performance, demonstrat-
ing the need for a systematic investigation of the potential
role of cocaine in accounting for the PM deficits that have
been observed here and in other studies.
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